Sentence,class,file
"http://dx.doi.org/10.1038/sj.emboj.7600873 Yang, J.S., C. Valente, R.S.",OADS,/arxiv_data1/oa_pdf/20/61/JGP_201311102.PMC3874574.pdf
"http://dx.doi.org/10.1038/ncb2273 Yoshimura, R.F., D.J.",OADS,/arxiv_data1/oa_pdf/20/61/JGP_201311102.PMC3874574.pdf
http://dx.doi.org/10.1124/jpet.107.128751,Non-OADS,/arxiv_data1/oa_pdf/20/61/JGP_201311102.PMC3874574.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"80:041901. http://dx.doi.org/ 10.1103/PhysRevE.80.041901 Codling, E.A., M.J. Plank, and S. Benhamou.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/ 10.1098/rsif.2008.0014 Corbin, J.D., P.H.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi .org/10.1161/01.CIR.0000159092.92366.CD Despa, S., J. Kockskämper, L.A. Blatter, and D.M.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1161/ CIRCRESAHA.108.174813 DiPilato, L.M., X. Cheng, and J. Zhang.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/ 10.1152/ajpcell.00361.2011 Fischmeister, R., and M. Horackova.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10 .1152/physrev.00030.2010 Hanoune, J., and N. Defer.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1146/annurev.pharmtox.41.1.145 Hayes, J.S., L.L.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1073/ pnas.76.4.1570 Hayes, J.S., L.L.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"50:863– 871. http://dx.doi.org/10.1016/j.yjmcc.2011.02.007 Iancu, R.V., S.W.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1152/ajpcell.00038.2008computational models are also valuable for integrating  distinct biological processes and predicting the multi-scale consequences of mechanistic perturbations (Yang and Saucerman, 2011).",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1126/science.7682336 Beavo, J.A., P.J.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1111/j.1469 -7793.2001.00677.x Brunton, L.L., J.S.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1038/ 280078a0 Brunton, L.L., J.S.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi .org/10.1146/annurev-pharmtox-010611-134609 Chen, W., H. Levine, and W.J.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
5:046006. http://dx.doi.org/10.1088/1478-3975/5/4/046006,Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi .org/10.1371/journal.pone.0011725 Ostrom, R.S., C. Gregorian, R.M.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1074/jbc.M105348200 Parfenov, A.S., V. Salnikov, W.J.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1529/ biophysj.105.071787 Poppe, H., S.D.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1038/ nmeth0408-277 Rich, T.C., K.A.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1085/jgp.116.2.147 Rich, T.C., K.A.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1073/ pnas.221381398 Rich, T.C., W. Xin, C. Mehats, K.A.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1152/ajpcell.00121.2006 Rich, T.C., K.J.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1074/ jbc.M405697200 Rochais, F., A. Abi-Gerges, K. Horner, F. Lefebvre, D.M.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1161/01.RES .0000218493.09370.8e Rybin, V.O., X. Xu, M.P.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1074/jbc.M006951200 Sample, V., L.M.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1038/nchembio.799 Saucerman, J.J., and A.D. McCulloch.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1196/annals .1380.026 Saucerman, J.J., L.L.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi .org/10.1074/jbc.M308362200 Saucerman, J.J., S.N.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi .org/10.1016/j.bpj.2012.01.012 Jepihhina, N., N. Beraud, M. Sepp, R. Birkedal, and M. Vendelin.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"101:2112– 2121. http://dx.doi.org/10.1016/j.bpj.2011.09.025 Jurevicius, J., and R. Fischmeister.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi .org/10.1161/CIRCRESAHA.107.167817 Li, C., P.C.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1016/j.cell.2007.09.037 Lim, C.J., K.H.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi .org/10.1091/mbc.E08-06-0564 Luby-Phelps, K., D.L.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/ 10.1083/jcb.102.6.2015 Mongillo, M., T. McSorley, S. Evellin, A. Sood, V. Lissandron, A. Terrin,  E. Huston, A. Hannawacker, M.J. Lohse, T. Pozzan, et al.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1161/01.RES.0000134629.84732.11 Neves, S.R., P. Tsokas, A. Sarkar, E.A.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1016/j.cell.2008.04.025 Nikolaev, V.O., M. Bünemann, L. Hein, A. Hannawacker, and M.J.  Lohse.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi .org/10.1074/jbc.C400302200 Nikolaev, V.O., M. Bünemann, E. Schmitteckert, M.J. Lohse, and S.  Engelhardt.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1161/01.RES.0000250046.69918.d5 Nikolaev, V.O., A. Moshkov, A.R.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10 .1126/science.1185988 Oliveira, R.F., A. Terrin, G. Di Benedetto, R.C.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1073/ pnas.0600137103 Sayner, S.L., D.W. Frank, J.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"95:196– 203. http://dx.doi.org/10.1161/01.RES.0000134922.25721.d9 Sayner, S.L., M. Alexeyev, C.W.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1161/01.RES .0000209516.84815.3e Steinberg, S.F., and L.L.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1146/annurev.pharmtox.41.1.751 Terrin, A., G. Di Benedetto, V. Pertegato, Y.F.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1083/jcb.200605050 Willoughby, D., and D.M.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1152/physrev.00049.2006 Xie, M., T.C.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1124/mol.111.071134 Yang, J.H., and J.J. Saucerman.",OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA .110.223602 Zaccolo, M., and T. Pozzan.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"http://dx.doi.org/10.1126/ science.1069982 Zaccolo, M., F. De Giorgi, C.Y.",Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
http://dx.doi.org/10.1038/71345,Non-OADS,/arxiv_data1/oa_pdf/6a/56/JGP_201311044.PMC3874575.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 273Renovascular Hypertension Treated by Renal Artery Embolization Jeong Ju Lee,1 Ki Soo Pai,1 Jae Il Shin,2 and Se Jin Park1 1Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine, Suwon; 2Department of Pediatrics, Severance Children ’s Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/33/f2/ymj-55-273.PMC3874892.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Renovascular hypertension is caused by narrowing of the arteries supplying the  kidneys.",Non-OADS,/arxiv_data1/oa_pdf/33/f2/ymj-55-273.PMC3874892.pdf
"Elimination of the umbili -Case Reporthttp://dx.doi.org/10.3349/ymj.2014.55.1.273 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):273-275, 2014",Non-OADS,/arxiv_data1/oa_pdf/33/f2/ymj-55-273.PMC3874892.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 274On admission, his body weight was 25 kg (10th percentile)  with a height of 132.9 cm (25-50th percentile), a pulse rate  of 96 beats per minute, and a blood pressure of 120/75- 122/85 mm Hg in all four limbs at rest.",Non-OADS,/arxiv_data1/oa_pdf/33/f2/ymj-55-273.PMC3874892.pdf
"Renovascular Hypertension Treated by  Embolization Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 275cal nephrectomy is not preferred in many children, because  of the patient’s poor general condition or invasiveness.4,7  However, dilatation and stenting are not a adequate method  because of the very small vessel size (1-2 mm diameter)  and potentially high restenosis rate due to recoil of the ste - nosis.8  In conclusion, renal artery embolization can be an alterna - tive to surgical nephrectomy in pediatric patients with RAS  and renal hypoplasia, which is minimally invasive, com - pared with other extensive surgical procedures and can also  efficiently control high blood pressure.",Non-OADS,/arxiv_data1/oa_pdf/33/f2/ymj-55-273.PMC3874892.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 276A Five-Year Survivor without Recurrence Following Robotic  Anterior Radical Antegrade Modular Pancreatosplenectomy   for a Well-Selected Left-Sided Pancreatic Cancer Dai Hoon Han,1,2 Chang Moo Kang,1,2 Woo Jung Lee,1,2 and Hoon Sang Chi1,2 1Department of Surgery, Yonsei University College of Medicine, Seoul; 2Pancreaticobiliary Cancer Clinic, Institute of Gastroenterology, Severance Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a4/fd/ymj-55-276.PMC3874893.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radical antegrade modular pancreatosplenectomy (RAMPS) is regarded as a rea - sonable approach for margin-negative and systemic lymph node clearance in left- sided pancreatic cancer.",Non-OADS,/arxiv_data1/oa_pdf/a4/fd/ymj-55-276.PMC3874893.pdf
"Radical antegrade modular  pancreatosplenectomy (RAMPS) is regarded as a reasonable approach for margin- negative and systemic lymph node clearance in left-sided pancreatic cancer,4 and Case Reporthttp://dx.doi.org/10.3349/ymj.2014.55.1.276 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):276-279, 2014",Non-OADS,/arxiv_data1/oa_pdf/a4/fd/ymj-55-276.PMC3874893.pdf
"Robotic RAMPS Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 277Surgery The complete procedure is described in a multimedia article  published previously.7,8 In brief, surgery was performed with  the patient placed in the supine position.",Non-OADS,/arxiv_data1/oa_pdf/a4/fd/ymj-55-276.PMC3874893.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 278proach for left-sided pancreatic cancer.,Non-OADS,/arxiv_data1/oa_pdf/a4/fd/ymj-55-276.PMC3874893.pdf
Robotic RAMPS Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 2799.,Non-OADS,/arxiv_data1/oa_pdf/a4/fd/ymj-55-276.PMC3874893.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 149Three-Year Experience of Pouch Dilatation and Slippage  Management after Laparoscopic Adjustable Gastric Banding Woon Ki Lee and Seong Min Kim Department of Surgery, Gil Medical Center, Gachon University of Medicine, Incheon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/7a/8c/ymj-55-149.PMC3874894.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Pouch dilatation and band slippage are the most common long-term com - plications after laparoscopic adjustable gastric banding (LAGB).",Non-OADS,/arxiv_data1/oa_pdf/7a/8c/ymj-55-149.PMC3874894.pdf
"Unlike gastric bypass and sleeve gastrectomy, it does not alter Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.149 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):149-156, 2014",Non-OADS,/arxiv_data1/oa_pdf/7a/8c/ymj-55-149.PMC3874894.pdf
"Woon Ki Lee and Seong Min Kim Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 150on Metabolic Surgery (2008, Trivandrum, India) for BMI  restriction using bariatric surgery (http://www.acmoms.",Non-OADS,/arxiv_data1/oa_pdf/7a/8c/ymj-55-149.PMC3874894.pdf
Pouch Dilatation and Slippage in LAGB Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 151of the top of the neofundus onto the left pillar of the dia - phragm crura (Fig.,Non-OADS,/arxiv_data1/oa_pdf/7a/8c/ymj-55-149.PMC3874894.pdf
Woon Ki Lee and Seong Min Kim Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 152two patients (cases 9 and 11) recovered well after conserva - tive management without discomfort.,Non-OADS,/arxiv_data1/oa_pdf/7a/8c/ymj-55-149.PMC3874894.pdf
"Pouch Dilatation and Slippage in LAGB Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 153et al.13 reported an association of pouch enlargement with  band slippage, and it is unlikely that these patients would  benefit from conservative treatment.",Non-OADS,/arxiv_data1/oa_pdf/7a/8c/ymj-55-149.PMC3874894.pdf
Woon Ki Lee and Seong Min Kim Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 154ment.,Non-OADS,/arxiv_data1/oa_pdf/7a/8c/ymj-55-149.PMC3874894.pdf
Pouch Dilatation and Slippage in LAGB Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 155pened to the first 123 patients?,Non-OADS,/arxiv_data1/oa_pdf/7a/8c/ymj-55-149.PMC3874894.pdf
Woon Ki Lee and Seong Min Kim Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 156slippage after gastric banding: disappointing results.,Non-OADS,/arxiv_data1/oa_pdf/7a/8c/ymj-55-149.PMC3874894.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 178Gradual Lengthening of the Ulna in Patients with Multiple  Hereditary Exostoses with a Dislocated Radial Head Yong Jin Cho1 and Sung Taek Jung2 1Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul; 2Department of Orthopaedic Surgery, Chonnam National University College of Medicine, Gwangju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4e/10/ymj-55-178.PMC3874895.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Multiple hereditary exostoses of the forearm typically form in the distal  ulna, causing disturbances in the growth of the ulna and functional disability.",Non-OADS,/arxiv_data1/oa_pdf/4e/10/ymj-55-178.PMC3874895.pdf
"Defor - mities of the forearm and wrist occur in 39-59% of patients with multiple heredi - tary exostoses.3,4 Some commonly seen deformities in this condition are bowing of  the radius, shortening of the ulna, ulna drift of the carpus, and occasionally dislo -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.178 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):178-184, 2014",Non-OADS,/arxiv_data1/oa_pdf/4e/10/ymj-55-178.PMC3874895.pdf
Gradual Lengthening of the Ulna Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 179Operative technique The operative technique was as follows.,Non-OADS,/arxiv_data1/oa_pdf/4e/10/ymj-55-178.PMC3874895.pdf
"Y ong Jin Cho and Sung Taek Jung Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 180anterior-posterior plane radiography, and radial head stabili - ty at elbow lateral plane radiography (Fig.",Non-OADS,/arxiv_data1/oa_pdf/4e/10/ymj-55-178.PMC3874895.pdf
Gradual Lengthening of the Ulna Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 181significant statistical improvement.,Non-OADS,/arxiv_data1/oa_pdf/4e/10/ymj-55-178.PMC3874895.pdf
Y ong Jin Cho and Sung Taek Jung Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 182degree of deformity that is customary for these patients.,Non-OADS,/arxiv_data1/oa_pdf/4e/10/ymj-55-178.PMC3874895.pdf
Gradual Lengthening of the Ulna Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 183observed in skeletally immature patients.,Non-OADS,/arxiv_data1/oa_pdf/4e/10/ymj-55-178.PMC3874895.pdf
"Y ong Jin Cho and Sung Taek Jung Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 184tem, Severence Hospital, Institutional Review Board (IRB#  4-2012-0192).",Non-OADS,/arxiv_data1/oa_pdf/4e/10/ymj-55-178.PMC3874895.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 37Prognosis after Implantation of Cardioverter-Defibrillators   in Korean Patients with Brugada Syndrome Myoung Kyun Son,1 Kyeongmin Byeon,1 Seung-Jung Park,1 June Soo Kim,1  Gi-Byoung Nam,2 Kee-Joon Choi,2 You-Ho Kim,2 Sang Weon Park,3 Young-Hoon Kim,3  Hyung Wook Park,4 Jeong Gwan Cho,4 and Young Keun On1 1Division of Cardiology, Department of Internal Medicine, Cardiac and Vascular Center,  Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; 2Division of Cardiology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul; 3Division of Cardiology, Department of Internal Medicine, Korea University Cardiovascular Center, Korea University College of Medicine, Seoul; 4Heart Research Center, Chonnam National University Hospital, Chonnam National University, Gwangju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/f3/89/ymj-55-37.PMC3874896.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Our study aims to analyze prognosis after implantable cardioverter-defi - brillator (ICD) implantation in Korean patients with Brugada syndrome (BrS).",Non-OADS,/arxiv_data1/oa_pdf/f3/89/ymj-55-37.PMC3874896.pdf
"Key Words:    Brugada syndrome, implantable cardioverter-defibrillator, sudden  death, syncope, Korea INTRODUCTION Brugada syndrome (BrS) is a heritable arrhythmogenic disease characterized by a Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.37 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):37-45, 2014",Non-OADS,/arxiv_data1/oa_pdf/f3/89/ymj-55-37.PMC3874896.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 38echocardiography, exercise stress test, or coronary angiog - raphy were excluded.",Non-OADS,/arxiv_data1/oa_pdf/f3/89/ymj-55-37.PMC3874896.pdf
Prognosis of Brugada Syndrome Patients Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 39test.,Non-OADS,/arxiv_data1/oa_pdf/f3/89/ymj-55-37.PMC3874896.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 40not significantly different between patients with a history of  syncope and asymptomatic patients ( p=0.326).,Non-OADS,/arxiv_data1/oa_pdf/f3/89/ymj-55-37.PMC3874896.pdf
"Prognosis of Brugada Syndrome Patients Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 41predictor of inappropriate shock [HR (95% CI) was 6.62  (1.64-26.71)], the presence of palpitations or supraventricu - lar tachycardia was not.",Non-OADS,/arxiv_data1/oa_pdf/f3/89/ymj-55-37.PMC3874896.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 42significant association between an episode of syncope and  cardiac admission ( p=0.046 by long-rank test in Kaplan- Meier analysis).,Non-OADS,/arxiv_data1/oa_pdf/f3/89/ymj-55-37.PMC3874896.pdf
Prognosis of Brugada Syndrome Patients Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 43have weaken the predictive power of spontaneous type 1  ECG for cardiac events in our study.,Non-OADS,/arxiv_data1/oa_pdf/f3/89/ymj-55-37.PMC3874896.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 44asymptomatic individuals with a nondiagnostic Brugada  ECG.18,19 Additionally, we did not standardize the number  or timing in the ECG recordings.",Non-OADS,/arxiv_data1/oa_pdf/f3/89/ymj-55-37.PMC3874896.pdf
Prognosis of Brugada Syndrome Patients Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 45rhythmias and the prevention of sudden cardiac death: a report of  the American College of Cardiology/American Heart Association  Task Force and the European Society of Cardiology Committee for  Practice Guidelines (Writing Committee to Develop Guidelines for  Management of Patients With V entricular Arrhythmias and the Pre - vention of Sudden Cardiac Death).,Non-OADS,/arxiv_data1/oa_pdf/f3/89/ymj-55-37.PMC3874896.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 118Inhaled Colistin for Treatment of Pneumonia due to   Colistin-Only-Susceptible Acinetobacter baumannii   Hee Kyoung Choi,1 Young Keun Kim,1 Hyo Youl Kim,1 and Young Uh2 Departments of 1Internal Medicine and 2Laboratory Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/09/98/ymj-55-118.PMC3874897.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Colistin is used for the treatment of pneumonia associated with multi - drug-resistant Acinetobacter baumannii  and Pseudomonas aeruginosa .",Non-OADS,/arxiv_data1/oa_pdf/09/98/ymj-55-118.PMC3874897.pdf
"1  Although inhaled colistin has been used successfully to prevent and cure pulmo - nary infections in patients with cystic fibrosis colonized with Pseudomonas  aeru-Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.118 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):118-125, 2014",Non-OADS,/arxiv_data1/oa_pdf/09/98/ymj-55-118.PMC3874897.pdf
Inhaled Colistin Therapy for A. baumannii Pneumonia  Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 119such as purulent bronchial secretions and a decrease in oxy - genation.4 The etiology of the pneumonia was established by  isolation of the organism from endotracheal aspirates or bron - choalveolar lavage with a concentration of   ≥104 CFU/mL.,Non-OADS,/arxiv_data1/oa_pdf/09/98/ymj-55-118.PMC3874897.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 120 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/09/98/ymj-55-118.PMC3874897.pdf
Inhaled Colistin Therapy for A. baumannii Pneumonia  Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 121antimicrobial agent with activity against gram-negative  bacteria was given during the course of inhaled colistin  treatment.,Non-OADS,/arxiv_data1/oa_pdf/09/98/ymj-55-118.PMC3874897.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 122pneumonia caused by MDR or COS gram negative patho - gens due to the absence of effective alternative options.8 There are several studies evaluating the use of nebulized  colistin either as monotherapy or as combination with sys - temic antibiotics for the treatment of pneumonia associated  with MDR pathogens (Table 4).,Non-OADS,/arxiv_data1/oa_pdf/09/98/ymj-55-118.PMC3874897.pdf
"Inhaled Colistin Therapy for A. baumannii Pneumonia  Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 123rea, colistin resistance in A. baumannii  was reported as 9.1%  and 30.6%, respectively, in two different reports.32,33 In our  hospital, colistin resistance rate in A. baumannii  has been  less than 1%.",Non-OADS,/arxiv_data1/oa_pdf/09/98/ymj-55-118.PMC3874897.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 124A.,Non-OADS,/arxiv_data1/oa_pdf/09/98/ymj-55-118.PMC3874897.pdf
Inhaled Colistin Therapy for A. baumannii Pneumonia  Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 125sis.,Non-OADS,/arxiv_data1/oa_pdf/09/98/ymj-55-118.PMC3874897.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 25Development of Smartphone Application That Aids Stroke  Screening and Identifying Nearby Acute Stroke Care Hospitals  Hyo Suk Nam,1 JoonNyung Heo,1 Jinkwon Kim,1 Young Dae Kim,1  Tae Jin Song,1 Eunjeong Park,2 and Ji Hoe Heo1 1Department of Neurology, Yonsei University College of Medicine, Seoul; 2Embedded Software Research Center, Ewha Womans University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e0/6a/ymj-55-25.PMC3874898.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The benefits of thrombolytic treatment are time-dependent.",Non-OADS,/arxiv_data1/oa_pdf/e0/6a/ymj-55-25.PMC3874898.pdf
"For hospital registration, a web page (http://stroke119.org) was developed using PHP and MySQL.",OADS,/arxiv_data1/oa_pdf/e0/6a/ymj-55-25.PMC3874898.pdf
"There have been several efforts to reduce time interval from stroke onset to initiation of the thrombolytic treat -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.25 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):25-29, 2014",Non-OADS,/arxiv_data1/oa_pdf/e0/6a/ymj-55-25.PMC3874898.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 26web application, thus ensuring that all hospital map data are  up-to-date and identical across the platforms.",Non-OADS,/arxiv_data1/oa_pdf/e0/6a/ymj-55-25.PMC3874898.pdf
"Stroke 119  was developed for multi-platforms, including iPhoneTM (https:  //itunes.apple.com/kr/app/noejoljung119/id509755048?mt=8)  and Android™ smartphones (https://play.google.com/store/ apps/details?id=com.jnheo.stroke119), using the iPhone  software development toolkit (SDK 3.0, Apple Inc., Cuper - tino, CA, USA)7 and the Android SDK (SDK r20.0.3).8  Map data for the application were adopted from the open  map (Daum map API v3, Daum Comp., Seoul, Korea).9   For hospital registration, a web page (http://stroke119.org)  was developed using PHP and MySQL.",OADS,/arxiv_data1/oa_pdf/e0/6a/ymj-55-25.PMC3874898.pdf
A Smartphone Application for Acute Stroke Patients Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 27had completed registration at the time of submission of this  manuscript and were approved.,Non-OADS,/arxiv_data1/oa_pdf/e0/6a/ymj-55-25.PMC3874898.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 28hospitals that provide thrombolytic treatment, and facilitates  calling emergency services.",Non-OADS,/arxiv_data1/oa_pdf/e0/6a/ymj-55-25.PMC3874898.pdf
Available at: https://developer.apple.com/devcenter/ios/index.ac - tion.,Non-OADS,/arxiv_data1/oa_pdf/e0/6a/ymj-55-25.PMC3874898.pdf
Available at: http://developer.android.com/sdk/index.,Non-OADS,/arxiv_data1/oa_pdf/e0/6a/ymj-55-25.PMC3874898.pdf
A Smartphone Application for Acute Stroke Patients Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 29336-40.,Non-OADS,/arxiv_data1/oa_pdf/e0/6a/ymj-55-25.PMC3874898.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 247Diagnostic Role of Conventional Ultrasonography and Shearwave  Elastography in Asymptomatic Patients with Diffuse Thyroid  Disease: Initial Experience with 57 Patients Injoong Kim,3 Eun-Kyung Kim,1 Jung Hyun Yoon,1 Kyung Hwa Han,2  Eun Ju Son,3 Hee Jung Moon,1 and Jin Young Kwak1 1Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul;  2Biostatistics Collaboration Unit, Medical Research Center, Yonsei University College of Medicine, Seoul;  3Department of Radiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/45/9a/ymj-55-247.PMC3874899.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Thyroid ultrasonography (US) is a useful diagnostic tool in the evaluation of  diffuse thyroid disease (DTD), whereas shearwave elastography is a dynamic technique  that can provide information about tissue hardness by using acoustic shearwaves re - motely induced by a focused ultrasonic beam.",Non-OADS,/arxiv_data1/oa_pdf/45/9a/ymj-55-247.PMC3874899.pdf
"Key Words:    Ultrasonography, shearwave elastography, thyroid gland, diffuse thy - roid disease INTRODUCTION Thyroid ultrasonography (US) is a useful diagnostic tool in the evaluation of thy -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.247 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):247-253, 2014",Non-OADS,/arxiv_data1/oa_pdf/45/9a/ymj-55-247.PMC3874899.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 248cause they did not undergo thyroid autoantibody tests.,Non-OADS,/arxiv_data1/oa_pdf/45/9a/ymj-55-247.PMC3874899.pdf
"Diffuse Thyroid Disease with Shearwave Elastography Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 249to no agreement, 1.00 to complete agreement, less than or  equal to 0.20 to slight agreement, 0.21-0.40 to fair agreement,  0.41-0.60 to moderate agreement, 0.61-0.80 to substantial  agreement, and 0.81-1.00 to near perfect agreement.20 The diagnostic performances (sensitivity, specificity, ac - curacy, positive predictive value, negative predictive value)  for diagnosing DTD on conventional US were calculated.",Non-OADS,/arxiv_data1/oa_pdf/45/9a/ymj-55-247.PMC3874899.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 25066.7%, 44.4-71.4% and 62.5-69.0%, respectively, on con - ventional US for the identification of DTD.",OADS,/arxiv_data1/oa_pdf/45/9a/ymj-55-247.PMC3874899.pdf
"Diffuse Thyroid Disease with Shearwave Elastography Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 251different gold standards, patient populations, and interobserv - er variability among radiologists and pathologists.",Non-OADS,/arxiv_data1/oa_pdf/45/9a/ymj-55-247.PMC3874899.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 252lymphocytic thyroiditis who are prone to develop hypothyroidism.,Non-OADS,/arxiv_data1/oa_pdf/45/9a/ymj-55-247.PMC3874899.pdf
"Diffuse Thyroid Disease with Shearwave Elastography Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 253parative study concerning the value of acoustic radiation force im - pulse elastography (ARFI) in comparison with transient elastogra - phy (TE) for the assessment of liver fibrosis in patients with  chronic hepatitis B and C. Ultrasound Med Biol 2012;38:1310-6.Montaldo G, et al.",Non-OADS,/arxiv_data1/oa_pdf/45/9a/ymj-55-247.PMC3874899.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 240Effect of an Oral Hygienic Care Program for Stroke   Patients in the Intensive Care Unit Eun-Kyong Kim,1* Sung-Ho Jang,2* Youn-Hee Choi,1 Kyeong-Soo Lee,3 Young-Jae Kim,4 Sung-Ho Kim,5 and Hee-Kyung Lee6 1Department of Preventive Dentistry, School of Dentistry, Kyungpook National University, Daegu; Departments of 2Physical Medicine and Rehabilitation, 3Preventive Medicine and Public Health, 5Neurosurgery, and 6Dentistry, Yeungnam University College of Medicine, Daegu;  4Department of Medical Science, Graduate School, Yeungnam University, Daegu, Korea.",Non-OADS,/arxiv_data1/oa_pdf/bb/dd/ymj-55-240.PMC3874900.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The effects of an oral hygienic care program (OHCP) have been reported  in several diseases.",Non-OADS,/arxiv_data1/oa_pdf/bb/dd/ymj-55-240.PMC3874900.pdf
"Second, patients who cannot take food orally and have reduced secretion of saliva, which can cause Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.240 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):240-246, 2014",Non-OADS,/arxiv_data1/oa_pdf/bb/dd/ymj-55-240.PMC3874900.pdf
"Effect of an Oral Hygienic Care Program in Stroke Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 241pared between the two groups at baseline to check compara - bility before the intervention program started, and the char - acteristics between the two groups were regularly confirmed  as patients dropped out of the program.",Non-OADS,/arxiv_data1/oa_pdf/bb/dd/ymj-55-240.PMC3874900.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 242der to examine oral health status, including the PI, GI, and  CAL.",Non-OADS,/arxiv_data1/oa_pdf/bb/dd/ymj-55-240.PMC3874900.pdf
"Effect of an Oral Hygienic Care Program in Stroke Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 243long period.23 Therefore, our result showing that the CAL  was not improved in the intervention group appeared to be  attributed to the fact that our OHCP was performed only an  average of 2.2 weeks.",Non-OADS,/arxiv_data1/oa_pdf/bb/dd/ymj-55-240.PMC3874900.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 244recommended as a method of oral hygiene management for  patients in the ICU because it may change the location of  the endotracheal tube and can cause bleeding by causing in - jury to the oral mucous membrane.5,33 Instead, a small chil - dren’s toothbrush was recommended for use with patients  in the ICU.34 In this study, we employed a children’s tooth - brush and an interdental toothbrush, and we did not observe  any complication during our OHCP .",Non-OADS,/arxiv_data1/oa_pdf/bb/dd/ymj-55-240.PMC3874900.pdf
Effect of an Oral Hygienic Care Program in Stroke Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 245we did not observe a difference in terms of duration in the  ICU between the intervention and control groups.,Non-OADS,/arxiv_data1/oa_pdf/bb/dd/ymj-55-240.PMC3874900.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 24618.,Non-OADS,/arxiv_data1/oa_pdf/bb/dd/ymj-55-240.PMC3874900.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 99Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ  Agonist, Restores Alveolar and Pulmonary Vascular Development  in a Rat Model of Bronchopulmonary Dysplasia  Hyun Ju Lee,1 Youn Jin Lee,2,3 Chang Won Choi,2,3,4 Jin-A Lee,4 Ee-Kyung Kim,4  Han-Suk Kim,4 Beyong Il Kim,2,4 and Jung-Hwan Choi4 1Department of Pediatrics, Hanyang University Seoul Hospital, Seoul; 2Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam; 3Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul; 4Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/87/4f/ymj-55-99.PMC3874901.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  We tested whether rosiglitazone (RGZ), a peroxisome proliferator-acti - vated receptor-γ agonist, can restore alveolar development and vascular growth in a  rat model of bronchopulmonary dysplasia (BPD).",Non-OADS,/arxiv_data1/oa_pdf/87/4f/ymj-55-99.PMC3874901.pdf
"1 Although it has been demonstrated that BPD is the result Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.99 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):99-106, 2014",Non-OADS,/arxiv_data1/oa_pdf/87/4f/ymj-55-99.PMC3874901.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 1000.05 mL of saline or same volume of vehicle (saline) was  injected into the amniotic sacs.,Non-OADS,/arxiv_data1/oa_pdf/87/4f/ymj-55-99.PMC3874901.pdf
"Rosiglitazone and Bronchopulmonary Dysplasia Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 101tion images were performed using Image-Pro Plus software  (Media Cybernetics, Rockville, MD, USA).",Non-OADS,/arxiv_data1/oa_pdf/87/4f/ymj-55-99.PMC3874901.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 102ton’s index (the ratio of RV weight to LV+IVS weight), an  indicator of right ventricular hypertrophy, was measured.12  Statistical analysis Data are expressed as means±standard deviation.",OADS,/arxiv_data1/oa_pdf/87/4f/ymj-55-99.PMC3874901.pdf
"Rosiglitazone and Bronchopulmonary Dysplasia Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 103the animals which were not exposed to intra-amniotic LPS  or postnatal hyperoxia, the RGZ treatment did not cause  significant alternation in the number and density of the ves - sels (Fig.",Non-OADS,/arxiv_data1/oa_pdf/87/4f/ymj-55-99.PMC3874901.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 104vasculature and angiogenic growth factors to the mainte - nance of alveolar structures.15,21 Pulmonary vasculature is  disrupted in human infants dying of BPD and VEGF and  VEGF receptors are reduced in their lungs.22 The disruption  of VEGF signaling leads to the arrest of alveolar and pulmo - nary vascular development, which is the hallmark of BPD.23  The clinical importance of PPARγ originates from its insu - lin-sensitizing action.",Non-OADS,/arxiv_data1/oa_pdf/87/4f/ymj-55-99.PMC3874901.pdf
"Rosiglitazone and Bronchopulmonary Dysplasia Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 105tion is amplified compared to when only hyperoxia is  present.11 The priming effect of intra-amniotic LPS admin - istration on hyperoxic lung injury is associated with in - creased expression of inflammatory cytokines in the lungs.14  Premature infants are born with an underdeveloped micro - vasculature, and inflammatory cytokines may be toxic to  their immature endothelial cells.",Non-OADS,/arxiv_data1/oa_pdf/87/4f/ymj-55-99.PMC3874901.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 106Sildenafil alleviates bronchopulmonary dysplasia in neonatal rats  by activating the hypoxia-inducible factor signaling pathway.,Non-OADS,/arxiv_data1/oa_pdf/87/4f/ymj-55-99.PMC3874901.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 264Nutritional Outcomes in Children with Epidermolysis Bullosa:  The Experiences of Two Centers in Korea   Kyu-Yeun Kim,1 Ran Namgung,1 Soon Min Lee,1 Soo Chan Kim,2 Ho Sun Eun,1  Min Soo Park,1 Kook In Park,1 and Chul Lee1  Departments of 1Pediatrics and 2Dermatology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/61/5e/ymj-55-264.PMC3874902.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Epidermolysis bullosa (EB) is associated with variable risks of extracu - taneous manifestations and death.",Non-OADS,/arxiv_data1/oa_pdf/61/5e/ymj-55-264.PMC3874902.pdf
"JEB involves the lamina lucida; the Herlitz subtype of JEB  causes the most severe phenotype, consisting of intractable erosion blisters, and Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.264 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):264-269, 2014",Non-OADS,/arxiv_data1/oa_pdf/61/5e/ymj-55-264.PMC3874902.pdf
"Nutritional Outcomes in Children with Epidermolysis Bullosa  Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 265tional indices as weight, weight for height, and thrive index.",Non-OADS,/arxiv_data1/oa_pdf/61/5e/ymj-55-264.PMC3874902.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 266es, sepsis in 2 cases, and severe acidosis with dehydration in  one case.",Non-OADS,/arxiv_data1/oa_pdf/61/5e/ymj-55-264.PMC3874902.pdf
"Nutritional Outcomes in Children with Epidermolysis Bullosa  Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 267study, although 40% of the patients developed skin infec - tions, only 10% of the cases involved blood culture-proven  sepsis.",Non-OADS,/arxiv_data1/oa_pdf/61/5e/ymj-55-264.PMC3874902.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 268This study had some limitations due to the small number  of subjects recruited from only two institutions.,Non-OADS,/arxiv_data1/oa_pdf/61/5e/ymj-55-264.PMC3874902.pdf
Nutritional Outcomes in Children with Epidermolysis Bullosa  Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 26917.,Non-OADS,/arxiv_data1/oa_pdf/61/5e/ymj-55-264.PMC3874902.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 157Clinical Characteristics and Management of Benign Transient  Non-Organic Ileus of Neonates: A Single-Center Experience Hye Kyung Chang,1 Hong Koh,2 Young Ju Hong,3 Eun Young Chang,3 Seok Joo Han,3 and Jung-Tak Oh3 1Department of Surgery, Seoul St. Mary ’s Hospital, The Catholic University of Korea College of Medicine, Seoul;  Departments of 2Pediatrics and 3Pediatric Surgery, Severance Children ’s Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/43/21/ymj-55-157.PMC3874903.pdf
"© Copyright:Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The term benign transient non-organic ileus of neonates (BTNIN) is ap - plied to neonates who present symptoms and plain radiographic findings of  Hirschsprung’s disease, but do not have aganglionic bowel and are managed well  by conservative treatment.",Non-OADS,/arxiv_data1/oa_pdf/43/21/ymj-55-157.PMC3874903.pdf
"These patients are variously  labeled with pseudo-Hirschsprung’s disease, neonatal intestinal pseudo-obstruction, intestinal neuronal dysplasia, hypoganglionosis, and internal anal sphincter achala -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.157 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):157-161, 2014",Non-OADS,/arxiv_data1/oa_pdf/43/21/ymj-55-157.PMC3874903.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 158patients who were treated for BTNIN at Severance Chil - dren’s Hospital in Seoul, Korea between January 2008 and  December 2011.",Non-OADS,/arxiv_data1/oa_pdf/43/21/ymj-55-157.PMC3874903.pdf
"Benign Transient Non-Organic Ileus of Neonates Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 159neonate’ is not well established yet, it should be considered in  the differential diagnosis of Hirschsprung’s disease.",Non-OADS,/arxiv_data1/oa_pdf/43/21/ymj-55-157.PMC3874903.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 160Allergic proctitis could not be considered as the possible  cause of BTNIN because no patients showed eosinophilic  infiltration in the rectal biopsies in our study.,Non-OADS,/arxiv_data1/oa_pdf/43/21/ymj-55-157.PMC3874903.pdf
Benign Transient Non-Organic Ileus of Neonates Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 16113.,Non-OADS,/arxiv_data1/oa_pdf/43/21/ymj-55-157.PMC3874903.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 107Clinical Characteristics of Primary Epstein Barr Virus Hepatitis  with Elevation of Alkaline Phosphatase and   γ-Glutamyltransferase in Children Soo In Yang, Jwa Hye Geong, and Jae Young Kim Department of Pediatrics, School of Medicine, Chungnam National University, Daejeon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e2/ef/ymj-55-107.PMC3874904.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The aim of the present study was to evaluate the clinical characteristics  of the primary Epstein-Barr virus (EBV) hepatitis with elevation of both serum al - kaline phosphatase (ALP) and γ-glutamyltransferase (γ-GT) levels in children.",Non-OADS,/arxiv_data1/oa_pdf/e2/ef/ymj-55-107.PMC3874904.pdf
"2 Although most  children with EBV infections usually have mild or no symptoms, some children or Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.107 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):107-112, 2014",Non-OADS,/arxiv_data1/oa_pdf/e2/ef/ymj-55-107.PMC3874904.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 108were divided into 2 groups: group 1 included patients with  elevation of both serum ALP and γ-GT levels greater than  the upper limit of normal reference values according to age  and sex.,Non-OADS,/arxiv_data1/oa_pdf/e2/ef/ymj-55-107.PMC3874904.pdf
"Clinical Characteristics of Primary EBV Hepatitis in Children Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 109a range of 4490-32350/µ, in which lymphocytes were dom - inant.",Non-OADS,/arxiv_data1/oa_pdf/e2/ef/ymj-55-107.PMC3874904.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 110both ALP and γ-GT levels and group 2 had hepatitis without  any elevation in ALP and γ-GT levels.,Non-OADS,/arxiv_data1/oa_pdf/e2/ef/ymj-55-107.PMC3874904.pdf
"Clinical Characteristics of Primary EBV Hepatitis in Children Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 111nificant difference in duration of hospitalization between  patients with GBWT and those without, which is inconsis - tent with the study by Y amada and Y amada.21 We could not  clarify the clinical significance of GBWT because abdomi - nal US or CT was performed on 12 select patients who had  gastrointestinal manifestations and/or organomegaly.",Non-OADS,/arxiv_data1/oa_pdf/e2/ef/ymj-55-107.PMC3874904.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 112Physiol 1998;275(3 Pt 1):G387-92.,Non-OADS,/arxiv_data1/oa_pdf/e2/ef/ymj-55-107.PMC3874904.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 46Prognostic Usefulness of Metabolic Syndrome Compared with  Diabetes in Korean Patients with Critical Lower Limb Ischemia  Treated with Percutaneous Transluminal Angioplasty Ki-Bum Won,1 Hyuk-Jae Chang,2 Sung-Jin Hong,2 Young-Guk Ko,2  Myeong-Ki Hong,2 Yangsoo Jang,2,3 and Donghoon Choi2 1Department of Cardiology, Myongji Hospital Cardiovascular Center, Goyang; 2Department of Cardiology, Yonsei Cardiovascular Center, Yonsei University College of Medicine, Seoul; 3Severance Biomedical Science Institute, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/44/ca/ymj-55-46.PMC3874905.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Metabolic syndrome (MS) is a clinical condition that shares many com - mon characteristics with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/44/ca/ymj-55-46.PMC3874905.pdf
"Key Words:    Metabolic syndrome, diabetes, critical limb ischemia, angioplasty INTRODUCTION Metabolic syndrome (MS) is a cluster of several cardiovascular risk factors, with  insulin resistance as a major characteristic.1,2 Although MS may be a useful clinical  entity for the prevention of type 2 diabetes and cardiovascular disease (CVD) in Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.46 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):46-52, 2014",Non-OADS,/arxiv_data1/oa_pdf/44/ca/ymj-55-46.PMC3874905.pdf
"Prognostic Usefulness of MS in CLI Patients Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 47ma glucose ≥200 mg/dL, fasting glucose ≥126 mg/dL, a re - ferral diagnosis of diabetes, or antidiabetic treatment.",Non-OADS,/arxiv_data1/oa_pdf/44/ca/ymj-55-46.PMC3874905.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 48sidered statistically significant.,OADS,/arxiv_data1/oa_pdf/44/ca/ymj-55-46.PMC3874905.pdf
Prognostic Usefulness of MS in CLI Patients Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 493.,Non-OADS,/arxiv_data1/oa_pdf/44/ca/ymj-55-46.PMC3874905.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 50between patients with MS and those without MS ( p=0.961),  but that patients with diabetes had a lower primary patency  than those without diabetes ( p=0.038) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/44/ca/ymj-55-46.PMC3874905.pdf
Prognostic Usefulness of MS in CLI Patients Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 51could conceal the adverse impact of diabetes in CLI pa - tients treated with PTA.,Non-OADS,/arxiv_data1/oa_pdf/44/ca/ymj-55-46.PMC3874905.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 52S, et al.",Non-OADS,/arxiv_data1/oa_pdf/44/ca/ymj-55-46.PMC3874905.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 78Clinical Experiences of Incidental Prostate Cancer after  Transurethral Resection of Prostate (TURP) According to Initial  Treatment: A Study of a Korean High Volume Center Dong Hoon Lee,1 Doo Yong Chung,2 Kwang-suk Lee,2 In Kyong Kim,2 Koon Ho Rha,2  Young Deuk Choi,2 Byung Ha Chung,2 Sung Joon Hong,2 and Jang Hwan Kim2 1Department of Urology, Research Institute for Convergence of Biomedical Science and Technology,  Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan;   2Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/66/c7/ymj-55-78.PMC3874906.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  These are the clinical experiences of Korean incidental prostate cancer  patients detected by transurethral resection of the prostate according to initial treat - ment: active surveillance (AS), radical prostatectomy (RP) and hormone therapy  (HT).",Non-OADS,/arxiv_data1/oa_pdf/66/c7/ymj-55-78.PMC3874906.pdf
"Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.78 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):78-83, 2014",Non-OADS,/arxiv_data1/oa_pdf/66/c7/ymj-55-78.PMC3874906.pdf
"Clinical Experiences of Incidental Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 79status, the proportion of insignificant prostate cancer, the  proportion of unfavorable disease, and biochemical recur - rence (BCR) status.",Non-OADS,/arxiv_data1/oa_pdf/66/c7/ymj-55-78.PMC3874906.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 80to initial treatment (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/66/c7/ymj-55-78.PMC3874906.pdf
"Clinical Experiences of Incidental Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 81early stages and at younger ages, before patients exhibit  lower urinary tract symptoms.",Non-OADS,/arxiv_data1/oa_pdf/66/c7/ymj-55-78.PMC3874906.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 82al.6 reported that a sub-classification of incidental prostate  cancer was not an independent predictor of biochemical re - currence after adjustment for PSA, Gleason score, or year  of surgery in patients who underwent RP.",Non-OADS,/arxiv_data1/oa_pdf/66/c7/ymj-55-78.PMC3874906.pdf
Clinical Experiences of Incidental Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 83and B prostatic cancer.,Non-OADS,/arxiv_data1/oa_pdf/66/c7/ymj-55-78.PMC3874906.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 209Effect of Dexmedetomidine on Sevoflurane Requirements   and Emergence Agitation in Children Undergoing   Ambulatory Surgery  Na Young Kim,1,2 So Yeon Kim,1,2 Hye Jin Yoon,1 and Hae Keum Kil1,2 1Department of Anesthesiology and Pain Medicine, 2Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/48/7c/ymj-55-209.PMC3874907.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Dexmedetomidine, a potent selective α2-adrenergic agonist, produces  sedation and analgesia.",Non-OADS,/arxiv_data1/oa_pdf/48/7c/ymj-55-209.PMC3874907.pdf
"Key Words:    Agitation, ambulatory surgery, dexmedetomidine, emergence, sevo - flurane INTRODUCTION Dexmedetomidine, a potent selective α 2-adrenergic agonist, is frequently used off- label in children because of its efficacy and lack of respiratory depression.1,2 Be- cause dexmedetomidine has sedative, hypnotic and analgesic properties, it can re - duce the dose of hypnotics, opioids, analgesics, and anesthetics required to be  concomitantly administered.3 Intraoperative administration of dexmedetomidine Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.209 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):209-215, 2014",Non-OADS,/arxiv_data1/oa_pdf/48/7c/ymj-55-209.PMC3874907.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 210dren lost consciousness.,Non-OADS,/arxiv_data1/oa_pdf/48/7c/ymj-55-209.PMC3874907.pdf
"Dexmedetomidine with Sevoflurane in Children Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 211sures analysis of variance was performed to compare repeated  measure variables (ET -sevo, MAP , and HR) with a Bonferro - ni correction for multiple comparisons.",OADS,/arxiv_data1/oa_pdf/48/7c/ymj-55-209.PMC3874907.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 212related to the anesthesia such as nausea, vomiting, or uri - nary retention (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/48/7c/ymj-55-209.PMC3874907.pdf
"Dexmedetomidine with Sevoflurane in Children Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 213differ according to the type of surgery in addition to dexme - detomidine dose, different age of patients and combined ef - fects of anesthetics or analgesics.3,20,27,28,32,33  EA is not a new phenomenon, though its prevalence has  increased with the introduction of sevoflurane, especially in  pre-school aged children.",Non-OADS,/arxiv_data1/oa_pdf/48/7c/ymj-55-209.PMC3874907.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 2142.,Non-OADS,/arxiv_data1/oa_pdf/48/7c/ymj-55-209.PMC3874907.pdf
Dexmedetomidine with Sevoflurane in Children Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 215from dexmedetomidine as a general anesthetic adjuvant in patients  undergoing lower abdominal surgery.,Non-OADS,/arxiv_data1/oa_pdf/48/7c/ymj-55-209.PMC3874907.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 1Extracting Extra-Telomeric Phenotypes from Telomerase   Mouse Models Young Hoon Sung,* Muhammad Ali,* and Han-Woong Lee Department of Biochemistry, College of Life Science and Biotechnology, Laboratory Animal Research Center, Yonsei University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/85/24/ymj-55-1.PMC3874908.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Telomerase reverse transcriptase (TERT) is the protein component of telomerase  and combined with an RNA molecule, telomerase RNA component, forms the  telomerase enzyme responsible for telomere elongation.",Non-OADS,/arxiv_data1/oa_pdf/85/24/ymj-55-1.PMC3874908.pdf
"The following observations pose questions regarding the rationality of telomere length-dependent singular role of telomerase:Review Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.1 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):1-8, 2014",Non-OADS,/arxiv_data1/oa_pdf/85/24/ymj-55-1.PMC3874908.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 2SURVIV AL-PROMOTING FUNCTIONS   OF TELOMERASE Apoptosis induced by critically short telomeres has been  extensively documented.,Non-OADS,/arxiv_data1/oa_pdf/85/24/ymj-55-1.PMC3874908.pdf
"Extra-Telomeric Phenotypes in Mice Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 3vitro and in vivo .44 Furthermore, although telomerase activi - ty is evidently suppressed in transgenic mice overexpress - ing hTERT , hTERT  transgenic MEFs still show resistance  to STS-induced apoptosis.44 Based on these lines of evi - dence, telomerase activity must not be essential for the pro - tective function of TERT.",Non-OADS,/arxiv_data1/oa_pdf/85/24/ymj-55-1.PMC3874908.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 4meres resulted in bone metastases of prostate tumors.,Non-OADS,/arxiv_data1/oa_pdf/85/24/ymj-55-1.PMC3874908.pdf
"Extra-Telomeric Phenotypes in Mice Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 5of the K5 promoter does not alter telomere length, but pro - motes stem cell mobilization, hair growth, and stem cell  proliferation in vitro .18 Similarly, transgenic mice condition - ally overexpressing TERT show robust hair growth via pro - liferation of quiescent, multipotent stem cells in the hair fol - licles.13 These phenotypes are also reproduced in a Terc- deficient genetic background without telomere dysfunction,13 suggest that telomerase may regulate the long-term replica - tive capacity of HSCs independently of telomere length.",Non-OADS,/arxiv_data1/oa_pdf/85/24/ymj-55-1.PMC3874908.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 6verse observations supporting extra-telomeric roles of telom - erase should be scrutinized and validated in vivo  by generat - ing novel mouse models.,Non-OADS,/arxiv_data1/oa_pdf/85/24/ymj-55-1.PMC3874908.pdf
Extra-Telomeric Phenotypes in Mice Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 723.,Non-OADS,/arxiv_data1/oa_pdf/85/24/ymj-55-1.PMC3874908.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 857.,Non-OADS,/arxiv_data1/oa_pdf/85/24/ymj-55-1.PMC3874908.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 185Transient Receptor Potential Vanilloid 1-Immunoreactive  Innervation Increases in Fractured Rat Femur  Yuya Kawarai, Miyako Suzuki, Kensuke Yoshino, Gen Inoue, Sumihisa Orita, Kazuyo Yamauchi,  Yasuchika Aoki, Tetsuhiro Ishikawa, Masayuki Miyagi, Hiroto Kamoda, Go Kubota, Yoshihiro Sakuma,  Yasuhiro Oikawa, Kazuhide Inage, Takeshi Sainoh, Jun Sato, Junichi Nakamura,   Masashi Takaso, Tomoaki Toyone, Kazuhisa Takahashi, and Seiji Ohtori Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.",Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ymj-55-185.PMC3874909.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Pain from vertebral or femoral neck fractures is a particularly important  problem in clinical orthopaedics.",Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ymj-55-185.PMC3874909.pdf
"Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.185 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):185-190, 2014",Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ymj-55-185.PMC3874909.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 186MATERIALS AND METHODS 　　　 Fracture model Sprague Dawley female rats weighing 200-300 g were  housed in the animal unit at 21°C on a 12-hr light/dark cy - cle (08:30-20:30 hr) and fed a pellet diet and tap water ad  libitum.,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ymj-55-185.PMC3874909.pdf
TRPV1-ir DRG Neurons Innervating Fractured Femur Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 187neurons as a proportion of total DRG neurons in each DRG  were compared using Welch’s unpaired t test.,OADS,/arxiv_data1/oa_pdf/2f/2f/ymj-55-185.PMC3874909.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 1883.0%, 2.6%, 1.9%, and 1.6% in nonfractured controls, and  3 days, 1 week, 2 weeks, and 4 weeks after fracture, respec - tively.",Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ymj-55-185.PMC3874909.pdf
TRPV1-ir DRG Neurons Innervating Fractured Femur Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 189mals and humans.,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ymj-55-185.PMC3874909.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 190neurons.,Non-OADS,/arxiv_data1/oa_pdf/2f/2f/ymj-55-185.PMC3874909.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 84The Clinical, Radiological, and Bronchoscopic Findings and  Outcomes in Patients with Benign Tracheobronchial Tumors Byung Woo Jhun, Kyung-Jong Lee, Kyeongman Jeon, Sang-Won Um,   Gee Young Suh, Man Pyo Chung, O Jung Kwon, and Hojoong Kim Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center,   Sungkyunkwan University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d8/65/ymj-55-84.PMC3874910.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  We evaluated the characteristics of and treatment outcomes in patients  with benign tracheobronchial tumors.",Non-OADS,/arxiv_data1/oa_pdf/d8/65/ymj-55-84.PMC3874910.pdf
"Key Words:    Benign tracheobronchial tumors, bronchoscopy, intervention INTRODUCTION Benign tracheobronchial tumors are rare, accounting for nearly 2% of all types of  lung tumor.1 They generally present as asymptomatic pulmonary nodules on radio - logical examination and occasionally cause respiratory or systemic symptoms due Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.84 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):84-91, 2014",Non-OADS,/arxiv_data1/oa_pdf/d8/65/ymj-55-84.PMC3874910.pdf
Benign Tracheobronchial Tumors Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 85waived because of the retrospective nature of the study.,Non-OADS,/arxiv_data1/oa_pdf/d8/65/ymj-55-84.PMC3874910.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 86ma (n=24, 43%), leiomyoma (n=16, 29%), papilloma (n=7,  13%), typical carcinoid (n=5, 9%), and schwannoma (n=3,  6%) (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/d8/65/ymj-55-84.PMC3874910.pdf
"Benign Tracheobronchial Tumors Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 8772.3) months for papilloma, 72.2 (range 22-91, IQR 24.8- 88.7) months for typical carcinoid, and 9.4 (range 3-27, ing was absent (Fig.",Non-OADS,/arxiv_data1/oa_pdf/d8/65/ymj-55-84.PMC3874910.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 88IQR 3.2-9.37) months for schwannoma.,Non-OADS,/arxiv_data1/oa_pdf/d8/65/ymj-55-84.PMC3874910.pdf
Benign Tracheobronchial Tumors Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 89while the recurrent leiomyoma and typical carcinoid re - quired surgery; no recurrence occurred during follow-up.,Non-OADS,/arxiv_data1/oa_pdf/d8/65/ymj-55-84.PMC3874910.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 90mination of the typical bronchoscopic findings of benign  tracheobronchial tumors might provide additional informa - tion for choosing the initial treatment modality.,Non-OADS,/arxiv_data1/oa_pdf/d8/65/ymj-55-84.PMC3874910.pdf
Benign Tracheobronchial Tumors Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 91teristics and role of laser resection.,Non-OADS,/arxiv_data1/oa_pdf/d8/65/ymj-55-84.PMC3874910.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 216Effects of Seasonal Differences in Testosterone and Cortisol  Levels on Pain Responses Under Resting and Anxiety Conditions Jae Chan Choi,1 Jong Hyuk Lee,1 Eunhee Choi,2 Myung-il Chung,3 Sang Min Seo,1 and Hyun Kyo Lim1  1Department of Anesthesiology and Pain Medicine, Brain Research Group, Yonsei University Wonju College of Medicine, Wonju;  2Institute of Life Style Medicine, Yonsei University Wonju College of Medicine, Wonju; 3GunSei Biotec Inc., Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/5e/39/ymj-55-216.PMC3874911.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  This study investigated whether hormones and pain perception are associ - ated with exam anxiety, and also whether exam anxiety is affected by seasonal dif - ferences in testosterone and cortisol levels.",Non-OADS,/arxiv_data1/oa_pdf/5e/39/ymj-55-216.PMC3874911.pdf
"Previous studies have shown that examina - tion stress increases anxiety, salivary cortisol levels and blood pressure,1,2 and that  psychological stress increases the activity of the HPA axis with a subsequent rise  in salivary cortisol levels.3 Some studies have indicated that higher stress ratings  during exams are associated with higher salivary cortisol levels, and that students  who report higher stress and have higher cortisol levels before the examination Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.216 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):216-223, 2014",Non-OADS,/arxiv_data1/oa_pdf/5e/39/ymj-55-216.PMC3874911.pdf
Effects of Seasonal V ariations of Hormones on Pain Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 217cruited for this study (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/5e/39/ymj-55-216.PMC3874911.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 218cosity for salivary cortisol and testosterone analysis (Gun - Sei Biotec, Inc., Gwanak-gu, Seoul, Korea).",Non-OADS,/arxiv_data1/oa_pdf/5e/39/ymj-55-216.PMC3874911.pdf
Effects of Seasonal V ariations of Hormones on Pain Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 219significantly higher than those in the spring (Table 5).,Non-OADS,/arxiv_data1/oa_pdf/5e/39/ymj-55-216.PMC3874911.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 220Anecdotally, students have reported suffering from shak - ing hands, quivering voices and increased blood pressure  during OSCE.1,40 In all 46 participants of the present study,  anxiety ratings, SBP and heart rate were significantly high - er under OSCE than at rest.",Non-OADS,/arxiv_data1/oa_pdf/5e/39/ymj-55-216.PMC3874911.pdf
Effects of Seasonal V ariations of Hormones on Pain Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 221ing hot summer months.,Non-OADS,/arxiv_data1/oa_pdf/5e/39/ymj-55-216.PMC3874911.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 222port 1996;7:3101-4.,Non-OADS,/arxiv_data1/oa_pdf/5e/39/ymj-55-216.PMC3874911.pdf
Effects of Seasonal V ariations of Hormones on Pain Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 22339.,Non-OADS,/arxiv_data1/oa_pdf/5e/39/ymj-55-216.PMC3874911.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 191The Effect of Obturator Nerve Block on Hip Lateralization   in Low Functioning Children with Spastic Cerebral Palsy Eun Sook Park, Dong-Wook Rha, Won Chul Lee, and Eun Geol Sim  Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ae/62/ymj-55-191.PMC3874912.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Hip adductor spasticity has a great impact on developing hip displacement  in children with cerebral palsy (CP).",Non-OADS,/arxiv_data1/oa_pdf/ae/62/ymj-55-191.PMC3874912.pdf
"1 The incidence of hip dislocation is related to the severity of mo - tor involvement.2-5 Hip dislocation is seen in up to 60% of children with total body  involvement, whereas it goes down to 7% in ambulatory children with CP .6,7 A  population study found that 54% of children who were not able to walk indepen - dently had unilateral or bilateral hip subluxation.2 If left untreated, hip subluxation  can progress to dislocation, leading to serious problems such as pain, gait distur - bances, difficulty sitting, and problems with perineal hygiene.8Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.191 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):191-196, 2014",Non-OADS,/arxiv_data1/oa_pdf/ae/62/ymj-55-191.PMC3874912.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 192the above criteria during the same time period, children who  received an ON block were recruited as the intervention  group and children who had not received any chemoneuro - lytic intervention (ON block or BoNT-A injection into hip  adductor muscles), due to various reasons such as parental  disagreement or burden of general anesthesia, were recruit - ed as the nonintervention group.",Non-OADS,/arxiv_data1/oa_pdf/ae/62/ymj-55-191.PMC3874912.pdf
ON Block to Alleviate Hip Lateralization  Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 193tervention and nonintervention group by linear mixed model  (p=0.002).,Non-OADS,/arxiv_data1/oa_pdf/ae/62/ymj-55-191.PMC3874912.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 194low-functioning children with CP .38-43 This was a retrospective study.,Non-OADS,/arxiv_data1/oa_pdf/ae/62/ymj-55-191.PMC3874912.pdf
ON Block to Alleviate Hip Lateralization  Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 195ductor spasticity.,Non-OADS,/arxiv_data1/oa_pdf/ae/62/ymj-55-191.PMC3874912.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 196Arch Phys Med Rehabil 2000;81:1432-5.,Non-OADS,/arxiv_data1/oa_pdf/ae/62/ymj-55-191.PMC3874912.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 141Effect of Peritoneal Dialysis Modality on the 1-Year Rate   of Decline of Residual Renal Function Chan Ho Kim,1 Hyung Jung Oh,1 Mi Jung Lee,1 Young Eun Kwon,1 Yung Ly Kim,1 Ki Heon Nam,1  Kyoung Sook Park,1 Seong Yeong An,1 Kwang Il Ko,1 Hyang Mo Koo,1 Fa Mee Doh,1  Seung Hyeok Han,1 Tae-Hyun Yoo,1 Beom Seok Kim,1 Shin-Wook Kang,1,2 and Kyu Hun Choi1 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul; 2Severance Biomedical Science Institute, Brain Korea 21, Yonsei University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/5c/c2/ymj-55-141.PMC3874913.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The effect of different peritoneal dialysis (PD) modalities on the decline in  residual renal function (RRF) is unclear due to inconsistencies among studies.",Non-OADS,/arxiv_data1/oa_pdf/5c/c2/ymj-55-141.PMC3874913.pdf
"1-5 RRF Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.141 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):141-148, 2014",Non-OADS,/arxiv_data1/oa_pdf/5c/c2/ymj-55-141.PMC3874913.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 142excluded patients who were younger than 18 years of age,  patients who did not undergo serial urea kinetic studies in - cluding measurement of RRF, patients who had residual  urine volume <100 mL/day, and patients who changed  their PD modality during the first year of therapy.",Non-OADS,/arxiv_data1/oa_pdf/5c/c2/ymj-55-141.PMC3874913.pdf
Effect of PD Modalities on Residual Renal Function Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 143for categorical variables.,Non-OADS,/arxiv_data1/oa_pdf/5c/c2/ymj-55-141.PMC3874913.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 144ter initiation of dialysis according to PD modality.,Non-OADS,/arxiv_data1/oa_pdf/5c/c2/ymj-55-141.PMC3874913.pdf
Effect of PD Modalities on Residual Renal Function Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 145to preserve RRF as long as possible after the initiation of  dialysis.,Non-OADS,/arxiv_data1/oa_pdf/5c/c2/ymj-55-141.PMC3874913.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 146who have sufficient urine volume and RRF.,Non-OADS,/arxiv_data1/oa_pdf/5c/c2/ymj-55-141.PMC3874913.pdf
Effect of PD Modalities on Residual Renal Function Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 14710.,Non-OADS,/arxiv_data1/oa_pdf/5c/c2/ymj-55-141.PMC3874913.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 14836.,Non-OADS,/arxiv_data1/oa_pdf/5c/c2/ymj-55-141.PMC3874913.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 92Does Medical Emergency Team Intervention Reduce the  Prevalence of Emergency Endotracheal Intubation Complications?,Non-OADS,/arxiv_data1/oa_pdf/ed/58/ymj-55-92.PMC3874914.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Emergency endotracheal intubation (EEI) is a complex process that  leads to various complications.",Non-OADS,/arxiv_data1/oa_pdf/ed/58/ymj-55-92.PMC3874914.pdf
"In one prospective study, the most common rea - sons for intubation were a patient’s inability to preserve their own airway (70%), Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.92 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):92-98, 2014",Non-OADS,/arxiv_data1/oa_pdf/ed/58/ymj-55-92.PMC3874914.pdf
"MET Reduce Emergency Intubation Complications Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 93MET intervention” period) and prospectively from March  to August, 2009 (a six-month “after MET intervention” pe - riod).",Non-OADS,/arxiv_data1/oa_pdf/ed/58/ymj-55-92.PMC3874914.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 94The Mallampati classification is used for assessing the de - gree of hypopharynx visible.,Non-OADS,/arxiv_data1/oa_pdf/ed/58/ymj-55-92.PMC3874914.pdf
"MET Reduce Emergency Intubation Complications Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 95Although statistical significance was not shown, the time  from induction to intubation was reduced after MET interven - tion (7 minutes before vs. 6 minutes after MET, p=0.064),  whereas, in-hospital or ICU mortality rates were not affect - ed by a MET intervention (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ed/58/ymj-55-92.PMC3874914.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 96While a controversy exists as to whether MET improves  outcomes, several studies have shown a favorable effect on  patient outcomes after MET intervention.7-9 These studies  reported that MET intervention was associated with a re - duction in-hospital cardiac arrest and unplanned ICU ad - mission.",Non-OADS,/arxiv_data1/oa_pdf/ed/58/ymj-55-92.PMC3874914.pdf
MET Reduce Emergency Intubation Complications Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 97a six-month period of MET intervention and we enrolled  relatively small patients for mortality.,Non-OADS,/arxiv_data1/oa_pdf/ed/58/ymj-55-92.PMC3874914.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 9814.,Non-OADS,/arxiv_data1/oa_pdf/ed/58/ymj-55-92.PMC3874914.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 170Changes in Sexual Function and Comparison of Questionnaires  Following Surgery for Pelvic Organ Prolapse Soo Rim Kim,1 Yeo Jung Moon,2 Sei Kwang Kim,1 and Sang Wook Bai1 1Department of Obstetrics and Gynecology, Institute of Women’ s Life Medical Science, Yonsei University College of Medicine, Seoul; 2Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a4/aa/ymj-55-170.PMC3874915.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The aim of this study was to evaluate the effect of surgical repair of pel - vic organ prolapse on female sexual function and to assess correlations between  the two using two current standardized questionnaires.",Non-OADS,/arxiv_data1/oa_pdf/a4/aa/ymj-55-170.PMC3874915.pdf
"2 Furthermore, several factors, including relation - ship conflicts, socioeconomic status, sexual compatibility, and physical and psychi - atric disorders can affect sexual function.3-5 Pelvic floor weakness and organ pro - lapse are common physical conditions that negatively affect sexual function and Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.170 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):170-177, 2014",Non-OADS,/arxiv_data1/oa_pdf/a4/aa/ymj-55-170.PMC3874915.pdf
The Effect of Prolapse Surgery on Sexual Function Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 171ed information on their general medical and sexual history.,Non-OADS,/arxiv_data1/oa_pdf/a4/aa/ymj-55-170.PMC3874915.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 172test were used to evaluate categorical data.,OADS,/arxiv_data1/oa_pdf/a4/aa/ymj-55-170.PMC3874915.pdf
"The Effect of Prolapse Surgery on Sexual Function Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 173menopause, smoking and hormonal replacement therapy  (HRT).",Non-OADS,/arxiv_data1/oa_pdf/a4/aa/ymj-55-170.PMC3874915.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 174DISCUSSION FSD is a common problem among the general population,  and especially in pelvic organ prolapse patients.",Non-OADS,/arxiv_data1/oa_pdf/a4/aa/ymj-55-170.PMC3874915.pdf
The Effect of Prolapse Surgery on Sexual Function Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 175might be considered a treatment of concomitant urinary in - continence.,Non-OADS,/arxiv_data1/oa_pdf/a4/aa/ymj-55-170.PMC3874915.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 176care Technology R&D Project, Ministry for Health, Welfare  & Family Affairs, Republic of Korea (A084120).",Non-OADS,/arxiv_data1/oa_pdf/a4/aa/ymj-55-170.PMC3874915.pdf
The Effect of Prolapse Surgery on Sexual Function Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 17727.,Non-OADS,/arxiv_data1/oa_pdf/a4/aa/ymj-55-170.PMC3874915.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 232Comprehensive Variant Screening of the UGT Gene Family Jason Yongha Kim,1 Hyun Sub Cheong,2 Byung Lae Park,2 Lyoung Hyo Kim,2  Suhg Namgoong,2 Ji On Kim,2 Hae Deun Kim,3 Young Hoon Kim,3 Myeon Woo Chung,3  Soon Young Han,4 and Hyoung Doo Shin1,2 1Department of Life Science, Sogang University, Seoul; 2Department of Genetic Epidemiology, SNP Genetics, Inc., Seoul; 3Clinical Research Division and 4Toxicological Evaluation and Research Department, National Institute of Food and  Drug Safety Evaluation, Osong Health Technology Administration Complex, Osong, Korea.",Non-OADS,/arxiv_data1/oa_pdf/52/b0/ymj-55-232.PMC3874916.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  UGT1A1 , UGT2B7 , and UGT2B15  are well-known pharmacogenes that  belong to the uridine diphosphate glucuronyltransferase gene family.",Non-OADS,/arxiv_data1/oa_pdf/52/b0/ymj-55-232.PMC3874916.pdf
"1,2 The enzyme is expressed Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.232 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):232-239, 2014",Non-OADS,/arxiv_data1/oa_pdf/52/b0/ymj-55-232.PMC3874916.pdf
"Screening of UGT Gene Family Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 233icans, 48 European Americans, 48 Japanese, and 48 Han  Chinese subjects.",Non-OADS,/arxiv_data1/oa_pdf/52/b0/ymj-55-232.PMC3874916.pdf
Primers for the  amplification and sequencing analysis were designed by us - ing Primer3 software (http://frodo.wi.mit.edu) based on the  sequence of respective genes (Ref.,OADS,/arxiv_data1/oa_pdf/52/b0/ymj-55-232.PMC3874916.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 234Table 1.,Non-OADS,/arxiv_data1/oa_pdf/52/b0/ymj-55-232.PMC3874916.pdf
"Screening of UGT Gene Family Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 235ferred by only using SNPs with detectable minor allele fre - quencies (MAFs) in at least one ethnic group, and the re - sults were shown in Supplementary Fig.",Non-OADS,/arxiv_data1/oa_pdf/52/b0/ymj-55-232.PMC3874916.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 236ics.,Non-OADS,/arxiv_data1/oa_pdf/52/b0/ymj-55-232.PMC3874916.pdf
"Screening of UGT Gene Family Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 237razepam.14,15 Such studies have shown that *2 ( rs1902023 )  could be used as a pharmacogenetic marker to personalize  treatments with oxazepam or lorazepam.",Non-OADS,/arxiv_data1/oa_pdf/52/b0/ymj-55-232.PMC3874916.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 238transferases.,OADS,/arxiv_data1/oa_pdf/52/b0/ymj-55-232.PMC3874916.pdf
Screening of UGT Gene Family Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 239clusters.,OADS,/arxiv_data1/oa_pdf/52/b0/ymj-55-232.PMC3874916.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 9Clinical Outcomes and Prognostic Factors of Empirical  Antifungal Therapy with Itraconazole in the Patients with  Hematological Malignancies: A Prospective Multicenter  Observational Study in Korea Jin Seok Kim,1 June-Won Cheong,1 Ho Jin Shin,2 Jong Wook Lee,3 Je-Hwan Lee,4 Deok-Hwan Yang,5  Won Sik Lee,6 Hawk Kim,7 Joon Seong Park,8 Sung-Hyun Kim,9 Yang Soo Kim,10 Jae-Yong Kwak,11  Yee Soo Chae,12 Jinny Park,13 Young Rok Do,14 and Yoo Hong Min1 1Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul; 2Department of Hematology/Oncology, Pusan National University Hospital, Pusan National University School of Medicine, Busan; 3Department of Internal Medicine, Seoul St. Mary ’s Hospital, The Catholic University of Korea, Seoul; 4Department of Hematology, Asan Medical Center,  University of Ulsan College of Medicine, Seoul; 5Department of Hematology/Oncology, Chonnam National University Hwasun Hospital, Hwasun; 6Department of Internal Medicine, Busan Paik Hospital, Inje University, Busan; 7Department of Internal Medicine, Ulsan University Hospital, University of  Ulsan College of Medicine, Ulsan; 8Department of Hematology-Oncology, Ajou University School of Medicine, Suwon; 9Department of Internal Medicine,  Dong-A University College of Medicine, Busan; 10Department of Internal Medicine, Kosin University Gospel Hospital, Busan; 11Department of Internal  Medicine, Chonbuk National University Medical School, Jeonju; 12Department of Hematology-Oncology, Kyungpook National University Hospital, Daegu; 13Department of Internal Medicine, Gachon University, Gil Medical Center, Incheon; 14Department of Internal Medicine, Dongsan Medical Center,  Keimyung University School of Medicine, Daegu, Korea.",Non-OADS,/arxiv_data1/oa_pdf/cd/10/ymj-55-9.PMC3874917.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To identify prognostic factors for the outcomes of empirical antifungal  therapy, we performed a multicenter, prospective, observational study in immuno - compromised patients with hematological malignancies.",Non-OADS,/arxiv_data1/oa_pdf/cd/10/ymj-55-9.PMC3874917.pdf
"Key Words:    Hematological malignancy, prognosis, itraconazole, empirical anti - fungal therapyOriginal Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.9 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):9-18, 2014",Non-OADS,/arxiv_data1/oa_pdf/cd/10/ymj-55-9.PMC3874917.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 10evaluate prognostic factors for predicting the outcomes of  empirical IV itraconazole therapy among clinical data.,Non-OADS,/arxiv_data1/oa_pdf/cd/10/ymj-55-9.PMC3874917.pdf
"Empirical Antifungal Therapy with Itraconazole Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 11cal antifungal therapy as successful if all five of the follow - ing criteria were met: 1) successful treatment of baseline  fungal infection, 2) absence of any breakthrough fungal in - fection during empirical antifungal therapy and within 7  days after the completion of empirical antifungal therapy,  3) survival for at least 7 days after discontinuation of em - pirical antifungal therapy, 4) resolution of fever (defined as  a temperature below 38°C for at least 2 days) prior to re - covery from neutropenia, and 5) no premature discontinua - tion of empirical antifungal therapy due to drug-related tox - icity or lack of efficacy.",Non-OADS,/arxiv_data1/oa_pdf/cd/10/ymj-55-9.PMC3874917.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 12were enrolled during consolidation chemotherapy.,Non-OADS,/arxiv_data1/oa_pdf/cd/10/ymj-55-9.PMC3874917.pdf
Empirical Antifungal Therapy with Itraconazole Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 13the underlying hematological malignancies.,Non-OADS,/arxiv_data1/oa_pdf/cd/10/ymj-55-9.PMC3874917.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 14with a poor outcome of empirical antifungal therapy with  IV itraconazole.,Non-OADS,/arxiv_data1/oa_pdf/cd/10/ymj-55-9.PMC3874917.pdf
"Empirical Antifungal Therapy with Itraconazole Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 15trials using IV itraconazole.6,7,12,13 We also identified prog - nostic factors for predicting the outcomes of empirical anti - fungal therapy in patients with recurrent or persistent neu - tropenic fever.",Non-OADS,/arxiv_data1/oa_pdf/cd/10/ymj-55-9.PMC3874917.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 16is (51.4% in high-risk group, 51.3% in low-risk group).",Non-OADS,/arxiv_data1/oa_pdf/cd/10/ymj-55-9.PMC3874917.pdf
Empirical Antifungal Therapy with Itraconazole Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 17et al.,Non-OADS,/arxiv_data1/oa_pdf/cd/10/ymj-55-9.PMC3874917.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 18empirical antifungal therapy in patients with neutropenia and per - sistent fever.,Non-OADS,/arxiv_data1/oa_pdf/cd/10/ymj-55-9.PMC3874917.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 53Efficacy of Short-Term Growth Hormone Treatment   in Prepubertal Children with Idiopathic Short Stature  Ho-Seong Kim,1 Sei Won Yang,2 Han-Wook Yoo,3 Byung Kyu Suh,4 Cheol Woo Ko,5 Woo Yeong Chung,6  Kee Hyoung Lee,7 Jin Soon Hwang,8 Hyi-Jeong Ji,9 Hyunji Ahn,9 and Duk Hee Kim10 Department of Pediatrics, 1Endocrine Research Institute, Yonsei University College of Medicine, Seoul;  2Department of Pediatrics, Seoul National University, Seoul; 3University of Ulsan, Seoul; 4The Catholic University of Korea, Seoul;  5Kyungpook National University, Daegu; 6Inje University, Busan; 7Korea University, Seoul;  8Ajou University, Suwon; 9LG Life Sciences, Ltd., Seoul; 10Sowha Children’ s Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/66/f6/ymj-55-53.PMC3874918.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  It has been reported that daily recombinant human growth hormone  (GH) treatment showed beneficial effects on growth in prepubertal children with  idiopathic short stature (ISS).",Non-OADS,/arxiv_data1/oa_pdf/66/f6/ymj-55-53.PMC3874918.pdf
"It is defined as a condition when height is more than 2 standard deviation  score (SDS) below the corresponding mean height for a given age, gender, and a Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.53 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):53-60, 2014",Non-OADS,/arxiv_data1/oa_pdf/66/f6/ymj-55-53.PMC3874918.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 54efficacious for increasing height SDS without any adverse  effects.,Non-OADS,/arxiv_data1/oa_pdf/66/f6/ymj-55-53.PMC3874918.pdf
Efficacy of GH in Idiopathic Short Stature Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 55dren and adolescents.8  Adverse event rates were summarized by System Organ  Class MedDRA (a registered trademark of the International  Federation of Pharmaceutical Manufacturers Associations)  thesaurus terminology (http://www.meddramsso.com).,Non-OADS,/arxiv_data1/oa_pdf/66/f6/ymj-55-53.PMC3874918.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 56the PPS (Fig.,Non-OADS,/arxiv_data1/oa_pdf/66/f6/ymj-55-53.PMC3874918.pdf
Efficacy of GH in Idiopathic Short Stature Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 57pruritus on injection site that was reported twice in a same  subject was assessed as being related to the study drug and  it was resolved without any intervention.,Non-OADS,/arxiv_data1/oa_pdf/66/f6/ymj-55-53.PMC3874918.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 58of treatment.11,12 The acceleration of height velocity after  GH treatment is more prominent at a higher dosage (50 μg/ kg/day) than that at a dosage close to a replacement dosage  (25 μg/kg/day).13 These results suggest that children with  ISS may not have sufficient endogenous GH secretion to  overcome decreased GH sensitivity, therefore, a larger re - placement dose of GH results in more increase of the growth  response.",Non-OADS,/arxiv_data1/oa_pdf/66/f6/ymj-55-53.PMC3874918.pdf
"Efficacy of GH in Idiopathic Short Stature Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 59creased risk of breast, prostate, lung and colon cancer.24 Re- cently, preliminary report of the French Safety and Appropri - ateness of Growth hormone treatments in Europe (SAGhE)  study demonstrated that mortality rates were increased in  adults treated with GH as children.",Non-OADS,/arxiv_data1/oa_pdf/66/f6/ymj-55-53.PMC3874918.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 6016.,Non-OADS,/arxiv_data1/oa_pdf/66/f6/ymj-55-53.PMC3874918.pdf
Available at:  http://www.cdc.go.kr/.,Non-OADS,/arxiv_data1/oa_pdf/66/f6/ymj-55-53.PMC3874918.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 197Epithelial Wound Healing after Cataract Surgery Comparing   Two Different Topical Fluoroquinolones Kyung Eun Han,1 Woo Suk Chung,2 Tae-im Kim,3 Sekyung Kim,3 Terry Kim,4 and Eung Kweon Kim3,5,6 1Department of Ophthalmology, Hallym University College of Medicine, Chuncheon Sacred Heart Hospital, Chuncheon;  2Siloam Eye Hospital, Seoul; 3Corneal Dystrophy Research Institute, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea;  4Department of Ophthalmology, Duke University, Durham, NC, USA; 5Severance Biomedical Science Institute;  6Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/7c/b4/ymj-55-197.PMC3874919.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To compare the epithelial wound healing response of two preservative- free fluoroquinolones, moxifloxacin and levofloxacin, in patients who underwent  cataract surgery.",Non-OADS,/arxiv_data1/oa_pdf/7c/b4/ymj-55-197.PMC3874919.pdf
"Moxifloxacin and gatifloxacin have demonstrated 2- to 3-fold penetration into the  anterior chamber, improved activity against atypical mycobacteria, and greater an - tibacterial effects against gram-positive bacteria compared to second-generation Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.197 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):197-202, 2014",Non-OADS,/arxiv_data1/oa_pdf/7c/b4/ymj-55-197.PMC3874919.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 198surgeon (E.K.K.),Non-OADS,/arxiv_data1/oa_pdf/7c/b4/ymj-55-197.PMC3874919.pdf
Comparison of Fluoroquinolones after Cataract Surgery Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 199without interruption were interpreted as a non-defect cut  (Fig.,Non-OADS,/arxiv_data1/oa_pdf/7c/b4/ymj-55-197.PMC3874919.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 200floxacin group; 64.6±8.7 years, p>0.05).",OADS,/arxiv_data1/oa_pdf/7c/b4/ymj-55-197.PMC3874919.pdf
"Comparison of Fluoroquinolones after Cataract Surgery Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 201ofloxacin, levofloxacin, gatifloxacin, or ciprofloxacin on  healthy rabbit corneas, and showed that moxifloxacin  caused the least damage to the corneal epithelium.",Non-OADS,/arxiv_data1/oa_pdf/7c/b4/ymj-55-197.PMC3874919.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 202Epithelial healing rates with topical ciprofloxacin, ofloxacin, and  ofloxacin with artificial tears after photorefractive keratectomy.",Non-OADS,/arxiv_data1/oa_pdf/7c/b4/ymj-55-197.PMC3874919.pdf
This study is registered at http://www.clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/7c/b4/ymj-55-197.PMC3874919.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 30Application of Array-Based Comparative Genomic   Hybridization to Pediatric Neurologic Diseases Jung Hye Byeon,1 Eunsim Shin,2 Gun-Ha Kim,1 Kyungok Lee,2  Young Sook Hong,1 Joo Won Lee,1 and Baik-Lin Eun1 1Department of Pediatrics, Korea University College of Medicine, Seoul; 2Neodine Medical Institute, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/fa/0d/ymj-55-30.PMC3874920.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Array comparative genomic hybridization (array-CGH) is a technique  used to analyze quantitative increase or decrease of chromosomes by competitive  DNA hybridization of patients and controls.",Non-OADS,/arxiv_data1/oa_pdf/fa/0d/ymj-55-30.PMC3874920.pdf
"In most of these cases of developmental delay and mental Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.30 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):30-36, 2014",Non-OADS,/arxiv_data1/oa_pdf/fa/0d/ymj-55-30.PMC3874920.pdf
Array-CGH in Pediatric Neurologic Diseases Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 31karyotyping and array CGH simultaneously.,OADS,/arxiv_data1/oa_pdf/fa/0d/ymj-55-30.PMC3874920.pdf
"The array was scanned at scanner resolution of 2.5 µm  using NimbleGen MS 200 Microarray Scanner and ana - lyzed using NimbleScan v2.6 software (Roche NimbleGen  Inc., Madison, WI, USA) and Genoglyphix analysis soft - ware (http://www.uk.genoglyphix.com) (Signature Genom - ics, Spokane, W A, USA) with the use of aberration filter of  three contiguous probes.",OADS,/arxiv_data1/oa_pdf/fa/0d/ymj-55-30.PMC3874920.pdf
"Public databases, such as American College of Medical  Genetics Practice Guidelines, University of California San - ta Cruz Genome Browser (http://genome.ucsc.edu), Deci - pher (http://decipher.sanger.ac.uk), the Database of Genom - ic Variants (DGV , http://projects.tcag.ca/variation/), the  International Standards for Cytogenomic Arrays (http://is - caconsortium.org), the National Center for Biotechnology  Information, and the Genoglyphix Chromosome Aberration  Database, a genoglyphix-user database provided by genol - gyphix, were used to classify and interpret the identified  CNVs into either benign CNVs (CNVs of uncertain clinical  significance) or pathogenic CNVs.",OADS,/arxiv_data1/oa_pdf/fa/0d/ymj-55-30.PMC3874920.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 32Clinically significant cases Nineteen patients had aberrations associated with known  syndromic regions (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/fa/0d/ymj-55-30.PMC3874920.pdf
Array-CGH in Pediatric Neurologic Diseases Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 33Table 1.,Non-OADS,/arxiv_data1/oa_pdf/fa/0d/ymj-55-30.PMC3874920.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 3427 had a 955.4 kb duplication in the 11q12.1(55,657,058- 56,612,480) region, which was associated with mental re - tardation in a previous report.17 No.",Non-OADS,/arxiv_data1/oa_pdf/fa/0d/ymj-55-30.PMC3874920.pdf
Array-CGH in Pediatric Neurologic Diseases Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 35mosaicisms of patient No.,Non-OADS,/arxiv_data1/oa_pdf/fa/0d/ymj-55-30.PMC3874920.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 3618.,Non-OADS,/arxiv_data1/oa_pdf/fa/0d/ymj-55-30.PMC3874920.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 61The Assessment of the Oncological Safety Margin of Insufficient  Lymph Node Dissection in pT2 (pm) Gastric Cancer Yoon Young Choi,1* Ji Yeong An,1* In Cho,1 In Gyu Kwon,1 Dae Ryong Kang,2  Woo Jin Hyung,1 and Sung Hoon Noh1 1Department of Surgery, 2Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/6e/f8/ymj-55-61.PMC3874921.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To identify the effect of insufficient lymph node dissection (LND) on  the survival of patients with pT2 gastric cancer.",Non-OADS,/arxiv_data1/oa_pdf/6e/f8/ymj-55-61.PMC3874921.pdf
"However, sometimes patients who were considered to  have EGC through preoperative evaluation can turn out to have AGC in the final Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.61 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):61-69, 2014",Non-OADS,/arxiv_data1/oa_pdf/6e/f8/ymj-55-61.PMC3874921.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 62then the dissection was classified as insufficient LND.,Non-OADS,/arxiv_data1/oa_pdf/6e/f8/ymj-55-61.PMC3874921.pdf
Insufficient LN Dissection in pT2 Gastric Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 63vival and the 95% confidence intervals (CI).,Non-OADS,/arxiv_data1/oa_pdf/6e/f8/ymj-55-61.PMC3874921.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 64the OR of performing insufficient LND was 2.5 ( p=0.01).,OADS,/arxiv_data1/oa_pdf/6e/f8/ymj-55-61.PMC3874921.pdf
"Insufficient LN Dissection in pT2 Gastric Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 65creased to 1.56 (95% CI: 0.60-4.08), but this value was not  statistically significant ( p=0.366).",Non-OADS,/arxiv_data1/oa_pdf/6e/f8/ymj-55-61.PMC3874921.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 66mor depth in preoperative evaluation, and the incidence of  focal invasion in pT2 GC was reported at 32.1%.11 There - fore, preoperative EGC is occasionally diagnosed as AGC  after surgical resection, whereas the opposite is observed in  some cases.",Non-OADS,/arxiv_data1/oa_pdf/6e/f8/ymj-55-61.PMC3874921.pdf
"Insufficient LN Dissection in pT2 Gastric Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 67on selected N2 stations (#10, 11, or 12a) or pT2 GC.21,22  Currently, it appears to be nearly impossible to determine  whether insufficient LND for pT2 GC is secure for patients  with pN2 or pN3 category after gastrectomy.",Non-OADS,/arxiv_data1/oa_pdf/6e/f8/ymj-55-61.PMC3874921.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 684.,Non-OADS,/arxiv_data1/oa_pdf/6e/f8/ymj-55-61.PMC3874921.pdf
Insufficient LN Dissection in pT2 Gastric Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 69MDCT with virtual gastroscopy: comparison with staging with  endoscopic ultrasound.,Non-OADS,/arxiv_data1/oa_pdf/6e/f8/ymj-55-61.PMC3874921.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 113Positive Maternal C-Reactive Protein Predicts Neonatal Sepsis  Ji Hyun Jeon,1 Ran Namgung,2 Min Soo Park,2 Koo In Park,2 and Chul Lee2 1Department of Pediatrics, CHA Gangnam Medical Center, CHA University, Seoul; 2Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/df/aa/ymj-55-113.PMC3874922.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To evaluate the diagnostic performance of maternal inflammatory mark - er: C-reactive protein (CRP) in predicting early onset neonatal sepsis (that occur - ring within 72 hours after birth).",Non-OADS,/arxiv_data1/oa_pdf/df/aa/ymj-55-113.PMC3874922.pdf
"6 The birth of preterm infants increases neonatal sep -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.113 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):113-117, 2014",Non-OADS,/arxiv_data1/oa_pdf/df/aa/ymj-55-113.PMC3874922.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 114days of birth;17 1) longer than 1 hour of unstable body tem - perature (axillary temperature: fever >37.5°C, hypothermia  <36.5°C), 2) cardiovascular abnormality (heart rate <100,  or >160 per minute, hypotension requiring inotropics), 3)  respiratory abnormality (respiration rate >60 per minute,  dyspnea, apnea, increased oxygen demand or treatment with  mechanical ventilator), 4) metabolic acidiosis (arterial blood  gas analysis: pH <7.35, base deficit ≥6), 5) gastrointestinal  tract abnormality (vomiting, abdominal distension, abnormal  gastric intolerance, bloody stool and umbilical erythema), 6)  neurological abnormality (drowsiness, muscle weakness, ex - cessive irritability and convulsion).",Non-OADS,/arxiv_data1/oa_pdf/df/aa/ymj-55-113.PMC3874922.pdf
Maternal C-Reactive Protein and Neonatal Sepsis Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 115the sepsis group was significantly higher than controls (Table  1).,Non-OADS,/arxiv_data1/oa_pdf/df/aa/ymj-55-113.PMC3874922.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 116in neonatal sepsis.,Non-OADS,/arxiv_data1/oa_pdf/df/aa/ymj-55-113.PMC3874922.pdf
Maternal C-Reactive Protein and Neonatal Sepsis Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 11712.,Non-OADS,/arxiv_data1/oa_pdf/df/aa/ymj-55-113.PMC3874922.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 19Change in Tinnitus after Treatment of Vestibular Schwannoma:  Microsurgery vs. Gamma Knife Radiosurgery Soon Hyung Park,1 Hee So Oh,2 Ju Hyun Jeon,3 Yong Ju Lee,2 In Seok Moon,2 and Won-Sang Lee2 1Department of Otorhinolaryngology, Keimyung University College of Medicine, Daegu; 2Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul;  3Department of Otorhinolaryngology, Inje Univertigy College of Medicine, Ilsan Paik Hospital, Goyang, Korea.",Non-OADS,/arxiv_data1/oa_pdf/8a/5c/ymj-55-19.PMC3874923.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Tinnitus is a very common symptom of vestibular schwannoma, present in  45 to 80% of patients.",Non-OADS,/arxiv_data1/oa_pdf/8a/5c/ymj-55-19.PMC3874923.pdf
"In addition to sensorineural hearing loss, tinnitus  is one of the most common symptoms in vestibular schwannoma patients,2-4 and Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.19 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):19-24, 2014",Non-OADS,/arxiv_data1/oa_pdf/8a/5c/ymj-55-19.PMC3874923.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 20tients who underwent TLM (n=54) or GKS (n=24) and reg - ularly followed at Severance Hospital between January 2009  and December 2012.,Non-OADS,/arxiv_data1/oa_pdf/8a/5c/ymj-55-19.PMC3874923.pdf
Cochlear Nerve Section Can Reduce Tinnitus Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 21DISCUSSION There are various results of changes in tinnitus after micro - surgery.,Non-OADS,/arxiv_data1/oa_pdf/8a/5c/ymj-55-19.PMC3874923.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 22that change in tinnitus occurred only in a few patients (4%),15,16  whereas other studies showed reduced tinnitus in about  45% of patients treated with GKS.17,18 In our study, patients  who underwent GKS showed worsened tinnitus in 74%,  based on tinnitus handicap inventory score.",Non-OADS,/arxiv_data1/oa_pdf/8a/5c/ymj-55-19.PMC3874923.pdf
Cochlear Nerve Section Can Reduce Tinnitus Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 23may be less effective or not helpful in reducing tinnitus af - ter operation.,Non-OADS,/arxiv_data1/oa_pdf/8a/5c/ymj-55-19.PMC3874923.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 2426.,Non-OADS,/arxiv_data1/oa_pdf/8a/5c/ymj-55-19.PMC3874923.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 270A Case of Pneumomediastinum and Parapneumonic Effusions  Following Pharyngeal Perforation Caused by Shouting Sei Won Kim,1  Hyeon Hui Kang,1 Ji Young Kang,1 Sung Kyoung Kim,1  Bae Young Lee,2 Sang Haak Lee,1 and Hwa Sik Moon1 1Division of Pulmonology, Critical Care and Sleep Medicine, Department of Internal Medicine and 2Department of Radiology, School of Medicine, The Catholic University of Korea, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c5/1f/ymj-55-270.PMC3874924.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Spontaneous pneumomediastinum is an uncommon disorder, and usually affects  young men and has a benign course.",Non-OADS,/arxiv_data1/oa_pdf/c5/1f/ymj-55-270.PMC3874924.pdf
"CASE REPORT A 43-year-old man presented with a 2-day history of dyspnea and chest pain after Case Reporthttp://dx.doi.org/10.3349/ymj.2014.55.1.270 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):270-272, 2014",Non-OADS,/arxiv_data1/oa_pdf/c5/1f/ymj-55-270.PMC3874924.pdf
"Pneumomediastinum Caused by Shouting Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 271left side was consistent with parapneumonic effusions (pH  8.0, red blood cell count 3840/mm3, white blood cell count  2880/mm3, neutrophils 95%, total protein 4.6 g/dL, albu - min 2.5 g/dL, lactate dehydrogenase 27198 IU/L, glucose  27 mg/dL).",Non-OADS,/arxiv_data1/oa_pdf/c5/1f/ymj-55-270.PMC3874924.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 272and parapneumonic effusions.,Non-OADS,/arxiv_data1/oa_pdf/c5/1f/ymj-55-270.PMC3874924.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 70Feasibility and Outcomes of Hypofractionated Simultaneous  Integrated Boost-Intensity Modulated Radiotherapy   for Malignant Gliomas: A Preliminary Report Jihye Cha,1 Chang-Ok Suh,1 Kwangwoo Park,1 Jong Hee Chang,2 Kyu Sung Lee,2 Se Hoon Kim,3  Jee Suk Chang,1 Joo Ho Kim,1 Yang-Gun Suh,1 Jun Won Kim,1 and Jaeho Cho1 Departments of 1Radiation Oncology, 2Neurosurgery, and 3Pathology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/40/88/ymj-55-70.PMC3874925.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The aim of this study was to assess the feasibility and efficacy of hypo - fractionated simultaneous integrated boost-intensity modulated radiotherapy (SIB- IMRT) using three-layered planning target volumes (PTV) for malignant gliomas.",Non-OADS,/arxiv_data1/oa_pdf/40/88/ymj-55-70.PMC3874925.pdf
"1 Although a number of trials have attempted to Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.70 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):70-77, 2014",Non-OADS,/arxiv_data1/oa_pdf/40/88/ymj-55-70.PMC3874925.pdf
Hypofractionated SIB-IMRT in Malignant Glioma Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 71surgery in principle.,Non-OADS,/arxiv_data1/oa_pdf/40/88/ymj-55-70.PMC3874925.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 72Toxicity assessment and follow-up Toxicity was graded according to the toxicity criteria of the  Radiation Therapy Oncology Group/European Organization  for Research and Treatment of Cancer.,Non-OADS,/arxiv_data1/oa_pdf/40/88/ymj-55-70.PMC3874925.pdf
Hypofractionated SIB-IMRT in Malignant Glioma Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 73Significant prognostic factors shown to be related to bet - ter OS on univariate analysis included Karnofsky perfor - mance status (KPS) 90 or 100 ( p=0.005) and a total dose  ≥125 BEDGy 3 (p=0.032).,Non-OADS,/arxiv_data1/oa_pdf/40/88/ymj-55-70.PMC3874925.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 7421 months after treatment of a tumor of left temporal ori - gin.,Non-OADS,/arxiv_data1/oa_pdf/40/88/ymj-55-70.PMC3874925.pdf
Hypofractionated SIB-IMRT in Malignant Glioma Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 75optimal fractionation should go beyond the fraction size of  1.8-2.0 Gy.,Non-OADS,/arxiv_data1/oa_pdf/40/88/ymj-55-70.PMC3874925.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 76chemotherapy.,Non-OADS,/arxiv_data1/oa_pdf/40/88/ymj-55-70.PMC3874925.pdf
Hypofractionated SIB-IMRT in Malignant Glioma Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 77glioblastoma in a randomised phase III study: 5-year analysis of  the EORTC-NCIC trial.,Non-OADS,/arxiv_data1/oa_pdf/40/88/ymj-55-70.PMC3874925.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 162Totally Laparoscopic Roux-en-Y Gastrojejunostomy after  Laparoscopic Distal Gastrectomy: Analysis of Initial   50 Consecutive Cases of Single Surgeon in Comparison   with Totally Laparoscopic Billroth I Reconstruction Ji Yeong An,* In Cho,* Yoon Young Choi, Yoo Min Kim, and Sung Hoon Noh Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/fd/19/ymj-55-162.PMC3874926.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Roux-en-Y reconstruction (RY) in laparoscopic distal gastrectomy for  gastric cancer is a more complicated procedure than Billroth-I (BI) or Billroth-II.",Non-OADS,/arxiv_data1/oa_pdf/fd/19/ymj-55-162.PMC3874926.pdf
"Therefore, RY has been the reconstruction method used the Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.162 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):162-169, 2014",OADS,/arxiv_data1/oa_pdf/fd/19/ymj-55-162.PMC3874926.pdf
"Laparoscopic RY Distal Gastrectomy Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 163organ resection such as cholecystectomy, hysterectomy, and  colectomy were excluded.",Non-OADS,/arxiv_data1/oa_pdf/fd/19/ymj-55-162.PMC3874926.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 164portant to transversely close the hole of the distal jejunum  30 cm distal from gastrojejunostomy for a patulous lumen  (Fig.,Non-OADS,/arxiv_data1/oa_pdf/fd/19/ymj-55-162.PMC3874926.pdf
"Laparoscopic RY Distal Gastrectomy Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 165method or Fisher’s exact test, and continuous data were an - alyzed using the Mann-Whitney U test.",Non-OADS,/arxiv_data1/oa_pdf/fd/19/ymj-55-162.PMC3874926.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 166of blood loss during surgery.,Non-OADS,/arxiv_data1/oa_pdf/fd/19/ymj-55-162.PMC3874926.pdf
Laparoscopic RY Distal Gastrectomy Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 167ples were obtained after an overnight fast.,Non-OADS,/arxiv_data1/oa_pdf/fd/19/ymj-55-162.PMC3874926.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 168the operation time and anastomosis time decrease with the  accumulation of case numbers.,Non-OADS,/arxiv_data1/oa_pdf/fd/19/ymj-55-162.PMC3874926.pdf
"Laparoscopic RY Distal Gastrectomy Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 169Schulick RD, et al.",Non-OADS,/arxiv_data1/oa_pdf/fd/19/ymj-55-162.PMC3874926.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 132Concomitant Impact of High-Sensitivity C-Reactive Protein and  Renal Dysfunction in Patients with Acute Myocardial Infarction  Yong Un Kang,1 Min Jee Kim,1 Joon Seok Choi,1 Chang Seong Kim,1 Eun Hui Bae,1 Seong Kwon Ma,1  Young-Keun Ahn,1,2 Myung Ho Jeong,1,2 Young Jo Kim,3 Myeong Chan Cho,4 Chong Jin Kim,5  Soo Wan Kim,1 and Other Korea Acute Myocardial Infarction Registry Investigators 1Department of Internal Medicine, Chonnam National University Medical School, Gwangju;  2Cardiovascular Research Institute of Chonnam National University, Gwangju; 3Department of Internal Medicine, Yeungnam University, Daegu;  4Department of Internal Medicine, Chungbuk National University, Cheongju; 5Department of Internal Medicine, Kyunghee University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d1/b9/ymj-55-132.PMC3874927.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The present study aimed to investigate the impact of high-sensitivity C- reactive protein (hs-CRP) and renal dysfunction on clinical outcomes in acute myo - cardial infarction (AMI) patients.",Non-OADS,/arxiv_data1/oa_pdf/d1/b9/ymj-55-132.PMC3874927.pdf
"Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.132 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):132-140, 2014",Non-OADS,/arxiv_data1/oa_pdf/d1/b9/ymj-55-132.PMC3874927.pdf
"Impact of hs-CRP and Renal Dysfunction in AMI  Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 133patients were excluded sequentially: patients who were not  available for estimation of glomerular filtration rate; patients  lacking information on levels of hs-CRP; patients with hs- CRP greater than 10 mg/dL and with active infections, tu - mors, or inflammatory disease; and patients who could not  be followed over 1 year or whose data were uncertain.",Non-OADS,/arxiv_data1/oa_pdf/d1/b9/ymj-55-132.PMC3874927.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 134of the 4 groups on survival over the 12-month follow-up pe - riod.,Non-OADS,/arxiv_data1/oa_pdf/d1/b9/ymj-55-132.PMC3874927.pdf
Impact of hs-CRP and Renal Dysfunction in AMI  Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 135hs-CRP (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/d1/b9/ymj-55-132.PMC3874927.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 136p<0.001; HR 3.003, 95% CI 2.269-3.974, p<0.001; HR  5.087, 95% CI 3.755-6.891, p<0.001) (Table 6, Fig.",Non-OADS,/arxiv_data1/oa_pdf/d1/b9/ymj-55-132.PMC3874927.pdf
"Impact of hs-CRP and Renal Dysfunction in AMI  Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 137Furthermore, recent studies clearly provided an indepen - dent, and inversely graded association between decreasing  levels of renal function and increasing risk of death, and car - diovascular events as eGFR fell below 60 mL·min-1·1.73 CVD.1 The high prevalence of CVD in CKD patients sug - gests the importance of traditional (hypertension, DM, smok - ing, and hyperlipidemia) as well as non-traditional [CRP , fi - brinogen, interleukin-6, factor VIIIc, lipoprotein(a) and  hemoglobin] CKD risk factors in the pathogenesis of CVD.7,17  The present study compared clinical outcomes and investi - gated the association between CKD and hs-CRP in patients  with AMI.",Non-OADS,/arxiv_data1/oa_pdf/d1/b9/ymj-55-132.PMC3874927.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 138function were a highly independent predictor of mortality.,Non-OADS,/arxiv_data1/oa_pdf/d1/b9/ymj-55-132.PMC3874927.pdf
Impact of hs-CRP and Renal Dysfunction in AMI  Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 139ter percutaneous coronary intervention in the community.,Non-OADS,/arxiv_data1/oa_pdf/d1/b9/ymj-55-132.PMC3874927.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 140ondary analysis from the JUPITER (Justification for the Use of  Statins in Prevention-an Intervention Trial Evaluating Rosuvas - tatin) trial.,Non-OADS,/arxiv_data1/oa_pdf/d1/b9/ymj-55-132.PMC3874927.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 254Psychological and Social Factors Affecting Internet Searches on  Suicide in Korea: A Big Data Analysis of Google Search Trends Tae Min Song,1 Juyoung Song,2 Ji-Young An,3 Laura L. Hayman,4 and Jong-Min Woo5 1Research Center on Psychosocial Health, Korea Institute for Health and Social Affairs, Seoul; 2International Center for Criminal Justice, Korean Institute of Criminology, Seoul; 3u-Healthcare Design & Healthcare Service Design Development Program, Design Institute, Inje University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/53/6d/ymj-55-254.PMC3874928.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The average mortality rate for death by suicide among OECD countries is  12.8 per 100000, and 33.5 for Korea.",Non-OADS,/arxiv_data1/oa_pdf/53/6d/ymj-55-254.PMC3874928.pdf
"Additionally, suicide rates among teenagers and the elderly were reported to be ex - traordinarily high compared to other OECD countries.2 The reported causes of sui - cide in Korea include economic issues, family problems, depression, and anxiety Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.254 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):254-263, 2014",Non-OADS,/arxiv_data1/oa_pdf/53/6d/ymj-55-254.PMC3874928.pdf
"Google Search Trends for a Big Data Analysis Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 255counterparts.20 On the contrary, among lifestyle-related be - haviors associated with better health, exercise is reported to  be a protective factor for preventing diseases or facilitating  recovery from diseases, as well as for maintaining and pro - moting optimal mental health.",Non-OADS,/arxiv_data1/oa_pdf/53/6d/ymj-55-254.PMC3874928.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 256sion and suicide, and that lifestyle factors related to health  have mediating effects on the relationship between stress  and suicide.",Non-OADS,/arxiv_data1/oa_pdf/53/6d/ymj-55-254.PMC3874928.pdf
Google Search Trends for a Big Data Analysis Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 257Model 3 (Condition model):    SSV ij=ϒ00+ϒ 01*YSR j   +ϒ 10*STSV ij   +ϒ 20*DSV ij   +ϒ 30*ESV ij   +u 0j+u 1j*STSV ij+u 2j*UER+u 3j*CES+r ij Model 4 (Interaction model):    SSV ij=ϒ00+ϒ 01*YSR j   +ϒ 10*STSV ij+ϒ 11*YSR j*STSV ij   +ϒ 20*DSV ij   +ϒ 30*ESV ij   +u 0j+u 1j*STSV ij+rij RESULTS   Descriptive statistics for major study variables A descriptive analysis was conducted to test the normality  of variables (Table 1).,OADS,/arxiv_data1/oa_pdf/53/6d/ymj-55-254.PMC3874928.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 258V ariance ratio that is explained by a difference in level 2  (yearly) =[Level 2 (year) variance]/[Level 1 (month) variance+  Level 2 (year) variance]  =127.98/(256.61+127.98) =0.33  This showed that yearly level variance accounted for about  33.2% of the total variance explained regarding monthly  SSV; consequently, the monthly level variance was shown  to make up about 66.8% of the total variance explained.",OADS,/arxiv_data1/oa_pdf/53/6d/ymj-55-254.PMC3874928.pdf
"Google Search Trends for a Big Data Analysis Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 259significant ( χ2=12.41, p=0.053), and there were differences  by year ( χ2=50.32, p<0.001).",OADS,/arxiv_data1/oa_pdf/53/6d/ymj-55-254.PMC3874928.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 260peared to affect stress-related searches ( χ2=15.29, p=0.018).",Non-OADS,/arxiv_data1/oa_pdf/53/6d/ymj-55-254.PMC3874928.pdf
"Google Search Trends for a Big Data Analysis Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 261ety, therefore, classifying data-driven information and se - curing personal data should be also considered to prepare  another societal challenge.",Non-OADS,/arxiv_data1/oa_pdf/53/6d/ymj-55-254.PMC3874928.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 262& Sons, Ltd.; 2008. p.275-91.",Non-OADS,/arxiv_data1/oa_pdf/53/6d/ymj-55-254.PMC3874928.pdf
Available at: http://www.hankyung.com/ news/app/newsview.php?aid=2007050274801&intype=1.,Non-OADS,/arxiv_data1/oa_pdf/53/6d/ymj-55-254.PMC3874928.pdf
"Google Search Trends for a Big Data Analysis Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 263vation, Competition, and Productivity; 2011.",OADS,/arxiv_data1/oa_pdf/53/6d/ymj-55-254.PMC3874928.pdf
Available at: http://news.donga.com/3/all/20121029/  50456912/1.,Non-OADS,/arxiv_data1/oa_pdf/53/6d/ymj-55-254.PMC3874928.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 203Inflammatory Cytokine and Osmolarity Changes in the Tears of  Dry Eye Patients Treated with Topical 1% Methylprednisolone Ji Hwan Lee, Kyung Min, Se Kyung Kim, Eung Kweon Kim, and Tae-im Kim Vision Research Institute, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4a/89/ymj-55-203.PMC3874929.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To evaluate changes in clinical outcomes, inflammatory cytokine levels,  and tear osmolarity in the tears of patients with moderate to severe dry eye syn - drome before and after the application of topical 1% methylprednisolone.",Non-OADS,/arxiv_data1/oa_pdf/4a/89/ymj-55-203.PMC3874929.pdf
"In - creased levels of osmolarity and inflammatory cytokines have been detected in the Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.203 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):203-208, 2014",Non-OADS,/arxiv_data1/oa_pdf/4a/89/ymj-55-203.PMC3874929.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 204Review Board of Severance Hospital and conducted ac - cording to the Declaration of Helsinki and Good Clinical  Practices.,Non-OADS,/arxiv_data1/oa_pdf/4a/89/ymj-55-203.PMC3874929.pdf
"Cytokine and Osmolarity Changes in Dry Eye Syndrome Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 205Biosciences, San Jose, CA, USA).",Non-OADS,/arxiv_data1/oa_pdf/4a/89/ymj-55-203.PMC3874929.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 206decreased at 8 weeks, but the decreases were not statistical - ly significant (Table 2, Fig.",OADS,/arxiv_data1/oa_pdf/4a/89/ymj-55-203.PMC3874929.pdf
Cytokine and Osmolarity Changes in Dry Eye Syndrome Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 207the improvement of dry eyes.,Non-OADS,/arxiv_data1/oa_pdf/4a/89/ymj-55-203.PMC3874929.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 208randomized studies of the efficacy and safety of cyclosporine oph - thalmic emulsion in moderate to severe dry eye disease.,Non-OADS,/arxiv_data1/oa_pdf/4a/89/ymj-55-203.PMC3874929.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 126The Immunogenicity of a Single Dose of Hepatitis A Virus  Vaccines (Havrix® and Epaxal®) in Korean Young Adults Jiseun Lim,1 Yeong-Jun Song,1 Woong-Sub Park,2 Haesook Sohn,3 Moo-Sik Lee,4  Dong-Hoon Shin,5 Chun-Bae Kim,6 Hwasung Kim,7 Gyung-Jae Oh,8 and Moran Ki1 1Department of Preventive Medicine, Eulji University School of Medicine, Daejeon;  2Department of Preventive Medicine & Public Health, College of Medicine, Kwandong University, Gangneung;  3Department of Preventive Medicine, School of Medicine, Inje University, Busan;  4Department of Preventive Medicine, College of Medicine, Konyang University, Daejeon;  5Department of Preventive Medicine, School of Medicine, Keimyung University, Daegu;  6Department of Preventive Medicine, Institute for Poverty Alleviation & International Development,  Yonsei University Wonju College of Medicine, Wonju;   7Deparment of Preventive Medicine, Medical College Soonchunhyang University, Cheonan;  8Department of Preventive Medicine, Wonkwang University Medical School, Iksan, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a6/c8/ymj-55-126.PMC3874930.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Assessing the immunogenicity of a single dose of hepatitis A virus  (HA V) vaccines is important because some people receive only a single dose.",Non-OADS,/arxiv_data1/oa_pdf/a6/c8/ymj-55-126.PMC3874930.pdf
"Key Words:    Hepatitis A virus, hepatitis A vaccine, immune, vaccine, young adults  INTRODUCTION Recently, hepatitis A virus (HA V) infection has become an important public health  problem in countries such as Korea that have seen improvements in their socio -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.126 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):126-131, 2014",Non-OADS,/arxiv_data1/oa_pdf/a6/c8/ymj-55-126.PMC3874930.pdf
Immunogenicity of a Single Dose of HA V V accines Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 127or Epaxal.,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/ymj-55-126.PMC3874930.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 128lated factors, gender, obesity, grade of alcohol use, and vac - cine type were found to significantly affect the seroconver - sion rate.",Non-OADS,/arxiv_data1/oa_pdf/a6/c8/ymj-55-126.PMC3874930.pdf
"Immunogenicity of a Single Dose of HA V V accines Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 129than women for both vaccines, but the gender-related differ - ence was statistically significant only for the Epaxal group  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/a6/c8/ymj-55-126.PMC3874930.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 130non-respondents (82.8%) was higher than that in the re - spondents (66.5%).,OADS,/arxiv_data1/oa_pdf/a6/c8/ymj-55-126.PMC3874930.pdf
Immunogenicity of a Single Dose of HA V V accines Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 1311999;6:228-33.,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/ymj-55-126.PMC3874930.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 224The Influence of Hypothermia on Transfusion Requirement   in Patients Who Received Clopidogrel in Proximity   to Off-Pump Coronary Bypass Surgery Bo Ra Lee,1 Jong Wook Song,1,2 Young Lan Kwak,1,2,3 Kyoung Jong Yoo,4 and Jae Kwang Shim1,2 1Department of Anesthesiology and Pain Medicine, 2Anesthesia and Pain Research Institute, 3Severance Biomedical Science Institute and  4Division of Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/71/6c/ymj-55-224.PMC3874931.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Hypothermia adversely affects the coagulation that could be of clinical  significance in patients receiving clopidogrel.",Non-OADS,/arxiv_data1/oa_pdf/71/6c/ymj-55-224.PMC3874931.pdf
"Key Words:    Clopidogrel, hypothermia, off-pump coronary artery bypass surgery,  transfusion INTRODUCTION With an increasing amount of evidence suggesting an ischemic benefit of some de - gree of platelet inhibition at the time of coronary artery bypass graft surgery (CABG), off-pump coronary artery bypass surgery (OPCAB) is gaining renewed interest in patients who continue clopidogrel as it is devoid of platelet dysfunction or throm -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.1.224 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):224-231, 2014",Non-OADS,/arxiv_data1/oa_pdf/71/6c/ymj-55-224.PMC3874931.pdf
"Hypothermia and Transfusion Requirement Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 225>5 days before surgery (n=166), preexisting hypothermia  (<36°C) or hyperthermia (>38°C, n=1), already enrolled in  another randomized controlled trial (n=207), required  emergent or salvage operations (n=21), required emergent  conversion to an on-pump procedure (n=2), a postoperative  temperature >38°C (n=2).",Non-OADS,/arxiv_data1/oa_pdf/71/6c/ymj-55-224.PMC3874931.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 226<0.05 between patients who required multiple transfusions  or not were first introduced to a univariate logistic regres - sion analysis.,Non-OADS,/arxiv_data1/oa_pdf/71/6c/ymj-55-224.PMC3874931.pdf
Hypothermia and Transfusion Requirement Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 227disease were identified as independent predictors (Table 5).,Non-OADS,/arxiv_data1/oa_pdf/71/6c/ymj-55-224.PMC3874931.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 228in the hypothermia group, no association was observed be - tween hypothermia and a composite of morbidity/mortality  endpoints.",Non-OADS,/arxiv_data1/oa_pdf/71/6c/ymj-55-224.PMC3874931.pdf
Hypothermia and Transfusion Requirement Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 229coronary patients presenting for surgery with some degree  of platelet inhibition to maximize the ischemic benefit of an - tiplatelet therapy.,Non-OADS,/arxiv_data1/oa_pdf/71/6c/ymj-55-224.PMC3874931.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 230line hematocrit level was similar between both groups and  that all other operative data were similar, we can only spec - ulate that intraoperative blood loss may have been greater  in the hypothermia group.",Non-OADS,/arxiv_data1/oa_pdf/71/6c/ymj-55-224.PMC3874931.pdf
Hypothermia and Transfusion Requirement Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 23120.,Non-OADS,/arxiv_data1/oa_pdf/71/6c/ymj-55-224.PMC3874931.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 280Cryopreserved Autologous Fat Injections as a Filler Agent   for Facial Augmentation: Are They Still Safe?,Non-OADS,/arxiv_data1/oa_pdf/5b/1c/ymj-55-280.PMC3874932.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.To the Editor,  A 57-year-old woman presented with multiple, asymptomatic, variable-sized,  erythematous nodules that had been present for the previous two months on both  inferior periorbital areas and the perioral area (Fig.",Non-OADS,/arxiv_data1/oa_pdf/5b/1c/ymj-55-280.PMC3874932.pdf
"Although the skin lesions did not coincide with injection sites, the presence of fat  vacuoles in non-injection sites was observed on histopathology, confirming its mi -Letter to the Editorhttp://dx.doi.org/10.3349/ymj.2014.55.1.280 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(1):280-281, 2014",Non-OADS,/arxiv_data1/oa_pdf/5b/1c/ymj-55-280.PMC3874932.pdf
Granuloma Formation after Autologous Fat Injections Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 281gration.,Non-OADS,/arxiv_data1/oa_pdf/5b/1c/ymj-55-280.PMC3874932.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/72/10/cia-9-063.PMC3875193.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 63–72Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  63OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S3004 8Efficacy of WBV as a modality for inducing  changes in body composition, aerobic   fitness, and muscular strength: a pilot study lauren r Tapp1,3 Joseph F signorile1,2,4 1Departments of Kinesiology and  Sport Sciences, Coral Gables, 2Center  on Aging, University of Miami Miller  School of Medicine, Miami, FL,   3Department of Kinesiology, Temple  University, Philadelphia, PA, 4geriatric  Research, Education, and Clinical  Center, Bruce W Carter Department  of Veterans Affairs Medical Center,   Miami, FL, USA Correspondence: Joseph F signorile   University of Miami, PO Box 248065,  Coral Gables, FL 33124, USA   Tel +1 305 898 1457   Fax +1 305 284 5168   email jsignorile@miami.ed uAbstract:  The purpose of this pilot study was to evaluate the effectiveness of whole body  vibration (WBV) training as a modality for inducing changes in body composition, cardiovas - cular condition, and muscular strength in sedentary postmenopausal women.",Non-OADS,/arxiv_data1/oa_pdf/72/10/cia-9-063.PMC3875193.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/72/10/cia-9-063.PMC3875193.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/10/cia-9-063.PMC3875193.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/57/clep-6-027.PMC3875194.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2014:6 27–36Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  27Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S5044 9registration of acute stroke: validity in the Danish  stroke registry and the Danish national   registry of Patients Cathrine Wildenschild¹ Frank Mehnert¹ reimar Wernich Thomsen¹ helle Klingenberg iversen² Karsten Vestergaard³ annette ingeman¹ søren Paaske Johnsen¹ ¹Department of Clinical Epidemiology,   aarhus University hospital, aarhus,   ²Department of neurology, glostrup  hospital, glostrup, ³Department of  neurology, aalborg hospital, aarhus  University hospital, aalborg, Denmark Correspondence: Cathrine Wildenschild   Department of Clinical Epidemiology,   aarhus University hospital,   Olof Palmes allé 43-45   8200 aarhus n, Denmark   Tel +45 8716 8229   Fax +45 8716 8063   Email cwni@dce.au.d kBackground:  The validity of the registration of patients in stroke-specific registries has seldom  been investigated, nor compared with administrative hospital discharge registries.",Non-OADS,/arxiv_data1/oa_pdf/ce/57/clep-6-027.PMC3875194.pdf
Available from:  http://www.eso-stroke.org/pdf/ESO08_Guidelines_Original_english.,Non-OADS,/arxiv_data1/oa_pdf/ce/57/clep-6-027.PMC3875194.pdf
"Available from:  http://apps.who.int/classifications/icd10/browse/2010/e n. Accessed  August 9, 2013.",OADS,/arxiv_data1/oa_pdf/ce/57/clep-6-027.PMC3875194.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/ce/57/clep-6-027.PMC3875194.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dd/a5/ccid-6-281.PMC3875240.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2013:6 281–288Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  281RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S3402 9Glycolic acid peel therapy – a current review Jaishree Sharad Skinfiniti Aesthetic Skin and   Laser Clinic, Mumbai, India Correspondence: Jaishree Sharad   Skinfiniti Aesthetic Skin & Laser Clinic,  202, Sun vihar, Plot 153, Sector 12,  vashi, Navi Mumbai, Maharashtra,   India, 400703   Tel +91 982 005 8598   email jaishree19@gmail.co mAbstract:  Chemical peels have been time-tested and are here to stay.",Non-OADS,/arxiv_data1/oa_pdf/dd/a5/ccid-6-281.PMC3875240.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/dd/a5/ccid-6-281.PMC3875240.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/a5/ccid-6-281.PMC3875240.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/c0/copd-9-051.PMC3875241.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 51–56International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  51OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5359 0Clinical factors associated with the humoral   immune response to influenza vaccination   in chronic obstructive pulmonary disease Karthik D nath1,2 Julie g Burel1 Viswanathan shankar3 antonia l Pritchard1 Michelle T owers2 David looke1,2 Janet M Davies1 John W Upham1,2 1The University of Queensland  (school of Medicine), Brisbane,   QlD, australia; 2Princess alexandra  hospital, Brisbane, QlD, australia;   3Department of epidemiology and  Population health, albert einstein  College of Medicine, new Y ork,    nY, Usa Correspondence: John W Upham   school of Medicine, The University   of Queensland, level 5, TrI Building,   Princess alexandra hospital,   Woolloongabba, Brisbane,   QlD, australia   Tel +61 7 3443 7000   Fax +61 7 3143 7779   email j.upham@uq.edu.a uBackground and objective:  Individuals with chronic obstructive pulmonary disease (COPD)  are at a high risk of developing significant complications from infection with the influenza virus.",Non-OADS,/arxiv_data1/oa_pdf/a1/c0/copd-9-051.PMC3875241.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a1/c0/copd-9-051.PMC3875241.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/c0/copd-9-051.PMC3875241.pdf
201; http://dx.doi.org/10.4172/2157-7560.S4-00 1.,Non-OADS,/arxiv_data1/oa_pdf/a1/c0/copd-9-051.PMC3875241.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/94/ppa-7-1189.PMC3875242.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 1189–1199Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1189OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5043 6effect of 10-week core stabilization exercise  training and detraining on pain-related outcomes  in patients with clinical lumbar instability rungthip Puntumetakul1,2 Pattanasin  Areeudomwong1,2 Alongkot emasithi1 Junichiro Yamauchi3,4 1school of Physical Therapy, Faculty   of Associated Medical sciences, Muang  District, Kohn Kaen, Thailand; 2Back,   neck and Other Joint Pain research  group, Khon Kaen University, Khon  Kaen, Thailand; 3graduate school  of human health sciences, Tokyo  Metropolitan University, T okyo,    Japan; 4Future institute for sport  sciences, T okyo, Japan correspondence: rungthip Puntumetakul   123 Khon Kaen University, Mitraphab  street, Muang District, Khon Kaen,  Thailand 40002   Tel +66 83 419 6186   Fax +66 43 202 399   email rungthip@kku.ac.t hBackground and aims:  Clinical lumbar instability causes pain and socioeconomic suffering;  however, an appropriate treatment for this condition is unknown.",Non-OADS,/arxiv_data1/oa_pdf/17/94/ppa-7-1189.PMC3875242.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/17/94/ppa-7-1189.PMC3875242.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/94/ppa-7-1189.PMC3875242.pdf
http://www.iie.org/Research-and-Publications/Open-Doors/Data/US-Study- Abroad/Student-Profile/2000-10Hartjes and Baumann Page 8 Nurs Rep .,Non-OADS,/arxiv_data1/oa_pdf/8b/d6/nihms404711.PMC3875293.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/43/08/idr-6-207.PMC3875366.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2013:6 207–213Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  207ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S4772 4Direct sequencing for rapid detection   of multidrug resistant Mycobacterium   tuberculosis  strains in Morocco Fathiah Zakham1,4 Imane chaoui1 amina hadbae echchaoui2 Fouad chetioui3 My Driss elmessaoudi3 My Mustapha ennaji4 Mohammed abid2 Mohammed el Mzibri1 1Unité de Biologie et Recherché  Médicale, centre national de  l’energie, des sciences et des  T echniques nucléaires (cnesTen ),   Rabat, 2laboratoire de génétique  Mycobacterienne, Institut Pasteur,   Tangier, 3laboratoire de T uberculose  Institut Pasteur, casablanca,   4laboratoire de Microbiologie,   hygiène et Virologie, Faculté des  sciences et T echniques, Mohammedia,   Morocco correspondence: Mohammed el Mzibri   Unité de Biologie et Recherches   Médicales, centre national de l’energie,   des sciences et Techniques nucléaires,   BP 1382 RP Rabat, Morocco   Tel +21 25 3771 2751   Fax +21 25 3771 1846   email mzibri@yahoo.co mBackground:  Tuberculosis (TB) is a major public health problem with high mortality and  morbidity rates, especially in low-income countries.",Non-OADS,/arxiv_data1/oa_pdf/43/08/idr-6-207.PMC3875366.pdf
Available from: http://www.who.int/tb/publications/mdr_surveillance/ en/.,OADS,/arxiv_data1/oa_pdf/43/08/idr-6-207.PMC3875366.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/43/08/idr-6-207.PMC3875366.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/08/idr-6-207.PMC3875366.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ef/4b/ceg-6-201.PMC3875367.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical and Experimental Gastroenterology 2013:6 201–208Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  201OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S5140 2Magnet tracking allows assessment of regional  gastrointestinal transit times in children Caroline hedsund1,2 iben Moeller Joensson2 Tine Gregersen1 lotte Fynne1 Vincent schlageter3 Klaus Krogh1 1neurogastroenterology Unit,   Department of hepatology and  Gastroenterology, 2Department of  Pediatrics, aarhus University hospital,   aarhus, Denmark; 3Motilis Medica sa,   lausanne, switzerland Correspondence: Caroline hedsund   neurogastroenterology Unit,  Department of hepatology and  Gastroenterology V, aarhus  University hospital, nørrebrogade 44,  DK-8000 aarhus C, Denmark   Tel +45 2984 9448   Fax +45 7846 2860   Email c_hedsund@hotmail.co mBackground:  Data on small intestinal transit time in healthy children are lacking, and normal  values for gastric emptying and colonic transit time are sparse.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/ceg-6-201.PMC3875367.pdf
Available from: http://www.nice.org.uk/cg99 .,Non-OADS,/arxiv_data1/oa_pdf/ef/4b/ceg-6-201.PMC3875367.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/ceg-6-201.PMC3875367.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/4b/ceg-6-201.PMC3875367.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/dc/f5/cmar-5-377.PMC3875371.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2013:5 377–385Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  377Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S4798 6Factors influencing choice of chemotherapy   in metastatic colorectal cancer (mCRC) Luigi Rossi Foteini vakiarou Federica Zoratto Loredana Bianchi Anselmo Papa enrico Basso Monica verrico Giuseppe Lo Russo Salvatore evangelista Guilia Rinaldi Francesca Perrone-Congedi Gian Paolo Spinelli valeria Stati Davide Caruso Alessandra Prete Silverio T omao Department of Medico-Surgical  Sciences and Biotechnologies,   “Sapienza” University of Rome,    Rome, Italy; Oncology Unit, ICOT,    Latina, Italy Correspondence: Luigi Rossi   Oncology Unit, ICOT, Franco Faggiana   Street, 1668, Latina, 04100, LT, Italy   Tel +39 349 564 3418   email dr.rossi@ymail.co mAbstract:  Management of metastatic colorectal cancer requires a multimodal approach and  must be performed by an experienced, multidisciplinary expert team.",Non-OADS,/arxiv_data1/oa_pdf/dc/f5/cmar-5-377.PMC3875371.pdf
Available from: http://clinicaltrials.gov/ show/NCT00265850.,Non-OADS,/arxiv_data1/oa_pdf/dc/f5/cmar-5-377.PMC3875371.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/dc/f5/cmar-5-377.PMC3875371.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/f5/cmar-5-377.PMC3875371.pdf
Avail - able from: http://clinicaltrials.gov/show/NCT00973609.,Non-OADS,/arxiv_data1/oa_pdf/dc/f5/cmar-5-377.PMC3875371.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/73/ijn-9-209.PMC3875520.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 209–221International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  209RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S4177 0First line treatment of advanced non-small-   cell lung cancer – specific focus on albumin   bound paclitaxel Neha Gupta Hassan Hatoum Grace K Dy Department of Medicine,    Roswell Park Cancer Institute,    Buffalo, NY, USA Correspondence: Grace Dy   Department of Medicine,   Roswell Park Cancer Institute,   elm and Carlton Streets, Buffalo,   NY 14263, USA   Tel +1 716 845 3099   Fax +1 716 845 3935   email grace.dy@roswellpark.or gAbstract:  Lung cancer is the leading cause of cancer mortality worldwide in both men  and women.",Non-OADS,/arxiv_data1/oa_pdf/52/73/ijn-9-209.PMC3875520.pdf
"Available from http://www.oncologypractice.com/ co/journal/articles/0603132.pd f. Accessed November 26, 2013.",Non-OADS,/arxiv_data1/oa_pdf/52/73/ijn-9-209.PMC3875520.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/52/73/ijn-9-209.PMC3875520.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/73/ijn-9-209.PMC3875520.pdf
Available from: http://clinicaltrials.gov/ct2/ show/NCT01872403?term=NCT+01872403&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/52/73/ijn-9-209.PMC3875520.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/15/d8/ijn-9-183.PMC3875521.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 183–195International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  183OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4946 0Polycaprolactone scaffold engineered   for sustained release of resveratrol: therapeutic   enhancement in bone tissue engineering Manjunath srinivas Kamath1 shiek ssJ ahmed2 M Dhanasekaran3 s Winkins santosh1 1Department of Biotechnology, school  of Bioengineering, srM University,   2Department of Biotechnology,   chettinad hospital and research  Institute, 3Department of stem cells,   life line rigid hospital Pvt ltd,   Kilpauk, Tamil Nadu, India correspondence: s Winkins santosh   Department of Biotechnology,   school of Bioengineering,   srM University, Kattankulathur   603 203, Tamil Nadu, India   Tel +91 86 9522 2205   email regenmed79@gmail.co mAbstract:  Biomaterials-based three-dimensional scaffolds are being extensively investigated  in bone tissue engineering.",Non-OADS,/arxiv_data1/oa_pdf/15/d8/ijn-9-183.PMC3875521.pdf
Available from: http://www.hindawi.com/isrn/ms/2011/240864 /.,Non-OADS,/arxiv_data1/oa_pdf/15/d8/ijn-9-183.PMC3875521.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/15/d8/ijn-9-183.PMC3875521.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/d8/ijn-9-183.PMC3875521.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/ijn-9-197.PMC3875522.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 197–207International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  197OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5587 5Novel tumor-targeting, self-assembling   peptide nanofiber as a carrier for effective   curcumin delivery Jianfeng liu Jinjian liu hongyan Xu Yumin Zhang liping chu Qingfen liu Naling song cuihong Yang Tianjin Key laboratory of Molecular  Nuclear Medicine, Institute of  radiation Medicine, chinese academy  of Medical science and Peking Union  Medical college, People’s republic   of china correspondence: cuihong Yang   Institute of radiation Medicine,   chinese academy of Medical science,  Tianjin 300071, People’s republic of china   Tel +86 228 568 2399   Fax +86 228 568 3033   email yangcuihong1983@163.co mAbstract:  The poor aqueous solubility and low bioavailability of curcumin restrict its  clinical  application for cancer treatment.",Non-OADS,/arxiv_data1/oa_pdf/2f/d9/ijn-9-197.PMC3875522.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2f/d9/ijn-9-197.PMC3875522.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/ijn-9-197.PMC3875522.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/3f/ijn-9-167.PMC3875523.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 167–181International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  167OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5466 83D conductive nanocomposite scaffold for bone  tissue engineering aref shahini1 Mostafa Yazdimamaghani2 Kenneth J Walker2 Margaret a eastman3 hamed hatami-Marbini4 Brenda J smith5 John l ricci6 sundar V Madihally2 Daryoosh Vashaee1 lobat Tayebi2,7 1school of electrical and computer  engineering, helmerich advanced  T echnology research center,   2school of chemical engineering,   3Department of chemistry, 4school  of Mechanical and aerospace  engineering, 5Department of  Nutritional sciences, Oklahoma  state University, stillwater, OK, Usa;   6Department of Biomaterials and  Biomimetics, New Y ork University,   New Y ork, NY; 7school of Material  science and engineering, helmerich  advanced T echnology research  center, Oklahoma state University,   T ulsa, OK, Usa correspondence: lobat Tayebi;  Daryoosh Vashaee   helmerich research center   700 N greenwood ave T ulsa,   OK 74106, Usa   Tel +1 918 594 8634   Fax +1 270 897 1179   email lobat.tayebi@okstate.ed u;  daryoosh.vashaee@okstate.ed uAbstract:  Bone healing can be significantly expedited by applying electrical stimuli in the  injured region.",Non-OADS,/arxiv_data1/oa_pdf/c4/3f/ijn-9-167.PMC3875523.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c4/3f/ijn-9-167.PMC3875523.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/3f/ijn-9-167.PMC3875523.pdf
"Mol Biol Cell 2011; 22:4472-85; PMID:21965288; http://dx.doi.org/10.1091/mbc.E11-04-0335.Keywords:  myelofibroblast, epithelial- mesenchymal transition, b -catenin,  myocardin-related transcription facr,  TGFbeta signalng, Smad3, smooth muscle actin, epithelial plasticity, fibrosis Submitted: 12/10/12Revised: 01/18/13Accepted: 01/21/13Citation: Charbonney E, Speight P,  Kapus A.",Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Tissue Barriers 2013; 1:e23699; http://dx.doi.org/10.4161/tisb.23699 *Correspondence to: András Kapus;   Email: kapusa@smh.caTissue accumulation of contrac - tile myofibroblasts is a key fea - ture of a multitude of fibrotic diseases.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Mol Biol Cell 2011; 22:4472-85; PMID:21965288;  http://dx.doi.org/10.1091/mbc.E11-04-0335.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Dev Dyn  1994; 201:378-93; PMID:7534501; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Dev Dyn 2005; 233:706-20; PMID:15937929;  http://dx.doi.org/10.1002/dvdy.20345.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Curr Opin Oncol 2013; 25:76- 84; PMID:23197193; http://dx.doi.org/10.1097/ CCO.0b013e32835b6371.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Cell Tissue Res  2012; 347:177-86; PMID:21866313; http://dx.doi.org/10.1007/s00441-011-1222-6.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
J Clin Invest 2009;  119:1420-8; PMID:19487818; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Annu Rev Cell Dev Biol 2011; 27:347-76; PMID:21740232; http://dx.doi.org/10.1146/annurev-cellbio-092910-154036.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Development 2012; 139:3471-86; PMID:22949611; http://dx.doi.org/10.1242/dev.071209.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
J Cell Biol 2010; 188:383- 99; PMID:20123992; http://dx.doi.org/10.1083/ jcb.200906155.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Am J Pathol 2012; 180:1340- 55; PMID:22387320; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
J Pathol 2013; 229:298-309; PMID:22996908; http://dx.doi.org/10.1002/path.4104.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
J Clin Invest 2009;  119:1429-37; PMID:19487819; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Am J Pathol 2010; 176:85- 97; PMID:20008127; http://dx.doi.org/10.2353/ ajpath.2010.090517.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Kidney Int 2011; 79:494-501;  PMID:20861816; http://dx.doi.org/10.1038/ ki.2010.338.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
J Am Soc Nephrol  2010; 21:1247-53; PMID:20651165; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Kidney Int 2011; 80:41-50; PMID:21430641; http://dx.doi.org/10.1038/ki.2011.77.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Am J Pathol 2004; 165:1955-67; PMID:15579439;  http://dx.doi.org/10.1016/S0002-9440(10)63247-6.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
J Biol Chem 2012; 287:7026-38;  PMID:22241478; http://dx.doi.org/10.1074/jbc.M111.276311.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Am J Pathol 2002; 160:1619-28; PMID:12000714; http://dx.doi.org/10.1016/S0002- 9440(10)61109-1.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Am J Physiol Heart  Circ Physiol 2008; 295:H1067-75; PMID:18586895;  http://dx.doi.org/10.1152/ajpheart.91421.2007.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Genes Cells  2005; 10:835-50; http://dx.doi.org/10.1111/j.1365- 2443.2005.00880.x; PMID:16098147.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Mol Cell Biol 2009; 29:2398- 408; PMID:19237536; http://dx.doi.org/10.1128/ MCB.01737-08.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Dev Cell 2010; 19:831-44; PMID:21145499; http://dx.doi.org/10.1016/j.devcel.2010.11.012.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Nat Cell Biol  2008; 10:837-48; PMID:18568018; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Curr Opin Rheumatol  2013; 25:101-7; PMID:23114590; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
J Invest Dermatol 2011; 131:2378-85; PMID:21776010;  http://dx.doi.org/10.1038/jid.2011.219.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Annu Rev  Cell Dev Biol 2005; 21:659-93; PMID:16212511;  http://dx.doi.org/10.1146/annurev.cell - bio.21.022404.142018.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
J Cell Biol 2007; 179:1027-42;  PMID:18056415; http://dx.doi.org/10.1083/jcb.200708174.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
J Biol Chem 2007; 282:15534- 40; PMID:17400544; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Biochem Biophys Res Commun 2002; 294:319-23;  PMID:12051713; http://dx.doi.org/10.1016/S0006- 291X(02)00471-0.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Cells  Tissues Organs 2011; 193:41-52; PMID:21051861;  http://dx.doi.org/10.1159/000320180.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
J  Biol Chem 2011; 286:30119-29; PMID:21712382;  http://dx.doi.org/10.1074/jbc.M111.258814.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
J  Biol Chem 2012; 287:5164-72; PMID:22203675; http://dx.doi.org/10.1074/jbc.M111.322123.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Proc Natl Acad Sci U S A 2010;  107:14309-14; PMID:20660310; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
J Cell Biol 2009; 184:309-22; PMID:19171760; http://dx.doi.org/10.1083/ jcb.200806067.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Am J  Pathol 2009; 175:580-91; PMID:19590041; http://dx.doi.org/10.2353/ajpath.2009.080983.,Non-OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Am J Pathol 2010; 177:512- 24; PMID:20581053; http://dx.doi.org/10.2353/ ajpath.2010.100168.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
FEBS Lett  2008; 582:291-8; PMID:18154735; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Nat Rev Mol Cell Biol 2010; 11:353- 65; PMID:20414257; http://dx.doi.org/10.1038/ nrm2890.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Lab Invest 2010; 90:1274- 84; PMID:20498652; http://dx.doi.org/10.1038/ labinvest.2010.104.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Cell 2003; 113:329-42;  PMID:12732141; http://dx.doi.org/10.1016/S0092- 8674(03)00278-2.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
Circ Res 2010; 107:294-304; PMID:20558820; http://dx.doi.org/10.1161/ CIRCRESAHA.110.223172.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
J Biol Chem 2011; 286:44116-25;  PMID:22049076; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/71/9a/tisb-1-e23699.PMC3875604.pdf
"OncoImmunology 2013;   2:e25963; http://dx.doi.org/10.4161/onci.25963A new role for NFκB in immunosurveillance   and its implications for cancer immunotherapy amer a Beg1,*, Tahira Khan1,2, and s cott J a ntonia1,3 1Department of Immunology; Moffitt Cancer Center; Tampa, FL usa ; 2atta ur r ehman s chool of a pplied Biosciences ( asa B); National u niversity  of science and Technology (N usT); Islamabad, Pakistan; 3Department of Thoracic Oncology; Moffitt Cancer Center; Tampa, FL usa Keywords:  immunosurveillance, chemokines, lung cancer, Immunotherapy, NF κB, inflammation The activation of NF κB in the tumor microenvironment is associated with inflammatory responses that promote  disease progression.",Non-OADS,/arxiv_data1/oa_pdf/13/05/onci-2-e25963.PMC3875605.pdf
Nature 2006; 441:431- 6; PMID:16724054 ; http://dx.doi.org/10.1038/ nature04870 2.,OADS,/arxiv_data1/oa_pdf/13/05/onci-2-e25963.PMC3875605.pdf
Nat Rev Immunol 2005 ; 5:749-59;  PMID:16175180 ; http://dx.doi.org/10.1038/nri1703 3.,Non-OADS,/arxiv_data1/oa_pdf/13/05/onci-2-e25963.PMC3875605.pdf
Cancer Res  2010 ; 70:3537 -46; PMID:20406971 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/05/onci-2-e25963.PMC3875605.pdf
J  Clin Invest 2013 ; 123:2509 -22; PMID:23635779 ;  http://dx.doi.org/10.1172/JCI67250 6.,Non-OADS,/arxiv_data1/oa_pdf/13/05/onci-2-e25963.PMC3875605.pdf
Cancer Res  2012 ; 72:3735 -43; PMID:22593190 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/05/onci-2-e25963.PMC3875605.pdf
Trends Immunol  2013 ; 34:67- 73; PMID:23122052 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/13/05/onci-2-e25963.PMC3875605.pdf
N Engl J Med 2012 ; 366:2443 -54; PMID:22658127 ;  http://dx.doi.org/10.1056/NEJMoa1200690 10.,OADS,/arxiv_data1/oa_pdf/13/05/onci-2-e25963.PMC3875605.pdf
N Engl J Med 2010 ; 363:711-23;  PMID:20525992 ; http://dx.doi.org/10.1056/ NEJMoa1003466,OADS,/arxiv_data1/oa_pdf/13/05/onci-2-e25963.PMC3875605.pdf
Tissue Barriers 2013; 1:e25391; http://dx.doi.org/10.4161/tisb.25391Teleost fishes are a large and diverse animal group that  represent close to 50% of all described vertebrate species.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Fish Manag Ecol 2013; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
"J Cell Biol 1963;  17:375-412; PMID:13944428; http://dx.doi.org/10.1083/jcb.17.2.375teleost fishes.97,98 In zebrafish, cldn-b  (= cldn-30d ) is prominently  expressed around the periphery of peridermal cells and is involved  in the development of the lateral line system.12,98 Conclusion and Perspectives It has been 13 y since the first cldn was reported in a teleost fish,  and we are now aware of ~63 cldns in 16 teleost species studied  so far (see Table 1 ).",OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Respir Physiol Neurobiol 2012; 184:269- 81; PMID:22640933; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
"The reversibility of the respiratory inhibi - tion in gills and the ultrastructural changes in chlo - ride cells from the rotenone-poisoned marine teleost,  Gadus callarias  L. Exp Cell Res 1967; 45:590-602;  PMID:6022569; http://dx.doi.org/10.1016/0014- 4827(67)90162-0 8.",OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
J Cell Biol  1963; 18:389-404; PMID:14079496; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
J Cell Biol 1998; 141:1539- 50; PMID:9647647; http://dx.doi.org/10.1083/ jcb.141.7.153910.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Physiol Rev 2013; 93:525- 69; PMID:23589827; http://dx.doi.org/10.1152/phys - rev.00019.2012 11.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Dev Biol  2000; 227:403-21; PMID:11071763; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Proc Natl Acad Sci U S A 2001; 98:10196- 201; PMID:11517306; http://dx.doi.org/10.1073/ pnas.171325898 13.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Annu Rev Physiol 2006; 68:403- 29; PMID:16460278; http://dx.doi.org/10.1146/ annurev.physiol.68.040104.131404 14.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Biochim  Biophys Acta 2008; 1778:631-45; PMID:18036336;  http://dx.doi.org/10.1016/j.bbamem.2007.10.01815.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Genome Res  2004; 14:1248-57; PMID:15197168; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Nature 2004; 431:946- 57; PMID:15496914; http://dx.doi.org/10.1038/ nature03025 17.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Genome Res 2003; 13:382- 90; PMID:12618368; http://dx.doi.org/10.1101/ gr.640303 18.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
PLoS Biol 2005;  3:e314; PMID:16128622; http://dx.doi.org/10.1371/ journal.pbio.0030314,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Can J Fish Aquat Sci 1991;  48:2028-33; http://dx.doi.org/10.1139/f91-241 50.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Mol Cell Endocrinol 2010; 317:120- 6; PMID:19969041; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Comp  Biochem Physiol A Mol Integr Physiol 2011; 160:52- 62; PMID:21600298; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Am J Physiol Regul Integr Comp Physiol  2008; 294:R1638-47; PMID:18353883; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
J  Comp Physiol B 2009; 179:419-31; PMID:19112569;  http://dx.doi.org/10.1007/s00360-008-0326-0 56.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
BMC Genomics  2010; 11:476; PMID:20716350; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
J  Comp Physiol B 2011; 181:219-38; PMID:20976602;  http://dx.doi.org/10.1007/s00360-010-0517-3 58.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Am J Physiol Regul Integr Comp Physiol  2012; 302:R300-11; PMID:21975646; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Am J Physiol  Regul Integr Comp Physiol 2008b; 294:R1563-74;  PMID:18321951; http://dx.doi.org/10.1152/ajp - regu.00915.2007 60.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
J Exp Biol 2011; 214:1473- 87; PMID:21490256; http://dx.doi.org/10.1242/ jeb.050062 61.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
J Exp Biol  2011; 214:2308-18; PMID:21697422; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Proc Natl Acad Sci U S A 2011; 108:6193- 8; PMID:21444822; http://dx.doi.org/10.1073/ pnas.101754210833.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Glia 2012; 60:253-70; PMID:22020875;  http://dx.doi.org/10.1002/glia.21260 34.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Dev Dyn 2010; 239:2041- 7; PMID:20549738; http://dx.doi.org/10.1002/ dvdy.22338 35.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Brain Res 2006; 1103:25- 31; PMID:16814265; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Brain Res Bull  2008; 75:619-28; PMID:18355638; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
BMC Dev  Biol 2010; 10:76; PMID:20653957; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Ann Neurol 2010; 68:835-44; PMID:21194153;  http://dx.doi.org/10.1002/ana.22318 39.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Bioessays  2010; 32:768-76; PMID:20652895; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Proc Natl Acad Sci U S A  2010; 107:1425-30; PMID:20080584; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
J Comp Neurol 2010; 518:4277- 87; PMID:20853506; http://dx.doi.org/10.1002/ cne.22481 42.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Pharmacol  Rev 2005; 57:173-85; PMID:15914466; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
J Neurosci Res 2011; 89:921- 8; PMID:21412815; http://dx.doi.org/10.1002/ jnr.22607 45.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Physiol Rev 2005; 85:97-177;  PMID:15618479; http://dx.doi.org/10.1152/phys - rev.00050.2003 46.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Am J Physiol Regul Integr Comp Physiol  2011; 301:R28-47; PMID:21451143; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Annu Rev Physiol  1997; 59:325-47; PMID:9074767; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
J Cell  Biol 1979; 80:96-117; PMID:422655; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
BMC Genomics 2012; 13:246; PMID:22702965;  http://dx.doi.org/10.1186/1471-2164-13-246 20.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Heredity (Edinb) 2005; 94:280-94;  PMID:15674378; http://dx.doi.org/10.1038/ sj.hdy.6800635 21.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Gen Comp Endocrinol  2011; 172:494-504; PMID:21549120; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Gen Comp Endocrinol 2012; 175:277- 83; PMID:22137907; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Am J Physiol Regul Integr Comp Physiol  2012b; 302:R727-39; PMID:22204956; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Clin Genet 2010; 77:314-25;  PMID:20447145; http://dx.doi.org/10.1111/j.1399- 0004.2010.01397.x 25.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Dev Dyn 2010; 239:715-22; PMID:20014098;  http://dx.doi.org/10.1002/dvdy.22172 26.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Mech Dev 2005; 122:949- 58; PMID:15925497; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Hum Mol Genet 2011; 20:3213- 26; PMID:21610158; http://dx.doi.org/10.1093/hmg/ ddr234 28.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Gastroenterology 2009; 137:1321-32;  PMID:19563808; http://dx.doi.org/10.1053/j.gas - tro.2009.06.050 29.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Nat Cell Biol 2007; 9:954-60;  PMID:17632505; http://dx.doi.org/10.1038/ncb1621 30.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
J Cell Sci 2009; 122:1507- 17; PMID:19383724; http://dx.doi.org/10.1242/ jcs.040113 31.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Regulation of intrahepatic biliary  duct morphogenesis by Claudin 15-like b. Dev Biol  2012; 361:68-78; PMID:22020048; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Cell Tissue Res  2009; 335:465-71; PMID:19037661; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Am J Physiol Renal Physiol 2008; 295:F867-76;  PMID:18480174; http://dx.doi.org/10.1152/ajpre - nal.90264.2008 92.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
J Exp Biol  2008; 211:1524-34; PMID:18456879; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
J  Comp Physiol B 2013; 183:203-13; PMID:22843140;  http://dx.doi.org/10.1007/s00360-012-0700-9 94.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Zoomorphologie 1976; 84:195-209; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Comp Biochem  Physiol A Mol Integr Physiol 2002; 132:645-57;  PMID:12044774; http://dx.doi.org/10.1016/S1095- 6433(02)00109-5 96.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Vet Microbiol 2013; 162:456- 70; PMID:23182910; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Proc Natl Acad Sci U S A 2005;  102:1496-501; PMID:15677337; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Comp  Biochem Physiol A Mol Integr Physiol 2010; 157:111- 5; PMID:20547237; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Aquat Toxicol 2011; 105:369-77;  PMID:21820383; http://dx.doi.org/10.1016/j.aqua - tox.2011.07.002 102.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Physiol Genomics 2007; 31:385- 401; PMID:17666525; http://dx.doi.org/10.1152/ physiolgenomics.00059.200777.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Comp Biochem  Physiol A Mol Integr Physiol 2012; 162:378-85;  PMID:22561661; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
J Histochem Cytochem  2006; 54:933-44; PMID:16651389; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
J Exp Biol  2006; 209:2939-51; PMID:16857878; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Am J Physiol Regul Integr Comp Physiol  2008; 294:R1402-12; PMID:18216137; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Cell Tissue Res 2004; 318:305-11; PMID:15503156;  http://dx.doi.org/10.1007/s00441-004-0934-2 86.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Cell Tissue Res 2007; 328:109-16; PMID:17120052;  http://dx.doi.org/10.1007/s00441-006-0323-0 87.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Vet Pathol 2010; 47:220-30; PMID:20106826;  http://dx.doi.org/10.1177/0300985809359381 88.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Comp Biochem  Physiol A Mol Integr Physiol 2003; 136:479-98;  PMID:14613779; http://dx.doi.org/10.1016/S1095- 6433(03)00162-4 89.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Comp Biochem Physiol A Mol Integr Physiol  2003; 136:453-78; PMID:14613778; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Comp  Biochem Physiol A Mol Integr Physiol 2008; 150:265- 73; PMID:18467139; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Gen Comp Endocrinol  2009; 163:270-7; PMID:19401202; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Dev Dyn  2005; 233:1163-72; PMID:15937927; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Blood  2005; 106:534-41; PMID:15802528; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Development 2005;  132:5199-209; PMID:16251212; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Gen Comp Endocrinol 2010; 168:388- 400; PMID:20553723; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Zoolog Sci 2001;  18:225-34; http://dx.doi.org/10.2108/zsj.18.225 71.,Non-OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Gen Comp Endocrinol 2011; 171:211- 7; PMID:21291886; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Gene 2006; 379:40- 50; PMID:16737785; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Comp Biochem  Physiol A Mol Integr Physiol 2010; 155:154-63;  PMID:19892030; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
Comp  Biochem Physiol A Mol Integr Physiol 2010; 155:361- 70; PMID:19969100; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/81/tisb-1-e25391.PMC3875606.pdf
"Tissue Barriers 2013; 1:e24333; http://dx.doi.org/10.4161/tisb.24333Introduction Airway epithelial cell (AEC) barrier dysfunction is increasingly  associated with allergic inflammation and asthma,1-3 but the  mechanisms involved remain poorly understood.",Non-OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
Science 2003; 300:1527-8;  PMID:12791978; http://dx.doi.org/10.1126/sci- ence.1085458.,OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
Curr Mol  Med 2008; 8:384-92; PMID:18691065; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
Science 1998; 282:2258- 61; PMID:9856949; http://dx.doi.org/10.1126/sci- ence.282.5397.2258.,OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
N Engl J Med 2011; 365:1088- 98; PMID:21812663; http://dx.doi.org/10.1056/ NEJMoa1106469.,OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
Lab Invest 2012; 92:1140-8; PMID:22584669; http://dx.doi.org/10.1038/labin- vest.2012.67.,OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
"J Allergy Clin Immunol 2012;  130:1087-96, e10; PMID:22840853; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
Mol Biol Cell 2005; 16:5040- 52; PMID:16055505; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
Biochim Biophys Acta 2009; 1788:864- 71; PMID:18952050; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
J Biol Chem 2010; 285:12037-46; PMID:20177070; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
Eur Respir J 2005; 26:1119-37; PMID:16319345; http://dx.doi.org /10.1183/09031936.05.00006005.,Non-OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
Immunity 2009; 31:425-37; PMID:19766085; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
Nat Rev Immunol  2013; 13:145-9; PMID:23348417; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
Int Arch  Allergy Immunol 2005; 138:142-50; PMID:16179825;  http://dx.doi.org/10.1159/000088436.,Non-OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
"J Allergy Clin Immunol 2011; 128:1216-24, e11; PMID:21996340; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
J Invest Dermatol 2007; 127:2525-32; PMID:17934504; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
Ann N Y Acad Sci 2009; 1165:1-6; PMID:19538280; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
Cold Spring Harb  Perspect Biol 2009; 1:a002899; PMID:20457565; http://dx.doi.org/10.1101/cshperspect.a002899.,Non-OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
Cold Spring Harb Perspect Biol  2009; 1:a003053; PMID:20066110; http://dx.doi.org/10.1101/cshperspect.a003053.,Non-OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
Am J Pathol 2010; 177:512-24; PMID:20581053; http://dx.doi.org/10.2353/ajpath.2010.100168.Tween-20 followed by incubation with horseradish peroxidase- conjugated secondary antibodies.,Non-OADS,/arxiv_data1/oa_pdf/82/46/tisb-1-e24333.PMC3875607.pdf
Tissue Barriers 2013; 1:e23992; http://dx.doi.org/10.4161/tisb.23992Blood testis barrier (BTB) is one of the tightest blood-barriers  controlling the entry of substances into the intratubular fluid.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Adv Exp Med  Biol 2008; 636:1-15; PMID:19856159; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Endocr Rev 2004; 25:747-806;  PMID:15466940; http://dx.doi.org/10.1210/er.2003- 0022.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
J Endocrinol  2002; 173:335-43; PMID:12010641; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Gen Comp Endocrinol 2001; 122:88- 97; PMID:11352557; http://dx.doi.org/10.1006/ gcen.2001.7619.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Mol Hum Reprod 2002; 8:109-17; PMID:11818513;  http://dx.doi.org/10.1093/molehr/8.2.109.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Nat Rev Urol 2012; 9:330-8;  PMID:22549313; http://dx.doi.org/10.1038/nru-rol.2012.77.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Biol  Reprod 1982; 26:445-55; PMID:7082719; http://dx.doi.org/10.1095/biolreprod26.3.445.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
J Reprod Fertil 1982; 65:431- 8; PMID:6808129; http://dx.doi.org/10.1530/ jrf.0.0650431.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Int J Androl 2005; 28:99- 106; PMID:15811071; http://dx.doi.org/10.1111/ j.1365-2605.2005.00516.x.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Cell Tissue Res 2008; 334:295- 304; PMID:18802725; http://dx.doi.org/10.1007/s00441-008-0656-y.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Biosci Rep 2012; 32:61-9; PMID:21671886;  http://dx.doi.org/10.1042/BSR20110030.19.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Front Biosci 2007; 12:1552-62;  PMID:17127402; http://dx.doi.org/10.2741/2168.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Biol Reprod 2003; 68:1087-97;  PMID:12606453; http://dx.doi.org/10.1095/biolre- prod.102.010371.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
J Cell Biol  1999; 145:579-88; PMID:10225958; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Biol Reprod 2001; 65:1340-51; PMID:11673248; http://dx.doi.org/10.1095/biolre- prod65.5.1340.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Cell Commun Adhes 2006; 13:127-38; PMID:16798613; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Reproduction  2007; 133:1169-79; PMID:17636171; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
T rends  Pharmacol Sci 2011; 32:99-106; PMID:21168226;  http://dx.doi.org/10.1016/j.tips.2010.11.007.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Reproduction  2009; 137:353-9; PMID:19028925; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
J Membr Biol  2009; 227:49-55; PMID:19050954; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Am J Anat  1952; 90:167-215; PMID:14923625; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Philos T rans R Soc Lond B Biol Sci 2010; 365:1593- 605; PMID:20403872; http://dx.doi.org/10.1098/rstb.2009.0251.References 1.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Spermatogenesis 2012; 2:6- 10; PMID:22553485; http://dx.doi.org/10.4161/ spmg.19878.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Philos T rans R Soc Lond B Biol Sci  2010; 365:1621-35; PMID:20403874; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Am J  Anat 1977; 148:313-28; PMID:857632; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Exp Cell Res 2008; 314:213-26; PMID:17964570;  http://dx.doi.org/10.1016/j.yexcr.2007.09.022.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Diabetes Res Clin Pract 2010; 87:4-14; PMID:19896746;  http://dx.doi.org/10.1016/j.diabres.2009.10.007.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Diabetes Res Clin Pract  2011; 94:311-21; PMID:22079683; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Diabetes Res Clin Pract  2011; 94:311-21; PMID:22079683; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Br J Diabetes Vasc Dis 2001; 1:37; http://dx.doi.org/10.1177/14746 514010010010601.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Int J Androl  2006; 29:34-45; PMID:16466522; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Int Urol Nephrol 2009; 41:777-84; PMID:19381857;  http://dx.doi.org/10.1007/s11255-009-9565-6.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Nature  2001; 414:782-7; PMID:11742409; http://dx.doi.org/10.1038/414782a.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Reproduction 2003; 125:769- 84; PMID:12773099; http://dx.doi.org/10.1530/ rep.0.1250769.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Reproduction 2005; 130:15- 28; PMID:15985628; http://dx.doi.org/10.1530/ rep.1.00358.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Anat  Rec 1985; 213:53-62; PMID:4073561; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Urol Res 2000; 28:342- 7; PMID:11127715; http://dx.doi.org/10.1007/ s002400000134.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Anat Rec 1986; 214:378- 82; PMID:2939778; http://dx.doi.org/10.1002/ ar.1092140407.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
J Pediatr  2005; 146:693-700; PMID:15870677; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Diabetes Care 2003; 26:1553- 79; PMID:12716821; http://dx.doi.org/10.2337/dia- care.26.5.1553.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Hum Reprod 2007; 22:1871-7;  PMID:17478459; http://dx.doi.org/10.1093/humrep/ dem077.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Curr Diabetes Rev 2011; 7:143-7; PMID:21348816;  http://dx.doi.org/10.2174/157339911794940693.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Acta Diabetol  Lat 1984; 21:115-21; PMID:6475450; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Diabetologia 1984;  26:300-3; PMID:6539717; http://dx.doi.org/10.1007/ BF00283654.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Int J Androl 2006; 29:482-8;  PMID:16524366; http://dx.doi.org/10.1111/j.1365- 2605.2006.00682.x.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Diabetes 1983; 32:112- 6; PMID:6219025; http://dx.doi.org/10.2337/diabe- tes.32.2.112.65.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
J Reprod Fertil 1981; 62:399-405; PMID:7252921;  http://dx.doi.org/10.1530/jrf.0.0620399.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Curr Top Membr 2012; 70:275-311;  PMID:23177990; http://dx.doi.org/10.1016/B978-0- 12-394316-3.00009-0.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Biochem J 1999; 343:281-99;  PMID:10510291; http://dx.doi.org/10.1042/0264- 6021:3430281.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
J Cell Physiol 2012; 227:2154- 62; PMID:21792931; http://dx.doi.org/10.1002/ jcp.22949.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Biosci Rep 2012; 32:61-9; PMID:21671886;  http://dx.doi.org/10.1042/BSR20110030.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Eur J Pharmacol 2004; 490:147-58;  PMID:15094081; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Biochim Biophys Acta  2010; 1802:942-51; PMID:20620209; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Synapse 2011; 65:457-66; PMID:20853444;  http://dx.doi.org/10.1002/syn.20863.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Diabetes Care 1998; 21:1167-72; PMID:9653614; http://dx.doi.org/10.2337/diacare.21.7.1167.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Diabetes 1997;  46:895-9; PMID:9133561; http://dx.doi.org/10.2337/ diabetes.46.5.895.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
J  Ophthalmol 2012; 2012:209538; PMID:22272370;  http://dx.doi.org/10.1155/2012/209538.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Nature 2001; 414:813-20;  PMID:11742414; http://dx.doi.org/10.1038/414813a.50.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Science 2005; 309:943-7;  PMID:16081739; http://dx.doi.org/10.1126/sci- ence.1112085.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Cell Mol Life Sci  2013; 70:777-93: http://dx.doi.org/10.1007/s00018-012-1079-1; PMID:23011766.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
J Androl 2011; 32:348-55; PMID:21088231; http://dx.doi.org/10.2164/jan- drol.110.011197.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Mol Membr Biol  2001; 18:247-56; PMID:11780753; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
JPEN J Parenter  Enteral Nutr 2004; 28:364-71; PMID:15449578;  http://dx.doi.org/10.1177/0148607104028005364.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Mol  Cell Endocrinol 1992; 87:131-7; PMID:1446785;  http://dx.doi.org/10.1016/0303-7207(92)90241-W. 60.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
J Comp Neurol 2002; 452:103- 14; PMID:12271485; http://dx.doi.org/10.1002/ cne.10368.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Proc Natl Acad Sci U S  A 2001; 98:2820-5; PMID:11226324; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Proc Natl Acad Sci U  S A 2000; 97:7313-8; PMID:10860996; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Biol Reprod 2012; 87:49; PMID:22649075; http://dx.doi.org/10.1095/biolreprod.111.097675.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Biol Reprod 1981; 24:1032- 41; PMID:6268203; http://dx.doi.org/10.1095/biolre-prod24.5.1032.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Kidney Int 1982; 21:689- 95; PMID:6981023; http://dx.doi.org/10.1038/ ki.1982.82.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Br Med J 1972;  2:13-9; PMID:5015964; http://dx.doi.org/10.1136/ bmj.2.5804.13.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
J Reprod Fertil 1975; 45:69- 72; PMID:1195257; http://dx.doi.org/10.1530/ jrf.0.0450069.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Diabetes  2006; 55:929-34; PMID:16567513; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Reproduction 2009; 137:469-79;  PMID:19074501; http://dx.doi.org/10.1530/REP-08- 0343.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Endocrinology  2001; 142:4272-81; PMID:11564684; http://dx.doi.org/10.1210/en.142.10.4272.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
J Reprod Fertil  1985; 73:497-503; PMID:4039365; http://dx.doi.org/10.1530/jrf.0.0730497.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Metabolism 2005; 54:515-21; PMID:15798960; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Arch Biochem Biophys 1982; 217:503-11; PMID:7138022;  http://dx.doi.org/10.1016/0003-9861(82)90531-8.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Endocrinology 1969; 85:607-9; PMID:4307365; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Endocrinology 1983; 113:1476-85;  PMID:6193956; http://dx.doi.org/10.1210/endo-113- 4-1476.113.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Diabetologia 2007; 50:1140-7; PMID:17415551;  http://dx.doi.org/10.1007/s00125-007-0599-y.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
J Clin Invest  1993; 91:819-28; PMID:8450063; http://dx.doi.org/10.1172/JCI116302.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Diabetes 2002; 51:724-33; PMID:11872673; http://dx.doi.org/10.2337/diabetes.51.3.724.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Diabetologia 1984; 26:155-8; PMID:6325283; http://dx.doi.org/10.1007/ BF00281125.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Mol Cell Endocrinol 1985; 42:39-48; PMID:3928417;  http://dx.doi.org/10.1016/0303-7207(85)90005-X.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Mol Cell Endocrinol  1987; 49:51-62; PMID:3549388; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Biochim Biophys Acta 2012; 1823:1389-94;  PMID:22705155; http://dx.doi.org/10.1016/j.bbam - cr.2012.06.002.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
J Reprod Fertil 1970; 22:69- 75; PMID:5448605; http://dx.doi.org/10.1530/ jrf.0.0220069.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
J Mol Endocrinol 2007; 39:279-88; PMID:17909267;  http://dx.doi.org/10.1677/JME-07-0054.99.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Horm Metab  Res 1985; 17:5-7; PMID:2981762; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Int J Androl 2006; 29:482-8;  PMID:16524366; http://dx.doi.org/10.1111/j.1365- 2605.2006.00682.x.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Andrologia 2009; 41:361-8;  PMID:19891634; http://dx.doi.org/10.1111/j.1439- 0272.2009.00937.x.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Anat  Rec 1985; 213:53-62; PMID:4073561; http://dx.doi.org/10.1002/ar.1092130108.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Urology 1997; 49:508-13;  PMID:9111618; http://dx.doi.org/10.1016/S0090-4295(96)00573-0.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Curr Opin Endocrinol Diabetes Obes 2007; 14:226-34; PMID:17940444; http://dx.doi.org/10.1097/ MED.0b013e32814db856.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Lancet 1998; 352:837- 53; PMID:9742976; http://dx.doi.org/10.1016/S0140-6736(98)07019-6.,OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Curr Diabetes  Rev 2011; 7:392-405; PMID:21846326; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Physiol Rev 2011; 91:79-118; PMID:21248163;  http://dx.doi.org/10.1152/physrev.00003.2010.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
Nat Rev Endocrinol 2009; 5:537-45;  PMID:19763126; http://dx.doi.org/10.1038/nren- do.2009.179.,Non-OADS,/arxiv_data1/oa_pdf/e5/7c/tisb-1-e23992.PMC3875609.pdf
"Circ Res 2012; 111:553-63; PMID:22777005; http://dx.doi.org/10.1161/CIRCRESAHA.112.274548.Keywords:  eNOS, microvascular   permeability, S-nitrosation, adherens  junction, nitric oxide Submitted: 12/03/12Revised: 02/02/13Accepted: 02/05/13Sánchez FA, Ehrenfeld IP, Durán WN.",OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
"Tissue Barriers 2013; 1:e23896; http://dx.doi.org/10.4161/tisb.23896 *Correspondence to: Fabiola A. Sánchez;   Email: fabiolasanchez@uach.clNitric oxide (NO) is a key factor  in inflammation as it regulates  microvascular permeability, leukocyte adhesion and wound healing.",Non-OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Am J Physiol Heart  Circ Physiol 2008; 295:H2221-2; PMID:18849327;  http://dx.doi.org/10.1152/ajpheart.01050.2008.,Non-OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Physiol Rev 2004; 84:869-901;  PMID :15269339; http://dx.doi.org/10.1152/phys - rev.00035.2003.,Non-OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
J Biol Chem 2006;  281:35593-7; PMID:17005550; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Cell Mol Neurobiol 2000; 20:623-32; PMID:11100972; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
J Physiol 2006; 574:275-81; PMID:16675496;  http://dx.doi.org/10.1113/jphysiol.2006.108175.9.,Non-OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Am J Physiol Heart Circ  Physiol 2008; 295:H1642-8; PMID:18708444;  http://dx.doi.org/10.1152/ajpheart.00629.2008.,Non-OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Nature 1999; 399:601-5; PMID:10376603; http://dx.doi.org/10.1038/21224.,Non-OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
J Biol Chem 1997; 272:25437- 40; PMID:9325253; http://dx.doi.org/10.1074/ jbc.272.41.25437.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Proc Natl Acad Sci U S A  2009; 106:6849-53; PMID:19342481; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Am J Physiol Heart Circ Physiol 2006; 291:H1058-64; PMID:16679407;  http://dx.doi.org/10.1152/ajpheart.00370.2006.,Non-OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
J Biol  Chem 2011; 286:30409-14; PMID:21757745;  http://dx.doi.org/10.1074/jbc.M111.234294.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Am J Physiol Heart  Circ Physiol 2006; 290:H741-50; PMID:16172166;  http://dx.doi.org/10.1152/ajpheart.00238.2005.,Non-OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Proc Natl Acad Sci U S A 2006; 103:19777- 82; PMID:17170139; http://dx.doi.org/10.1073/ pnas.0605907103.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Proc Natl Acad Sci U S A 1992; 89:7674- 7; PMID:1502182; http://dx.doi.org/10.1073/ pnas.89.16.7674.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Cell 2007;  129:511-22; PMID:17482545; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Circ Res 2008; 103:606-14; PMID:18669924; http://dx.doi.org/10.1161/ CIRCRESAHA.108.175133.,Non-OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Am J Physiol Heart Circ  Physiol 2012; 303:H597-604; PMID:22730391;  http://dx.doi.org/10.1152/ajpheart.00138.2012.,Non-OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Cell 2003; 115:139-50;  PMID:14567912; http://dx.doi.org/10.1016/S0092- 8674(03)00803-1.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Proc Natl Acad Sci U S A 2001; 98:2604-9; PMID:11226286; http://dx.doi.org/10.1073/ pnas.041359198.30.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Inflammation  2000; 24:99-113; PMID:10718113; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Free Radic Biol Med 1998; 24:1015-22; PMID:9607613; http://dx.doi.org/10.1016/S0891- 5849(97)00433-4.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Mol  Cell 2010; 39:468-76; PMID:20705246; http://dx.doi.org/10.1016/j.molcel.2010.07.013.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
J  Biol Chem 2005; 280:19888-94; PMID:15774480;  http://dx.doi.org/10.1074/jbc.M413058200.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Nature 1980;  288:373-6; PMID:6253831; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
J  Neurochem 2008; 106:1952-63; PMID:18565207;  http://dx.doi.org/10.1111/j.1471-4159.2008.05531.x.,Non-OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Cell 1999; 98:147-57; PMID:10428027; http://dx.doi.org/10.1016/S0092- 8674(00)81010-7.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
J Clin Invest 1996; 98:886- 93; PMID:8770858; http://dx.doi.org/10.1172/ JCI118870.,Non-OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
J Cell Biol 2003; 163:525-34; PMID:14610055; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
J Biol Chem 2003; 278:19199-208; PMID:12626512; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Mol Biol Cell 2005; 16:5141-51; PMID:16120645;  http://dx.doi.org/10.1091/mbc.E05-05-0440.,Non-OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
Arterioscler Thromb Vasc Biol 1999; 19:2286- 97; PMID:10521356; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/9e/d3/tisb-1-e23896.PMC3875611.pdf
"Tissue  Barriers 2013; 1:e24252; http://dx.doi.org/10.4161/ tisb.24252 *Correspondence to: C. Yan Cheng;   Email: ccheng@rockefeller.eduFocal adhesion kinase (FAK), as its  name implied, is an important medi - ator of integrin-based signaling function  in mammalian cells at the focal adhe - sion complex (FAC, also known as focal  contact) at the cell-extracellular matrix  interface.",OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Proc Natl Acad Sci U S A  2012; 109:12562-7; PMID:22797892; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Proc Natl Acad Sci U S A  2008; 105:8950-5; PMID:18579774; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Pharmacol Rev 2008; 60:146- 80; PMID:18483144; http://dx.doi.org/10.1124/ pr.107.07105.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Biol Reprod 2009; 80:581-9; PMID:19038859;  http://dx.doi.org/10.1095/biolreprod.108.073122.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Biol Reprod 2010; 82:516-27;  PMID:19828778; http://dx.doi.org/10.1095/biolre - prod.109.080374.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Biol Reprod 2011; 85:1203-15;  PMID:21832167; http://dx.doi.org/10.1095/biolre - prod.111.093484.12.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
J Androl 2005; 26:354-9;  PMID:15867003; http://dx.doi.org/10.2164/jan - drol.04142.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Int J Biochem Cell Biol 2002; 34:1178-83;  PMID:12127568; http://dx.doi.org/10.1016/S1357- 2725(02)00064-X.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Biochem J  2011; 435:553-62; PMID:21486226; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
FASEB J 2009; 23:2555-67; PMID:19293393;  http://dx.doi.org/10.1096/fj.06-070573.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Reproduction  2012; 143:347-57; PMID:22157319; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Biol Reprod 2009; 80:162-74;  PMID:18799754; http://dx.doi.org/10.1095/biolre - prod.108.070623.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Spermatogenesis 2011; 1:123-36; PMID:22319661;  http://dx.doi.org/10.4161/spmg.1.2.16393.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Endocrinology  2012; 153:6041-53; PMID:23038739; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Microsc Res Tech 2009; 72:580-5; PMID:19263493;  http://dx.doi.org/10.1002/jemt.20699.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Hum  Reprod Update 2006; 12:275-82; PMID:16446319;  http://dx.doi.org/10.1093/humupd/dmk001.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Am J Anat  1983; 167:143-61; PMID:6351582; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Am J Anat 1983; 167:181- 92; PMID:6613903; http://dx.doi.org/10.1002/ aja.1001670204.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Adv Exp  Med Biol 2008; 636:212-33; PMID:19856170;  http://dx.doi.org/10.1007/978-0-387-09597-4_12.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Prog Histochem Cytochem 2011; 46:49-127;  PMID:21705043; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Biol Reprod 2011; 85:1091-3;  PMID:21900678; http://dx.doi.org/10.1095/biolre - prod.111.095976.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Nat Rev  Endocrinol 2010; 6:380-95; PMID:20571538;  http://dx.doi.org/10.1038/nrendo.2010.71.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Crit Rev Biochem Mol Biol 2009;  44:245-63; PMID:19622063; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Spermatogenesis 2012; 2:73- 8; PMID:22670216; http://dx.doi.org/10.4161/ spmg.20223.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Endocrinology 2012; 153:5023-35;  PMID:22872576; http://dx.doi.org/10.1210/ en.2012-1286.38.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Endocrinology 2012; 153:5036-48;  PMID:22948214; http://dx.doi.org/10.1210/ en.2012-1665.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
FASEB J 2013; 27:1137-52;  PMID:23288930; http://dx.doi.org/10.1096/fj.12- 212977.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Int Rev Cell Mol Biol 2013; 301:291- 358; PMID:23317821; http://dx.doi.org/10.1016/ B978-0-12-407704-1.00006-3.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
J Cell Sci 2012; 125:5677-89; PMID:22976294;  http://dx.doi.org/10.1242/jcs.107987.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Nat Rev Mol Cell Biol 2009;  10:126-39; PMID:19165215; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Science  2006; 313:363-7; PMID:16778019; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Cancer Res 2010; 70:8259-63;  PMID:20841486; http://dx.doi.org/10.1158/0008- 5472.CAN-10-0604.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
J Cell Sci 2004; 117:783-98; PMID:14734653;  http://dx.doi.org/10.1242/jcs.00900.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Biol Reprod  2009; 80:153-61; PMID:18799755; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Int J Androl  2012; 35:86-101; PMID:21696392; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/c1/tisb-1-e24252.PMC3875635.pdf
Tissue Barriers 2013; 1:e23119; http://dx.doi.org/10.4161/tisb.23119 *Correspondence to: Katharina Brandl;   Email: kbrandl@ucsd.eduA major challenge for the human body  is to maintain symbiotic relation - ships with bacterial communities that colonize their intestines.,Non-OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Nat Rev Immunol 2010; 10:159-69; PMID:20182457; http://dx.doi.org/10.1038/ nri2710.,Non-OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Science 1999; 286:420-1; PMID:10577203; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Nat Rev Immunol 2004; 4:953-64; PMID:15573130;  http://dx.doi.org/10.1038/nri1499.,Non-OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Science 2005; 307:731-4; PMID:15692051; http://dx.doi.org/10.1126/science.1104911.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Nat Immunol 2000; 1:113-8;  PMID:11248802; http://dx.doi.org/10.1038/77783.,Non-OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Nat Protoc 2007; 2:541-6;  PMID:17406617; http://dx.doi.org/10.1038/ nprot.2007.41.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Curr Opin Immunol  2012; 24:678-85; PMID:23123276; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Proc Natl Acad Sci U S A 2010; 107:19967-72;  PMID:21041656; http://dx.doi.org/10.1073/ pnas.1014669107.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Proc Natl Acad Sci U S A 2009; 106:3300-5;  PMID:19202076; http://dx.doi.org/10.1073/ pnas.0813036106.14.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
PLoS  Med 2008; 5:e54; PMID:18318598; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
EMBO J 1998; 17:4954-63;  PMID:9724632; http://dx.doi.org/10.1093/ emboj /17.17.4954.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
FEBS Lett 2002; 515:89-98;  PMID:11943201; http://dx.doi.org/10.1016/S0014- 5793(02)02442-0.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
J Biol Chem 2001; 276:40008-17; PMID:11489904; http://dx.doi.org/10.1074/jbc.M106189200.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Biochem Biophys  Res Commun 2003; 312:850-7; PMID:14680843;  http://dx.doi.org/10.1016/j.bbrc.2003.10.197.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Mol Biol Cell  2003; 14:1852-67; PMID:12802060; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Mol Biol Cell 2003; 14:1882-99; PMID:12802062;  http://dx.doi.org/10.1091/mbc.E02-10-0639.,Non-OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Cell 2004; 116:153-66;  PMID:14744428; http://dx.doi.org/10.1016/S0092- 8674(03)01079-1.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
J Cell Biol 1989; 109:1015-22; PMID:2504726; http://dx.doi.org/10.1083/ jcb.109.3.1015.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
J Cell Biol 1997; 137:563- 80; PMID:9151665; http://dx.doi.org/10.1083/ jcb.137.3.563.27.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
EMBO J  1998; 17:2156-65; PMID:9545229; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
J Cell Biol 2008; 183:607-15; PMID:19001129; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
J Cell Biol 1996; 132:755-67; PMID:8603910; http://dx.doi.org/10.1083/ jcb.132.5.755.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Cell 2008; 133:1202-13; PMID:18585354; http://dx.doi.org/10.1016/j.cell.2008.04.049.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Nature 2007; 445:941- 4; PMID:17287728; http://dx.doi.org/10.1038/ nature05527.,Non-OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Genetics 2004; 168:1827-41;  PMID:15611160; http://dx.doi.org/10.1534/genet - ics.104.032888.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Mol Biol Cell 2005; 16:1673-83; PMID:15659647; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
EMBO J 2000; 19:4485-92;  PMID:10970842; http://dx.doi.org/10.1093/ emboj /19.17.4485.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
J Biol Chem 2001; 276:12100-12; PMID:11278413; http://dx.doi.org/10.1074/jbc.M008439200.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
J Cell Biol  2003; 163:57-69; PMID:14557247; http://dx.doi.org/10.1083/jcb.200306118.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Science 1999; 286:113-7; PMID:10506557; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
EMBO J 2002; 21:6105-13;  PMID:12426382; http://dx.doi.org/10.1093/emboj/ cdf605.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Cell 2003; 114:497-509; PMID:12941277; http://dx.doi.org/10.1016/S0092-8674(03)00609-3.45.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
PLoS One 2012; 7:e34320; PMID:22485163; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Proc Natl Acad Sci U S A 2009; 106:11143-8;  PMID:19549835; http://dx.doi.org/10.1073/ pnas.0811227106.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Curr Opin Genet Dev  2009; 19:350-6; PMID:19559596; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Nature 2008; 455:804-7; PMID:18724361; http://dx.doi.org/10.1038/nature07250.40.,Non-OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
J Biol Chem 2003; 278:19878-84;  PMID:12657649; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Cell 1980; 21:205-15; PMID:6996832; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Exp Cell Res 2008; 314:3427-43; PMID:18718466; http://dx.doi.org/10.1016/j.yexcr.2008.07.023.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Cell Struct Funct 2011; 36:171- 85; PMID:21757827; http://dx.doi.org/10.1247/ csf.11002.,OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
Mol Biol Cell 2010; 21:1556-68; PMID:20237155;  http://dx.doi.org/10.1091/mbc.E09-12-1002.,Non-OADS,/arxiv_data1/oa_pdf/54/75/tisb-1-e23119.PMC3875636.pdf
"Mol Biol Cell 2012; 23:2845-55; PMID:22696678; http://dx.doi.org/10.1091/mbc.E12-02-0097.Keywords:  transcription factor, epithelial  morphogenesis, epithelial polarity, liver  development, bile duct, cholangiocyte, hepatic progenitor cell Submitted: 11/04/12Revised: 12/24/12Accepted: 01/04/13Citation: Tanimizu N, Mitaka T. Role  of grainyhead-like 2 in the formation of functional tight junctions.",OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
"Tissue Barriers 2013; 1:e23495; http://dx.doi.org/10.4161/tisb.23495 *Correspondence to: Naoki Tanimizu;   Email: tanimizu@sapmed.ac.jpEpithelial cells develop intercellular  junctions, including tight junctions  (TJs) and adherens junctions (AJs).",OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
FEBS Lett 2011; 585:606- 12; PMID:21276448; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
J Cell Sci 2002; 115:4969- 76; PMID:12432083; http://dx.doi.org/10.1242/jcs.00165.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Biochim Biophys Acta 2009; 1788:813-9; PMID:18706387; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Clin Genet 2010; 77:314-25;  PMID:20447145; http://dx.doi.org/10.1111/j.1399- 0004.2010.01397.x.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Gastroenterology  2009; 136:2325-33; PMID:19403103; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Development 2009; 136:1727-39; PMID:19369401;  http://dx.doi.org/10.1242/dev.029140.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Genes Dev 2005; 19:1849- 54; PMID:16103213; http://dx.doi.org/10.1101/gad.340305.10.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
J Cell Sci 2004; 117:3165-74; PMID:15226394; http://dx.doi.org/10.1242/jcs.01169.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Nat Genet 2003; 34:292-6; PMID:12808453; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Biochem Biophys Res Commun  2012; 423:454-60; PMID:22668877; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
J Biol Chem  2012; 287:6582-91; PMID:22235125; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Am J Pathol  2010; 177:698-712; PMID:20566751; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
PLoS One  2012; 7:e37174; PMID:22719836; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Biochem Biophys Res Commun 2010; 397:592- 7; PMID:20617560; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
J Cell Sci 2004; 117:6425- 34; PMID:15572411; http://dx.doi.org/10.1242/jcs.01572.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Mol Biol Cell 2007; 18:1472-9; PMID:17314404; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Mol Biol Cell 2012; 23:2845-55; PMID:22696678;  http://dx.doi.org/10.1091/mbc.E12-02-0097.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Nat Cell Biol 2010; 12:1035- 45; PMID:20890297; http://dx.doi.org/10.1038/ncb2106.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Curr Top Dev Biol 2012; 98:35-63; PMID:22305158; http://dx.doi.org/10.1016/B978- 0-12-386499-4.00002-1.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Dev Biol 2008; 319:56-67;  PMID:18485343; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
EMBO J 2009; 28:1890-903; PMID:19494835;  http://dx.doi.org/10.1038/emboj.2009.142.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Regulation of intrahepatic biliary  duct morphogenesis by Claudin 15-like b. Dev Biol  2012; 361:68-78; PMID:22020048; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Genes Dev  2010; 24:1295-305; PMID:20551175; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Cell 2007; 128:383- 97; PMID:17254974; http://dx.doi.org/10.1016/j.cell.2006.11.051.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Nat Cell Biol 2007; 9:954-60; PMID:17632505; http://dx.doi.org/10.1038/ ncb1621.28.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Development 2010; 137:3835-45; PMID:20978075;  http://dx.doi.org/10.1242/dev.055483.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Dev Biol 2011; 353:38-49; PMID:21377456; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/30/tisb-1-e23495.PMC3875637.pdf
Tissue Barriers 2013; 1:e25247; http://dx.doi.org/10.4161/tisb.25247;  http://dx.doi.org/10.4161/tisb.25247Claudins form the paracellular tight junction seal in epithelial  tissues.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Cell Biol 1963; 17:375- 412; PMID:13944428; http://dx.doi.org/10.1083/ jcb.17.2.375.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
FEBS Lett 2011; 585:606-12;  PMID:21276448; http://dx.doi.org/10.1016/j.febs - let.2011.01.028.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Physiol Rev 2013; 93:525- 69; PMID:23589827; http://dx.doi.org/10.1152/phys - rev.00019.2012.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Cell Sci 2006; 119:4819- 27; PMID:17130295; http://dx.doi.org/10.1242/ jcs.03233.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Curr Biol  2013; 23:731-6; PMID:23562268; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Clin Invest 2001; 107:1319-27; PMID:11375422;  http://dx.doi.org/10.1172/JCI12464.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Cell Sci 2005; 118:1427- 36; PMID:15769849; http://dx.doi.org/10.1242/ jcs.01735.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Am J Physiol Cell Physiol  2003; 284:C1346-54; PMID:12700140; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Histochem Cell Biol 2008; 129:211-22;  PMID:17989991; http://dx.doi.org/10.1007/s00418- 007-0354-y.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Eur J Cell Biol 2006; 85:1131-44;  PMID:16959372; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Cell Biol 1999; 147:891- 903; PMID:10562289; http://dx.doi.org/10.1083/ jcb.147.4.891.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Protein  Sci 2003; 12:218-27; PMID:12538885; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Biol Chem  2011; 286:3442-50; PMID:21098027; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Mol Biol Cell  2011; 22:1495-504; PMID:21372174; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Anat Rec (Hoboken) 2007; 290:1431- 8; PMID:17853415; http://dx.doi.org/10.1002/ ar.20597.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Mol Biol Cell 2008; 19:4687-93;  PMID:18768749; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Cell Mol Life Sci 2011; 68:3903-18;  PMID:21533891; http://dx.doi.org/10.1007/s00018- 011-0680-z.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Cell Biol 2003; 160:629- 33; PMID:12615908; http://dx.doi.org/10.1083/ jcb.200210140.24.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Proc Natl Acad Sci U S A 2010; 107:18010- 5; PMID:20921420; http://dx.doi.org/10.1073/ pnas.1009399107.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Cell Mol Life Sci 2010; 67:2131-40;  PMID:20333434; http://dx.doi.org/10.1007/s00018- 010-0332-8.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
FASEB J 2008; 22:146-58; PMID:17761522;  http://dx.doi.org/10.1096/fj.07-8319com.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J  Biol Chem 2007; 282:30005-13; PMID:17699514;  http://dx.doi.org/10.1074/jbc.M703547200.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Curr  Biol 1999; 9:1035-8; PMID:10508613; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Cell Sci 2004; 117:1247- 57; PMID:14996944; http://dx.doi.org/10.1242/ jcs.00972.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Cell Biol  2008; 181:683-95; PMID:18474622; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Proc Natl Acad Sci U S A 2003; 100:3971- 6; PMID:12651952; http://dx.doi.org/10.1073/ pnas.0630649100.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Cell Biol  1993; 123:1777-88; PMID:8276896; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Biol Chem 2013;  288:12253-68; PMID:23486470; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Mol  Cell Proteomics 2007; 6:1855-67; PMID:17644758;  http://dx.doi.org/10.1074/mcp.M700183-MCP200.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
"Clin Liver Dis  2008; 12:693-712, x; PMID:18625435; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Curr Opin Cell Biol  2007; 19:534-42; PMID:17928214; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
EMBO J 2005; 24:3700- 11; PMID:16211011; http://dx.doi.org/10.1038/ sj.emboj.7600831.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Dev Biol 2011; 355:138- 51; PMID:21539827; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Biol Chem 2005; 280:42375- 82; PMID:16236711; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Am J Physiol Cell Physiol 2002; 283:C142-7;  PMID:12055082; http://dx.doi.org/10.1152/ajp - cell.00038.2002.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Biol Chem 2009; 284:29205-17;  PMID:19690347; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Biol Chem 2010; 285:37060- 9; PMID:20807759; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
IUBMB Life  2009; 61:431-7; PMID:19319969; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Eur J Cell Biol 2004; 83:135-44;  PMID:15260435; http://dx.doi.org/10.1078/0171- 9335-00366.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Membr Biol 2004; 199:29-38; PMID:15366421;  http://dx.doi.org/10.1007/s00232-004-0673-z.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Am J Hum Genet 2003; 73:1293-301;  PMID:14628289; http://dx.doi.org/10.1086/380418.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Biol Chem 2006; 281:22312-20; PMID:16737969;  http://dx.doi.org/10.1074/jbc.M602901200.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Cell Biol 2002; 159:361- 72; PMID:12403818; http://dx.doi.org/10.1083/ jcb.200207050.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Biol Chem 2002; 277:27501-9; PMID:12021270;  http://dx.doi.org/10.1074/jbc.M201177200.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Cancer  Res 2009; 69:5627-9; PMID:19584271; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Exp Cell Res 2005; 309:345- 57; PMID:16054130; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Mol Cancer Res  2007; 5:553-67; PMID:17579117; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Mol Cancer  Res 2009; 7:285-99; PMID:19276185; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Dev Biol 2012; 371:136- 45; PMID:22819673; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Cell Biol 1998; 141:397- 408; PMID:9548718; http://dx.doi.org/10.1083/ jcb.141.2.397.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Cell Sci 2013; 126:554-64; PMID:23203797;  http://dx.doi.org/10.1242/jcs.114306.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Cell Biol  2005; 171:939-45; PMID:16365161; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Mol Biol Cell  2010; 21:1200-13; PMID:20164257; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Cell Biol 2011; 193:565- 82; PMID:21536752; http://dx.doi.org/10.1083/ jcb.201010065.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Biol Chem 2010;  285:21092-102; PMID:20375010; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Am J Pathol 2008; 172:905-15; PMID:18349130;  http://dx.doi.org/10.2353/ajpath.2008.070698.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Am J Physiol Cell Physiol 2005; 288:C1231- 41; PMID:15689410; http://dx.doi.org/10.1152/ajp - cell.00581.2004.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Cell Sci 2010; 123:2844- 52; PMID:20663912; http://dx.doi.org/10.1242/ jcs.065581.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Cell Death Dis 2012;  3:e273; PMID:22361748; http://dx.doi.org/10.1038/ cddis.2012.14.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Ann N Y Acad Sci 2009; 1165:113-20;  PMID:19538295; http://dx.doi.org/10.1111/j.1749- 6632.2009.04440.x.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Proc Natl Acad Sci U S A 1999; 96:511- 6; PMID:9892664; http://dx.doi.org/10.1073/ pnas.96.2.511.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
J Cell Biol  1999; 147:1351-63; PMID:10601346; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
Mol Biol Cell 2012; 23:577-90; PMID:22190737;  http://dx.doi.org/10.1091/mbc.E11-09-0791.,Non-OADS,/arxiv_data1/oa_pdf/f2/df/tisb-1-e25247.PMC3875638.pdf
"Tissue Barriers 2013; 1:e24517; http://dx.doi.org/10.4161/tisb.24517Introduction Tight junctions are required to maintain the integrity and func - tion of epithelial and endothelial cell barriers, where they have  two well-established roles in the cell.",Non-OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
T rends Cell Biol 2010; 20:142- 9; PMID:20061152; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Prog Biophys Mol Biol 2003;  81:1-44; PMID:12475568; http://dx.doi.org/10.1016/ S0079-6107(02)00037-8.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Nat Rev Mol Cell Biol 2003; 4:225- 36; PMID:12612641; http://dx.doi.org/10.1038/ nrm1055.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
J Cell Biol 1998; 141:1539- 50; PMID:9647647; http://dx.doi.org/10.1083/ jcb.141.7.1539.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Annu Rev Physiol 2006; 68:403- 29; PMID:16460278; http://dx.doi.org/10.1146/ annurev.physiol.68.040104.131404.,Non-OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Am J Physiol Renal Physiol 2008; 295:F867-76;  PMID:18480174; http://dx.doi.org/10.1152/ajpre - nal.90264.2008.8.,Non-OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Genome Biol  2009; 10:235; PMID:19706201; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
J Cell Biol 1999; 147:891- 903; PMID:10562289; http://dx.doi.org/10.1083/ jcb.147.4.891.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
J Biol Chem 2002; 277:455-61; PMID:11689568;  http://dx.doi.org/10.1074/jbc.M109005200.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Am J Hum Genet 2006; 79:949-57;  PMID:17033971; http://dx.doi.org/10.1086/508617.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Am J Physiol Renal Physiol  2010; 298:F24-34; PMID:19759267; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
J Biol Chem  2007; 282:17114-22; PMID:17442678; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Proc Natl Acad Sci U S A  2012; 109:14241-6; PMID:22891322; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Gene Expr Patterns 2005;  6:40-4; PMID:16024293; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Biol Reprod 2010; 82:202-13; PMID:19741204;  http://dx.doi.org/10.1095/biolreprod.109.078907.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Nature 2004; 432:695- 716; PMID:15592404; http://dx.doi.org/10.1038/ nature03154.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Bioinformatics 2007; 23:2947-8;  PMID:17846036; http://dx.doi.org/10.1093/bioinfor - matics/btm404.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Science 1989; 246:941-2;  PMID:17812579; http://dx.doi.org/10.1126/sci - ence.246.4932.941.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
J Morphol 1951; 88:49; http://dx.doi.org/10.1002/ jmor.1050880104.,Non-OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Methods Cell Biol 1996; 51:219-35;  PMID:8722478; http://dx.doi.org/10.1016/S0091- 679X(08)60630-5.22.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Hum Mol Genet 2003; 12:2049-61;  PMID:12913076; http://dx.doi.org/10.1093/hmg/ ddg210.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Gene Expr Patterns 2005; 5:553-60; PMID:15749086;  http://dx.doi.org/10.1016/j.modgep.2004.10.009.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Gene Expr Patterns 2012; PMID:22326481;  http://dx.doi.org/10.1016/j.gep.2012.01.005.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Genome Res  2004; 14:1248-57; PMID:15197168; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Annu Rev Physiol 2013; 75:479-501;  PMID:23140368; http://dx.doi.org/10.1146/annurev- physiol-030212-183705.,Non-OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Ann N Y Acad Sci 2009; 1165:34-43;  PMID:19538285; http://dx.doi.org/10.1111/j.1749- 6632.2009.04057.x.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Brain Res Brain Res Rev  2005; 49:167-78; PMID:16111547; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Eur J Hum Genet 2000; 8:414- 22; PMID:10878661; http://dx.doi.org/10.1038/ sj.ejhg.5200475.11.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Mech Dev  2006; 123:210-27; PMID:16500087; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
J Cell Biol  1999; 147:1351-63; PMID:10601346; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Regulation of intrahepatic biliary  duct morphogenesis by Claudin 15-like b. Dev Biol  2012; 361:68-78; PMID:22020048; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Clin Genet 2010; 77:314-25;  PMID:20447145; http://dx.doi.org/10.1111/j.1399- 0004.2010.01397.x.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Biochim Biophys Acta  2009; 1788:813-9; PMID:18706387; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Nat Cell Biol 2007; 9:954-60;  PMID:17632505; http://dx.doi.org/10.1038/ ncb1621.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Dev Biol  2007; 312:509-22; PMID:17980358; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Dev Dyn 2010; 239:715-22; PMID:20014098;  http://dx.doi.org/10.1002/dvdy.22172.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Dev Dyn 2008; 237:504- 12; PMID:18213590; http://dx.doi.org/10.1002/ dvdy.21437.,Non-OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
J Cell Biol  2005; 169:527-38; PMID:15883201; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
Gastroenterology  2012; 142:292-304; PMID:22079592; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7f/a2/tisb-1-e24517.PMC3875640.pdf
"Clin Cancer Res 2012; 18:3340-51; PMID:22535153; http://dx.doi.org/10.1158/1078-0432.CCR-11-3213 and Beyer I, van Rensburg R, Strauss R, Li ZY, Wang H, Persson J, et al.",Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
"Cancer Res 2011; 71:7080-90; PMID:21990319; http://dx.doi.org/10.1158/0008-5472.CAN-11-2009.Keywords:  adenovirus, desmoglein  2, EMT, chemotherapy, monoclonal  antibodies Submitted: 12/20/12Revised: 01/15/13Accepted: 01/16/13Citation: Beyer I, van Rensburg R,  Liber A. Overcoming physical barriers in cancer therapy.",Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
"Tissue Barriers 2013; 1:e23647; http://dx.doi.org/10.4161/tisb.23647 *Correspondence to: André Lieber;   Email: lieber00@u.washington.eduMost solid tumors are of epithelial  origin and, although malignant  cells are de-differentiated, they main - tain intercellular junctions, a key feature  of epithelial cells, both in the primary  tumor as well as in metastatic lesions.",Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Nat Clin Pract Oncol 2008; 5:280- 90; PMID:18349857; http://dx.doi.org/10.1038/ ncponc1089.,Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Cancer Res  2006; 66:8319-26; PMID:16951136; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
PLoS One 2011; 6:e16186;  PMID:21264259; http://dx.doi.org/10.1371/jour - nal.pone.0016186.,Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Cancer Res 2011; 71:7080-90; PMID:21990319;  http://dx.doi.org/10.1158/0008-5472.CAN-11- 2009.5.,Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Clin Cancer Res 2012; 18:3340-51; PMID:22535153; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Adv Drug Deliv Rev 2001; 46:3-26; PMID:11259830; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Bioconjug Chem  2010; 21:1264-70; PMID:20536171; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Mol Ther 2011; 19:479- 89; PMID:21081901; http://dx.doi.org/10.1038/ mt.2010.256.,OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
J Virol 2012; 86:6286-302; PMID:22457526; http://dx.doi.org/10.1128/ JVI.00205-12.,Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Mol Ther 2009; 17:1724-32; PMID:19602998; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Mol Ther 2008; 16:1665- 73; PMID:18665155; http://dx.doi.org/10.1038/ mt.2008.162.,Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Gene Ther 1998; 5:189-95; PMID:9578838;  http://dx.doi.org/10.1038/sj.gt.3300564.,OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Int J Biochem Cell Biol 2007;  39:2153-60; PMID:17825600; http://dx.doi.org/10.1016/j.biocel.2007.07.011.,OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Cell 2009; 139:871-90;  PMID:19945376; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
J Cell Biol 1999; 147:195-204; PMID:10508866;  http://dx.doi.org/10.1083/jcb.147.1.195.,OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Pharm Res 2002; 19:1680-8; PMID:12458674; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
J Pharm Sci 2000; 89:429-42; PMID:10737905;  http://dx.doi.org/10.1002/(SICI)1520- 6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J.,OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Nat Med 2011; 17:96- 104; PMID:21151137; http://dx.doi.org/10.1038/ nm.2270.,OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
J Virol  2011; 85:6390-402; PMID:21525338; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
J Cell Sci  2008; 121:298-305; PMID:18198187; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Mol Biol Cell 2007; 18:4565-78; PMID:17804817; http://dx.doi.org/10.1091/mbc.E07-05-0426.,Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
Mol Cancer Ther  2005; 4:704-14; PMID:15897234; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
J Cell Biochem 2011; 112:10-29; PMID:21104905; http://dx.doi.org/10.1002/jcb.22952.,Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
BMC Cancer 2010; 10:255; PMID:20525277; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
J Pathol 2005; 207:199- 206; PMID:16025435; http://dx.doi.org/10.1002/ path.1821.,Non-OADS,/arxiv_data1/oa_pdf/78/39/tisb-1-e23647.PMC3875641.pdf
" COMMENTARY www.landesbioscience.com Worm e23704-1Worm 2:3, e23704; July/August/September 2013; © 2013 Landes BioscienceCOMMENTARY Keywords:  senescence, extrinsic  mortality, evolution, longevity,  Medawar-Williams prediction, tradeoff, reproduction, condition-dependence, stress, heat-shock Submitted: 01/07/13Accepted: 01/17/13http://dx.doi.org/10.4161/worm.23704 Correspondence to: Alexei Maklakov;   Email: Alexei.Maklakov@ebc.uu.seOrganisms age because of the “selec - tion shadow”—the decline of  the force of natural selection with age.",Non-OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Curr Biol 2012; 22:2140-3; PMID:23084993; http://dx.doi.org/10.1016/j.cub.2012.09.021,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
PLoS One  2010; 5:e9978; PMID:20369008; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
BMC Evol Biol 2011; 11:339; PMID:22103856; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
BMC Evol Biol 2011; 11:157;  PMID:21645395; http://dx.doi.org/10.1186/1471- 2148-11-157.,Non-OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
"The C. elegans   Research Community, WormBook, doi/10.1895/ wormbook.1.21.1,http://www.wormbook.org.",Non-OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Genetics 2006; 173:677-83;  PMID:16582430; http://dx.doi.org/10.1534/genet - ics.106.056093.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
PLoS Biol 2011; 9:e1000586;  PMID:21283608; http://dx.doi.org/10.1371/jour - nal.pbio.1000586.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Nature  2004; 431:1095-9; PMID:15510147; http://dx.doi.org/10.1038/nature02936.,Non-OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Biol Fertil  Soils 1996; 21:121-7; http://dx.doi.org/10.1007/ BF00336003.,Non-OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Oecologia 1999; 120:279-86; http://dx.doi.org/10.1007/s004420050859.,Non-OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
"The C. elegans  Research Community, WormBook,  http://dx.doi.org/10.1895/wormbook.1.115.1, http:// www.wormbook.org.11.",Non-OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Trends Ecol Evol  2006; 21:458-63; PMID:16766081; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Proc Natl Acad Sci U S A  2000; 97:3309-13; PMID:10716732; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Bioessays 2011; 33:860-9; PMID:21922504; http://dx.doi.org/10.1002/bies.201100051.,Non-OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Curr Biol 2012; 22:2130-3; PMID:2012WORM099;  http://dx.doi.org/10.1016/j.cub.2012.09.021.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Evolution 1993;  47:877-87; http://dx.doi.org/10.2307/2410191.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Trends Ecol Evol 2007; 22:173- 4; PMID:17287044; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Nature 2004; 431:1048-9; PMID:15510135;  http://dx.doi.org/10.1038/4311048a.,Non-OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
BMC Evol Biol 2012; 12:25; PMID:22369091; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Curr Biol 2012; 22:R947-9; PMID:23174294;  http://dx.doi.org/10.1016/j.cub.2012.09.029.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Nature 2009;  462:1061-4; PMID:19956092; http://dx.doi.org/10.1038/nature08619.,Non-OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Mech Ageing Dev 2005; 126:1011- 6; PMID:15893805; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Science 2007; 315:1133-7; PMID:17272684; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Cell Cycle 2007; 6:2997-3003; PMID:18156807; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Cell Cycle 2009; 8:4055-9;  PMID:19923900; http://dx.doi.org/10.4161/ cc.8.24.10310.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Cell Cycle 2008; 7:3355- 61; PMID:18948731; http://dx.doi.org/10.4161/ cc.7.21.6919.,Non-OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Curr Biol 2010; 20:R965- 9; PMID:21093785; http://dx.doi.org/10.1016/j.cub.2010.09.050.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Annu Rev Entomol 2005; 50:421-45; PMID:15355246; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Nature  1977; 270:301-4; PMID:593350; http://dx.doi.org/10.1038/270301a0.,Non-OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Nature 1993;  362:305-11; PMID:8455716; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
J Theor Biol 1966; 12:12-45;  PMID:6015424; http://dx.doi.org/10.1016/0022- 5193(66)90184-6.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Evolution 1957; 11:398- 411; http://dx.doi.org/10.2307/2406060.,Non-OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
Philos Trans R Soc Lond B Biol Sci 1991; 332:15- 24; PMID:1677205; http://dx.doi.org/10.1098/ rstb.1991.0028.,OADS,/arxiv_data1/oa_pdf/33/d4/worm-2-e23704.PMC3875642.pdf
" COMMENTARY www.landesbioscience.com Worm e23834-1Worm 2:3, e23834; July/August/September 2013; © 2013 Landes BioscienceCOMMENTARY Keywords:  ADF, alternative splicing,  ASD-2, fluorescence splicing reporter,  body wall muscle, pre-mRNA processing, RBFOX, SUP-12, unc-60 Abbreviations:  A, alanine; ADF,  actin depolymerising factor; ChAT,  choline acetyltransferase; EMSA, electrophoretic mobility shift assay; GFP, green fluorescent protein; NMD, nonsense-mediated mRNA decay; ORF, open reading frame; PAS, polyadenylation signal; pre-mRNA, precursor messenger RNA; Q, glutamine; RFP, red fluorescent protein; RRM, RNA recognition motif; STAR, signal transduction and activation of RNA; Unc, uncoordinated; UTR, untranslated region; VAChT, vesicular acetylcholine transporter Submitted: 01/02/13Revised: 01/27/13Accepted: 01/30/13http://dx.doi.org/10.4161/worm.23834 *Correspondence to: Hidehito Kuroyanagi;   Email: kuroyana.end@tmd.ac.jpAlternative processing of precursor  mRNAs (pre-mRNAs), including  alternative transcription start sites, alter - native splicing and alternative polyad - enylation, is the major source of protein diversity and plays crucial roles in devel - opment, differentiation and diseases in higher eukaryotes.",Non-OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
PLoS Genet 2012; 8: e1002991; PMID:23071450; http://dx.doi.org/10.1371/journal.pgen.102991,Non-OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Nucleic Acids Res  2012;PMID:23416545;http://dx.doi.org/10/1093/nar/gkt097.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Mol Gen Genet 1994; 242:346-57; PMID:8107682; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
J Biol Chem 1998; 273:3778-83; PMID:9452511; http://dx.doi.org/10.1074/ jbc.273.6.3778.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Biochemistry 2005; 44:14238-47; PMID:16245940; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
J Cell Sci 2003; 116:2073- 85; PMID:12679387; http://dx.doi.org/10.1242/jcs.00421.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
J Cell Sci  2008; 121:2662-70; PMID:18653537; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
J Cell Biol  2002; 156:1065-76; PMID:11901171; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Science  2010; 329:432-5; PMID:20522740; http://dx.doi.org/10.1126/science.1191244.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Nat  Struct Mol Biol 2005; 12:691-8; PMID:16041388; http://dx.doi.org/10.1038/nsmb963.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
PLoS Genet 2012; 8:e1002632; PMID:22479211; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Cell Mol Life Sci 2009; 66:3895-907;  PMID:19688295; http://dx.doi.org/10.1007/ s00018-009-0120-5.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
J Mol Biol  1994; 241:627-30; PMID:8057385; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Mol Cell Biol  2001; 21:4985-95; PMID:11438655; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
J Cell Biol 2004; 167:639- 47; PMID:15545320; http://dx.doi.org/10.1083/jcb.200407085.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Mol Cell  Biol 2004; 24:6811-23; PMID:15254247; http://dx.doi.org/10.1128/MCB.24.15.6811-6823.2004.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Genetics 2004; 168:1293-306; PMID:15579686; http://dx.doi.org/10.1534/genetics.104.029827.,Non-OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Nat Methods 2010; 7:407- 11; PMID:20364149; http://dx.doi.org/10.1038/nmeth.1445.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Genes Dev 2008; 22:279-85;  PMID:18245441; http://dx.doi.org/10.1101/ gad.1643108.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
"WormBook  - Molecular biology -: http://www.wormbook.org, 2005:1-13.",Non-OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
"WormBook - Molecular biology -: http://www.wormbook.org, 2012:1-21.",Non-OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Nat Methods 2006; 3:909- 15; PMID:17060915; http://dx.doi.org/10.1038/nmeth944.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Mol Cell  Biol 2007; 27:8612-21; PMID:17923701; http://dx.doi.org/10.1128/MCB.01508-07.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Genes Dev 2008; 22:360- 74; PMID:18230701; http://dx.doi.org/10.1101/ gad.1620608.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Nat Protoc 2010; 5:1495-517; PMID:20725066;  http://dx.doi.org/10.1038/nprot.2010.107.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
PLoS Genet  2012; 8:e1002991; PMID:23071450; http://dx.doi.org/10.1371/journal.pgen.1002991.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Cell  2011; 144:16-26; PMID:21215366; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Annu Rev Biochem 2003; 72:291- 336; PMID:12626338; http://dx.doi.org/10.1146/ annurev.biochem.72.121801.161720.,Non-OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Nat Rev Neurosci  2007; 8:819-31; PMID:17895907; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Trends Genet  2011; 27:89-97; PMID:21232811; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Genome  Res 2011; 21:342-8; PMID:21177968; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
J Biol Chem 2001; 276:11913- 21; PMID:11110798; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Development 2003;  130:3757-66; PMID:12835392; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
Nat Neurosci 2007; 10:1300- 7; PMID:17891142; http://dx.doi.org/10.1038/nn1981.,Non-OADS,/arxiv_data1/oa_pdf/df/14/worm-2-e23834.PMC3875643.pdf
" COMMENTARY www.landesbioscience.com Worm e23843-1Worm 2:3, e23843; July/August/September 2013; © 2013 Landes BioscienceCOMMENTARY Keywords:  TGF- β signaling, glypican,  LON-2, body size, heparan sulfate  proteoglycan, RGD-binding protein, glycosylphosphatidylinositol anchor Abbreviations:  BMP, bone morphoge - netic protein; DBL-1, Dpp and BMP- like; Dpp, decapentaplegic; FGF, fibro - blast growth factor; GPC1, glypican 1; GPC3, glypican 3; GPC4, glypican 4; GPC5, glypican 5; GPI, glycosylphos - phatidylinositol; GPN-1, glypican; HCC, hepatocellular carcinoma; Hh, hedgehog; HS-GAG, heparan sulfate glycosamino - glycan; LON-2, long; RGD, arginine gly - cine aspartic acid; TGF- β, transforming  growth factor-β ; Wnt, wingless and Int Submitted: 01/10/13 Accepted: 01/31/13http://dx.doi.org/10.4161/worm.23843 *Correspondence to: Tina L Gumienny;   Email: Gumienny@medicine.tamhsc.eduRegulated intercellular signaling is  critical for the normal development  and maintenance of multicellular organ - isms.",Non-OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Dev Biol 2012; 371:66-76; PMID:22922164; http://dx.doi.org/10.1016/j.ydbio.2012.08.006,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Dev Biol 2006; 300:570-82; PMID:17055473; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Nature  1999; 400:281-4; PMID:10421372; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Development 2003; 130:2129-38; PMID:12668627;  http://dx.doi.org/10.1242/dev.00435.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
J  Biol Chem 2005; 280:2116-25; PMID:15537637;  http://dx.doi.org/10.1074/jbc.M410090200.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Dev Cell 2001; 1:251- 64; PMID:11702784; http://dx.doi.org/10.1016/S1534-5807(01)00005-3.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Nature 1999; 400:276-80; PMID:10421371; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Dev Biol 2007; 312:203- 16; PMID:17959166; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Dev Cell  2009; 17:470-81; PMID:19853561; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
J Biol Chem 1997; 272:7574- 7; PMID:9065409; http://dx.doi.org/10.1074/ jbc.272.12.7574.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Development 2010;  137:2033-44; PMID:20501592; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Dev Biol 2008; 313:408-19; PMID:18054902; http://dx.doi.org/10.1016/j.ydbio.2007.10.035.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Development 2009; 136:3715-28; PMID:19855014; http://dx.doi.org/10.1242/dev.031534.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Genome  Biol 2008; 9:224; PMID:18505598; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Cancer Res  2005; 65:6245-54; PMID:16024626; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Dev Cell 2008; 14:700-11;  PMID:18477453; http://dx.doi.org/10.1016/j.dev - cel.2008.03.006.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Dev Dyn 2000; 219:353-67; PMID:11066092; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Dev Biol 2005; 284:204- 18; PMID:15963974; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
J  Biol Chem 2005; 280:41201-6; PMID:16227623;  http://dx.doi.org/10.1074/jbc.M507004200.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Cancer Res 2004; 64:2418-23; PMID:15059894; http://dx.doi.org/10.1158/0008-5472.CAN-03- 2191.,Non-OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Dev Biol 2006; 294:352- 65; PMID:16677626; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Cold Spring Harb Perspect Biol 2011; 3:a005017; PMID:21900405; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
J Biol Chem 1998; 273:18459-69; PMID:9660815; http://dx.doi.org/10.1074/ jbc.273.29.18459.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
J Cell Biol 2007; 179:1311-23; PMID:18086923; http://dx.doi.org/10.1083/jcb.200704042.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Cold Spring Harb Perspect Biol  2009; 1:a002493; PMID:20066107; http://dx.doi.org/10.1101/cshperspect.a002493.,Non-OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Biochem J  2011; 433:263-76; PMID:21175431; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Dev Biol  2012; 371:66-76; PMID:22922164; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
J Cell Biol 1998; 141:1407- 14; PMID:9628896; http://dx.doi.org/10.1083/ jcb.141.6.1407.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
J Cell Biol 2011; 192:691-704; PMID:21339334; http://dx.doi.org/10.1083/jcb.201008087.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Dev Biol 2010; 348:107-18; PMID:20883685; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Dev Cell 2008; 14:712-25; PMID:18477454; http://dx.doi.org/10.1016/j.devcel.2008.03.001.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Annu Rev Biochem  1999; 68:729-77; PMID:10872465; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Exp Cell Res 1993; 208:10-8; PMID:8395393; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Int J Cancer  2011; 128:2246-7; PMID:20617511; http://dx.doi.org/10.1002/ijc.25549.,Non-OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
J Cell Biol 2003; 163:625- 35; PMID:14610063; http://dx.doi.org/10.1083/ jcb.200302152.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Cell Mol Life Sci 2011; 68:923- 9; PMID:18087675; http://dx.doi.org/10.1007/ s00018-007-7471-6.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Proc Natl Acad Sci U S A 2010; 107:5869-74; PMID:20231458; http://dx.doi.org/10.1073/ pnas.1001777107.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Eur J Cancer 2011; 47:333- 8; PMID:21112773; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Curr Biol 2007; 17:159- 64; PMID:17240342; http://dx.doi.org/10.1016/j.cub.2006.11.065.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Dev Biol 2000; 225:179-87; PMID:10964473;  http://dx.doi.org/10.1006/dbio.2000.9831.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
Curr Biol 2002; 12:205-9;  PMID:11839272; http://dx.doi.org/10.1016/S0960- 9822(01)00684-4.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
J Biol Chem 2011; 286:17103-11; PMID:21454551; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/c8/c8/worm-2-e23843.PMC3875644.pdf
" RESEARCH PAPER www.landesbioscience.com Worm e25040-1Worm 2:3, e25040; July/August/September 2013; © 2013 Landes BioscienceRESEARCH PAPER *Correspondence to: Paul E. Mains; Email: mains@ucalgary.ca Submitted: 03/14/13; Revised: 05/10/13; Accepted: 05/14/13http://dx.doi.org/10.4161/worm.25040Introduction Morphogenesis is the process by which the organism attains its  three dimensional body form.",Non-OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Trends Genet 2008; 24:221-30; PMID:18375008;  http://dx.doi.org/10.1016/j.tig.2008.02.005 2.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Dev Biol 1986; 117:156-73;  PMID:3743895; http://dx.doi.org/10.1016/0012- 1606(86)90358-1 3.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
J Cell Sci  2011; 124:679-83; PMID:21321325; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
J Physiol  2000; 522:177-85; PMID:10639096; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Development 2003; 130:5695- 704; PMID:14522875; http://dx.doi.org/10.1242/ dev.00807 7.,Non-OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Development 2009; 136:3109-19;  PMID:19675126; http://dx.doi.org/10.1242/ dev.039412 8.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
J Cell Biol 1999; 146:439- 51; PMID:10427096; http://dx.doi.org/10.1083/jcb.146.2.439 9.,Non-OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Genes Dev 1997; 11:409- 22; PMID:9042856; http://dx.doi.org/10.1101/ gad.11.4.409 10.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
J Muscle Res Cell Motil  1998; 19:325-41; PMID:9635276; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
J Cell Biol  1994; 124:475-90; PMID:8106547; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Development 2007;  134:2469-79; PMID:17537791; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
FEBS Lett 2007; 581:4337-41;  PMID:17716666; http://dx.doi.org/10.1016/j.febs- let.2007.08.005 16.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Dev Biol 1999; 209:111- 27; PMID:10208747; http://dx.doi.org/10.1006/ dbio.1999.9242 17.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Nat Rev Mol Cell Biol 2010; 11:62- 74; PMID:19997130; http://dx.doi.org/10.1038/ nrm2816 18.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Annu  Rev Biochem 2007; 76:593-627; PMID:17373907;  http://dx.doi.org/10.1146/annurev.bio- chem.75.103004.142647 19.,Non-OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Mol Biol Cell  2005; 16:1-13; PMID:15509653; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
J Biol Chem 2003;  278:38902-12; PMID:12857739; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
J Biol Chem 2008; 283:27891-903; PMID:18694941;  http://dx.doi.org/10.1074/jbc.M801800200 23.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Cell  Mol Life Sci 2013; 70:893-908; PMID:23052206;  http://dx.doi.org/10.1007/s00018-012-1154-7 24.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Structure  2008; 16:1313-23; PMID:18786395; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Exp Cell Res 2005; 306:192-202; PMID:15878344; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
J Cell Sci 2003; 116:1745-55; PMID:12665555;  http://dx.doi.org/10.1242/jcs.00386 27.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
J Biol Chem 2009;  284:29873-81; PMID:19706596; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
J Cell Biol  2010; 191:1159-72; PMID:21149568; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
PLoS One 2012; 7:e34765;  PMID:22509354; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
J Cell Biol 2012; 198:87-102; PMID:22753896;  http://dx.doi.org/10.1083/jcb.201202053 31.,Non-OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Cell 2001; 105:81- 91; PMID:11301004; http://dx.doi.org/10.1016/ S0092-8674(01)00298-7 33.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Biochem Biophys Res Commun 2000; 269:64-9; PMID:10694478; http://dx.doi.org/10.1006/ bbrc.2000.2260 34.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Nature 2011; 471:99-103; PMID:21368832;  http://dx.doi.org/10.1038/nature09765 35.,Non-OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
J Cell Biochem 2004;  92:29-41; PMID:15095401; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Biochem Biophys Res  Commun 2005; 336:1285-91; PMID:16169515;  http://dx.doi.org/10.1016/j.bbrc.2005.08.257 38.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Biochem Biophys  Res Commun 2005; 335:1090-4; PMID:16112087;  http://dx.doi.org/10.1016/j.bbrc.2005.07.191 39.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
J Biol Chem 2008; 283:24949- 61; PMID:18586681; http://dx.doi.org/10.1074/jbc.M801728200 40.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Curr Biol 2002; 12:317-21;  PMID:11864573; http://dx.doi.org/10.1016/S0960- 9822(02)00652-8 41.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
J Cell Biol  2002; 157:665-77; PMID:11994313; http://dx.doi.org/10.1083/jcb.200111051 42.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Dev Cell  2002; 3:113-25; PMID:12110172; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Dev Biol 1983; 100:64-119;  PMID:6684600; http://dx.doi.org/10.1016/0012- 1606(83)90201-447.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Methods Cell Biol 1995; 48:365-94;  PMID:8531735; http://dx.doi.org/10.1016/S0091- 679X(08)61396-5 48.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Dev Biol 1997; 184:373-84; PMID:9133443; http://dx.doi.org/10.1006/dbio.1997.853044.,Non-OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Nature  2003; 421:231-7; PMID:12529635; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
Nature 1998; 391:806-11; PMID:9486653; http://dx.doi.org/10.1038/35888,Non-OADS,/arxiv_data1/oa_pdf/e7/44/worm-2-e25040.PMC3875645.pdf
"Although this bottleneck is avoided when resorting to large-scale RNA interference (RNAi) screens, 2 no  *Correspondence to: Sophie Jariault; Email: sophie@igbmc.fr Submitted: 04/05/13; Revised: 05/16/13; Accepted: 05/17/13Citation: http://dx.doi.org/10.4161/worm.25081The development of next-generation sequencing technologies  has enabled rapid and cost effective whole genome sequencing.",Non-OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
J Mol Biol  1977; 117:525-67; PMID:609095; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Proc Natl Acad Sci USA 1960;  46:1585-94; PMID:16590785; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Curr Opin Genet Dev 2009; 19:105- 12; PMID:19328674; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Genetics  2012; 192:1249-69; PMID:23051646; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Nucleic Acids Res 2012; 40(Database  issue):D735-41; PMID:22067452; http://dx.doi.org/10.1093/nar/gkr954 36.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Nucleic Acids Res 2008; 36:e122;  PMID:18753151; http://dx.doi.org/10.1093/nar/ gkn502 37.,Non-OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Nat Biotechnol  2012; 30:20-5; PMID:22231086; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Nat Methods 2009;  6:549; PMID:19620971; http://dx.doi.org/10.1038/ nmeth.f.260 39.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Genome Res 2008; 18:1851- 8; PMID:18714091; http://dx.doi.org/10.1101/ gr.078212.108 40.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Bioinformatics  2010; 26:589-95; PMID:20080505; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Genome Biol 2009;  10:R25; PMID:19261174; http://dx.doi.org/10.1186/ gb-2009-10-3-r25 42.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Bioinformatics 2009; 25:2078- 9; PMID:19505943; http://dx.doi.org/10.1093/bioin-formatics/btp352 43.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Development 2012; 139:4280-90; PMID:23052906;  http://dx.doi.org/10.1242/dev.083931 18.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Nat Methods 2009; 6:550-1; PMID:19644454;  http://dx.doi.org/10.1038/nmeth0809-550 19.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
PLoS  One 2010; 5:e15435; PMID:21079745; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Curr Opin Plant Biol 2009; 12:107- 18; PMID:19157957; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Genetics 2007; 177:1163- 71; PMID:17660537; http://dx.doi.org/10.1534/ genetics.107.078147 25.,Non-OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Genome  Res 2007; 17:240-8; PMID:17189378; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Genetics  2011; 189:767-78; PMID:21900274; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Proc Natl Acad Sci USA 2008; 105:3790- 5; PMID:18308937; http://dx.doi.org/10.1073/ pnas.0712159105 28.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Development 2011; 138:1483- 92; PMID:21389048; http://dx.doi.org/10.1242/ dev.063115 29.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Nat Rev Genet  2002; 3:356-69; PMID:11988761; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Methods 2003; 30:313-21;  PMID:12828945; http://dx.doi.org/10.1016/S1046- 2023(03)00050-1 3.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Nat Genet  2001; 28:160-4; PMID:11381264; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Nat Biotechnol 2008; 26:1135-45; PMID:18846087;  http://dx.doi.org/10.1038/nbt1486 7.,Non-OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Nat Rev Genet 2010; 11:685-96;  PMID:20847746; http://dx.doi.org/10.1038/nrg2841 8.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Nat Rev Genet 2012; 13:565- 75; PMID:22805709; http://dx.doi.org/10.1038/ nrg3241 9.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Semin Cell Dev Biol 2012; 23:222- 9; PMID:22210502; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Nat Methods 2008;  5:865-7; PMID:18677319; http://dx.doi.org/10.1038/nmeth.1249 11.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Genetics 2010; 185:417-30;  PMID:20439776; http://dx.doi.org/10.1534/genet- ics.110.116319 12.,Non-OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Genetics 2010; 186:427- 30; PMID:20610404; http://dx.doi.org/10.1534/ genetics.110.119230 13.,Non-OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Nat Methods 2008; 5:183-8; PMID:18204455; http://dx.doi.org/10.1038/ nmeth.1179 14.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Genetics 2010; 185:431- 41; PMID:20439774; http://dx.doi.org/10.1534/ genetics.110.116616 15.,Non-OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
PLoS One 2010; 5:e13922; PMID:21085631;  http://dx.doi.org/10.1371/journal.pone.0013922 16.,Non-OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
Nature  2004; 430:679-82; PMID:15295601; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/ad/worm-2-e25081.PMC3875646.pdf
" Short CommuniC ation www.landesbioscience.com Worm e25214-1Worm 2:3, e25214; July/a ugust/September 2013; © 2013 Landes BioscienceShort CommuniC ation *Correspondence to: Gang Dong; Email: gang.dong@meduniwien.ac.at Submitted: 02/22/13; Revised: 05/05/13; Accepted: 05/29/13http://dx.doi.org/10.4161/worm.25214Introduction Centrioles are the fundamental units for both centrosome forma - tion and cilium biogenesis.",Non-OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Curr Biol 2005; 15:2199-207;  PMID:16326102; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Nat Cell Biol 2005; 7:1140-6; PMID:16244668;  http://dx.doi.org/10.1038/ncb1320 15.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
J Cell Biol 2010; 188:313-23; PMID:20123993;  http://dx.doi.org/10.1083/jcb.200910016 16.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
EMBO J 2011; 30:4790-804; PMID:22020124;  http://dx.doi.org/10.1038/emboj.2011.378 17.,Non-OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Nature 2006; 444:619-23; PMID:17136092;  http://dx.doi.org/10.1038/nature05318 19.,Non-OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Cell 2011; 144:364- 75; PMID:21277013; http://dx.doi.org/10.1016/j.cell.2011.01.0086.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Nat Cell  Biol 2004; 6:656-64; PMID:15232593; http://dx.doi.org/10.1038/ncb1146 7.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Dev Cell 2004; 7:815-29; PMID:15572125;  http://dx.doi.org/10.1016/j.devcel.2004.10.015 8.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Dev Cell 2005; 9:317-25; PMID:16139223; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Cell 2006; 125:1375-86; PMID:16814722; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Nat Cell  Biol 2005; 7:115-25; PMID:15665853; http://dx.doi.org/10.1038/ncb1220 11.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Cell  2001; 105:547-58; PMID:11371350; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Dev Cell 2003; 4:431-9;  PMID:12636923; http://dx.doi.org/10.1016/S1534- 5807(03)00062-5 5.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Cell 2003; 112:575-87;  PMID:12600319; http://dx.doi.org/10.1016/S0092- 8674(03)00117-XFigure 2.  the S aS-5 nt D forms a tetramer with residues 1–81 being intrinsically disordered.,Non-OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Nucleic  Acids Res 2010; 38(Web Server issue):W563-8;  PMID:20507913; http://dx.doi.org/10.1093/nar/ gkq42723.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
EMBO J 2012; 31:4334- 47; PMID:23064147; http://dx.doi.org/10.1038/ emboj.2012.280 24.,Non-OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Nucleic Acids Res 2003; 31:3701- 8; PMID:12824398; http://dx.doi.org/10.1093/nar/ gkg51920.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Science  2011; 331:1196-9; PMID:21273447; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Science 2012; 337:553;  PMID:22798403; http://dx.doi.org/10.1126/sci- ence.1222789 22.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
Nat Chem  Biol 2011; 7:650-3; PMID:21931303; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/2b/worm-2-e25214.PMC3875647.pdf
"www.landesbioscience.com Worm  e25546 -1Worm 2:3, e25546; Worm 2013; © 2013 Landes Bioscience Commentary Commentary Keywords:  compartmental calcium sig - nal, global calcium signal, regulation of  navigation, wiring diagram, acetylcholine signaling, corollary discharge Submitted: 06/05/13Accepted: 06/25/13http://dx.doi.org/10.4161/worm.25546 Correspondence to: Michael Hendricks and Yun  Zhang; Email: s.michael.hendricks@gmail.com  and yzhang@oeb.harvard.eduRecently, we have reported novel and  complex calcium dynamics in the  RIA interneuron, which has been impli - cated in several navigational behaviors in C. elegans .",Non-OADS,/arxiv_data1/oa_pdf/50/c4/worm-2-e25546.PMC3875648.pdf
Nature 2012; 487:99-103; PMID:22722842; http://dx.doi.org/ 10.1038/nature11081,Non-OADS,/arxiv_data1/oa_pdf/50/c4/worm-2-e25546.PMC3875648.pdf
Proc Natl Acad Sci USA 1975; 72:4061-5; PMID:1060088; http://dx.doi.org/10.1073/ pnas.72.10.4061 6.,OADS,/arxiv_data1/oa_pdf/50/c4/worm-2-e25546.PMC3875648.pdf
Nature 1995;  376:344-8; PMID:7630402; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/50/c4/worm-2-e25546.PMC3875648.pdf
J Exp Biol 2006; 209:4652-62; PMID:17114399; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/50/c4/worm-2-e25546.PMC3875648.pdf
J Neurosci 2009; 29:5370-80;  PMID:19403805; http://dx.doi.org/10.1523/ JNEUROSCI.3633-08.2009 9.,Non-OADS,/arxiv_data1/oa_pdf/50/c4/worm-2-e25546.PMC3875648.pdf
Nat Methods  2011; 8:599-605; PMID:21666667; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/50/c4/worm-2-e25546.PMC3875648.pdf
Nature  2012; 490:273-7; PMID:23000898; http://dx.doi.org/10.1038/nature11431 11.,Non-OADS,/arxiv_data1/oa_pdf/50/c4/worm-2-e25546.PMC3875648.pdf
Bioessays 2012; 34:458-65; PMID:22396302; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/50/c4/worm-2-e25546.PMC3875648.pdf
Neuron 2010; 68:1173-86;  PMID:21172617; http://dx.doi.org/10.1016/j.neu - ron.2010.11.025 14.,OADS,/arxiv_data1/oa_pdf/50/c4/worm-2-e25546.PMC3875648.pdf
Neuron 1998; 20:763- 72; PMID:9581767; http://dx.doi.org/10.1016/ S0896-6273(00)81014-4 15.,OADS,/arxiv_data1/oa_pdf/50/c4/worm-2-e25546.PMC3875648.pdf
Nat Rev Mol Cell Biol 2012; 13:566- 78; PMID:22850819; http://dx.doi.org/10.1038/ nrm3412Identifying the site and mode of action  of modulatory signals is a major chal - lenge.,Non-OADS,/arxiv_data1/oa_pdf/50/c4/worm-2-e25546.PMC3875648.pdf
Nat Methods 2009; 6:875- 81; PMID:19898485; http://dx.doi.org/10.1038/ nmeth.1398 4.,OADS,/arxiv_data1/oa_pdf/50/c4/worm-2-e25546.PMC3875648.pdf
Nat Rev Neurosci 2008; 9:587- 600; PMID:18641666; http://dx.doi.org/10.1038/ nrn2457compartments suggest that these axo - nal domains are not electrically isolated;  instead independent calcium dynamics in different axonal compartments provides one mechanism for the small nervous sys - tem to enhance its computational poten - tial by integrating global activity with  functional domains on a subcellular scale.,OADS,/arxiv_data1/oa_pdf/50/c4/worm-2-e25546.PMC3875648.pdf
"www.landesbioscience.com Worm  e25644-1Worm 2:3, e25644; Worm 2013; © 2013 Landes Bioscience Commentary Commentary Keywords:  myofibrillogenesis,   proteostasis, molecular chaperone,   ubiquitin, sarcopenia, aging, UNC-45, CDC-48/p97, C. elegans Submitted: 06/26/13 Accepted: 07/05/13http://dx.doi.org/10.4161/worm.25644 *Correspondence to: Thorsten Hoppe;   Email: thorsten.hoppe@uni-koeln.deThe activity and assembly of various  myosin subtypes is coordinated by  conserved UCS ( UNC-45/ CRO1/ She4p)  domain proteins.",Non-OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Cell 2013; 152:183-95; PMID:23332754; http://dx.doi.org/10.1016/j.cell.2012.12.025,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Cell  2013; 152:183-95; PMID:23332754; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
J Cell Biol  2008; 180:1163-75; PMID:18347070; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Nat Cell Biol 2007; 9:379- 90; PMID:17369820; http://dx.doi.org/10.1038/ncb1554 22.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
J Cell Biol  2007; 177:205-10; PMID:17438072; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Cell  2004; 118:337-49; PMID:15294159; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
EMBO J 2012; 31:3334-50; PMID:22773186; http://dx.doi.org/10.1038/ emboj.2012.178 25.,Non-OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Nat Genet 2004; 36:377-81; PMID:15034582;  http://dx.doi.org/10.1038/ng1332 26.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Trends Cell Biol 2008; 18:264- 72; PMID:18495480; http://dx.doi.org/10.1016/j.tcb.2008.03.007 27.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Future Cardiol 2008;  4:65-75; PMID:19543439; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
"Ao W, Pilgrim D. Caenorhabditis elegans UNC-45 is a component of muscle thick filaments and  colocalizes with myosin heavy chain B, but not  myosin heavy chain A. J Cell Biol 2000; 148:375- 84; PMID:10648570; http://dx.doi.org/10.1083/ jcb.148.2.375 31.",Non-OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
J Biol Chem 2010; 285:39597-608; PMID:20940294;  http://dx.doi.org/10.1074/jbc.M110.129718 32.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
PLoS One 2011; 6:e22579; PMID:21799905; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Dev Biol 2007; 308:133-43;  PMID:17586488; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
J Cell Sci 2004; 117:641-52; PMID:14709723;  http://dx.doi.org/10.1242/jcs.00899 6.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
J Cell Sci  2002; 115:3983-90; PMID:12356904; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
J Cell  Biol 1998; 143:1215-25; PMID:9832550; http://dx.doi.org/10.1083/jcb.143.5.1215 11.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Nature 1974;  250:579-80; PMID:4845659; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
J Cell Sci 2002; 115:4013-23; PMID:12356907;  http://dx.doi.org/10.1242/jcs.00108 13.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Dev Biol 2008; 318:258-67; PMID:18462713; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Mol Cell Biol 2006; 26:1722- 30; PMID:16478993; http://dx.doi.org/10.1128/ MCB.26.5.1722-1730.2006 15.,Non-OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Am J Pathol  2007; 171:1640-9; PMID:17872978; http://dx.doi.org/10.2353/ajpath.2007.070325 16.,Non-OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Dev Biol 2007; 303:483-92; PMID:17189627; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
PLoS One  2008; 3:e2137; PMID:18478096; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Development  2008; 135:1147-56; PMID:18256191; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Adv Protein Chem  2005; 71:161-93; PMID:16230112; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
Annu Rev Cell Dev Biol  2002; 18:637-706; PMID:12142273; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/c0/worm-2-e25644.PMC3875649.pdf
"www.landesbioscience.com Worm  e25715-1Worm 2:3, e25715; Worm 2013; © 2013 Landes Bioscience Commentary Commentary Keywords:  flamingo, Wnt, axon   outgrowth Submitted: 07/02/13Accepted: 07/10/13http://dx.doi.org/10.4161/worm.25715 Correspondence to: Brian D Ackley;   Email: bdackley@ku.eduDuring development, multiple envi - ronmental cues, e.g., growth fac - tors, cell adhesion molecules, etc.,  interact to influence the pattern of out - growth of axons and dendrites in a cell-specific fashion.",Non-OADS,/arxiv_data1/oa_pdf/b4/98/worm-2-e25715.PMC3875650.pdf
Dev Biol 2013; 377:224-35; PMID:23376536; http://dx.doi.org/ 10.1016/j.ydbio.2013.01.014,OADS,/arxiv_data1/oa_pdf/b4/98/worm-2-e25715.PMC3875650.pdf
"We found additional evidence for this  in an ultrastructural analysis of an animal at L1/L2 lethargus (available at http://www.wormimage.org/, worm name: L1_Lethargus).",Non-OADS,/arxiv_data1/oa_pdf/b4/98/worm-2-e25715.PMC3875650.pdf
"t hese are the general morpholo - gies, (see http://wormatlas.org/neurons/Individual%20 neurons/ neuronframeset.html for details  on individual neurons).",OADS,/arxiv_data1/oa_pdf/b4/98/worm-2-e25715.PMC3875650.pdf
Neuron 1990; 4:61-85;  PMID:2310575; http://dx.doi.org/10.1016/0896- 6273(90)90444-K 2.,OADS,/arxiv_data1/oa_pdf/b4/98/worm-2-e25715.PMC3875650.pdf
Nature 1993; 364:327-30; PMID:8332188;  http://dx.doi.org/10.1038/364327a0 4.,Non-OADS,/arxiv_data1/oa_pdf/b4/98/worm-2-e25715.PMC3875650.pdf
Dev Biol  2013; 377:224-35; PMID:23376536; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/98/worm-2-e25715.PMC3875650.pdf
J Neurosci 2012; 32:4196- 211; PMID:22442082; http://dx.doi.org/10.1523/ JNEUROSCI.3094-11.2012the dorsal/ventral axis downstream of  UNC-5/UNC-40 signaling?,Non-OADS,/arxiv_data1/oa_pdf/b4/98/worm-2-e25715.PMC3875650.pdf
Development 2010; 137:3663-73;  PMID:20876647; http://dx.doi.org/10.1242/ dev.054320 8.,OADS,/arxiv_data1/oa_pdf/b4/98/worm-2-e25715.PMC3875650.pdf
Mol Cell Neurosci  2011; 48:349-58; PMID:21722732; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/98/worm-2-e25715.PMC3875650.pdf
Science 2010; 327:704-7;  PMID:20056854; http://dx.doi.org/10.1126/sci - ence.1182179 10.,OADS,/arxiv_data1/oa_pdf/b4/98/worm-2-e25715.PMC3875650.pdf
"J Cell Biol 2010; 191:875- 90; PMID:21059852; http://dx.doi.org/10.1083/ jcb.201004154 11. de Anda FC, Pollarolo G, Da Silva JS, Camoletto PG,  Feiguin F, Dotti CG.",OADS,/arxiv_data1/oa_pdf/b4/98/worm-2-e25715.PMC3875650.pdf
Nature 2005; 436:704- 8; PMID:16079847; http://dx.doi.org/10.1038/ nature03811 12.,Non-OADS,/arxiv_data1/oa_pdf/b4/98/worm-2-e25715.PMC3875650.pdf
PLoS Genet 2011; 7:e1002257; PMID:21912529; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/98/worm-2-e25715.PMC3875650.pdf
"www.landesbioscience.com Worm  e25716-1Worm 2:3, e25716; Worm 2013; © 2013 Landes Bioscience Commentary Commentary Keywords:  CUL-2, LRR-1, E3   ubiquitin-ligase, C. elegans , DNA   replication checkpoint, germline,   proliferation, differentiation Submitted: 07/05/13Accepted: 07/10/13http://dx.doi.org/10.4161/worm.25716 *Correspondence to: Jorge Merlet and   Lionel Pintard; Email: jorge.merlet@fmi.ch  and pintard.lionel@ijm.univ-paris-diderot.frThe ubiquitin-proteolytic system  (UPS) regulates a variety of cellu - lar and biological processes by control - ling the stability of regulatory proteins, in space and time.",Non-OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
PLoS Genet 2013; 9:e1003375; PMID:23555289; http://dx.doi.org/10.1371/journal.pgen.1003375,Non-OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Annu Rev Cell Dev Biol  2007; 23:405-33; PMID:17506698; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Nature 2002; 417:660-3; PMID:12050669; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Adv Exp Med Biol 2013; 786:29-46; PMID:23696350; http://dx.doi.org/10.1007/978- 94-007-6621-1_3 27.,Non-OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Development 2010; 137:1787-98; PMID:20431119;  http://dx.doi.org/10.1242/dev.050799 28.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Dev Cell 2008; 14:263-74; PMID:18267094;  http://dx.doi.org/10.1016/j.devcel.2007.11.016 29.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Genes Dev 2009; 23:1763-78; PMID:19574299; http://dx.doi.org/10.1101/ gad.1808809 30.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Development 2011; 138:2223-34; PMID:21558371; http://dx.doi.org/10.1242/ dev.059535 31.,Non-OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Front Oncol 2012; 2:10; PMID:22649776;  http://dx.doi.org/10.3389/fonc.2012.00010 14.,Non-OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Development 2010; 137:3857- 66; PMID:20978077; http://dx.doi.org/10.1242/ dev.054866 15.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Dev Cell  2010; 19:753-64; PMID:21074724; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Mol  Gen Genet 2000; 264:119-26; PMID:11016841; http://dx.doi.org/10.1007/s004380000291 17.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Cell Cycle 2004; 3:1196-200; PMID:15326393;  http://dx.doi.org/10.4161/cc.3.9.1116 19.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Annu Rev Genet 2002; 36:617-56; PMID:12429704; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
J Biol Chem 2007; 282:30357- 62; PMID:17716975; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
EMBO J 2011; 30:4805-14; PMID:22081107; http://dx.doi.org/10.1038/emboj.2011.404References 1.,Non-OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Nat Rev Mol Cell Biol 2009; 10:755- 64; PMID:19851334; http://dx.doi.org/10.1038/ nrm2780 3.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Nat Rev Mol Cell Biol 2009; 10:319-31; PMID:19352404; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Biochim Biophys Acta 2004; 1695:133-70;  PMID:15571813; http://dx.doi.org/10.1016/j.bbam - cr.2004.09.027 5.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Nat Rev Mol Cell  Biol 2005; 6:9-20; PMID:15688063; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Cell  Div 2008; 3:7; PMID:18282298; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Cell Mol Life Sci 2009; 66:1924- 38; PMID:19194658; http://dx.doi.org/10.1007/ s00018-009-8712-7 8.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Annu Rev Biochem 2009; 78:399- 434; PMID:19489725; http://dx.doi.org/10.1146/ annurev.biochem.78.101807.093809 9.,Non-OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Genome Biol 2011; 12:220; PMID:21554755; http://dx.doi.org/10.1186/gb-2011-12-4-220 11.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
Nat Cell Biol  1999; 1:486-92; PMID:10587644; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
J Biol Chem  2008; 283:8005-13; PMID:18187417; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/f0/worm-2-e25716.PMC3875651.pdf
"www.landesbioscience.com Worm  e25717-1Worm 2:3, e25717; Worm 2013; © 2013 Landes Bioscience Commentary Commentary Keywords:  spermatheca, filamin,   ovulation, phospholipase C,   calcium signaling Submitted: 07/01/13Accepted: 07/10/13http://dx.doi.org/10.4161/worm.25717 *Correspondence to: Erin J Cram;   Email: e.cram@neu.eduMechanical properties of the micro - environment are fundamental in  orchestrating normal tissue function, dis - ease progression, and organismal devel - opment.",Non-OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
PLoS Genet 2013; 9:e1003510; PMID:23671426; http://dx.doi.org/10.1371/journal.pgen.1003510,OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
J Cell Biol  1986; 103:2241-52; PMID:3782297; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
WormAtlas (2009); http://dx.doi.org/10.3908/wor - matlas.1.22 5.,Non-OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
Science 2001; 291:2144-7;  PMID:11251118; http://dx.doi.org/10.1126/sci - ence.1057586 6.,OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
Cell 1998; 92:523-33; PMID:9491893;  http://dx.doi.org/10.1016/S0092-8674(00)80945-9 7.,OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
Mol Biol Cell 2004;  15:3938-49; PMID :15194811; http://dx.doi.org/10.1091/mbc.E04-03-0198 8.,Non-OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
Dev Biol 2004; 274:201-10; PMID:15355798; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
Regulation of phosphoinositide-specific  phospholipase C. Annu Rev Biochem 2001; 70:281-312; PMID:11395409; http://dx.doi.org/10.1146/ annurev.biochem.70.1.281 10.,Non-OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
Trends Cell Biol 2006; 16:640-8; PMID:17085049;  http://dx.doi.org/10.1016/j.tcb.2006.10.007 11.,OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
Methods Enzymol  2006; 407:281-90; PMID:16757332; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
Oncogene 2002; 21:8105- 13; PMID:12444546; http://dx.doi.org/10.1038/ sj.onc.1206003 14.,OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
J Biol Chem 2008; 283:29690- 8; PMID:18765661; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
J Biol Chem 1998; 273:6218-22; PMID:9497345; http://dx.doi.org/10.1074/jbc.273.11.6218 16.,OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
Dev Biol 2010; 347:247-57; PMID:20707996; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
PLoS One  2011; 6:e22428; PMID:21799850; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
Dev Biol 1999; 205:111- 28; PMID:9882501; http://dx.doi.org/10.1006/ dbio.1998.9109The strongest pulses of calcium are asso - ciated with the zygote exiting into the  uterus.,Non-OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
Nat Cell Biol 2000; 2:888-92; PMID:11146652;  http://dx.doi.org/10.1038/35046533 26.,OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
Nat Cell Biol 2006; 8:803-14; PMID:16862148; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
PLoS Genet 2008; 4:e1000043; PMID:18369461;  http://dx.doi.org/10.1371/journal.pgen.100004319.,Non-OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
J Cell Biol 2007; 179:1011-25; PMID:18056414;  http://dx.doi.org/10.1083/jcb.200707073 20.,Non-OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
Biophys J 2007;  PMID:17921200; http://dx.doi.org/10.1529/bio - physj.107.118802 22.,OADS,/arxiv_data1/oa_pdf/b3/99/worm-2-e25717.PMC3875652.pdf
"www.landesbioscience.com Worm  e25765-1Worm 2:3, e25765; Worm 2013; © 2013 Landes Bioscience Commentary Commentary Keywords:  nicotinic receptor, synapse,  motor behavior, Caenorhabditis elegans ,  electrophysiology Submitted: 07/07/13Accepted: 07/15/13http://dx.doi.org/10.4161/worm.25765 *Correspondence to: Michael M Francis;   Email: michael.francis@umassmed.eduNicotinic or ionotropic acetylcholine  receptors (iAChRs) mediate excit - atory signaling throughout the nervous system, and the heterogeneity of these receptors contributes to their multifac - eted roles.",Non-OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
J Neurosci 2013; 33:5524- 32; PMID:23536067; http://dx.doi.org/10.1523/JNEUROSCI.4384-12.2013,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
Annu Rev Pharmacol Toxicol  2007; 47:699-729; PMID:17009926; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
Nat  Rev Neurosci 2010; 11:389-401; PMID:20485364;  http://dx.doi.org/10.1038/nrn2849 8.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
Mol Pharmacol  2013; 83:753-8; PMID:23247824; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
Int Rev  Neurobiol 2007; 78:225-46; PMID:17349863;  http://dx.doi.org/10.1016/S0074-7742(06)78008-4 11.,OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
Prog Neurobiol 2000; 61:75- 111; PMID:10759066; http://dx.doi.org/10.1016/ S0301-0082(99)00045-3 12.,OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
J Comp Neurol 2008; 506:398-408; PMID:18041778; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
Nature 1993; 364:334-7; PMID:8332190; http://dx.doi.org/10.1038/364334a0 15.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
Neuron 2011; 72:572-86;  PMID:22099460; http://dx.doi.org/10.1016/j.neu - ron.2011.09.005 16.,OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
Neuron  2012; 76:750-61; PMID:23177960; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
Curr Biol 2005; 15:340-6; PMID:15723795;  http://dx.doi.org/10.1016/j.cub.2005.02.025 18.,OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
BMC Genomics 2005; 6:42; PMID:15780142; http://dx.doi.org/10.1186/1471-2164-6-42 19.,OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
PLoS Biol  2009; 7:e1000265; PMID:20027209; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
J Neurosci  2013; 33:5319-25; PMID:23516296; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
J Neurosci  2010; 30:13932-42; PMID:20962215; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
J Neurosci 2013; 33:5524-32; PMID:23536067; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
Invert Neurosci 2007; 7:129-31;  PMID:17503100; http://dx.doi.org/10.1007/s10158-007-0049-z 4.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
Physiol Rev 2008; 88:333-49; PMID:18391166; http://dx.doi.org/10.1152/physrev.00040.2006 5.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
Biochem Pharmacol 2007; 74:1120-33; PMID:17689497; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
Neuron 2001; 31:131-41;  PMID:11498056; http://dx.doi.org/10.1016/S0896- 6273(01)00332-426.,OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
Nat Methods  2011; 8:153-8; PMID:21240278; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
Curr Biol 2007; 17:1334-9; PMID:17658257; http://dx.doi.org/10.1016/j.cub.2007.06.060 23.,OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
PLoS One  2011; 6:e19505; PMID:21559335; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
J Neurosci  2010; 30:11151-6; PMID:20720122; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/worm-2-e25765.PMC3875653.pdf
" Commentary www.landesbioscience.com Worm e26169-1Worm 2:3, e26169; July-September 2013; © 2013 Landes BioscienceCommentary Keywords:  invasion, basement  membrane, netrin, invadopodia Abbreviations:  AC, anchor cell; DCC,  deleted in colorectal cancer *Correspondence to: David R Sherwood;  Email: david.sherwood@duke.edu Submitted: 07/23/13Revised: 08/14/13Accepted: 08/15/13http://dx.doi.org/10.4161/worm.26169Cell invasion through basement mem - brane is an essential part of normal  development and physiology, and occurs  during the pathological progression of human inflammatory diseases and can - cer.",Non-OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
J Cell Biol 2013; 201:903-13; PMID:23751497; http://dx.doi.org/10.1083/jcb.201301091,Non-OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Nat Rev Cancer  2003; 3:422-33; PMID:12778132; http://dx.doi.org/10.1038/nrc1094 2.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
J Cell Biol 2012; 196:671-9; PMID:22431747;  http://dx.doi.org/10.1083/jcb.201109041 3.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Cell Adh Migr 2013; 7:56- 63; PMID:23076216; http://dx.doi.org/10.4161/ cam.21831 4.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Microsc Res Tech 2008;  71:357-70; PMID:18219669; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Development 2004; 131:1619-28; PMID:14998921;  http://dx.doi.org/10.1242/dev.01037 6.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Curr Opin Cell Biol 2011; 23:589- 96; PMID:21632231; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Trends Cell Biol  2008; 18:560-74; PMID:18848450; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
J Cell Sci 2009; 122:3009-13; PMID:19692587; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Trends Immunol 2012; 33:579-89; PMID:22926201;  http://dx.doi.org/10.1016/j.it.2012.07.004 10.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
J Exp Zool 1989; 251:167- 85; PMID:2549171; http://dx.doi.org/10.1002/ jez.1402510206 11.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Proc Natl Acad Sci U S A 1980; 77:6687- 91; PMID:6256755; http://dx.doi.org/10.1073/ pnas.77.11.668712.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Nat Rev Mol Cell Biol  2011; 12:413-26; PMID:21697900; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Curr Biol  2010; 20:339-45; PMID:20137952; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Annu Rev Cell Dev Biol 2011; 27:185-211;  PMID:21801014; http://dx.doi.org/10.1146/ annurev-cellbio-092910-154216 15.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Dev  Cell 2003; 5:21-31; PMID:12852849; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Dev Cell 2009; 17:187- 98; PMID:19686680; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Sci Signal 2010; 3:ra35; PMID:20442418; http://dx.doi.org/10.1126/scisignal.2000654 19.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Cell 2005; 121:951-62; PMID:15960981; http://dx.doi.org/10.1016/j.cell.2005.03.031 20.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Nat Cell Biol 2009; 11:183-9; PMID:19098902; http://dx.doi.org/10.1038/ ncb1825 21.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Mol Biol Cell 2010; 21:4108-19; PMID:20926684;  http://dx.doi.org/10.1091/mbc.E10-07-0580 24.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Genes Cells 2003; 8:1019-27; PMID:14750956; http://dx.doi.org/10.1111/j.1365-2443.2003.00695.x 25.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Dev Cell 2008; 15:813-28;  PMID:19081071; http://dx.doi.org/10.1016/j.dev - cel.2008.09.003,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Cancer Sci 2010; 101:1632-8; PMID:20426790; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
PLoS Biol  2012; 10:e1001386; PMID:22973180; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Eur J Cell Biol 2012; 91:896- 901; PMID:22633185; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Sci Signal 2012;  5:ra66; PMID:22969158; http://dx.doi.org/10.1126/scisignal.2002964 30.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Curr  Opin Cell Biol 2012; 24:662-9; PMID:22980730;  http://dx.doi.org/10.1016/j.ceb.2012.08.005 31.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Development 2011; 138:2153-69; PMID:21558366;  http://dx.doi.org/10.1242/dev.044529 32.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Development  2009; 136:911-22; PMID:19211675; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Curr Biol 2008; 18:44- 50; PMID:18158244; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Cell 2009; 139:731- 43; PMID:19914166; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Cancer  Lett 1980; 9:359-66; PMID:7397689; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Genes Dev 2006; 20:2673-86; PMID:16983145; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Nat Rev Cancer 2006; 6:227-39; PMID:16498445; http://dx.doi.org/10.1038/nrc1821 39.,Non-OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Nat Rev Mol Cell Biol 2007; 8:221-33; PMID:17318226; http://dx.doi.org/10.1038/ nrm2125 40.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
J Cell Biol 2001; 154:1069-79; PMID:11535623;  http://dx.doi.org/10.1083/jcb.200103111 41.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Dev Cell 2010; 19:13-26;  PMID:20643347; http://dx.doi.org/10.1016/j.dev - cel.2010.06.013 42.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Nat Cell Biol 2011; 13:641- 51; PMID:21572423; http://dx.doi.org/10.1038/ ncb2233 43.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Nat Cell Biol 2007; 9:893- 904; PMID:17618273; http://dx.doi.org/10.1038/ ncb1616 45.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Biomarkers  2011; 16:172-80; PMID:21303223; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
Oncogene 2007; 26:5615-25; PMID:17334389; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/77/worm-2-e26169.PMC3875654.pdf
"OncoImmunology 2013; 2:e26329; http://dx.doi.org/10.4161/onci.26329hTERT deficiency in naïve T cells affects  lymphocyte homeostasis in myelodysplastic  syndrome patients Lili y ang1,2, erika a e ksioglu3, and s heng w ei3,* 1Department of Immunology; Tianjin Cancer Institute and h ospital; Tianjin Medical u niversity; Tianjin, China;   2Key Laboratory of Cancer Immunology and Biotherapy; Tianjin, China; 3Immunology Program at the h .",Non-OADS,/arxiv_data1/oa_pdf/a7/bc/onci-2-e26329.PMC3875656.pdf
Curr Opin Hematol 2009; 16:70-6; http://dx.doi.org/10.1097/MOH.0b013e3283257ac7 ;  PMID:19468267 2.,Non-OADS,/arxiv_data1/oa_pdf/a7/bc/onci-2-e26329.PMC3875656.pdf
Leuk Lymphoma 2011;  52:1528-36; http://dx.doi.org/10.3109/10428194.20 11.568648 ; PMID:216352043.,Non-OADS,/arxiv_data1/oa_pdf/a7/bc/onci-2-e26329.PMC3875656.pdf
Blood 2006; 108:2632- 41; http://dx.doi.org/10.1182/blood-2005-09-3902 ;  PMID:16614248 4.,Non-OADS,/arxiv_data1/oa_pdf/a7/bc/onci-2-e26329.PMC3875656.pdf
Immunol Today 1997; 18:450-4;  http://dx.doi.org/10.1016/S0167-5699(97)01079-7 ;  PMID:92931625.,Non-OADS,/arxiv_data1/oa_pdf/a7/bc/onci-2-e26329.PMC3875656.pdf
Leuk Res 2005; 29:1131-9; http://dx.doi.org/10.1016/j.leu - kres.2005.03.006 ; PMID:16111531 6.,OADS,/arxiv_data1/oa_pdf/a7/bc/onci-2-e26329.PMC3875656.pdf
Exp Gerontol 2007; 42:416-20; http://dx.doi.org/10.1016/j.exger.2006.11.005 ;  PMID:17182206,OADS,/arxiv_data1/oa_pdf/a7/bc/onci-2-e26329.PMC3875656.pdf
Leukemia  2009; 23:1288-96; http://dx.doi.org/10.1038/ leu.2009.14 ; PMID:19282834 8.,Non-OADS,/arxiv_data1/oa_pdf/a7/bc/onci-2-e26329.PMC3875656.pdf
Exp Gerontol  2006; 41:246-51; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a7/bc/onci-2-e26329.PMC3875656.pdf
"8 While the precise  *Correspondence to: Mark R Hellmich; Email: mhellmic@utmb.edu; Csaba Szabo; Email: szabocsaba@aol.com Submitted: 07/19/2013; Accepted: 08/05/2013http://dx.doi.org/10.4161/cc.26064Comment on: Szabo C, et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/ca/cc-12-2915.PMC3875657.pdf
Szabo C. Sci Transl Med 2010; 2:59ps54;  PMID:21106939 ; http://dx.doi.org/10.1126/ scitranslmed.3000721 2.,Non-OADS,/arxiv_data1/oa_pdf/8b/ca/cc-12-2915.PMC3875657.pdf
Wang R. Physiol Rev 2012; 92:791-896;  PMID:22535897 ; http://dx.doi.org/10.1152/ physrev.00017.2011 3.,Non-OADS,/arxiv_data1/oa_pdf/8b/ca/cc-12-2915.PMC3875657.pdf
Proc Natl Acad Sci U S A 2009; 106:21972-7;  PMID:19955410 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/ca/cc-12-2915.PMC3875657.pdf
Proc Natl Acad Sci U S A 2013;  110:12474-9;  PMID:23836652 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/ca/cc-12-2915.PMC3875657.pdf
FASEB J 2007; 21:1699-706; PMID:17314140 ; http://dx.doi.org/10.1096/ fj.06-7407com 6.,Non-OADS,/arxiv_data1/oa_pdf/8b/ca/cc-12-2915.PMC3875657.pdf
FASEB J 2013; 27:601-11;  PMID:23104984 ; http://dx.doi.org/10.1096/ fj.12-216507 7.,Non-OADS,/arxiv_data1/oa_pdf/8b/ca/cc-12-2915.PMC3875657.pdf
Sci Signal 2009; 2:ra72; PMID:19903941 ; http://dx.doi.org/10.1126/ scisignal.2000464 8.,OADS,/arxiv_data1/oa_pdf/8b/ca/cc-12-2915.PMC3875657.pdf
"Cell Biol Int 2010; 34:565-72;  PMID:20184555 ; http://dx.doi.org/10.1042/ CBI20090368 Figure 1.  stimulation of colorectal cancer cell growth, proliferation, migration, and peritumor angiogenesis and blood flow by the CBs /H2s axis.",OADS,/arxiv_data1/oa_pdf/8b/ca/cc-12-2915.PMC3875657.pdf
"7 Thus,  *Correspondence to: Huilin Li; Email: hli@bnl.gov; Christian Speck; Email: chris.speck@imperial.ac.uk Submitted: 08/08/2013; Accepted: 08/12/2013http://dx.doi.org/10.4161/cc.26132Comment on: Sun J, et al.",Non-OADS,/arxiv_data1/oa_pdf/c3/0a/cc-12-2917.PMC3875658.pdf
"Nat Struct Mol Biol 2013; 20:944-51; PMID:23851460; http://dx.doi.org/10.1038/nsmb.2629Seeing is believing The MCM2–7 helicase trapped   in complex with its DNA loader alberto r iera1, Huilin l i2,3,*, and Christian speck1,* 1dNa replication Group; M rC Clinical s ciences Centre; i mperial College; l ondon, u K; 2Biosciences d epartment; Brookhaven National  laboratory; u pton, N y usa ; 3department of Biochemistry and Cell Biology; s tony Brook u niversity; s tony Brook, N y usa",Non-OADS,/arxiv_data1/oa_pdf/c3/0a/cc-12-2917.PMC3875658.pdf
Oncogene 2002; 21:6624-32;  PMID:12242660 ; http://dx.doi.org/10.1038/ sj.onc.1205910 2.,OADS,/arxiv_data1/oa_pdf/c3/0a/cc-12-2917.PMC3875658.pdf
Proc Natl Acad Sci U S A 2009; 106:20240-5;  PMID:19910535 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/0a/cc-12-2917.PMC3875658.pdf
Cell 2009; 139:719-30; PMID:19896182 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c3/0a/cc-12-2917.PMC3875658.pdf
Nat Struct Mol Biol 2013; 20:944- 51; PMID:23851460 ; http://dx.doi.org/10.1038/ nsmb.2629 5.,OADS,/arxiv_data1/oa_pdf/c3/0a/cc-12-2917.PMC3875658.pdf
Mol Cell 2013; 50:577-88; PMID:23603117 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c3/0a/cc-12-2917.PMC3875658.pdf
Nature 2013; 495:339-43; PMID:23474987 ; http://dx.doi.org/10.1038/ nature11920 7.,Non-OADS,/arxiv_data1/oa_pdf/c3/0a/cc-12-2917.PMC3875658.pdf
Mol Cell 2008; 31:287-93;  PMID:18657510 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c3/0a/cc-12-2917.PMC3875658.pdf
"Whether or not this can be achieved remains to be determined, but if successful, it would represent a significant  *Correspondence to: David G Brooks; Email: dbrooks@microbio.ucla.edu Submitted: 06/10/13; Accepted: 06/24/13http://dx.doi.org/10.4161/cc.26175Comment on: Wilson EB, et al.",Non-OADS,/arxiv_data1/oa_pdf/25/d6/cc-12-2919.PMC3875659.pdf
"Science 2013; 340:202-7; PMID:23580528; http://dx.doi.org/10.1126/science.1235208Interfering with type I Interferon A novel approach to purge persistent viral infection Elizabeth B  Wilson  and d avid G  Brooks * department of Microbiology; i mmunology and Molecular Genetics and the u Cla aids i nstitute; d avid Geffen  school of Medicine; u niversity of California, l os a ngeles; l os a ngeles, C a usa",Non-OADS,/arxiv_data1/oa_pdf/25/d6/cc-12-2919.PMC3875659.pdf
Curr Top Microbiol Immunol  2007; 316:41-70;  PMID:17969443 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/d6/cc-12-2919.PMC3875659.pdf
Annu Rev Pathol 2011; 6:223-48;  PMID:21034222 ; http://dx.doi.org/10.1146/ annurev-pathol-011110-130254 3.,Non-OADS,/arxiv_data1/oa_pdf/25/d6/cc-12-2919.PMC3875659.pdf
Science 2013; 340:202-7;  PMID:23580528 ; http://dx.doi.org/10.1126/ science.1235208 7.,OADS,/arxiv_data1/oa_pdf/25/d6/cc-12-2919.PMC3875659.pdf
Science 2013; 340:207-11;  PMID:23580529 ; http://dx.doi.org/10.1126/ science.1235214 8.,OADS,/arxiv_data1/oa_pdf/25/d6/cc-12-2919.PMC3875659.pdf
Cell Host Microbe 2012; 11:481-91; PMID:22607801 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/25/d6/cc-12-2919.PMC3875659.pdf
"*Correspondence to: Elsa Kress; Email: elsa.kress@univ-lyon1.fr Submitted: 06/17/13; Accepted: 06/20/13http://dx.doi.org/10.4161/cc.26177Comment on: Kress E, et al.",Non-OADS,/arxiv_data1/oa_pdf/5f/97/cc-12-2921.PMC3875660.pdf
"J Cell Biol 2013; 201:559-75; PMID:23649807; http://dx.doi.org/10.1083/jcb.201209107When the Swiss clock goes wrong Regulation of Aurora A by UBXN-2/CDC -48 Elsa Kress1,* and Monica Gotta2 1Centre de Génétique et Physiologie Moléculaire et Cellulaire; u niversité l yon 1; l yon, France; 2département de Physiologie  Cellulaire et Métabolisme; Centre Médico- universitaire; u niversité de Genève; Geneva, s witzerland",Non-OADS,/arxiv_data1/oa_pdf/5f/97/cc-12-2921.PMC3875660.pdf
Dev Cell 2011; 21:102-19;  PMID:21763612 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5f/97/cc-12-2921.PMC3875660.pdf
J Cell Biol 2013; 201:559-75;  PMID:23649807 ; http://dx.doi.org/10.1083/ jcb.201209107 3.,Non-OADS,/arxiv_data1/oa_pdf/5f/97/cc-12-2921.PMC3875660.pdf
J Cell Sci 2007; 120:2987-96; PMID :17715155 ; http://dx.doi.org/10.1242/ jcs.013136 4.,OADS,/arxiv_data1/oa_pdf/5f/97/cc-12-2921.PMC3875660.pdf
Biochem Soc Trans 2008; 36:126- 30; PMID:18208399 ; http://dx.doi.org/10.1042/ BST0360126 Figure  1.,OADS,/arxiv_data1/oa_pdf/5f/97/cc-12-2921.PMC3875660.pdf
"Moreover, unwind - ing DNA from a nucleosome produces one negative supercoil, which can eventu - ally produce non-B DNA that promotes  *Correspondence to: Tasuku Honjo; E-mail: honjo@mfour.med.kyoto-u.ac.jp Submitted: 06/17/13; Accepted: 06/24/13http://dx.doi.org/10.4161/cc.26178Comment on: Aida M, et al.",OADS,/arxiv_data1/oa_pdf/31/eb/cc-12-2923.PMC3875661.pdf
Cell 2000; 102:553-63;  PMID:11007474 ; http://dx.doi.org/10.1016/ S0092-8674(00)00078-7 2.,OADS,/arxiv_data1/oa_pdf/31/eb/cc-12-2923.PMC3875661.pdf
Proc Natl Acad Sci U S A 2013;  110:7784-9;  PMID:23610419 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/eb/cc-12-2923.PMC3875661.pdf
Biochemistry 2012; 51:5243- 56; PMID:22712724 ; http://dx.doi.org/10.1021/ bi3005895 4.,Non-OADS,/arxiv_data1/oa_pdf/31/eb/cc-12-2923.PMC3875661.pdf
Proc Natl Acad Sci U S A 2009; 106:22375-80;  PMID:20018730 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/eb/cc-12-2923.PMC3875661.pdf
Proc Natl Acad Sci U S A 2010;  107:22190-5;  PMID:21139053 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/eb/cc-12-2923.PMC3875661.pdf
Cell 2010; 143:122-33; PMID:20887897 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/31/eb/cc-12-2923.PMC3875661.pdf
Proc Natl Acad Sci U S A 2012;  109:2479-84;  PMID:22308462 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/eb/cc-12-2923.PMC3875661.pdf
EMBO J 2013; 32:1381-92; PMID:23463099 ; http://dx.doi.org/10.1038/ emboj.2013.42,OADS,/arxiv_data1/oa_pdf/31/eb/cc-12-2923.PMC3875661.pdf
"4 It will thus be interest - ing to test if enhanced heterochromatin  *Correspondence to: Gunnar Schotta; Email: gunnar.schotta@med.uni-muenchen.de Submitted: 06/11/13; Accepted: 06/24/13http://dx.doi.org/10.4161/cc.26179Hahn M, et al.",Non-OADS,/arxiv_data1/oa_pdf/86/c5/cc-12-2925.PMC3875662.pdf
"Genes Dev 2013; 27:859-72; PMID:23599346; http://dx.doi.org/10.1101/gad.210377.112The compact view on heterochromatin silvia dambacher, Matthias Hahn, and Gunnar s chotta* ludwig Maximilians u niversity and Munich Center for i ntegrated Protein s cience (CiP sM); adolf-Butenandt- institute; Munich, Germany",Non-OADS,/arxiv_data1/oa_pdf/86/c5/cc-12-2925.PMC3875662.pdf
Genes Dev 2004; 18:1251-62;  PMID :15145825 ; http://dx.doi.org/10.1101/ gad.300704 2.,OADS,/arxiv_data1/oa_pdf/86/c5/cc-12-2925.PMC3875662.pdf
Nat Struct Mol Biol  2012; 19:1023-30;  PMID:22983563 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/c5/cc-12-2925.PMC3875662.pdf
Cell 2012; 150:948-60; PMID:22939622 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/86/c5/cc-12-2925.PMC3875662.pdf
Genes Dev 2013; 27:859-72;  PMID:23599346 ; http://dx.doi.org/10.1101/ gad.210377.112 5.,OADS,/arxiv_data1/oa_pdf/86/c5/cc-12-2925.PMC3875662.pdf
Proc Natl Acad Sci U S A 2006; 103:8703-8;  PMID:16738054 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/c5/cc-12-2925.PMC3875662.pdf
Cell 2013; 152:584-98;  PMID:23374351 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/86/c5/cc-12-2925.PMC3875662.pdf
Nat Commun 2013; 4:1868;  PMID:23695662 ; http://dx.doi.org/10.1038/ ncomms2885 8.,OADS,/arxiv_data1/oa_pdf/86/c5/cc-12-2925.PMC3875662.pdf
Nat Genet 2005; 37:391-400; PMID:15765097 ; http://dx.doi.org/10.1038/ng1531Figure 1.,OADS,/arxiv_data1/oa_pdf/86/c5/cc-12-2925.PMC3875662.pdf
"In breast cancer cells, where Src is activated by EphA2, this activity is essential for MT1-MMP cleavage-depen - dent internalization of the signaling com - plexes in conjunction with increased RhoA  *Correspondence to: Kaisa Lehti; Email: kaisa.lehti@helsinki.fi Submitted: 06/12/13; Accepted: 06/24/13http://dx.doi.org/10.4161/cc.26180Comment on: Sugiyama N, et al.",Non-OADS,/arxiv_data1/oa_pdf/cf/dd/cc-12-2927.PMC3875663.pdf
"J Cell Biol 2013; 201:467-84; PMID:23629968; http://dx.doi.org/10.1083/jcb.201205176EphA2 bears plasticity to tumor invasion Nami s ugiyama, Erika Gucciardo, and Kaisa l ehti* research Programs u nit; Genome- scale Biology and Haartman i nstitute; Biomedicum Helsinki; u niversity of Helsinki; Helsinki, Finland",OADS,/arxiv_data1/oa_pdf/cf/dd/cc-12-2927.PMC3875663.pdf
J Cell Biol 2013; 201:467- 84; http://dx.doi.org/10.1083/jcb.201205176 ;  PMID:23629968 2.,Non-OADS,/arxiv_data1/oa_pdf/cf/dd/cc-12-2927.PMC3875663.pdf
PLoS One 2011; 6:e28325; http://dx.doi.org/10.1371/journal.pone.0028325 ;  PMID:22164270 3.,Non-OADS,/arxiv_data1/oa_pdf/cf/dd/cc-12-2927.PMC3875663.pdf
Genes Dev 2005; 19:979-91; http://dx.doi.org/10.1101/gad.1294605 ; PMID :15805464 4.,OADS,/arxiv_data1/oa_pdf/cf/dd/cc-12-2927.PMC3875663.pdf
J Cell Sci 2009; 122:126-35; http://dx.doi.org/10.1242/jcs.035279 ; PMID:19066283 5.,OADS,/arxiv_data1/oa_pdf/cf/dd/cc-12-2927.PMC3875663.pdf
Proc Natl Acad Sci U S A  2010; 107:15786-91; http://dx.doi.org/10.1073/ pnas.0914459107 ; PMID:20798051 6.,OADS,/arxiv_data1/oa_pdf/cf/dd/cc-12-2927.PMC3875663.pdf
Cancer Res 2010; 70:7851-61;  http://dx.doi.org/10.1158/0008-5472.CAN-10- 1223 ; PMID:20876804 7.,Non-OADS,/arxiv_data1/oa_pdf/cf/dd/cc-12-2927.PMC3875663.pdf
Dev Cell 2012; 22:1176-90; http://dx.doi.org/10.1016/j.devcel.2012.04.014 ;  PMID:22632802 8.,OADS,/arxiv_data1/oa_pdf/cf/dd/cc-12-2927.PMC3875663.pdf
J Biol Chem 2013; 288:12114-29; http://dx.doi.org/10.1074/jbc.M112.409599 ;  PMID:23519472Figure  1.,OADS,/arxiv_data1/oa_pdf/cf/dd/cc-12-2927.PMC3875663.pdf
"This prompted us to assess whether inhibition of Hsp90 might be a potent means to block fibrosis, pathological  *Correspondence to: Sara A Wickström; Email: wickstroem@age.mpg.de Submitted: 05/24/13; Accepted: 07/09/13http://dx.doi.org/10.4161/cc.26213Radovanac K, et al.",Non-OADS,/arxiv_data1/oa_pdf/67/db/cc-12-2929.PMC3875664.pdf
"EMBO J 2013; 32:1409-24; PMID:23612611; http://dx.doi.org/10.1038/emboj.2013.90The weakest link A new paradigm for stabilizing the integrin–actin connection Jessica Morgner and s ara a Wickström* Paul Gerson u nna Group “ skin Homeostasis and a geing”; Max Planck i nstitute for Biology of a geing; Cologne, Germany",Non-OADS,/arxiv_data1/oa_pdf/67/db/cc-12-2929.PMC3875664.pdf
Science 2009; 326:1216-9;  PMID:19965464 ; http://dx.doi.org/10.1126/ science.1176009 2.,Non-OADS,/arxiv_data1/oa_pdf/67/db/cc-12-2929.PMC3875664.pdf
Cold Spring Harb Perspect Biol  2011; 3;  PMID:21421914 ; http://dx.doi.org/10.1101/ cshperspect.a0051163.,Non-OADS,/arxiv_data1/oa_pdf/67/db/cc-12-2929.PMC3875664.pdf
EMBO J 2010; 29:281-91;  PMID:20033063 ; http://dx.doi.org/10.1038/ emboj.2009.376 4.,Non-OADS,/arxiv_data1/oa_pdf/67/db/cc-12-2929.PMC3875664.pdf
Mol Cell 2009; 36:819-30;  PMID:20005845 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/67/db/cc-12-2929.PMC3875664.pdf
Nature 2009; 461:1002-6;  PMID:19829382 ; http://dx.doi.org/10.1038/ nature08468 6.,Non-OADS,/arxiv_data1/oa_pdf/67/db/cc-12-2929.PMC3875664.pdf
EMBO J 2013; 32:1409-24;  PMID:23612611 ; http://dx.doi.org/10.1038/ emboj.2013.90 7.,Non-OADS,/arxiv_data1/oa_pdf/67/db/cc-12-2929.PMC3875664.pdf
Nat Rev Mol Cell Biol 2010; 11:515- 28; PMID:20531426 ; http://dx.doi.org/10.1038/ nrm2918 8.,OADS,/arxiv_data1/oa_pdf/67/db/cc-12-2929.PMC3875664.pdf
EMBO Rep 2011; 12:259-66; PMID :21311561 ; http://dx.doi.org/10.1038/ embor.2011.5,OADS,/arxiv_data1/oa_pdf/67/db/cc-12-2929.PMC3875664.pdf
"Interestingly, contrary to  *Correspondence to: Bechara Kachar; Email; kacharb@nidcd.nih.gov Submitted: 06/20/13; Accepted: 06/24/13http://dx.doi.org/10.4161/cc.26229Comment on: Ebrahim S, et al.",Non-OADS,/arxiv_data1/oa_pdf/59/1a/cc-12-2931.PMC3875665.pdf
"Curr Biol 2013; 23:731-6; PMID:23562268; http://dx.doi.org/10.1016/j.cub.2013.03.039Myosin transcellular networks regulate  epithelial apical geometry seham Ebrahim and Bechara Kachar* National i nstitutes on d eafness and o ther Communication d isorders; National i nstitutes of Health; Bethesda, M d usa",Non-OADS,/arxiv_data1/oa_pdf/59/1a/cc-12-2931.PMC3875665.pdf
Dev Biol 2010; 341:5-19;  PMID:19751720 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/59/1a/cc-12-2931.PMC3875665.pdf
Nature 2004; 429:667-71;  PMID :15190355 ; http://dx.doi.org/10.1038/ nature025903.,OADS,/arxiv_data1/oa_pdf/59/1a/cc-12-2931.PMC3875665.pdf
J Physiol 2002; 545:485-99;  PMID:12456828 ; http://dx.doi.org/10.1113/ jphysiol.2002.031161 4.,Non-OADS,/arxiv_data1/oa_pdf/59/1a/cc-12-2931.PMC3875665.pdf
Curr Biol 2013; 23:731-6; PMID:23562268 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/59/1a/cc-12-2931.PMC3875665.pdf
Science 2003; 299:1743-7; PMID:12637748 ; http://dx.doi.org/10.1126/ science.1081412 7.,OADS,/arxiv_data1/oa_pdf/59/1a/cc-12-2931.PMC3875665.pdf
Dis Esophagus 2012; 25:427-36; PMID:21951916 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/1a/cc-12-2931.PMC3875665.pdf
"*Correspondence to: Carol L Williams; Email: Williams@mcw.edu Submitted: 07/08/13; Accepted: 07/10/13http://dx.doi.org/10.4161/cc.26230Comment on: Ntantie E, et al.",Non-OADS,/arxiv_data1/oa_pdf/ae/81/cc-12-2933.PMC3875666.pdf
"Sci Signal 2013; 6:ra39; PMID:23716716; http://dx.doi.org/10.1126/scisignal.2003374A new signaling paradigm to control   the prenylation and trafficking of small GTPases Carol l  Williams department of Pharmacology and t oxicology; Cancer Center and Cardiovascular Center; Medical College of Wisconsin; Milwaukee, W i usa",Non-OADS,/arxiv_data1/oa_pdf/ae/81/cc-12-2933.PMC3875666.pdf
J Lipid Res 2006; 47:883-91;  PMID:16543601 ; http://dx.doi.org/10.1194/jlr.,OADS,/arxiv_data1/oa_pdf/ae/81/cc-12-2933.PMC3875666.pdf
Curr Opin Pharmacol 2012;  12:704-9;  PMID:22817869 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/81/cc-12-2933.PMC3875666.pdf
J Biol Chem 2010; 285:35255-66; PMID:20709748 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ae/81/cc-12-2933.PMC3875666.pdf
Sci Signal 2013; 6:ra39;  PMID:23716716 ; http://dx.doi.org/10.1126/ scisignal.2003374 5.,OADS,/arxiv_data1/oa_pdf/ae/81/cc-12-2933.PMC3875666.pdf
J Biol Chem 2011; 286:12141-8; PMID:21242305 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ae/81/cc-12-2933.PMC3875666.pdf
Linden J. Sci Signal 2013; 6:pe20; PMID:23716715 ;  http://dx.doi.org/10.1126/scisignal.2004290 7.,OADS,/arxiv_data1/oa_pdf/ae/81/cc-12-2933.PMC3875666.pdf
Proc Natl Acad Sci U S A 2010; 107:1547-52 ;  PMID:20080644 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/81/cc-12-2933.PMC3875666.pdf
Proc Natl Acad Sci U S A 2013; 110:5139-44;  PMID:23483055 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/81/cc-12-2933.PMC3875666.pdf
"This balance is frequently tipped toward survival in cancer cells, and switching it back by interfering with Keywords:  Bcl-2 family, cas  p ase,  E2F-1, Myc, NF κB Abbreviations: MOMP, mitochondrial outer membrane permeabilization; TNFR, tumor necrosis factor receptor; BH, Bcl-2 homology; ROS, reactive oxy-gen species; ER, endoplasmic reticulum Submitted: 06/28/2013Revised: 07/30/2013Accepted: 07/30/2013http://dx.doi.org/10.4161/cc.25972 *Correspondence to: Frédérique Braun; Email:  frederique.braun@univ-nantes.fr; Philippe Juin: Email: philippe.juin@univ-nantes.fr",Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Nat Rev Mol Cell Biol 2010; 11:621-32; PMID:20683470 ; http://dx.doi.org/10.1038/ nrm2952 2.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Nat Rev Cancer 2013; 13:455-65; PMID:23783119 ; http://dx.doi.org/10.1038/ nrc3538 3.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cell 2012; 151:344-55; PMID:23063124 ;  http://dx.doi.org/10.1016/j.cell.2012.08.038 4.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Science 2011; 334:1129-33; PMID:22033517 ; http://dx.doi.org/10.1126/ science.1206727 5.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Dev Cell 2010; 18:802-13; PMID:20493813 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Mol Cell Biol 2012; 32:4523-33; PMID:22949508 ; http://dx.doi.org/10.1128/ MCB.00774-127.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cancer Res 2011; 71:506-15; PMID:21084274 ; http://dx.doi.org/10.1158/0008- 5472.CAN-10-1977 8.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cell Death Differ 2013; 20:755-64; PMID:23429261 ;  http://dx.doi.org/10.1038/cdd.2013.6 9.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Biochim Biophys Acta 2013; 1833:1755-65; PMID:23360981 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Proc Natl Acad Sci U S A 2002; 99:9830-5; PMID:12118121 ; http://dx.doi.org/10.1073/ pnas.152571899 11.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cell Mol Life Sci 2013; 70:1171-83; PMID:22955373 ; http://dx.doi.org/10.1007/ s00018-012-1118-y 12.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
J Mol Cell Cardiol 2001; 33:2135-44; PMID:11735260 ;  http://dx.doi.org/10.1006/jmcc.2001.1476 13.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
J Biol Chem 2008; 283:11477-84;  PMID:18299329 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Nature 2003; 424:952-6; PMID:12931191 ; http://dx.doi.org/10.1038/ nature01825 16.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
J Cell Biol 2011; 195:263-76;  PMID:21987637 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Nat Cell Biol 2011; 13:1224-33; PMID:21926988 ; http://dx.doi.org/10.1038/ ncb2330 18.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Nat Cell Biol 2012; 14:575- 83; PMID:22544066 ; http://dx.doi.org/10.1038/ ncb2488 19.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
EMBO J 2007; 26:2527-39; PMID:17446862 ; http://dx.doi.org/10.1038/ sj.emboj.7601689 21.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cancer Cell 2010; 17:249-61; PMID:20227039 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Biochim Biophys Acta 2009; 1787:1342-51;  PMID:19341702 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Curr Opin Pharmacol 2011; 11:354-9;  PMID :21571591 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Nat Cell Biol 2003; 5:28-37; PMID:12510191 ; http://dx.doi.org/10.1038/ncb894 26.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
J Biol Chem 2004; 279:54470-8; PMID :15471874 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
J Biol Chem 2006; 281:40493-502; PMID:17090549 ; http://dx.doi.org/10.1074/ jbc.M606181200 28.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
J Cell Biochem 2012; 113:3-12;  PMID:21898539 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Mutat Res 2012; 751:247-57; PMID:22677530 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cell 2007; 129:45-56; PMID:17418785 ;  http://dx.doi.org/10.1016/j.cell.2007.01.04534.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Proc Natl Acad Sci U S A 2009; 106:3935-40;  PMID:19223583 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cell 2009; 137:413-31; PMID:19410540 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Nature 2009; 458:1127-30; PMID:19407794 ; http://dx.doi.org/10.1038/ nature07986 37.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
J Biol Chem 1999; 274:6469-75; PMID:10037739 ;  http://dx.doi.org/10.1074/jbc.274.10.6469 38.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cell Death Differ 2013; PMID:23703322 ;  http://dx.doi.org/10.1038/cdd.2013.52 39.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Trends Cell Biol 2008; 18:528-35; PMID:18805009 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
DNA Repair (Amst) 2004; 3:1071-9; PMID:15279795 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cell Cycle 2012; 11:3067-78; PMID:22871739 ; http://dx.doi.org/10.4161/ cc.21476 42.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cancer Cell 2009; 15:184-94; PMID:19249677 ;  http://dx.doi.org/10.1016/j.ccr.2009.01.026 43.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cell Death Differ 2006; 13:1351-9;  PMID:16763616 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
J Exp Med 1996; 183:2219-26; PMID:8642331 ; http://dx.doi.org/10.1084/ jem.183.5.2219 45.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cell Cycle 2004; 3:7-9; PMID:14657653 ;  http://dx.doi.org/10.4161/cc.3.1.602 49.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Mol Cell Biol 2000; 20:4745-53; PMID:10848600 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Oncogene 2002; 21:7765-75; PMID:12420213 ; http://dx.doi.org/10.1038/ sj.onc.1205928 52.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
J Biol Chem 2008; 283:34108-20; PMID:18818203 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Nat Cell Biol 2005; 7:137-47; PMID :15619620 ;  http://dx.doi.org/10.1038/ncb1215 54.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cell Cycle 2012; 11:2159-69; PMID:22617334 ; http://dx.doi.org/10.4161/ cc.20672 55.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cell Cycle 2011; 10:3886-96;  PMID:22071694 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
EMBO J 2003; 22:5459-70;  PMID:14532118 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Oncogene 2001; 20:2918-26; PMID:11420704 ; http://dx.doi.org/10.1038/ sj.onc.1204414 58.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Annu Rev Immunol 2009; 27:693-733; http://dx.doi.org/10.1146/annurev.immu - nol.021908.132641 ; PMID:19302050 59.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Proc Natl Acad Sci U S A 1999; 96:9136-41;  PMID:10430908 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Nat Cell Biol 1999; 1:227-33; PMID:10559921 ;  http://dx.doi.org/10.1038/12050,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Mol Cell  2001; 8:1005-16;  PMID:11741536 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Oncogene 1999; 18:6853-66;  PMID:10602461 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Nature 2006; 441:431-6; PMID:16724054 ; http://dx.doi.org/10.1038/ nature04870 67.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Mol Cancer Res 2007; 5:761-71; PMID:17699103 ; http://dx.doi.org/10.1158/1541- 7786.MCR-07-0088 68.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
J Neurochem 2008; 107:871-82;  PMID:18786178 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Int J Cancer 2000; 86:188-96; PMID:10738245 ; http://dx.doi.org/10.1002/ (SICI)1097-0215(20000415)86:2<188::AID-IJC7>3.0.CO;2-W 70.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cell Death Differ 2007; 14:1657-66; PMID:17572663 ; http://dx.doi.org/10.1038/ sj.cdd.4402174 71.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
J Biol Chem 2002; 277:38676-82; PMID:12167626 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
J Biol Chem 1999; 274:29505-9; PMID:10506215 ;  http://dx.doi.org/10.1074/jbc.274.41.29505 74.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Oncogene 2003; 22:8961-82;  PMID:14663476 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Eur J Cell Biol 2000; 79:121-9; PMID:10727020 ;  http://dx.doi.org/10.1078/S0171-9335(04)70014-X 76.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
J Biol Chem 2008; 283:25003-13; PMID:18599488 ;  http://dx.doi.org/10.1074/jbc.M802511200 77.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Mol Biol Cell 2005; 16:943-53; PMID:15574883 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Curr Opin Cell Biol 2010; 22:816-27; PMID:20807678 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cancer Cell 2008; 14:447-57; PMID:19061836 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Nature 2004; 432:307-15;  PMID :15549092 ;  http://dx.doi.org/10.1038/nature0309882.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Genes Dev 1999; 13:1367-81;  PMID :10364155 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Mol Cell Biol 2002; 22:6158-69;  PMID:12167710 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Mol Cancer 2011; 10:110; PMID:21899728 ;  http://dx.doi.org/10.1186/1476-4598-10-110 85.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Oncogene 2008; 27:6462-72; PMID:18955973 ; http://dx.doi.org/10.1038/ onc.2008.312 86.,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
J Biol Chem 2006; 281:14446-56; PMID:16554306 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Cell Signal 2009; 21:1054-9; PMID:19258038 ;  http://dx.doi.org/10.1016/j.cellsig.2009.02.020 88.,OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
Annu Rev Immunol 2013; 31:51-72; PMID :23157435 ; http://dx.doi.org/10.1146/ annurev-immunol-032712-100008,Non-OADS,/arxiv_data1/oa_pdf/45/a0/cc-12-2937.PMC3875667.pdf
"15,17 In mammals, Rag  GTPase heterodimers associate with the Ego1 equivalent p18 (LAMTOR1), the Keywords:  Rag GTPases, TOR  com  plex 1, EGO complex, SEA com  plex,  amino acid signaling, Iml1-Npr2-Npr3 Rag GTPase GAP complex, GATOR1, GATOR2, Seh1, Sec13 Abbreviations: TORC1, TOR complex   1;  EGOC, EGO complex; SEAC, SEA  complex Submitted: 07/12/2013 Accepted: 08/01/2013 http://dx.doi.org/10.4161/cc.26000 *Correspondence to: Claudio De Virgilio;  Email: Claudio.DeVirgilio@unifr.ch",OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Curr Opin Cell Biol 2009; 21:825- 36; PMID:19767189 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Nat Rev Mol Cell Biol 2011; 12:21-35; PMID :21157483 ; http://dx.doi.org/10.1038/ nrm3025 3.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Int J Biochem Cell Biol 2006; 38:1476-81;  PMID:16647875 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Oncogene 2006 ; 25: 6392-415;  PMID:17041625 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Nat Rev Mol Cell Biol 2013; 14:133-9;  PMID:23361334 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Nat Cell Biol 2008; 10:935-45; PMID:18604198 ; http://dx.doi.org/10.1038/ ncb1753 9.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Mol Cell 2009; 35:563-73; PMID:19748353 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Science 2008; 320:1496-501; PMID:18497260 ; http://dx.doi.org/10.1126/ science.1157535 11.,Non-OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Cell Cycle 2009; 8:1014-8;  PMID:19270521 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Cell 2010; 141:290-303; PMID:20381137 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Mol Cell 2005; 19:15-26 ; PMID :15989961 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Cell Cycle 2010; 9:221-2; PMID:20023374 ;  http://dx.doi.org/10.4161/cc.9.2.10585 15.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
J Mol Biol 2010; 402:388-98; PMID:20655927 ;  http://dx.doi.org/10.1016/j.jmb.2010.07.034 16.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
FEMS  Microbiol Rev 2012; 36:306-39; PMID:21658086 ;  http://dx.doi.org/10.1111/j.1574-6976.2011.00287.x 17.,Non-OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Structure 2012; 20:2151-60;  PMID:23123112 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Cell 2012; 150:1196-208; PMID:22980980 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Mol Cell Proteomics 2011; 10:006478; PMID:21454883 ; http://dx.doi.org/10.1074/mcp.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Autophagy 2011; 7:1392-3; PMID:21804352 ; http://dx.doi.org/10.4161/ auto.7.11.17347 22.,Non-OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Mol Biol Cell 2011; 22:4124-33; PMID:21900499 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Sci Signal 2013; 6:ra42; PMID:23716719 ;  http://dx.doi.org/10.1126/scisignal.2004112 24.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Science 2013; 340:1100-6;  PMID:23723238 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Cell 1980 ; 21:205-15;  PMID:6996832 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Mol Cell 2002; 10:457-68; PMID:12408816 ; http://dx.doi.org/10.1016/ S1097-2765(02)00636-6 29.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Annu Rev Biochem 2011; 80:613-43;  PMID:21495847 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Nat Rev Mol Cell Biol 2006; 7:727-38; PMID:16990852 ; http://dx.doi.org/10.1038/ nrm2025,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Genome Res 2011; 21:433-46; PMID:21239477 ; http://dx.doi.org/10.1101/ gr.111492.110 33.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Proc Natl Acad Sci U S A 2006; 103:17840-5; PMID:17095607 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Cell 1989; 58:133-45; PMID:2526682 ;  http://dx.doi.org/10.1016/0092-8674(89)90410-8 35.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Mol Cell 2009; 33:704-16; PMID:19328065 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Science 2011; 334:678-83; PMID:22053050 ; http://dx.doi.org/10.1126/ science.1207056 37.,Non-OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Mol Cell 2012; 46:105-10;  PMID:22424774 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Cell 2012; 149:410-24; PMID:22424946 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Mol Cell 2012; 47:349-58;  PMID:22749528 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Curr Biol 2013; 23:1269-79;  PMID:23810534 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Genetics 2007; 176:2139-50; PMID:17565946 ; http://dx.doi.org/10.1534/ genetics.107.072835 42.,Non-OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Nature 2013; 493:679-83;  PMID:23263183 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
J Biol Chem 2010; 285:19705-9;  PMID:20457610 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Cell Cycle 2012; 11:4107-8; PMID:23095634 ;  http://dx.doi.org/10.4161/cc.22632 45.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Cell Cycle 2010; 9:1869-70; PMID:20436274 ;  http://dx.doi.org/10.4161/cc.9.10.11679 46.,Non-OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Mol Biol Cell 2010; 21:833-41; PMID:20053679 ;  http://dx.doi.org/10.1091/mbc.E09-09-0756 47.,Non-OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Yeast 1998; 14:115-32; PMID:9483801 ; http://dx.doi.org/10.1002/ (SICI)1097-0061(19980130)14:2<115::AID-YEA204>3.0.CO;2-2 48.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Nat Biotechnol 2011; 29:361-7; PMID:21441928 ;  http://dx.doi.org/10.1038/nbt.183249.,Non-OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Science 1999; 285:901-6;  PMID:10436161 ;  http://dx.doi.org/10.1126/science.285.5429.901 50.,Non-OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Mol Cell 2007; 26:663-74;  PMID:17560372 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
J Cell Biol 2001; 154:109-22;  PMID:11448994 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
EMBO J 2003; 22:4465-77; PMID:12941698 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
Immunobiology 2011; 216:343-50; PMID:20961651 ;  http://dx.doi.org/10.1016/j.imbio.2010.07.006,Non-OADS,/arxiv_data1/oa_pdf/3f/be/cc-12-2948.PMC3875668.pdf
"1A) and the mouse small intestine to  directly address the role of Rac1  in ISCs by Keywords: Rac1, intestinal stem cells, Drosophila , mouse, ROS, regeneration Submitted: 07/15/2013 Accepted: 08/02/2013http://dx.doi.org/10.4161/cc.26031 *Correspondence to: Owen J Sansom;   Email: o.sansom@beatson.gla.ac.uk;  Julia B Cordero; Email: j.cordero@beatson.gla.ac.uk",Non-OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Nature 2004; 431:997-1002; PMID :15496926 ; http://dx.doi.org/10.1038/ nature02989 2.,Non-OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Nature 2009; 461:537-41; PMID:19727075 ; http://dx.doi.org/10.1038/ nature08313 3.,Non-OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Brain Res 2005; 1040:137-50; PMID:15804435 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Cell Stem Cell 2007; 1:140- 52; PMID:18371346 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Cell Stem Cell  2007; 1:101-12;  PMID:18371339 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Science 2005; 307:1904- 9; PMID :15790842 ; http://dx.doi.org/10.1126/ science.1104815 9.,OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Cell Stem Cell 2013; 12:761-73;  PMID:23665120 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Cell Stem Cell  2008; 3:442-55;  PMID:18940735 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Biochim Biophys Acta 2008; 1780:1093- 100; PMID:18656526 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Genes Dev 2009; 23:2333-44; PMID:19797770 ; http://dx.doi.org/10.1101/ gad.1827009 13.,OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Clin Exp Metastasis 2007; 24:657-72;  PMID:18000759 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Cell Stem Cell 2009; 4:49-61; PMID:19128792 ;  http://dx.doi.org/10.1016/j.stem.2008.10.016 18.,OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Cell Host Microbe 2009; 5:200- 11; PMID:19218090 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Cell 2009; 137:1343-55;  PMID:19563763 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Dev Cell 2010; 19:259-69;  PMID:20708588 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Genesis  2004; 39:186-93;  PMID :15282745 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
Science  2003; 302:459-62;  PMID:14564011 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
EMBO J 2012; 31:3901-17; PMID:22948071 ;  http://dx.doi.org/10.1038/emboj.2012.248,Non-OADS,/arxiv_data1/oa_pdf/47/cf/cc-12-2973.PMC3875672.pdf
"Consequently, a simple binary classification of gene expression (“on” or “off”) in relation  *Correspondence to: Amit Tzur; Email: amit.tzur@biu.ac.il Submitted: 07/01/2013; Accepted: 08/02/2013http://dx.doi.org/10.4161/cc.26030Unbiased transcriptome signature   of in vivo cell proliferation reveals   pro- and antiproliferative gene networks Meital Cohen1,2,†, Manuela Vecsler1,2,†, arthur Liberzon3, Meirav Noach1,2, eitan Zlotorynski1, and a mit Tzur1,2,* 1The Mina and e verard Goodman Faculty of Life Sciences; Bar-Ilan University; Ramat-Gan, Israel; 2advanced Materials and  Nanotechnology Institute; Bar-Ilan University; Ramat-Gan, Israel; 3Broad Institute; Cambridge, M a US a †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Mol Biol Cell 2002; 13:1977- 2000;  PMID:12058064 ; http://dx.doi.org/10.1091/ mbc.02-02-0030.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Methods Enzymol  2005; 399:404-14;  PMID:16338372 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Dev Cell 2012; 23:681- 90; PMID:23000141 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Cell 2008; 132:487-98; PMID:18267078 ;  http://dx.doi.org/10.1016/j.cell.2007.12.033 5.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Biochem Biophys Res Commun 1999; 260:712- 7; PMID:10403831 ; http://dx.doi.org/10.1006/ bbrc.1999.0954 6.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
J Biomed Biotechnol  2008; 2008:453590; PMID:18401450 ; http:// dx.doi.org/10.1155/2008/453590 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
PLoS  One 2006; 1:e54; PMID:17183684 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
J Biol Chem 2006; 281:1808-16;  PMID :16239215 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Proc Natl Acad Sci U S A 2011; 108:9845-50; PMID:21628590 ; http://dx.doi.org/10.1073/ pnas.1106136108 13.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Mol Cell  2012; 45:75-86;  PMID :22153967 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
J Cell Sci 2012; 125:2393-406;  PMID:22344256 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Blood 2010; 115:5202- 13; PMID:20382844 ; http://dx.doi.org/10.1182/ blood-2009-12-259523 16.,Non-OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Cancer Res 2008; 68:1251-3; PMID:18316586 ;  http://dx.doi.org/10.1158/0008-5472.CAN-07-5983 17.,Non-OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Br J Cancer 2010; 103:354- 61; PMID:20628382 ; http://dx.doi.org/10.1038/ sj.bjc.6605793 18.,Non-OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Cell 2005; 122:915-26;  PMID:16153703 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
J Cell Biol 2004; 164:233- 41; PMID:14734534 ; http://dx.doi.org/10.1083/ jcb.200309035 20.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Dev Biol  2007; 308:355-67;  PMID:17580084 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Cell  1989; 57:79-88;  PMID:2649247 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Trends Cell Biol 2009; 19:111-8; PMID:19201609 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Dev Cell 2005; 9:442-4; PMID:16198285 ;  http://dx.doi.org/10.1016/j.devcel.2005.09.006 27.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Cancer Res 2009; 69:1800-8; PMID:19223542 ;  http://dx.doi.org/10.1158/0008-5472.CAN-08-2725 28.,Non-OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Dev Cell 2008; 14:1-3;  PMID:18194644 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Cell Cycle 2012; 11:2030-8; PMID:22580462 ;  http://dx.doi.org/10.4161/cc.20643 30.,Non-OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Cell  2003; 113:101-13;  PMID:12679038 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Science 1999; 285:418-22;  PMID:10411507 ;  http://dx.doi.org/10.1126/science.285.5426.418,Non-OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Cell Cycle 2010; 9:3956- 64; PMID:20948288 ; http://dx.doi.org/10.4161/ cc.9.19.13162 34.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Genes Dev 1994; 8:1526-37;  PMID:7958837 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
J Genet Genomics  2008; 35:215-24;  PMID:18439978 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Mol Cell Biol 2007; 27:65- 78; PMID:17167174 ; http://dx.doi.org/10.1128/ MCB.02147-05 38.,Non-OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Genes Dev 2001; 15:3278-85; PMID:11751633 ;  http://dx.doi.org/10.1101/gad.94570139.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Mol Cell Biol 2001; 21:3692- 703; PMID:11340163 ; http://dx.doi.org/10.1128/ MCB.21.11.3692-3703.2001 40.,Non-OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
EMBO Rep 2008; 9:252- 9; PMID:18202719 ; http://dx.doi.org/10.1038/ sj.embor.7401158 41.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Science 2012; 336:1157-60;  PMID:22539553 ; http://dx.doi.org/10.1126/ science.1217405 43.,Non-OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Gene Ther 2000; 7:2036-40;  PMID:11175316 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
Science 1999; 286:531-7;  PMID:10521349 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/69/cc-12-2992.PMC3875674.pdf
"A restric - tion point exists within G1 that dictates if cells continue to  divide and transit into the S phase, or if they exit from the cell  *Correspondence to: Marcel Egli; Email: marcel.egli@hslu.ch Submitted: 06/17/2013; Revised: 07/29/2013; Accepted: 08/02/2013http://dx.doi.org/10.4161/cc.26029Gravitational force modulates G2/M phase  exit in mechanically unloaded myoblasts tatiana Benavides Damm1,2, Alfredo Franco- obregón2,3, and Marcel e gli1,* 1CC Aerospace Biomedical Science & t echnology; Space Biology Group; University of Applied Sciences and Arts; Hergiswil, Switzerland; 2Institute for Biomechanics;  eidgenössische t echnische Hochschule Zürich; Zürich, Switzerland; 3Department of Surgery; Yong Loo Lin School of Medicine; National University of Singapore; Singapore Keywords:  mechanotransduction, muscle atrophy, cell cycle, cyclins, microgravity, hypergravity, mechanical unloading.",Non-OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
"Materials and Methods Cell culture C2C12 mouse skeletal myoblasts were obtained from ATCC  (American Type Culture Collection, http://www.lgcstandards-atcc.org/products/all/CRL-1772.aspx?geo_country=ch) and cultured in growth medium (GM) consisting of Dulbecco modi - fied Eagle medium (Life Technologies, http://www.invitrogen.com/site/us/en/home/support/Product- T echnical-Resources/media_formulation.171.html) supplemented with 20% fetal bovine serum (FBS, Life Technologies, http://products.invit - rogen.com/ivgn/product/10270106) and 2 mM L-Glutamine (Life Technologies, https://products.invitrogen.com/ivgn/product/25030024?ICID=search-product) in a humidified atmosphere at 37 °C in 7% CO 2.",Non-OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
"Myoblasts were seeded 15 h before the start of each experiment at 8000 cells/cm 2 in 25 cm2 flasks (Semadeni, http://eshop.semad - eni.com/).",Non-OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
"Cell proliferation Cell growth was monitored with the CellTrace CFSE Cell  Proliferation Kit (Life Technologies, http://products.invitrogen.com/ivgn/product/C34554), according to the manufacturer’s instructions.",OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
"Cells were plated and collected after 6, 12, and 24 h of growth under different gravitational conditions, and then resuspended in 10% Cell Fix (BD Biosciences, catalog number 340181, http://www.bdbiosciences.com/ptProduct.jsp?prodId=651184&key=cellfix&param=search&mterms=true&from=dTable) for overnight storage at 4 °C before fluorescence activated cell sorting (FACS) analysis.",OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
"Cell cycle synchronization and analysis Cells were synchronized at G 0/G1 by addition of 1 mM  hydroxyurea (Sigma, http://www.sigmaaldrich.com/catalog/prod - uct/sigma/h8627?lang=fr&region=CH), an inhibitor of DNA synthesis, for 3 h. Cells were then washed twice with PBS and cul - tured with fresh GM to resume cycling into S and G 2/M phases.",Non-OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
"Cell cycle was analyzed based on DNA content through propidium iodide (PI)/RNase staining (BD Biosciences, catalog number 550825, http://www.bdbiosciences.com/ptProd - uct.jsp?ccn=550825) by FACS.",OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
"Samples were stained with FITC Cyclin B1 Antibody Reagent Set (BD Biosciences, catalog number 554108, http://www.bdbiosciences.com/ptProduct.jsp?prodId=9845&key=FITC+Cyclin+B1+Antibody+Reagent+Set&param=search&mterms=true&from=dTable) and FITC Mouse Anti-Human Cyclin D1 Antibody Set (BD Biosciences, catalog number 554109, http://www.bdbiosciences.com/external_files/pm/doc/tds/cell_bio/live/web_enabled/1372KK_554109.pdf#search=(FITC Mouse Anti-Human Cyclin D1 Antibody Set)) according to the manufacturer’s protocol.",Non-OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
"Flow cytometry FACS Calibur (BD Biosciences, http://www.bdbiosciences.com/ instruments/facscalibur/) was used to analyze cell proliferation, cell cycle, and cyclin expression.",OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
"CFSE fluorescence intensity, cell cycle profiles, and the percentage of positive cells expressing cyclin B and D were analyzed and quantified with the FlowJo flow cytometry analysis software (Tree Star, Inc., http://www.flowjo.com/).",OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
Eur J Appl Physiol  2011; 111:403-20;  PMID:20617334 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
FASEB J 2013; 27:2045- 54; PMID:23363573 ; http://dx.doi.org/10.1096/ fj.12-218693 5.,OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
Cytometry 1996;  25:1-13;  PMID:8875049 ; http://dx.doi.org/10.1002/ (SICI)1097-0320(19960901)25:1<1::AID- CYTO1>3.0.CO;2-N 6.,Non-OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
Cell Prolif 1994; 27:357-71; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
Curr Biol 2003; 13:373-83; PMID:12620185 ;  http://dx.doi.org/10.1016/S0960-9822(03)00127-1 8.,OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
Biol Reprod  2003 ; 69:1552-64 ;  PMID:12826587 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
J Cell Biol  1991; 115:1-17;  PMID:1717476 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
PLoS One 2006; 1:e128; PMID:17205132 ; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
J Neurol  Sci 1988; 84:275-94; PMID:3379447 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
Gerontology 2010;  56 :157-66 ;  PMID:19851058 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
Cancer Res 2009; 69:6565-72;  PMID:19638577 ; http://dx.doi.org/10.1158/0008- 5472.CAN-09-0913 18.,Non-OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
Cancer Lett  2009; 283:43-51;  PMID:19394138 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
Curr Cancer Drug Targets 2013; 13:103-16;  PMID:22920441 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
Am J Respir Cell Mol Biol 2010; 43:26-34; PMID:19648475 ; http://dx.doi.org/10.1165/ rcmb.2009-0073OC 26.,OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
Eur J Cell Biol 2012; 91:834-46;  PMID:22727433 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
Physiology (Bethesda) 2010; 25:50- 6; PMID:20134028 ; http://dx.doi.org/10.1152/ physiol.00042.2009 28.,Non-OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
Biochem Biophys Res Commun  1998; 244:317-24;  PMID:9514855 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
J Cell Biol 1990; 111:183- 96; PMID:2114410 ; http://dx.doi.org/10.1083/ jcb.111.1.183 30.,Non-OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
J Biol Chem 2003; 278:33730-7; PMID:12821654 ;  http://dx.doi.org/10.1074/jbc.M305023200 31.,OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
J Physiol 2006; 575:913-24; PMID:16825296 ;  http://dx.doi.org/10.1113/jphysiol.2006.115154 32.,Non-OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
J Biosci Bioeng  2012; 113:258-61;  PMID:22055920 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
Cell  Physiol Biochem 2013; 31:432-51; PMID:23548630 ;  http://dx.doi.org/10.1159/000343380 35.,Non-OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
Cytometry 1987; 8:1- 8; PMID:3803091 ; http://dx.doi.org/10.1002/ cyto.990080101,Non-OADS,/arxiv_data1/oa_pdf/92/0a/cc-12-3001.PMC3875675.pdf
"*Correspondence to: Eldad Zacksenhaus; Email: eldad.zacksenhaus@utoronto.ca; Tyler JW Robinson; Email: tyler.robinson@mail.utoronto.ca Submitted: 07/20/2013; Accepted: 08/05/2013http://dx.doi.org/10.4161/cc.26063High-throughput screen identifies   disulfiram as a potential therapeutic   for triple-negative breast cancer cells Interaction with IQ motif-containing factors ty ler JW Robinson1,*, Melody pa i2,†, Jeff C Liu1,†, Frederick Vizeacoumar3, th omas Sun3,  Sean  e  eg an4, Alessandro Datti3,5, Jing Huang2,6, and el dad Zacksenhaus1,7,* 1Department of Laboratory Medicine and pa thobiology; University of tor onto; tor onto, on tario, Canada; 2Molecular Biology Institute; University of  California, Los Angeles; Los Angeles, CA USA ;3S.M.A.R.",Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Oncologist 2011; 16(Suppl 1):61- 70; PMID:21278442 ; http://dx.doi.org/10.1634/ theoncologist.2011-S1-61 2.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Cell Cycle 2011; 10:1563-70; PMID :21502814 ; http://dx.doi.org/10.4161/ cc.10.10.15703 3.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Cancer Cell 2006 ; 10 :515-27; PMID :17157791 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Pharmacogenomics 2013; 14:799-811;  PMID:23651027 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Expert Opin Pharmacother 2007; 8:485-95; PMID:17309343 ;  http://dx.doi.org/10.1517/14656566.8.4.4857.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Am J Clin Oncol 2013; PMID:23608830 ;  http://dx.doi.org/10.1097/COC.0b013e31828f5b01 8.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Asian Pac J Cancer Prev 2013; 14:2013-7;  PMID:23679310 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Neoplasma 2012; 59:38-42;  PMID:22103897 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Ann Oncol 2012; 23(Suppl 6):vi40-5;  PMID:23012301 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
J Clin Invest 1979; 63:1241-8; PMID:447842 ; http://dx.doi.org/10.1172/ JCI109419 16.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Clin Cancer Res 2009; 15:6070-8; PMID:19789329 ;  http://dx.doi.org/10.1158/1078-0432.CCR-09-1035 17.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Curr Cancer Drug Targets 2011; 11:332-7;  PMID:21247389 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Br J Cancer 2011; 104:1564-74; PMID:21487404 ; http://dx.doi.org/10.1038/ bjc.2011.126 23.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Mol Biosyst 2005; 1:127-34;  PMID:16880974 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Mol Carcinog 1998; 22:235-46; PMID:9726816 ;  http://dx.doi.org/10.1002/(SICI)1098-2744(199808)22:4<235::AID-MC5>3.0.CO;2-I 25.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
J Cell Mol Med 2009; 13(8B):2236-52;  PMID:18681906 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Stem Cells 2011; 29:32-45;  PMID :21280157 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
ACS Chem Biol 2011; 6:34-46; PMID:21077692 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
J Cell Sci 2009; 122:2024-33;  PMID:19454477 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
PLoS One 2008; 3:e3848;  PMID:19050761 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Cell Signal 2012; 24:1856-62;  PMID:22634185 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Bioarchitecture 2012; 2; PMID:22964981 ; http://dx.doi.org/10.4161/ bioa.21182 34.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
EMBO Rep 2003; 4:571-4;  PMID:12776176 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Biochem Biophys Res Commun 2012; 428:173-8;  PMID:23068101 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
J Cell Biol 2012; 199:669-83; PMID:23128239 ; http://dx.doi.org/10.1083/ jcb.201205056 37.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Dev Biol 2012; 369:356-61; PMID:22820068 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
FEBS Lett 2002; 513:107-13; PMID:11911888 ; http://dx.doi.org/10.1016/ S0014-5793(01)03239-2 39.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Nat Med 2013; 19:538-40;  PMID:23652103 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Oncogene 1999; 18:7034-45; PMID:10597304 ; http://dx.doi.org/10.1038/ sj.onc.1203183 42.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Hum Mol Genet 2001; 10:237-42; PMID:11159942 ;  http://dx.doi.org/10.1093/hmg/10.3.237 43.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
J Biol Chem 2002; 277:25847-50;  PMID:12011103 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Cancer Chemother Pharmacol 2013; 71:13-20;  PMID:23073611 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
J Biol Chem 2006; 281:8518-27;  PMID :16415355 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
J Biol Chem 1998; 273:27104-10;  PMID:9765227 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
J Cancer 2013; 4:315-9; PMID:23569464 ;  http://dx.doi.org/10.7150/jca.5956 49.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activ - ity and contributes to survival signals generated by phospholipase D. Oncogene 2006; 25:7305-10; PMID:16785993 ; http://dx.doi.org/10.1038/ sj.onc.1209735 50.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
J Biol Chem 2002; 277:35509-15; PMID:12101184 ;  http://dx.doi.org/10.1074/jbc.M205477200 51.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Cancer Cell 2012; 21:793-806; PMID:22698404 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Nat Med 1997; 3:730-7; PMID:9212098 ; http://dx.doi.org/10.1038/ nm0797-730 54.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Science 2009; 324:1670-3;  PMID:19556499 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Curr Pharm Biotechnol 2011; 12:196-205;  PMID:21044007 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Breast Cancer Res 2008; 10:R25; PMID:18366788 ; http://dx.doi.org/10.1186/ bcr1982 58.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
J Biol Chem 2012; 287:38367-78; PMID:22992742 ;  http://dx.doi.org/10.1074/jbc.M112.377499 59.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Cell Signal 2009;  21:1471-8;  PMID:19269319 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Clin Cancer Res 2010; 16:6009-18;  PMID:20959410 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Mod Pathol 2008; 21:544-52; PMID:18246045 ; http://dx.doi.org/10.1038/ modpathol.2008.3 64.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
FEBS Lett 2009; 583:1817-24; PMID:19433088 ;  http://dx.doi.org/10.1016/j.febslet.2009.05.007 65.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Cell Signal 2012; 24:826-34; PMID:22182509 ;  http://dx.doi.org/10.1016/j.cellsig.2011.12.005 66.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
BMC Gastroenterol 2010; 10:125; PMID:20977743 ;  http://dx.doi.org/10.1186/1471-230X-10-125 68.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
FEBS Lett 2009; 583:1817-24; PMID:19433088 ;  http://dx.doi.org/10.1016/j.febslet.2009.05.007 69.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Biochim Biophys Acta 2012; 1822:875-84; PMID:22406297 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Blood 2003; 101:3021-8;  PMID :12515716 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Int J Dev Biol 2011; 55:835-40; PMID:22161839 ; http://dx.doi.org/10.1387/ ijdb.113336ld 74.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
PLoS One 2011; 6:e18409; PMID:21533124 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Dis Esophagus 2012; 25:427-36;  PMID:21951916 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
J Cell Physiol 1997; 172:126-36; PMID:9207933 ;  http://dx.doi.org/10.1002/(SICI)1097-4652(199707)172:1<126::AID-JCP14>3.0.CO;2-A 77.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Mol Oncol 2012; 6:299-310;  PMID:22366308 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Cell 2011; 144:703-18; PMID:21376233 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Nat Med 2013; 19:626-30;  PMID:23603816 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Lancet Oncol 2013; 14:72-80; PMID:23246022 ;  http://dx.doi.org/10.1016/S1470-2045(12)70525-9 83.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Curr Cardiol Rev 2011; 7:214-20; PMID:22758622 ;  http://dx.doi.org/10.2174/157340311799960645 85.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Med Res Rev 2013; PMID:23494977; http://dx.doi.org/10.1002/ med.21280 86.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
J Biomol Screen 2003; 8:634-47;  PMID:14711389 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Leuk Res 1995; 19:175-81; PMID:7700079 ;  http://dx.doi.org/10.1016/0145-2126(94)00126-U 88.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
Int J Cell Cloning 1988; 6:378-91; PMID:3230328 ; http://dx.doi.org/10.1002/ stem.5530060603 90.,OADS,/arxiv_data1/oa_pdf/ce/24/cc-12-3013.PMC3875676.pdf
"Some of these adverse drug reactions can be similar to the underly - ing disease for which they are given, making management of  *Correspondence to: Anne E Willis; Email: aew5@le.ac.uk; Gerry Melino; Email: gm89@le.ac.uk Submitted: 07/31/2013; Accepted: 08/06/2013http://dx.doi.org/10.4161/cc.26067Metabolic profiling of human CD4+ cells  following treatment with methotrexate  and anti-TNF- α infliximab Maria Sole Chimenti1, paola t ucci2,3, eleonora Candi4, Roberto p erricone1, Gerry Melino3,4,*, and Anne e Willis3,* 1Rheumatology, Allergology and Clinical Immunology; Department of Internal Medicine; University of Rome t or Vergata; Rome, Italy;  2Department of p harmacy, Health and Nutritional Sciences; University of Calabria; Rende, Cosenza, Italy; 3Medical Research Council;  toxicology Unit; Leicester, UK; 4Department of e xperimental Medicine and Surgery; University of Rome t or Vergata; Rome, Italy Keyword: rheumatoid arthritis, autoimmunity disease, apoptosis, T cells Abbreviations : RA, rheumatoid arthritis; MTX, methotrexate; DHFR, dihydrofolate reductase; PFK1,  phosphofructose kinase 1; DHAP, dihydroxyacetone phosphate; PEP, phosphoenolpyru  vate; PPP, pen  tose  phosphate pathway; PLA, phospholipase A; TNF- α, tumour necrosis factor- α; GC/MS, gas chroma - tography/mass spectrometry; LC/MS/MS, liquid chromatography/mass spectrometry the autoimmune process in rheumatoid arthritis depends on activation of immune cells, which utilize intracellular  kinases to respond to external stimuli such as cytokines, immune complexes, and antigens.",Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Arthritis Rheum 1988; 31:167- 75; PMID:3279962 ; http://dx.doi.org/10.1002/ art.1780310203 2.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Autoimmun Rev 2013; 12:599-606; PMID:23183378 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Lancet  1999; 354:1932-9;  PMID:10622295 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ  2012; 19:756-67;  PMID:22052192 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Cycle  2011; 10:2821-2;  PMID :21857151 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2012; 3:e320;  PMID:22695613 ; http://dx.doi.org/10.1038/ cddis.2012.64 9.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Lancet 2008; 372:375- 82; PMID:18635256 ; http://dx.doi.org/10.1016/ S0140-6736(08)61000-4 11.,OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Nat Rev Gastroenterol Hepatol 2012; 9:496-503; PMID:22751454 ; http://dx.doi.org/10.1038/ nrgastro.2012.125 12.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Nature  2013; 493:346-55;  PMID:23325217 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Immunity 2011; 35:871-82; PMID:22195744 ;  http://dx.doi.org/10.1016/j.immuni.2011.09.021 14.,OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ 2012; 19:1505-13;  PMID:22421969 ; http://dx.doi.org/10.1038/ cdd.2012.2615.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ 2012; 19:1277- 87; PMID:22322859 ; http://dx.doi.org/10.1038/ cdd.2012.7 17.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ 2011; 18:619-31;  PMID:21052094 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Cycle 2012; 11:4563-9; PMID:23165210 ;  http://dx.doi.org/10.4161/cc.22810 19.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ 2012; 19:144-52;  PMID:21660048 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2012; 3:e270; PMID:22318539 ; http://dx.doi.org/10.1038/ cddis.2012.9 21.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis  2012; 3:e338;  PMID:22764097 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ 2011; 18:90-8;  PMID:20523353 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ  2011; 18:690-9;  PMID:21164518 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ  2011; 18:712-20;  PMID:21164519 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Cycle 2011; 10:1341-2; PMID :21566459 ; http://dx.doi.org/10.4161/ cc.10.9.15294 30.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Cycle  2011; 10 :1527;  PMID:21478679 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Cycle 2012; 11:4305- 9; PMID:23032366 ; http://dx.doi.org/10.4161/ cc.22135 33.,OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2011; 2:e165; PMID:21633388 ; http://dx.doi.org/10.1038/ cddis.2011.49 34.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ 2012; 19:107-20;  PMID:21760595 ; http://dx.doi.org/10.1038/ cdd.2011.96 39.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ  2012; 19:1093-5;  PMID:22684093 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Oncogene 2013;  •••: http://dx.doi.org/10.1038/onc.2012.640 ;  PMID:23416979 41.,OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ 2005; 12(Suppl 2):1457- 62; PMID:16247490 ; http://dx.doi.org/10.1038/ sj.cdd.4401781 44.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ 2011; 18:783- 92; PMID:21072052 ; http://dx.doi.org/10.1038/ cdd.2010.136 45.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Eur  J Immunol 2003; 33:2223-32; PMID:12884297 ;  http://dx.doi.org/10.1002/eji.200324048 46.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2013; 4e:549;  PMID:23519118 ; http://dx.doi.org/10.1038/ cddis.2013.76 47.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Cycle 2013;  12; PMID:23839040 ; http://dx.doi.org/10.4161/ cc.25450 48.,OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Nature 2003; 423:356-61;  PMID:12748655 ;  http://dx.doi.org/10.1038/nature01661 49.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Autoimmun Rev  2011; 10:636-40;  PMID :21536151 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Cycle 2011; 10:1784-93;  PMID:21566463 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell  Death Differ 2011; 18:571-80; PMID :21311563 ;  http://dx.doi.org/10.1038/cdd.2010.191 55.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell  Death Differ 2011; 18:1257-62; PMID :21527936 ;  http://dx.doi.org/10.1038/cdd.2011.43 56.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ 2012; 19:1228-38;  PMID:22322858 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2011; 2:e129;  PMID:21390063 ; http://dx.doi.org/10.1038/ cddis.2011.12 60.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2012; 3:e373;  PMID:22898871 ; http://dx.doi.org/10.1038/ cddis.2012.111 61.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Cycle  2011; 10:4032-8;  PMID:22101267 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Cycle 2012; 11:436-7;  PMID:22262191 ; http://dx.doi.org/10.4161/ cc.11.3.19224 64.,OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ 2011; 18:5- 15; PMID:20798688 ; http://dx.doi.org/10.1038/ cdd.2010.106 65.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death  Dis 2012; 3:e297; PMID:22495352 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ 2011; 18:1780-90;  PMID :21597464 ; http://dx.doi.org/10.1038/ cdd.2011.50 67.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell  Death Differ 2012; 19:573-81; PMID:21959934 ;  http://dx.doi.org/10.1038/cdd.2011.126 68.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ  2012 ; 19: 605-15;  PMID:21979465 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell  Death Differ 2012; 19:735-42; PMID:22421963 ;  http://dx.doi.org/10.1038/cdd.2012.25 70.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ 2012; 19:1733-40; PMID:22935609 ;  http://dx.doi.org/10.1038/cdd.2012.105 71.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Differ 2012; 19:2003- 14; PMID:22814620 ; http://dx.doi.org/10.1038/ cdd.2012.90 72.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2011; 2:e135; PMID:21430708 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis  2011; 2:e125;  PMID:21368896 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2011; 2:e171;  PMID:21654829 ; http://dx.doi.org/10.1038/ cddis.2011.55 75.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis  2011; 2:e174;  PMID:21697949 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2011; 2:e166;  PMID:21633389 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2011; 2:e187;  PMID:21814285 ; http://dx.doi.org/10.1038/ cddis.2011.7078.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2011; 2:e188; PMID:21814286 ;  http://dx.doi.org/10.1038/cddis.2011.72 79.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2011; 2:e202;  PMID:21881604 ; http://dx.doi.org/10.1038/ cddis.2011.89 80.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death  Dis 2011; 2:e222;  PMID:22030538 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2011; 2:e212; PMID:21975294 ;  http://dx.doi.org/10.1038/cddis.2011.93 83.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2011; 2:e223; PMID:22048166 ; http://dx.doi.org/10.1038/ cddis.2011.103 84.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2012; 3:e247; PMID:22237204 ;  http://dx.doi.org/10.1038/cddis.2011.122 85.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2012; 3:e288;  PMID:22460384 ; http://dx.doi.org/10.1038/ cddis.2012.28 86.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2012; 3:e277;  PMID:22402601 ; http://dx.doi.org/10.1038/ cddis.2012.18 87.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death  Dis 2012; 3:e383;  PMID:22932725 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death  Dis 2012; 3:e407; PMID:23059826 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Death Dis 2012; 3:e404; PMID:23059823 ; http://dx.doi.org/10.1038/ cddis.2012.130 90.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Cycle 2012; 11:871- 6; PMID:22333735 ; http://dx.doi.org/10.4161/ cc.11.5.1930091.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Cycle 2011; 10:1516-7; PMID:21467842 ;  http://dx.doi.org/10.4161/cc.10.10.15434 96.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Cycle  2011; 10:4217-24;  PMID :22157190 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Cycle 2012;  11:2285-302;  PMID:22684298 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Cell Cycle 2012; 11:3919-25;  PMID:22983094 ; http://dx.doi.org/10.4161/ cc.21804 99.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Autoimmun Rev 2011; 10:617-23; PMID:21549221 ;  http://dx.doi.org/10.1016/j.autrev.2011.04.012 103.,OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
Proc Natl Acad Sci U S A 2012; 109:15312-7;  PMID:22949650 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/fa/cc-12-3025.PMC3875677.pdf
"*Correspondence to: Nicholas B La Thangue; Email: nick.lathangue@oncology.ox.ac.uk Submitted: 08/05/2013; Accepted: 08/07/2013http://dx.doi.org/10.4161/cc.26078E2F-7 couples DNA damage-dependent  transcription with the DNA repair process Lykourgos- pan agiotis Zalmas1, Amanda S Coutts1, th omas Helleday2, and Nicholas B La th angue1,* 1Laboratory of Cancer Biology; Department of on cology; University of ox ford; ox ford, UK; 2Science for Life Laboratory;  Department of Medical Biochemistry and Biophysics;Karolinska Institute; Stockholm, Sweden Keywords:  E2F, transcription, DNA damage, DNA repair, somatic mutation th e cellular response to DNA damage, mediated by the DNA repair process, is essential in maintaining the integrity  and stability of the genome.",Non-OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
"Shown are 28 point mutations, of which 24 are missense and 4 are nonsense, as  indicated, which are confirmed somatic by comparison to matched (non-tumor) germline DNA (http://cancer.sanger.ac.uk/cancergenome/projects/cos - mic/).",Non-OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Oncogene 2007;  26:7717-9;  PMID:18066083 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
DNA Repair (Amst) 2004; 3:969-78; PMID :15279783 ;  http://dx.doi.org/10.1016/j.dnarep.2004.03.010 3.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Semin Cell Dev Biol 2011; 22:886-97; PMID:22027614 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
J Biol Chem 1998; 273:5858-68;  PMID:9488723 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
EMBO J 2010; 29:2864-74; PMID:20647996 ;  http://dx.doi.org/10.1038/emboj.2010.165 6.,Non-OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Nature 1991; 351:494-7;  PMID:1710781 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Cell 1995; 81:323-30; PMID:7736585 ;  http://dx.doi.org/10.1016/0092-8674(95)90385-2 9.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Oncogene 2004; 23:5138-50; PMID:15133492 ; http://dx.doi.org/10.1038/ sj.onc.1207649 10.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
"EMBO J 2003; 22:6289-98; PMID:14633988 ; http://dx.doi.org/10.1093/emboj/ cdg613 11.  d e Bruin A, Maiti B, Jakoi L, Timmers C, Buerki R,  Leone G. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation.",OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
J Biol Chem 2003; 278:42041-9;  PMID:12893818 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
EMBO Rep 2008; 9:252-9; PMID:18202719 ; http://dx.doi.org/10.1038/ sj.embor.740115813.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Cancer Chemother Pharmacol 1999; 44:411-6; PMID :10501915 ; http://dx.doi.org/10.1007/ s002800050997 14.,Non-OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Br J Cancer 2000; 82:1827-34; PMID:10839298 ; http://dx.doi.org/10.1054/ bjoc.2000.1149 15.,Non-OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Mutat Res 2003; 532:173-203;  PMID:14643436 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Annu Rev Genet 2010; 44:113-39;  PMID:20690856 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
"Cancer Res 2010; 70:5389-98; PMID:20551068 ; http://dx.doi.org/10.1158/0008- 5472.CAN-09-4716in annealing buffer (100 mM Tris-Cl pH 7.6, 10 mM DTT, 20  mM MgCl2, 2 mM Spermidine) as follows: E2F-1 F and R for  the E2F probe (40-mer), repair 5 ′ F and repair R for the 5 ′ over - hang probe (79-mer with 42 nt in double strand and 37 nt 5 ′  overhang), repair 3 ′ F and repair R for the 3 ′ overhang probe  (79-mer with 42 nt in double strand and 37 nt 3 ′ overhang), and  repair blunt end F and R for the BE probe (40-mer).",Non-OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Analysis of human tumor derived mutations of E2F-7The Catalogue of Somatic Mutations in Cancer (COSMIC)  database (http://www.sanger.ac.uk/genetics/CGP/cosmic/) 40  was interrogated for mutations of E2F-7 (NM_203394.2) in human tumor samples.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
PLoS One 2011; 6:e25814;  PMID:21998700 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Nat Protoc 2011; 6:134-9; PMID:21293454 ; http://dx.doi.org/10.1038/ nprot.2010.183 20.,Non-OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Nucleic Acids Res 2010; 38:1489-503; PMID:20008512 ; http://dx.doi.org/10.1093/nar/ gkp1149 21.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
EMBO J 2009; 28:3667-80; PMID:19851285 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Cell Rep 2012; 2:1657-69;  PMID:23260667 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Annu Rev Genet 2011; 45:247-71;  PMID:21910633 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
FEBS Lett 2003; 540:255-8; PMID :12681518 ;  http://dx.doi.org/10.1016/S0014-5793(03)00275-8 25.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
FEBS Lett 1998; 429:183-8;  PMID:9650586 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Nature 1994; 368:769-72;  PMID :8152490 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Cell Cycle 2011; 10:261-7;  PMID:21212734 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Nat Cell Biol 2011; 13:1161-9;  PMID:21968989 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Genes Dev 2011; 25:409-33; PMID:21363960 ; http://dx.doi.org/10.1101/ gad.2021311 31.,Non-OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Nat Rev Mol Cell Biol 2005; 6:44-55; PMID:15688066 ;  http://dx.doi.org/10.1038/nrm1546 32.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
DNA Repair (Amst) 2003; 2:483-99; PMID:12713809 ; http://dx.doi.org/10.1016/ S1568-7864(03)00002-8 33.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Oncogene 2004; 23:9025-33; PMID :15489903 ;  http://dx.doi.org/10.1038/sj.onc.1207982 34.,Non-OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Carcinogenesis 2001; 22:1971-8; PMID:11751427 ;  http://dx.doi.org/10.1093/carcin/22.12.1971 35.,Non-OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Proc Natl Acad Sci U S A 1994; 91:413-7; PMID:8278402 ; http://dx.doi.org/10.1073/ pnas.91.1.41336.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Oncogene 2005; 24:5000-4; PMID :15897886 ; http://dx.doi.org/10.1038/ sj.onc.1208703 37.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Genes Dev 2001; 15:3237-42 ;  PMID:11751629 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
EMBO J 2006; 25:5527-38; PMID:17082765 ; http://dx.doi.org/10.1038/ sj.emboj.7601411 39.,OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
Nature 2010; 467:678-83; PMID:20729832 ; http://dx.doi.org/10.1038/ nature09399 40.,Non-OADS,/arxiv_data1/oa_pdf/8f/52/cc-12-3037.PMC3875678.pdf
"Cyclin D1  is one of the best-known NF κB target genes involved in cell cycle  regulation during G1 phase,7 and its expression is regulated by  p52 in co-operation with Bcl-3 and RelA.6,7 Skp2, which can also  *Correspondence to: Neil D Perkins; Email: neil.perkins@ncl.ac.uk Submitted: 06/12/2013; Revised: 08/07/2013; Accepted: 08/07/2013http://dx.doi.org/10.4161/cc.26086NFκB regulates expression of Polo-like kinase 4 Adeline C Ledoux1, Hélène Sellier1, Katie Gillies†, Alessio Iannetti1, John James2, and Neil D pe rkins1,* 1Institute for Cell and Molecular Biosciences; Faculty of Medical Sciences; Newcastle University; Newcastle  Upon  ty ne, UK; 2College of Life Sciences; University of Dundee; Dundee, UK  †Current affiliation: Health Services Research Unit; University of Aberdeen; Aberdeen, UK Keywords:  NFκB, PLK4, centrosome, mitosis, promoter, cell cycle, cancer, IKK Abbreviations : NFκB, nuclear factor κ B; PLK4, Polo-like kinase 4; Iκ B, inhibitor of NF κB; TLR, toll-like   recep  tor;  IKK, Iκ B kinase; NEMO, NF κB essential modifier; CDK2, cyclin-dependent kinase; Skp2, S-phase kinase-associ- ated protein 2; SAS6, spindle assembly 6 homolog; siRNA, short interfering RNA; FACs, fluorescence-activated cell  sorting; MEFs, mouse embryonic fibroblasts; PCR, polymerase chain reaction; ChIP, chromatin immunoprecipita- tion; DMEM, Dulbecco modified Eagle medium; FBS, fetal bovine serum; PBS, phosphate buffered saline Activation of the NF κB signaling pathway allows the cell to respond to infection and stress and can affect many cel - lular processes.",Non-OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Cell 2008; 132:344-62; PMID:18267068 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Mol Cell Biol 2005; 25:10136-47; PMID:16260626 ; http://dx.doi.org/10.1128/ MCB.25.22.10136-10147.2005 5.,Non-OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
EMBO J 2006; 25:3801-12; PMID:16902410 ;  http://dx.doi.org/10.1038/sj.emboj.7601259 6.,Non-OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
EMBO J 2006; 25:4820-32;  PMID:16990795 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
EMBO J 2007; 26:4841-55; PMID:17962807 ;  http://dx.doi.org/10.1038/sj.emboj.7601899 8.,Non-OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Mol Cell 2010; 38:524-38; PMID:20513428 ;  http://dx.doi.org/10.1016/j.molcel.2010.03.018 11.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Cell Cycle 2006; 5:2371-80;  PMID:17102620 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Proc Natl Acad Sci U S A 2007; 104:16940-5;  PMID:17939994 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Cell Cycle 2006; 5:853-64;  PMID:16627997 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Nat Cell Biol 2005; 7:1140-6; PMID:16244668 ;  http://dx.doi.org/10.1038/ncb1320 16.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Curr Biol 2005; 15:2199-207; PMID:16326102 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Science 2007; 316:1046-50;  PMID:17463247 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Hepatology 2013; 57:2004-13; PMID:23300120 ; http://dx.doi.org/10.1002/ hep.26233 19.,Non-OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Nat Commun 2013; 4:1775;  PMID:23653187 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Neoplasia 2005; 7:312-23; PMID :15967108 ; http://dx.doi.org/10.1593/ neo.04325 21.,Non-OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Oncogene 2005; 24:306-12;  PMID:15640847 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
PLoS Genet 2011; 7:e1001285;  PMID:21298084 ; http://dx.doi.org/10.1371/jour- nal.pgen.1001285 24.,Non-OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Nat Rev Mol Cell Biol 2007; 8:451-63; PMID:17505520 ; http://dx.doi.org/10.1038/ nrm2180 25.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
J Biol Chem 2003; 278:51786-95; PMID:14523000 ;  http://dx.doi.org/10.1074/jbc.M306275200 26.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Cell 2011; 147:853-67;  PMID:22078882 ;  http://dx.doi.org/10.1016/j.cell.2011.10.022 27.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Cell Cycle 2010; 9:4200-12; PMID:20962589 ; http://dx.doi.org/10.4161/ cc.9.20.13532 29.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Clin Cancer Res 2011; 17:4285-95;  PMID:21610149 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
Nucleic Acids Res 2001; 29:e45; PMID:11328886 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/dd/cc-12-3052.PMC3875679.pdf
"As expected,  *Correspondence to: Olga V Leontieva; Email: olga.leontieva@roswellpark.org ; Mikhail V Blagosklonny; Email: mikhail.blagosklonny@roswellpark.org Submitted: 06/01/2013; Revised: 08/08/2013; Accepted: 08/09/2013 http://dx.doi.org/10.4161/cc.26130CDK4/6-inhibiting drug substitutes  for p21 and p16 in senescence Duration of cell cycle arrest and MTOR  activity determine geroconversion olga V Leontieva and Mikhail V Blagosklonny Department of Cell Stress Biology; Roswell p ark Cancer Institute; e lm & Carlton Streets; Buffalo, NY USA Keywords:  aging, cancer, rapalogs, CDKN1A, CDKN2A CDKN1A (p21) and CDKN2A (p16) inhibit CDK4/6, initiating senescence.",Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle 2008; 7:3355- 61; PMID:18948731 ; http://dx.doi.org/10.4161/ cc.7.21.6919 3.,Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle 2009;  8:1888-95;  PMID:19471117 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Proc Natl Acad Sci U S A  2010; 107:9660-4;  PMID:20457898 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Proc Natl Acad Sci U S A 2012; 109:13314-8;  PMID:22847439 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Death Differ  2013; 20:1241-9;  PMID:23852369 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Oncogene 1999; 18:4808-18;  PMID:10490814 ;  http://dx.doi.org/10.1038/sj.onc.1203078 9.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Oncogene 2000; 19:2165-70; PMID:10815808 ;  http://dx.doi.org/10.1038/sj.onc.1203573 10.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Proc Natl Acad Sci U S A 2002; 99:389- 94; PMID:11752408 ; http://dx.doi.org/10.1073/ pnas.012602599 11.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
J  Med Chem 2005; 48:2388-406; PMID :15801831 ;  http://dx.doi.org/10.1021/jm049354h12.,Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle 2012;  11:3599-610;  PMID:22935696 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
PLoS One 2011; 6:e26126;  PMID:22022534 ; http://dx.doi.org/10.1371/jour - nal.pone.0026126 14.,Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Nat Rev Cancer 2006; 6:729-34; PMID:16915295 ; http://dx.doi.org/10.1038/nrc1974,Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle 2012; 11:594-603; PMID:22262166 ; http://dx.doi.org/10.4161/ cc.11.3.19096 20.,Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Nat Rev Mol Cell Biol 2011; 12:21-35; PMID :21157483 ; http://dx.doi.org/10.1038/ nrm3025 21.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle 2012; 11:3159-65; PMID:22895181 ;  http://dx.doi.org/10.4161/cc.21194 23.,Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Curr Opin Genet Dev  2013; 23:53-62;  PMID:23317514 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell 1997; 88:593-602; PMID:9054499 ;  http://dx.doi.org/10.1016/S0092-8674(00)81902-9 27.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle 2005; 4:1364-8;  PMID:16177573 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Nature 2011; 479:232-6;  PMID:22048312 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle 2012; 11:2231- 2; PMID:22714590 ; http://dx.doi.org/10.4161/ cc.21065 32.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle 2012; 11:2391-401;  PMID:22627671 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Sci Transl Med 2011; 3:89ra58; PMID :21715679 ;  http://dx.doi.org/10.1126/scitranslmed.3002346 36.,Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Am J Pathol  2012; 181:278-93;  PMID:22698676 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle 2011; 10:2450- 3; PMID:21720215 ; http://dx.doi.org/10.4161/ cc.10.15.16886 39.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Stem Cell 2009; 5:279-89;  PMID:19733540 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Stem Cell 2012; 11:401- 14; PMID:22958932 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Science  2009; 326:140-4;  PMID:19797661 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
J Gerontol A Biol Sci Med Sci  2011; 66:191-201;  PMID:20974732 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle 2011; 10:4230-6;  PMID:22107964 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Aging Cell 2012; 11:675-82; PMID:22587563 ;  http://dx.doi.org/10.1111/j.1474-9726.2012.00832.x 50.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle 2012; 11:17- 8; PMID:22186783 ; http://dx.doi.org/10.4161/ cc.11.1.18736 54.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Aging Cell 2013; PMID:23734717 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Death Dis 2013; 4:e472;  PMID:23348586 ; http://dx.doi.org/10.1038/ cddis.2012.202 60.,Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle  2012; 11:2092-9;  PMID:22580468 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle 2012; 11:4296- 7; PMID :23152185 ; http://dx.doi.org/10.4161/ cc.22868 64.,Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell 2013; 152:340- 51; PMID:23332765 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle 2011; 10:2497- 503; PMID:21775818 ; http://dx.doi.org/10.4161/ cc.10.15.16776 67.,Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Nature 2005;  436:642;  PMID:16079833 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Nature 2005; 436:720-4; PMID:16079850 ;  http://dx.doi.org/10.1038/nature03890 70.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cancer Res 2012; 72:165-75;  PMID:22080569 ; http://dx.doi.org/10.1158/0008- 5472.CAN-11-255271.,Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle 2012;  11:3599-610;  PMID:22935696 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Nat Cell Biol 2007; 9:493- 505; PMID:17450133 ; http://dx.doi.org/10.1038/ ncb1567 74.,OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
Cell Cycle 2011; 10:457- 68; PMID:21248468 ; http://dx.doi.org/10.4161/ cc.10.3.14707,Non-OADS,/arxiv_data1/oa_pdf/5f/6e/cc-12-3063.PMC3875680.pdf
"11-14 Consequently, loss of CHD4 or  *Correspondence to: Haico van Attikum; Email: h.van.attikum@lumc.nl Submitted: 07/29/2013; Accepted: 08/02/2013http://dx.doi.org/10.4161/cc.26033Remodeling and spacing factor 1 (RSF1) deposits  centromere proteins at DNA double-strand breaks  to promote non-homologous end-joining Angela Helfricht1, Wouter W Wiegant1, peter e t hijssen1,2, Alfred C Vertegaal3, Martijn S Luijsterburg1, and Haico van Attikum1,* 1Department of t oxicogenetics; Leiden University Medical Center; Leiden, t he Netherlands; 2Department of Human Genetics; Leiden University  Medical Center; Leiden, t he Netherlands; 3Department of Molecular Cell Biology; Leiden University Medical Center; Leiden, t he Netherlands Keywords:  RSF1, SMARCA5/SNF2H, chromatin remodeling, centromere pro  teins,  DNA double-strand break repair, non-homologous end-joining the cellular response to ionizing radiation (IR)-induced DNA double-strand breaks (DSBs) in native chromatin requires  a tight coordination between the activities of DNA repair machineries and factors that modulate chromatin structure.",Non-OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
"All primer pairs were designed using Primer3Plus software (http://primer3plus.com), tested for efficiency, and are listed in Table S1 .",OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Nature 2009; 461:1071- 8; PMID:19847258 ; http://dx.doi.org/10.1038/ nature08467 2.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Mol Cell 2010;  40:179-204;  PMID:20965415 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Mol Cell 2012; 47:497-510; PMID:22920291 ;  http://dx.doi.org/10.1016/j.molcel.2012.07.029 4.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Annu Rev Biochem 2013; 82:55-80; PMID:23414304 ; http://dx.doi.org/10.1146/ annurev-biochem-061809-174504 5.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Cell 2009; 136:435-46;  PMID:19203579 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Cell 2007; 131:901-14; PMID:18001825 ;  http://dx.doi.org/10.1016/j.cell.2007.09.041 8.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Cell 2007; 131:887- 900;  PMID:18001824 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Cell 2009; 136:420-34;  PMID:19203578 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Proc Natl Acad Sci U S A 2007; 104:20759-63; PMID:18077395 ; http://dx.doi.org/10.1073/ pnas.0710061104 11.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
J Cell Biol 2010; 190:731- 40; PMID:20805324 ; http://dx.doi.org/10.1083/ jcb.200912135 12.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
EMBO J 2012; 31:2511-27;  PMID:22531782 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
J Cell Sci 2013; 126:889-903; PMID:23264744 ;  http://dx.doi.org/10.1242/jcs.109413 14.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
J Cell Biol 2010; 190:741- 9; PMID:20805320 ; http://dx.doi.org/10.1083/ jcb.201001048 15.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Mol Cell 2011; 41:515-28; PMID:21362548 ;  http://dx.doi.org/10.1016/j.molcel.2011.02.002 17.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
EMBO J 2010; 29:3130-9; PMID:20693977 ;  http://dx.doi.org/10.1038/emboj.2010.188 18.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Trends Mol Med 2007; 13:373-80;  PMID:17822959 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Nucleic  Acids Res 2011; 39:8445-56; PMID:21745822 ;  http://dx.doi.org/10.1093/nar/gkr435 20.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
J Biol Chem 2010;  285:38260-9;  PMID:20923775 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
J Cell Sci  2007; 120:2731-40;  PMID:17646676 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Cell 2010; 141:970- 81; PMID:20550933 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
J Cell Biol 2009; 185:397-407; PMID:19398759 ; http://dx.doi.org/10.1083/ jcb.200903088 24.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Methods Enzymol  2006; 409:524-40;  PMID:16793422 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Proc Natl Acad Sci U S A 2009; 106:15762- 7; PMID:19717431 ; http://dx.doi.org/10.1073/ pnas.0908233106 27.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Mol Cell  2010; 37:879-86;  PMID:20347429 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Mol Cell 2010; 37:865-78;  PMID:20347428 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
EMBO J 2012; 31:2511-27;  PMID:22531782 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
J Cell Biol 2012;  197:267-81;  PMID:22492724 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Science 2008; 320:1507-10;  PMID:18483401 ;  http://dx.doi.org/10.1126/science.1159051 33.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Nature 2011; 474:230- 4; PMID:21654808 ; http://dx.doi.org/10.1038/ nature10155 34.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
J Cell Biol 2009; 186:173- 82; PMID:19620631 ; http://dx.doi.org/10.1083/ jcb.200903100 37.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Nat Cell Biol  2006; 8:458-69;  PMID:16622419 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Proc Natl Acad Sci U S A 2005; 102:14004- 9; PMID:16172393 ; http://dx.doi.org/10.1073/ pnas.0504195102 39.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Mol Oncol 2011; 5:387- 93; PMID:21821475 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Hum Mol Genet 2004; 13:2369-76;  PMID:15333585 ; http://dx.doi.org/10.1093/hmg/ ddh27441.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Nucleic Acids Res  2013; 41:2950-62;  PMID:23358825 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Nature 2007; 450:509- 14; PMID:17965729 ; http://dx.doi.org/10.1038/ nature06337 43.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Nature 2012; 489:581-4; PMID:22960744 ; http://dx.doi.org/10.1038/ nature11353 44.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Cell Death Differ  2013; 20:490-502;  PMID:23197296 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Nat Struct Mol Biol  2011; 18:1345-50;  PMID:22120668 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
J Cell Biol 2012;  197:267-81;  PMID:22492724 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
Genes Dev 1999; 13:2633-8;  PMID:10541549 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/de/cc-12-3070.PMC3875681.pdf
"3-5) Review http://dx.doi.org/10.4070/kcj.2013.43.12.785 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Primary Carnitine Deficiency and Cardiomyopathy Lijun Fu, MD, Meirong Huang, MD, and Shubao Chen, MD Department of Cardiology, Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China Carnitine is essential for the transfer of long-chain fatty acids from the cytosol into mitochondria for subsequent β-oxidation.",Non-OADS,/arxiv_data1/oa_pdf/5b/6f/kcj-43-785.PMC3875693.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.In this review article, an overview of the clinical characteristics, di - agnosis, treatment, and long-term outcome of PCD is provided with  an emphasis on cardiac involvement.",Non-OADS,/arxiv_data1/oa_pdf/5b/6f/kcj-43-785.PMC3875693.pdf
"786 Primary Carnitine Deficiency and Cardiomyopathy http://dx.doi.org/10.4070/kcj.2013.43.12.785 www.e-kcj.org Clinical Carnitine Deficiency Syndrome Two distinct carnitine deficiency states have been reported, which  include “primary” and “secondary” carnitine deficiency.8) Primary carnitine deficiency (OMIM 212140), also known as carni- tine uptake defect, carnitine transporter deficiency or systemic car - nitine deficiency, is an autosomal recessive disorder of the carnitine  cycle that results in defective fatty acid oxidation.",Non-OADS,/arxiv_data1/oa_pdf/5b/6f/kcj-43-785.PMC3875693.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.12.785 www.e-kcj.org etary insufficiency (chronic TPN, malabsorption, soybean based in- fant formula), and drug therapy such as valproate acid and piva-mpicillin.",Non-OADS,/arxiv_data1/oa_pdf/5b/6f/kcj-43-785.PMC3875693.pdf
788 Primary Carnitine Deficiency and Cardiomyopathy http://dx.doi.org/10.4070/kcj.2013.43.12.785 www.e-kcj.org He noted a bizarre T-wave enlargement (60 to 80 mm) similar to  that seen in extensive posterior-wall ischemia as well as hyperka-lemia in the mid-precordial leads.,Non-OADS,/arxiv_data1/oa_pdf/5b/6f/kcj-43-785.PMC3875693.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.12.785 www.e-kcj.org A genetic epidemiological study in Japan showed that the preva - lence of heterozygotes for SLC22A5 mutations was 1.01%, and the  echocardiography analysis revealed that they were predisposed to late onset benign cardiac hypertrophy (odds ratio 15.1, 95% CI 1.39-164) compared with wild-types.",OADS,/arxiv_data1/oa_pdf/5b/6f/kcj-43-785.PMC3875693.pdf
"790 Primary Carnitine Deficiency and Cardiomyopathy http://dx.doi.org/10.4070/kcj.2013.43.12.785 www.e-kcj.org tients; within a few months of therapy, there was a reduction of  heart size toward normal.",Non-OADS,/arxiv_data1/oa_pdf/5b/6f/kcj-43-785.PMC3875693.pdf
http://dx.doi.org/10.4070/kcj.2013.43.12.785 www.e-kcj.org 118:1519-31.,Non-OADS,/arxiv_data1/oa_pdf/5b/6f/kcj-43-785.PMC3875693.pdf
792 Primary Carnitine Deficiency and Cardiomyopathy http://dx.doi.org/10.4070/kcj.2013.43.12.785 www.e-kcj.org nitine deficiency: heterozygote and intrafamilial phenotypic variation.,Non-OADS,/arxiv_data1/oa_pdf/5b/6f/kcj-43-785.PMC3875693.pdf
"9) These  findings were confirmed again by Pak et al.10) Idiopathic VAs from  the PM are uncommon and rare in a sustained form.4) They are not re- producibly induced by programmed stimulation and sensitive to Editorial http://dx.doi.org/10.4070/kcj.2013.43.12.793 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Papillary Muscle Ventricular Tachycardia:  Another Zigsaw Puzzle to Be Solved Dong-Gu Shin, MD Cardiovascular Division, Department of Internal Medicine, Yeungnam University Hospital, Daegu, Korea Correspondence: Dong-Gu Shin, MD, Cardiovascular Division, Department  of Internal Medicine, Yeungnam University Hospital, 170 Hyeonchung-ro, Nam-gu, Daegu 705-717, KoreaTel: 82-53-620-3843, Fax: 82-53-654-8386E-mail: dgshin@med.yu.ac.kr • The author has no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/31/ba/kcj-43-793.PMC3875694.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.catecholamines, which suggest triggered activity or abnormal au- tomaticity as its mechanism.",Non-OADS,/arxiv_data1/oa_pdf/31/ba/kcj-43-793.PMC3875694.pdf
794 Papillary Muscle Ventricular Tachycardia http://dx.doi.org/10.4070/kcj.2013.43.12.793  www.e-kcj.orgfractionated potentials at the ablation site experienced VAs recur- rence.,Non-OADS,/arxiv_data1/oa_pdf/31/ba/kcj-43-793.PMC3875694.pdf
795 Dong-Gu Shin http://dx.doi.org/10.4070/kcj.2013.43.12.793  www.e-kcj.orgbrillation in isolated swine right ventricle.,Non-OADS,/arxiv_data1/oa_pdf/31/ba/kcj-43-793.PMC3875694.pdf
"796 Copyright © 2013 The Korean Society of CardiologyKorean Circulation Journal Introduction  Atherosclerosis is not merely a passive accumulation of lipids  within artery walls, but a multifactorial, multistep inflammatory dis -Original Article http://dx.doi.org/10.4070/kcj.2013.43.12.796 Print ISSN 1738-5520 • On-line ISSN 1738-5555 The Impacts of C-Reactive Protein and Atrial Fibrillation  on Carotid Atherosclerosis and Ischemic Stroke in Patients  with Suspected Ischemic Cerebrovascular Disease:  A Single-Center Retrospective Observational Cohort Study So Young Ock, MD*, Kyoung Im Cho, MD*, Hyung Joon Kim, MD, Nae Young Lee, RN,  Eun Jeong Kim, MD, Nam Kyu Kim, MD, Weon Hyoung Lee, MD, Go Eun Yeo, MD,  Jae Joon Heo, MD, You Jin Han, MD, and Tae-Joon Cha, MD Division of Cardiology, Department of Internal Medicine, Cardiovascular Research Institute, Kosin University College of Medicine, Busan, Korea Background and Objectives: Carotid intima-media thickness (IMT) is associated with chronic inflammation, and C-reactive protein (CRP)  level is elevated in patients with atrial fibrillation (AF).",Non-OADS,/arxiv_data1/oa_pdf/e6/df/kcj-43-796.PMC3875695.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ease that involves chronic inflammation at every stage, from initi- ation to plaque rupture.1)2) Various cytokines, growth factors, and in - flammatory cells are abundant in atheromatous plaques.3)4) C-reac- tive protein (CRP), interleukin-6, and homocysteine are inflammation-",Non-OADS,/arxiv_data1/oa_pdf/e6/df/kcj-43-796.PMC3875695.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.12.796 www.e-kcj.org sensitive proteins that have been studied in relation to cardiovascular  disease risk.5) Among these, CRP is the most sensitive as a cardio- vascular risk factor using Framingham risk scoring and is also easy and cost-effective to measure.",Non-OADS,/arxiv_data1/oa_pdf/e6/df/kcj-43-796.PMC3875695.pdf
798 C-Reactive Protein and Atrial Fibrillation http://dx.doi.org/10.4070/kcj.2013.43.12.796 www.e-kcj.org tracking system.,OADS,/arxiv_data1/oa_pdf/e6/df/kcj-43-796.PMC3875695.pdf
http://dx.doi.org/10.4070/kcj.2013.43.12.796 www.e-kcj.org patients with a sinus rhythm were placed on 24-48 hour Holter  monitoring to monitor for paroxysmal AF.,Non-OADS,/arxiv_data1/oa_pdf/e6/df/kcj-43-796.PMC3875695.pdf
800 C-Reactive Protein and Atrial Fibrillation http://dx.doi.org/10.4070/kcj.2013.43.12.796 www.e-kcj.org ing to age and CRP level among various cardiovascular risk factors  (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/e6/df/kcj-43-796.PMC3875695.pdf
http://dx.doi.org/10.4070/kcj.2013.43.12.796 www.e-kcj.org with elevated CRP.,Non-OADS,/arxiv_data1/oa_pdf/e6/df/kcj-43-796.PMC3875695.pdf
802 C-Reactive Protein and Atrial Fibrillation http://dx.doi.org/10.4070/kcj.2013.43.12.796 www.e-kcj.org epidemiological selection bias was excluded.,Non-OADS,/arxiv_data1/oa_pdf/e6/df/kcj-43-796.PMC3875695.pdf
http://dx.doi.org/10.4070/kcj.2013.43.12.796 www.e-kcj.org risk factor for atrial fibrillation.,Non-OADS,/arxiv_data1/oa_pdf/e6/df/kcj-43-796.PMC3875695.pdf
"804 Copyright © 2013 The Korean Society of CardiologyKorean Circulation Journal Introduction Hypertension frequently occurs among pediatric patients who  have received allogeneic hematopoietic stem cell transplantation Original Article http://dx.doi.org/10.4070/kcj.2013.43.12.804 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Incidence and Risk Factors for Early-Onset Hypertension  after Allogeneic Hematopoietic Stem Cell Transplantation in Children Dae Hyun Kwon, MD, Seungwon Jung, MD, Eun-Jung Lee, MD, Jae Young Lee, MD, Sena Moon, MD,  Jae Wook Lee, MD, Nack Gyun Chung, MD, Bin Cho, MD, and Hack Ki Kim, MD Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea Background and Objectives: Survivors of pediatric hematopoietic stem cell transplantation (HSCT) are at risk for developing hyperten- sion.",Non-OADS,/arxiv_data1/oa_pdf/bc/e2/kcj-43-804.PMC3875696.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.(HSCT).",Non-OADS,/arxiv_data1/oa_pdf/bc/e2/kcj-43-804.PMC3875696.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.12.804 www.e-kcj.org suppressants may lead to late-onset hypertension, little is known  about the risk factors for hypertension during the early post-trans - plantation period, which includes the time period from actual trans - plant to full hematopoietic engraftment.11)12) Numerous post-trans - plant complications, such as acute graft-versus-host disease (GVHD) and sinusoidal obstruction syndrome (SOS), occur during this peri-od, and an understanding of the risk factors for hypertension may help to predict and lower other early transplant-related morbidities and mortality.",Non-OADS,/arxiv_data1/oa_pdf/bc/e2/kcj-43-804.PMC3875696.pdf
"806 Hypertension after Hematopoietic Stem Cell Transplantation http://dx.doi.org/10.4070/kcj.2013.43.12.804 www.e-kcj.org nificantly associated with hypertension in our univariate analyses:  age, antecedent acute GVHD, treatment with amphotericin B, diag - nosis of SOS, and changes in serum Cr from baseline to day 14, and from baseline to day 21 after transplant.",Non-OADS,/arxiv_data1/oa_pdf/bc/e2/kcj-43-804.PMC3875696.pdf
http://dx.doi.org/10.4070/kcj.2013.43.12.804 www.e-kcj.org (ANOVA).,OADS,/arxiv_data1/oa_pdf/bc/e2/kcj-43-804.PMC3875696.pdf
808 Hypertension after Hematopoietic Stem Cell Transplantation http://dx.doi.org/10.4070/kcj.2013.43.12.804 www.e-kcj.org HSCT was higher than expected.,Non-OADS,/arxiv_data1/oa_pdf/bc/e2/kcj-43-804.PMC3875696.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.12.804 www.e-kcj.org hypertension was defined as average systolic and/or diastolic  blood pressure ≥95th percentile for sex, age, and height, on at  least three separate occasions.13) Other factors, such as the “white coat” hypertension effect, post- transplant stress, or fever, may have influenced patients’ blood pres-sure and lead to instances of transient hypertension, thereby in-creasing the prevalence of hypertension in our study population.",Non-OADS,/arxiv_data1/oa_pdf/bc/e2/kcj-43-804.PMC3875696.pdf
810 Hypertension after Hematopoietic Stem Cell Transplantation http://dx.doi.org/10.4070/kcj.2013.43.12.804 www.e-kcj.org subsequent cardiovascular disease.,Non-OADS,/arxiv_data1/oa_pdf/bc/e2/kcj-43-804.PMC3875696.pdf
"811 Copyright © 2013 The Korean Society of CardiologyKorean Circulation Journal Introduction The papillary muscle (PM) has been implicated as a potential site Original Article http://dx.doi.org/10.4070/kcj.2013.43.12.811 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Electrophysiological Characteristics Related to Outcome  after Catheter Ablation of Idiopathic Ventricular Arrhythmia  Originating from the Papillary Muscle in the Left Ventricle Ji-Eun Ban, MD1, Hyun-Soo Lee, MPH1, Dae-In Lee, MD1, Hwan-Cheol Park, MD2, Jae-Seok Park, MD1,   Yasutsugu Nagamoto, MD1, Jong-Il Choi, MD1, Hong-Euy Lim, MD1, Sang-Weon Park, MD1, and Young-Hoon Kim, MD1 1Division of Cardiology, Department of Internal Medicine, Korea University Medical Center, Seoul, Korea   2Division of Cardiology, Department of Internal Medicine, Hanyang University Guri Hospital, Guri, Korea Background and Objectives: The electrophysiological properties associated with favorable outcome of radiofrequency catheter ablation  (RFCA) for idiopathic ventricular arrhythmia (VA) originating from the papillary muscle (PM) remain unclear.",Non-OADS,/arxiv_data1/oa_pdf/21/96/kcj-43-811.PMC3875697.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.of arrhythmogenesis that may contribute to ventricular tachycar- dia (VT) or fibrillation in animal models1-3) and as an arrhythmogen - ic focus or part of the reentrant circuit of VT in patients with prior myocardial infarction.",Non-OADS,/arxiv_data1/oa_pdf/21/96/kcj-43-811.PMC3875697.pdf
812 VAs Originating from the Papillary Muscle  http://dx.doi.org/10.4070/kcj.2013.43.12.811 www.e-kcj.org Subjects and Methods Study population A total of 284 consecutive patients (153 females and 131 males;  mean age 44 ±14 years) with idiopathic VA underwent RFCA at our  institution between January 2006 and June 2012.,Non-OADS,/arxiv_data1/oa_pdf/21/96/kcj-43-811.PMC3875697.pdf
http://dx.doi.org/10.4070/kcj.2013.43.12.811 www.e-kcj.org ued if RFCA was acutely successful.,Non-OADS,/arxiv_data1/oa_pdf/21/96/kcj-43-811.PMC3875697.pdf
"814 VAs Originating from the Papillary Muscle  http://dx.doi.org/10.4070/kcj.2013.43.12.811 www.e-kcj.org During the 12 ±9 months of follow-up (range, 3-23 months), eight  patients remained VA-free, while the remaining four patients experi - enced VA recurrence (33.3% recurrence rate) that occurred at a mean of 50 ±43 days after the first ablation procedure.",Non-OADS,/arxiv_data1/oa_pdf/21/96/kcj-43-811.PMC3875697.pdf
http://dx.doi.org/10.4070/kcj.2013.43.12.811 www.e-kcj.org peat ablation.,Non-OADS,/arxiv_data1/oa_pdf/21/96/kcj-43-811.PMC3875697.pdf
"816 VAs Originating from the Papillary Muscle  http://dx.doi.org/10.4070/kcj.2013.43.12.811 www.e-kcj.org demonstrated in several previous studies.14-16) Recently, Doppalapudi  et al.7) reported that, in VAs originating from PM, no high-frequency  Purkinje potential were identified at effective ablation sites, sug- gesting that the Purkinje system is not directly involved.",Non-OADS,/arxiv_data1/oa_pdf/21/96/kcj-43-811.PMC3875697.pdf
http://dx.doi.org/10.4070/kcj.2013.43.12.811 www.e-kcj.org of a wavefront from the arrhythmogenic myocardial tissue.,Non-OADS,/arxiv_data1/oa_pdf/21/96/kcj-43-811.PMC3875697.pdf
818 VAs Originating from the Papillary Muscle  http://dx.doi.org/10.4070/kcj.2013.43.12.811 www.e-kcj.org tachycardia.,Non-OADS,/arxiv_data1/oa_pdf/21/96/kcj-43-811.PMC3875697.pdf
1-3) According to the Framingham Heart Original Article http://dx.doi.org/10.4070/kcj.2013.43.12.819 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Do Different Arterial Stiffness Parameters Provide Similar Information in High-Risk Patients for Coronary Artery Disease?,Non-OADS,/arxiv_data1/oa_pdf/f3/f6/kcj-43-819.PMC3875698.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Study, systolic blood pressure (SBP) is positively associated with  coronary heart disease, whereas diastolic blood pressure (DBP) has a negative relationship.",Non-OADS,/arxiv_data1/oa_pdf/f3/f6/kcj-43-819.PMC3875698.pdf
"820 Comparison of Arterial Stiffness Parameters in CAD http://dx.doi.org/10.4070/kcj.2013.43.12.819 www.e-kcj.org risk factors that correlate with cardiovascular disease, others have  demonstrated no such relationship.",Non-OADS,/arxiv_data1/oa_pdf/f3/f6/kcj-43-819.PMC3875698.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.12.819 www.e-kcj.org Results Clinical characteristics of subject groups Out of a total of 965 patients, 468 (48.5%) were diagnosed with  coronary heart disease (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/f3/f6/kcj-43-819.PMC3875698.pdf
"822 Comparison of Arterial Stiffness Parameters in CAD http://dx.doi.org/10.4070/kcj.2013.43.12.819 www.e-kcj.org disease: 16.2 ±3.3 m/sec; 2-vessel disease: 16.8 ±3.4 m/sec; 3-ves- sel disease: 17.3 ±4.0 m/sec, p<0.001).",Non-OADS,/arxiv_data1/oa_pdf/f3/f6/kcj-43-819.PMC3875698.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.12.819 www.e-kcj.org stiffness, and a number of related studies have been performed.",Non-OADS,/arxiv_data1/oa_pdf/f3/f6/kcj-43-819.PMC3875698.pdf
824 Comparison of Arterial Stiffness Parameters in CAD http://dx.doi.org/10.4070/kcj.2013.43.12.819 www.e-kcj.org 5.,Non-OADS,/arxiv_data1/oa_pdf/f3/f6/kcj-43-819.PMC3875698.pdf
"825 Copyright © 2013 The Korean Society of CardiologyKorean Circulation Journal Introduction Cardiopulmonary bypass with subsequent chemical changes is  caused by electrophysiological changes in the ventricle.1-3) Correc- tion of congenital heart disease, due to hemodynamic changes, can  cause changes in the electrocardiogram (ECG).4-7) ECG changes af-Original Article http://dx.doi.org/10.4070/kcj.2013.43.12.825 Print ISSN 1738-5520 • On-line ISSN 1738-5555 QTc Prolongation after Ventricular Septal Defect Repair in Infants Chang Woo Han, MD1, Saet Byul Woo, MD1, Jae Young Choi, MD1, Jo Won Jung, MD1,   Yong Hwan Park, MD2, Han Ki Park, MD2, Hong Ju Shin, MD2, and Nam Kyun Kim, MD1 1Division of Pediatric Cardiology, Department of Pediatrics, 2Division of Cardiovascular Surgery, Congenital Heart Disease Center, Severance Cardiovascular Hospital,   Yonsei University College of Medicine, Seoul, Korea Background and Objectives: Prolonging of the corrected QT interval (QTc) has been reported after cardiac surgery in some studies.",Non-OADS,/arxiv_data1/oa_pdf/bc/e7/kcj-43-825.PMC3875699.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ter the correction of congenital heart disease, especially changes in  the corrected QT interval (QTc) have not been sufficiently studied,7)  especially in patients who underwent ventricular septal defect (VSD) surgery at less than one year of age.",Non-OADS,/arxiv_data1/oa_pdf/bc/e7/kcj-43-825.PMC3875699.pdf
826 QTc Prolongation after Ventricular Septal Defect Repair in Infants http://dx.doi.org/10.4070/kcj.2013.43.12.825 www.e-kcj.org tained post-operation.,Non-OADS,/arxiv_data1/oa_pdf/bc/e7/kcj-43-825.PMC3875699.pdf
http://dx.doi.org/10.4070/kcj.2013.43.12.825 www.e-kcj.org Factors associated with QTc prolongation  The Aristotle score is a scoring system that predicts the relevance  of the difficulty of surgery and of the post-operative mortality and  morbidity.,Non-OADS,/arxiv_data1/oa_pdf/bc/e7/kcj-43-825.PMC3875699.pdf
"828 QTc Prolongation after Ventricular Septal Defect Repair in Infants http://dx.doi.org/10.4070/kcj.2013.43.12.825 www.e-kcj.org A unique aspect of our study is the homogeneity of the patient  population in terms of the patients’ ages, diseases and surgeries, as  well as the fact that this study analyzed the QTc changes after sur-gery and studied their relationship to other factors.",Non-OADS,/arxiv_data1/oa_pdf/bc/e7/kcj-43-825.PMC3875699.pdf
http://dx.doi.org/10.4070/kcj.2013.43.12.825 www.e-kcj.org cant than the basic Aristotle score.,Non-OADS,/arxiv_data1/oa_pdf/bc/e7/kcj-43-825.PMC3875699.pdf
"Case A 15-year-old female with a prior history of aborted cardiac death Case Report http://dx.doi.org/10.4070/kcj.2013.43.12.830 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Repeated Aborted Sudden Cardiac Death with Long QT Syndrome  in a Patient with Anomalous Origin of the Right Coronary Artery  from the Left Coronary Cusp Yae Min Park, MD1, Su Ji Kim, MD1, Chul-Hyun Park, MD2, Woong Chol Kang, MD1,   Mi-Seung Shin, MD1, Kwang Kon Koh, MD1, and In Suck Choi, MD1 1Cardiology Division, 2Thoracic and Cardiovascular Surgery Division, Gachon University Gil Hospital, Incheon, Korea A 15-year-old female with a prior history of aborted cardiac death and surgical correction of anomalous origin of the right coronary ar- tery (RCA) presented with polymorphic ventricular tachycardia.",Non-OADS,/arxiv_data1/oa_pdf/fc/6c/kcj-43-830.PMC3875700.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.and surgical correction of anomalous origin of the RCA was referr- ed to the cardiology department due to repeated aborted sudden cardiac death after physical exertion with boxing.",Non-OADS,/arxiv_data1/oa_pdf/fc/6c/kcj-43-830.PMC3875700.pdf
http://dx.doi.org/10.4070/kcj.2013.43.12.830 www.e-kcj.org diac arrest.,OADS,/arxiv_data1/oa_pdf/fc/6c/kcj-43-830.PMC3875700.pdf
"832 Sudden Cardiac Death Associated with LQTS and Coronary Anomaly http://dx.doi.org/10.4070/kcj.2013.43.12.830 www.e-kcj.org left sinus were found in approximately 0.92% in a recent prospec- tive study.3) Anomalous origin of the RCA from the left coronary  cusp which courses between the pulmonary artery and aorta can cause a malignant arrhythmia due to the potential for RCA ische-mia, particularly during exertion or stress.",Non-OADS,/arxiv_data1/oa_pdf/fc/6c/kcj-43-830.PMC3875700.pdf
http://dx.doi.org/10.4070/kcj.2013.43.12.830 www.e-kcj.org transient marked QT prolongation following successful emergent per - cutaneous coronary intervention for acute coronary syndrome.,Non-OADS,/arxiv_data1/oa_pdf/fc/6c/kcj-43-830.PMC3875700.pdf
"PE has been listed as stressors of stress-induced cardiomyopathy, 2)3) because the pain and Case Report http://dx.doi.org/10.4070/kcj.2013.43.12.834 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Inverted-Takotsubo Cardiomyopathy in a Patient  with Pulmonary Embolism Seung-Hyun Lee, MD, Dong-Hyun Kim, MD, Min-Suk Jung, MD, Jang-Won Lee, MD,  Kyung-Min Nam, MD, Young-Sun Cho, MD, and Joon-Hoon Jeong, MD Cardiology Division, Department of Internal Medicine, Wallace Memorial Baptist Hospital, Busan, Korea As the use of early coronary angiography and echocardiography become widely available in the setting of acute coronary syndrome, the  gradual increase for variant forms of transient left ventricular (LV) apical ballooning syndrome have been recognized.",Non-OADS,/arxiv_data1/oa_pdf/fd/68/kcj-43-834.PMC3875701.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.the decreased perfusion within the lung related to PE probably cause  a release of catecholamines.4)5) However, it is uncommon to present  reverse types of stress-induced cardiomyopathy in the setting of PE for our patient.",Non-OADS,/arxiv_data1/oa_pdf/fd/68/kcj-43-834.PMC3875701.pdf
http://dx.doi.org/10.4070/kcj.2013.43.12.834 www.e-kcj.org L) aroused suspicion of PE.,Non-OADS,/arxiv_data1/oa_pdf/fd/68/kcj-43-834.PMC3875701.pdf
836 Inverted-Takotsubo Cardiomyopathy http://dx.doi.org/10.4070/kcj.2013.43.12.834 www.e-kcj.org improvements in ejection fractions of 58% with no wall motion ab- normalities (Fig.,Non-OADS,/arxiv_data1/oa_pdf/fd/68/kcj-43-834.PMC3875701.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.12.834 www.e-kcj.org lated to PE seem to result in the development of LV wall motion  abnormalities.4)5) In this case, it is difficult to detect PE and reverse  takotsubo cardiomyopathy independently, due to the fact that both clinical features mimic acute coronary syndromes.",Non-OADS,/arxiv_data1/oa_pdf/fd/68/kcj-43-834.PMC3875701.pdf
838 Inverted-Takotsubo Cardiomyopathy http://dx.doi.org/10.4070/kcj.2013.43.12.834 www.e-kcj.org 9.,Non-OADS,/arxiv_data1/oa_pdf/fd/68/kcj-43-834.PMC3875701.pdf
"Case Report http://dx.doi.org/10.4070/kcj.2013.43.12.839 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Ventricular Fibrillation in a Patient with Tachycardia-Induced  Cardiomyopathy after Liver Transplantation Soo Yong Lee, MD, Jun Kim, MD, Sang Hyun Lee, MD, Jin Hee Choi, MD,  Yong Hyun Park, MD, June Hong Kim, MD, and Kook Jin Chun, MD Department of Cardiology, Pusan National University Yangsan Hospital, Yangsan, Korea We report a case of atrial fibrillation-related tachycardia induced cardiomyopathy and ventricular fibrillation after liver transplantation in  a 41-year-old man with end-stage liver failure.",Non-OADS,/arxiv_data1/oa_pdf/a5/1b/kcj-43-839.PMC3875702.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case  A 41-year-old man with end-stage liver failure due to hepatitis B  virus-associated liver cirrhosis underwent orthotopic liver transplan- tation (OLT).",Non-OADS,/arxiv_data1/oa_pdf/a5/1b/kcj-43-839.PMC3875702.pdf
840 Ventricular Fibrillation in a Patient with Tachycardia-Induced Cardiomyopathy after Liver Transplantation http://dx.doi.org/10.4070/kcj.2013.43.12.839 www.e-kcj.org improved left ventricular ejection fraction of 42%.,Non-OADS,/arxiv_data1/oa_pdf/a5/1b/kcj-43-839.PMC3875702.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.12.839 www.e-kcj.org myopathy after liver transplantation were reported.8)9) Absence of  ST-segment change, elevation of cardiac enzymes, typical echocar- diographic findings excluded stress-induced cardiomyopathy as a cause of ventricular dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/a5/1b/kcj-43-839.PMC3875702.pdf
Supplementary Materials The online-only Data Supplement is available with this article at  http://dx.doi.org/10.4070/kcj.2013.43.12.839.,Non-OADS,/arxiv_data1/oa_pdf/a5/1b/kcj-43-839.PMC3875702.pdf
"2) Embolic complications  can occur after surgical interventions,3) but cases reported after pri- mary sutures are uncommon.4)5) Herein, we report two cases of large  right atrial thrombus developed in the late stage after repairs of ASDs which were treated surgically.Case Report http://dx.doi.org/10.4070/kcj.2013.43.12.842 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Large Thrombus Formation from Right Atrial Incision Site  after Closure of Atrial Septal Defect Olcay Murat Disli, MD1, Nevzat Erdil, MD1, Barıs Akca, MD1, Yılmaz Omur Otlu, MD2, and Bektas Battaloglu, MD1 1Departments of Cardiovascular Surgery and 2Cardiology, Inonu University Faculty of Medicine, Malatya, Turkey Atrial septal defect (ASD) is the common congenital anomaly which requires surgical interventions.",Non-OADS,/arxiv_data1/oa_pdf/cc/5d/kcj-43-842.PMC3875703.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cases Case 1 A 24-year-old female patient with a history of primary repair for  ASD performed 8 years ago admitted to our clinic for her annual ch- eckups.",Non-OADS,/arxiv_data1/oa_pdf/cc/5d/kcj-43-842.PMC3875703.pdf
http://dx.doi.org/10.4070/kcj.2013.43.12.842 www.e-kcj.org and the right femoral vein.,Non-OADS,/arxiv_data1/oa_pdf/cc/5d/kcj-43-842.PMC3875703.pdf
"844 Thrombus Formation in Right Atrium after Atrial Septal Defect Operation http://dx.doi.org/10.4070/kcj.2013.43.12.842 www.e-kcj.org devices,9) prosthetic patches10) and pericardial patches.11) However,  cases of embolization or intracardiac thrombus developed after pri - mary closure of ASD are less common.",Non-OADS,/arxiv_data1/oa_pdf/cc/5d/kcj-43-842.PMC3875703.pdf
"However, the diagnosis of congenital pericardial defect may be dif - ficult or delayed because of various diseases that present with ch-est pain.Case Report http://dx.doi.org/10.4070/kcj.2013.43.12.845 Print ISSN 1738-5520 • On-line ISSN 1738-5555 A Case of Partial Congenital Pericardial Defect Presenting  as Acute Coronary Syndrome Jae Hoon Chung, MD, Rak Kyeong Choi, MD, Sam Se Oh, MD,  Tae Sik Kim, MD, Suk Jin Lee, MD, and Dae Sung Ahn, MD Division of Internal Medicine, Sejong General Hospital, Bucheon, Korea Congenital pericardial defects are rare and asymptomatic for both partial and complete defects.",Non-OADS,/arxiv_data1/oa_pdf/95/81/kcj-43-845.PMC3875704.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.This case report summarizes our experience in the diagnosis and  treatment of a patient who had a congenital pericardial defect with  concomitant coronary artery disease.",Non-OADS,/arxiv_data1/oa_pdf/95/81/kcj-43-845.PMC3875704.pdf
846 Congenital Pericardial Defect http://dx.doi.org/10.4070/kcj.2013.43.12.845 www.e-kcj.org angiography without noninvasive testing.,Non-OADS,/arxiv_data1/oa_pdf/95/81/kcj-43-845.PMC3875704.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.12.845 www.e-kcj.org ering the presence of significant stenosis with heavy calcification  of the mid-LAD, which can cause ischemia.",Non-OADS,/arxiv_data1/oa_pdf/95/81/kcj-43-845.PMC3875704.pdf
848 Congenital Pericardial Defect http://dx.doi.org/10.4070/kcj.2013.43.12.845 www.e-kcj.org characteristic coronary angiographic findings such as the geograph - ically circumferential diastolic compression of the coronary arteries.,Non-OADS,/arxiv_data1/oa_pdf/95/81/kcj-43-845.PMC3875704.pdf
"6: 227-234, December, 2013http://dx.doi.org/10.4110/in.2013.13.6.227 pISSN 1598-2629    eISSN 2092-6685 227REVIEW ARTICLE Received on December 2, 2013.",Non-OADS,/arxiv_data1/oa_pdf/62/b0/in-13-227.PMC3875780.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/b0/in-13-227.PMC3875780.pdf
"6: 235-239, December, 2013http://dx.doi.org/10.4110/in.2013.13.6.235 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 235Received on November 20, 2013.",Non-OADS,/arxiv_data1/oa_pdf/e7/c8/in-13-235.PMC3875781.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/c8/in-13-235.PMC3875781.pdf
"6: 240-248, December, 2013http://dx.doi.org/10.4110/in.2013.13.6.240 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 240Received on November 15, 2013.",Non-OADS,/arxiv_data1/oa_pdf/85/e7/in-13-240.PMC3875782.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/e7/in-13-240.PMC3875782.pdf
"6: 249-256, December, 2013http://dx.doi.org/10.4110/in.2013.13.6.249 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 249Received on November 20, 2013.",Non-OADS,/arxiv_data1/oa_pdf/20/28/in-13-249.PMC3875783.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/28/in-13-249.PMC3875783.pdf
"6: 257-263, December, 2013http://dx.doi.org/10.4110/in.2013.13.6.257 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 257Received on October 1, 2013.",Non-OADS,/arxiv_data1/oa_pdf/f1/dd/in-13-257.PMC3875784.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/dd/in-13-257.PMC3875784.pdf
"6: 264-274, December, 2013http://dx.doi.org/10.4110/in.2013.13.6.264 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 264Received on September 23, 2013.",Non-OADS,/arxiv_data1/oa_pdf/1d/35/in-13-264.PMC3875785.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/35/in-13-264.PMC3875785.pdf
"6: 275-282, December, 2013http://dx.doi.org/10.4110/in.2013.13.6.275 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 275Received on December 3, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c7/d1/in-13-275.PMC3875786.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/d1/in-13-275.PMC3875786.pdf
"6: 283-288, December, 2013http://dx.doi.org/10.4110/in.2013.13.6.283 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 283Received on November 29, 2013.",Non-OADS,/arxiv_data1/oa_pdf/9b/ec/in-13-283.PMC3875787.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/ec/in-13-283.PMC3875787.pdf
"6: 289-294, December, 2013http://dx.doi.org/10.4110/in.2013.13.6.289 pISSN 1598-2629    eISSN 2092-6685 289Received on November 20, 2013.",OADS,/arxiv_data1/oa_pdf/b1/ab/in-13-289.PMC3875788.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/ab/in-13-289.PMC3875788.pdf
In press: http://doi.org/10.1016/j.neures.,OADS,/arxiv_data1/oa_pdf/b1/ab/in-13-289.PMC3875788.pdf
"6: 295-300, December, 2013http://dx.doi.org/10.4110/in.2013.13.6.295 pISSN 1598-2629    eISSN 2092-6685 295Received on August 12, 2013.",OADS,/arxiv_data1/oa_pdf/0a/f6/in-13-295.PMC3875789.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/f6/in-13-295.PMC3875789.pdf
"Review Article Corresponding author:  Jong Eun Lee  Department of Anatomy, Yonsei University College of Medicine, Brain  Korea 21 Project for Medical Science, Yonsei University, 50 Yonsei-ro,  Seodaemun-gu, Seoul 120-752, Korea  Tel: +82-2-2228-1646, 1659, Fax: +82-2-365-0700, E-mail: jelee@yuhs.ac This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/cb/89/acb-46-229.PMC3875839.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.4.229 pISSN 2093-3665   eISSN 2093-3673 Adiponectin as a new paradigm for  approaching Alzheimer’s disease Juhyun Song1, Jong Eun Lee1,2 1Department of Anatomy, Y onsei University College of Medicine, 2BK21 Plus Project for Medical Sciences, Y onsei University College of Medicine, Seoul,  Korea Abstract:  Adiponectin is an adipocytokine released by the adipose tissue and has multiple roles in the immune system and in  the metabolic syndromes such as cardiovascular disease, Type 2 diabetes, obesity and also in the neurodegenerative disorders  including Alzheimer’s disease.",Non-OADS,/arxiv_data1/oa_pdf/cb/89/acb-46-229.PMC3875839.pdf
"Anat Cell Biol 2013;46: 229-234 Juhyun Song and Jong Eun Lee 230 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.229vated protein kinase and Rab5 leads to increased glucose  transporter 4 membrane translocation [28, 29].",OADS,/arxiv_data1/oa_pdf/cb/89/acb-46-229.PMC3875839.pdf
The relationship between adiponectin and Alzheimer’s disease http://dx.doi.org/10.5115/acb.2013.46.4.229Anat Cell Biol 2013;46:229-234 231 www.acbjournal.orgThe Role of Adiponectin on Neuroinflam­ mation Adiponectin has a cardinal role in immune system in  CNS.,OADS,/arxiv_data1/oa_pdf/cb/89/acb-46-229.PMC3875839.pdf
"Anat Cell Biol 2013;46: 229-234 Juhyun Song and Jong Eun Lee 232 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.229Future Perspective Adiponectin associates with various disease inclu - ding diabetes, obesity, cardiovascular disease and neuro - degenerative diseases.",OADS,/arxiv_data1/oa_pdf/cb/89/acb-46-229.PMC3875839.pdf
The relationship between adiponectin and Alzheimer’s disease http://dx.doi.org/10.5115/acb.2013.46.4.229Anat Cell Biol 2013;46:229-234 233 www.acbjournal.orgLipidol 2003;14:561-6.,Non-OADS,/arxiv_data1/oa_pdf/cb/89/acb-46-229.PMC3875839.pdf
Anat Cell Biol 2013;46: 229-234 Juhyun Song and Jong Eun Lee 234 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.229Endocrinol Metab 2008;93:3165-72.,OADS,/arxiv_data1/oa_pdf/cb/89/acb-46-229.PMC3875839.pdf
"Box 300, Greece Tel: +30-2310999330, Fax: +30-2310999334, E-mail: g_paraskevas@ yahoo.gr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/cf/a8/acb-46-235.PMC3875840.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.4.235 pISSN 2093-3665   eISSN 2093-3673 Evolution of the paranasal sinuses’ anatomy  through the ages  Alexandra Mavrodi, George Paraskevas Department of Anatomy, Medical Faculty, Aristotle University of Thessaloniki, Thessaloniki, Greece Abstract:  Previously, anatomists considered paranasal sinuses as a mysterious region of the human skull.",Non-OADS,/arxiv_data1/oa_pdf/cf/a8/acb-46-235.PMC3875840.pdf
Anat Cell Biol 2013;46: 235-238 Alexandra Mavrodi and George Paraskevas 236 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.235sinuses.,Non-OADS,/arxiv_data1/oa_pdf/cf/a8/acb-46-235.PMC3875840.pdf
History of paranasal sinuses’ anatomy http://dx.doi.org/10.5115/acb.2013.46.4.235Anat Cell Biol 2013;46:235-238 237 www.acbjournal.orgthe sphenoid septum (Fig.,Non-OADS,/arxiv_data1/oa_pdf/cf/a8/acb-46-235.PMC3875840.pdf
Anat Cell Biol 2013;46: 235-238 Alexandra Mavrodi and George Paraskevas 238 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.235one of his female patients.,Non-OADS,/arxiv_data1/oa_pdf/cf/a8/acb-46-235.PMC3875840.pdf
Available from: http://www.drawingsofleonardo.org/.,Non-OADS,/arxiv_data1/oa_pdf/cf/a8/acb-46-235.PMC3875840.pdf
Available  from: http://vesalius.northwestern.edu/flash.html.,Non-OADS,/arxiv_data1/oa_pdf/cf/a8/acb-46-235.PMC3875840.pdf
"Original Article Corresponding author:  Jongsoon Choi Department of Family Medicine, Kosin University College of Medicine,  262 Gamcheon-ro, Seo-gu, Busan 602-702, Korea Tel: +82-51-990-6475, Fax: +82-51-990-3045, E-mail: fmcjs@naver.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/87/8b/acb-46-239.PMC3875841.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.4.239 pISSN 2093-3665   eISSN 2093-3673 Vitamin C modulates lead excretion in rats Hoseob Lihm1, Hyun Kim2, Heekyung Chang3, Myunghee Y oon4, Kayoung Lee5, Jongsoon Choi1 Departments of 1Family Medicine, 2Anatomy, 3Pathology, and 4Surgery, Kosin University College of Medicine, 5Department of Family Medicine, Inje  University College of Medicine, Busan, Korea Abstract:  Lead, one of the most toxic heavy metals, takes longer time to be excreted from the body than other heavy metals.",Non-OADS,/arxiv_data1/oa_pdf/87/8b/acb-46-239.PMC3875841.pdf
"Anat Cell Biol 2013;46: 239-245 Hoseob Lihm, et al 240 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.239C does not increase the impact of DMSA in the rat exposed to  lead [9], but there have been few data about human subjects.",Non-OADS,/arxiv_data1/oa_pdf/87/8b/acb-46-239.PMC3875841.pdf
Vitamin C modulates lead excretion in rats http://dx.doi.org/10.5115/acb.2013.46.4.239Anat Cell Biol 2013;46:239-245 241 www.acbjournal.orgkg/day) after the lead administration (n=11); and a group  administered with a high dose of vitamin C solution (2 g/kg/ day) after the lead administration (n=9).,Non-OADS,/arxiv_data1/oa_pdf/87/8b/acb-46-239.PMC3875841.pdf
"Anat Cell Biol 2013;46: 239-245 Hoseob Lihm, et al 242 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.239rats (100%) that were administered lead and high-dose of  vitamin C survived and were used for analysis.",OADS,/arxiv_data1/oa_pdf/87/8b/acb-46-239.PMC3875841.pdf
"Vitamin C modulates lead excretion in rats http://dx.doi.org/10.5115/acb.2013.46.4.239Anat Cell Biol 2013;46:239-245 243 www.acbjournal.orgWith post-hoc  test, Lead excretion in feces in low dose vitamin  C group was higher than the excretion in lead only group,  but it was statistically insignificant ( P=0.282).",OADS,/arxiv_data1/oa_pdf/87/8b/acb-46-239.PMC3875841.pdf
"Anat Cell Biol 2013;46: 239-245 Hoseob Lihm, et al 244 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.239vitamin C group, lead excretion in high dose vitamin C group  was increased but not statistically meaningful (Table 6, Fig.",OADS,/arxiv_data1/oa_pdf/87/8b/acb-46-239.PMC3875841.pdf
Vitamin C modulates lead excretion in rats http://dx.doi.org/10.5115/acb.2013.46.4.239Anat Cell Biol 2013;46:239-245 245 www.acbjournal.orgthan the amount of lead that was administered on the same  date.,Non-OADS,/arxiv_data1/oa_pdf/87/8b/acb-46-239.PMC3875841.pdf
"Original Article Corresponding author:  Lorenzo Alibardi Department of Bigea, University of Bologna, via Selmi 3, 40126,  Bologna, Italy Tel:  +39-051-2094138, Fax:  +39-051-2094286,  E-mail: lorenzo.alibardi@ unibo.it This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/5e/44/acb-46-246.PMC3875842.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.4.246 pISSN 2093-3665   eISSN 2093-3673 Ultrastructural immunolocalization of beta- defensin-27 in granulocytes of the dermis  and wound epidermis of lizard suggests they  contribute to the anti-microbial skin barrier Lorenzo Alibardi Department of Bigea, University of Bologna, Bologna, Italy Abstract:  The high resistance to infections in lizard wounds suggests that these reptiles possess effective antimicrobial peptides  in their tissues.",Non-OADS,/arxiv_data1/oa_pdf/5e/44/acb-46-246.PMC3875842.pdf
Beta-defensin-27 in lizard tissues  http://dx.doi.org/10.5115/acb.2013.46.4.246Anat Cell Biol 2013;46:246-253 247 www.acbjournal.orgactivity (Fig.,Non-OADS,/arxiv_data1/oa_pdf/5e/44/acb-46-246.PMC3875842.pdf
Anat Cell Biol 2013;46: 246-253 Lorenzo Alibardi 248 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.2461% toluidine blue for the histological examination or were  utilized for the immunohistochemical study.,Non-OADS,/arxiv_data1/oa_pdf/5e/44/acb-46-246.PMC3875842.pdf
Beta-defensin-27 in lizard tissues  http://dx.doi.org/10.5115/acb.2013.46.4.246Anat Cell Biol 2013;46:246-253 249 www.acbjournal.orgomitted or pre-absorbed for 24 hours at 4°C mixing 3:1 the  solution containing the antigen with the purified antibody  solution.,Non-OADS,/arxiv_data1/oa_pdf/5e/44/acb-46-246.PMC3875842.pdf
"Anat Cell Biol 2013;46: 246-253 Lorenzo Alibardi 250 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.246connectives and in the apical blastema, and their cytoplasm  contained immunofluorescent granules (Fig.",OADS,/arxiv_data1/oa_pdf/5e/44/acb-46-246.PMC3875842.pdf
"Beta-defensin-27 in lizard tissues  http://dx.doi.org/10.5115/acb.2013.46.4.246Anat Cell Biol 2013;46:246-253 251 www.acbjournal.orgDiscussion Numerous studies in mammals, lizards, snake and turtle  have shown that antimicrobial peptides are mainly stored and  released from granulocytes and keratinocytes under microbial  challenge [5, 17, 18-22], although other cell types can also  form these peptides constitutionally or under microbial or  injury challenge [9, 23].",Non-OADS,/arxiv_data1/oa_pdf/5e/44/acb-46-246.PMC3875842.pdf
"Anat Cell Biol 2013;46: 246-253 Lorenzo Alibardi 252 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.246cell structures were these granules, although the labeling was  generally low.",OADS,/arxiv_data1/oa_pdf/5e/44/acb-46-246.PMC3875842.pdf
Beta-defensin-27 in lizard tissues  http://dx.doi.org/10.5115/acb.2013.46.4.246Anat Cell Biol 2013;46:246-253 253 www.acbjournal.orgdefensin 2 is expressed and associated with Mycobacterium  tuberculosis  during infection of human alveolar epithelial cells.,Non-OADS,/arxiv_data1/oa_pdf/5e/44/acb-46-246.PMC3875842.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/8b/b5/acb-46-254.PMC3875843.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.4.254 pISSN 2093-3665   eISSN 2093-3673 Ascorbic acid insufficiency induces the severe  defect on bone formation via the down- regulation of osteocalcin production   Won Kim1,2,*, Seyeon Bae1,*, Hyemin Kim1, Yejin Kim1, Jiwon Choi1, Sun Young Lim3, Hei Jin Lee1,  Jihyuk Lee1, Jiyea Choi1, Mirim Jang1, Kyoung Eun Lee4, Sun G. Chung2, Y oung-il Hwang1, Jae Seung  Kang1, Wang Jae Lee1 1Labratory of Vitamin C and Immunology, Department of Anatomy, Seoul National University College of Medicine, 2Department of Rehabilitation  Medicine, Seoul National University College of Medicine, Seoul, Korea, 3Department of Psychology, Boston College, Chestnut Hill, MA, USA, 4Division of  Hematology-Oncology, Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea Abstract:  The L-gulono-γ-lactone oxidase gene ( Gulo ) encodes an essential enzyme in the synthesis of ascorbic acid from  glucose.",Non-OADS,/arxiv_data1/oa_pdf/8b/b5/acb-46-254.PMC3875843.pdf
Defect on bone formation by ascorbic acid insufficiency http://dx.doi.org/10.5115/acb.2013.46.4.254Anat Cell Biol 2013;46:254-261 255 www.acbjournal.orgosteoporosis [6-8].,Non-OADS,/arxiv_data1/oa_pdf/8b/b5/acb-46-254.PMC3875843.pdf
"Anat Cell Biol 2013;46: 254-261 Won Kim, et al 256 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.254the groups were tested using the Kruskal-Wallis test, and  subsequent comparisons of each group were performed  using a Mann-Whitney test.",OADS,/arxiv_data1/oa_pdf/8b/b5/acb-46-254.PMC3875843.pdf
Defect on bone formation by ascorbic acid insufficiency http://dx.doi.org/10.5115/acb.2013.46.4.254Anat Cell Biol 2013;46:254-261 257 www.acbjournal.orgDecreased plasma osteocalcin levels in Gulo-/- mice in  response to ascorbic acid withdrawal We hypothesized that the loss in body weight of the Gulo-/-  mice in response to ascorbic acid withdrawal might be related  to defects in bone metabolism.,Non-OADS,/arxiv_data1/oa_pdf/8b/b5/acb-46-254.PMC3875843.pdf
"Anat Cell Biol 2013;46: 254-261 Won Kim, et al 258 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.254the conclusion of the experiment (Fig.",OADS,/arxiv_data1/oa_pdf/8b/b5/acb-46-254.PMC3875843.pdf
"Defect on bone formation by ascorbic acid insufficiency http://dx.doi.org/10.5115/acb.2013.46.4.254Anat Cell Biol 2013;46:254-261 259 www.acbjournal.orgto ascorbic acid insufficiency, including decreased total  cholesterol, high density lipoproteins and cate  cholamine  levels, and increased low density lipoproteins and weight  loss [14], are recapitulated in Gulo-/- mice.",Non-OADS,/arxiv_data1/oa_pdf/8b/b5/acb-46-254.PMC3875843.pdf
"Anat Cell Biol 2013;46: 254-261 Won Kim, et al 260 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.254reductions of both trabecular bone volume in the proximal  metaphysis near the growth plate, and trabecular bone  attachment to the growth plate (Fig.",OADS,/arxiv_data1/oa_pdf/8b/b5/acb-46-254.PMC3875843.pdf
"Defect on bone formation by ascorbic acid insufficiency http://dx.doi.org/10.5115/acb.2013.46.4.254Anat Cell Biol 2013;46:254-261 261 www.acbjournal.orgGC, Wergedal J, Baylink DJ.",Non-OADS,/arxiv_data1/oa_pdf/8b/b5/acb-46-254.PMC3875843.pdf
"Original Article Corresponding author:  Young-il Hwang Department of Anatomy, Seoul National University College of  Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea Tel: +82-2-740-8209, Fax: +82-2-745-9528, E-mail: hyi830@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/25/0d/acb-46-262.PMC3875844.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.4.262 pISSN 2093-3665   eISSN 2093-3673 Suppression of in vitro  murine T cell  proliferation by human adipose tissue-derived  mesenchymal stem cells is dependent mainly  on cyclooxygenase-2 expression Jin-Hee Kim1, Y ong-Taek Lee2, Jun Man Hong1, Y oung-il Hwang1 1Department of Anatomy, Seoul National University College of Medicine, 2Department of Physical and Rehabilitation Medicine, Kangbuk Samsung  Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Abstract:  Mesenchymal stem cells (MSCs) of human origin have been frequently applied to experimental animal models  to evaluate their immunomodulatory functions.",Non-OADS,/arxiv_data1/oa_pdf/25/0d/acb-46-262.PMC3875844.pdf
"Suppression of mouse T cell proliferation by human mesenchymal cells http://dx.doi.org/10.5115/acb.2013.46.4.262Anat Cell Biol 2013;46:262-271 263 www.acbjournal.orgcytokines from T cells before they express cyclooxygenase-2  (COX-2) and thus secrete prostaglandin E2 (PGE2) [6, 8],  express indoleamine 2,3-dioxygenase (IDO) [9], or induce  inducible NO synthase (iNOS) to secrete nitric oxide (NO)  [10].",Non-OADS,/arxiv_data1/oa_pdf/25/0d/acb-46-262.PMC3875844.pdf
"Anat Cell Biol 2013;46: 262-271 Jin-Hee Kim, et al 264 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.262Immunophenotyping The hAd-MSCs were washed and suspended in PBS with  0.5% BSA in aliquots of 5×105 cells.",OADS,/arxiv_data1/oa_pdf/25/0d/acb-46-262.PMC3875844.pdf
Suppression of mouse T cell proliferation by human mesenchymal cells http://dx.doi.org/10.5115/acb.2013.46.4.262Anat Cell Biol 2013;46:262-271 265 www.acbjournal.orginstruc tions.,Non-OADS,/arxiv_data1/oa_pdf/25/0d/acb-46-262.PMC3875844.pdf
"Anat Cell Biol 2013;46: 262-271 Jin-Hee Kim, et al 266 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.262Corp., San Leandro, CA, USA).",OADS,/arxiv_data1/oa_pdf/25/0d/acb-46-262.PMC3875844.pdf
Suppression of mouse T cell proliferation by human mesenchymal cells http://dx.doi.org/10.5115/acb.2013.46.4.262Anat Cell Biol 2013;46:262-271 267 www.acbjournal.orgiNOS (Fig.,Non-OADS,/arxiv_data1/oa_pdf/25/0d/acb-46-262.PMC3875844.pdf
"Anat Cell Biol 2013;46: 262-271 Jin-Hee Kim, et al 268 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.262these cells.",OADS,/arxiv_data1/oa_pdf/25/0d/acb-46-262.PMC3875844.pdf
"Suppression of mouse T cell proliferation by human mesenchymal cells http://dx.doi.org/10.5115/acb.2013.46.4.262Anat Cell Biol 2013;46:262-271 269 www.acbjournal.orgConcordantly, hAd-MSCs expressed IDO when they were  treated with human IFN-γ (Electronic Supplementary  Fig.",Non-OADS,/arxiv_data1/oa_pdf/25/0d/acb-46-262.PMC3875844.pdf
Electronic Supplementary Materials Supplementary data including three figures can be found  with this article online at http://www.acbjournal.org/src/sm/ acb-46-262-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/25/0d/acb-46-262.PMC3875844.pdf
"Anat Cell Biol 2013;46: 262-271 Jin-Hee Kim, et al 270 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.262derived stem cells.",OADS,/arxiv_data1/oa_pdf/25/0d/acb-46-262.PMC3875844.pdf
"Suppression of mouse T cell proliferation by human mesenchymal cells http://dx.doi.org/10.5115/acb.2013.46.4.262Anat Cell Biol 2013;46:262-271 271 www.acbjournal.orgHandgretinger R, Müller I.",Non-OADS,/arxiv_data1/oa_pdf/25/0d/acb-46-262.PMC3875844.pdf
"Original Article Corresponding author:  Baik Hwan Cho Department of Surgery, Chonbuk National University Medical School,  20 Geonji-ro, Deokjin-gu, Jeonju 561-712, Korea Tel: +82-63-250-1570, Fax: +82-63-271-6197, E-mail: chobh@jbnu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/39/dd/acb-46-272.PMC3875845.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.4.272 pISSN 2093-3665   eISSN 2093-3673 Expression of carbonic anhydrase IX in  human fetal joints, ligaments and tendons: a  potential marker of mechanical stress in fetal  development?",Non-OADS,/arxiv_data1/oa_pdf/39/dd/acb-46-272.PMC3875845.pdf
"Expression of CA IX in human fetus http://dx.doi.org/10.5115/acb.2013.46.4.272Anat Cell Biol 2013;46:272-284 273 www.acbjournal.orgwas shown to change the expression of intermediate filaments  (10-nm filaments), glial fibrillary acidic protein (GFAP),  and desmin [6].",OADS,/arxiv_data1/oa_pdf/39/dd/acb-46-272.PMC3875845.pdf
"Anat Cell Biol 2013;46: 272-284 Ji Hyun Kim, et al 274 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.272chemical detection of CA9: 1) a rabbit polyclonal anti-human  CA9 (1:500), originally established by a group organized  by the second author [19]; and 2) a commercially available  rabbit polyclonal anti-human CA9 (1:1,000, ab15086, Abcam,  Cambridge, UK).",OADS,/arxiv_data1/oa_pdf/39/dd/acb-46-272.PMC3875845.pdf
"Expression of CA IX in human fetus http://dx.doi.org/10.5115/acb.2013.46.4.272Anat Cell Biol 2013;46:272-284 275 www.acbjournal.orgLikewise, CA9 immunoreactivity was weaker in the larger,  older specimen in the trachea and larynx (specifically in  the tracheal cartilage rings), the cricoarytenoid joint of the  larynx and an attachment between the thyroid cartilage and  the greater horn of the hyoid bone (Fig.",Non-OADS,/arxiv_data1/oa_pdf/39/dd/acb-46-272.PMC3875845.pdf
"Anat Cell Biol 2013;46: 272-284 Ji Hyun Kim, et al 276 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.272was positive at all stages examined (data not shown).",OADS,/arxiv_data1/oa_pdf/39/dd/acb-46-272.PMC3875845.pdf
Expression of CA IX in human fetus http://dx.doi.org/10.5115/acb.2013.46.4.272Anat Cell Biol 2013;46:272-284 277 www.acbjournal.orgcircumferential articular surface of the head of the radius (Fig.,Non-OADS,/arxiv_data1/oa_pdf/39/dd/acb-46-272.PMC3875845.pdf
"Anat Cell Biol 2013;46: 272-284 Ji Hyun Kim, et al 278 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.272was CA9-negative.",OADS,/arxiv_data1/oa_pdf/39/dd/acb-46-272.PMC3875845.pdf
"Expression of CA IX in human fetus http://dx.doi.org/10.5115/acb.2013.46.4.272Anat Cell Biol 2013;46:272-284 279 www.acbjournal.orgno desmin immunoreactivity in the joint, tendon, or ligament  (Figs.",Non-OADS,/arxiv_data1/oa_pdf/39/dd/acb-46-272.PMC3875845.pdf
"Anat Cell Biol 2013;46: 272-284 Ji Hyun Kim, et al 280 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.272CA9-positive cells accumulated.",OADS,/arxiv_data1/oa_pdf/39/dd/acb-46-272.PMC3875845.pdf
Expression of CA IX in human fetus http://dx.doi.org/10.5115/acb.2013.46.4.272Anat Cell Biol 2013;46:272-284 281 www.acbjournal.organd the two structures are never attached in adults owing to  the presence of the joint capsule.,Non-OADS,/arxiv_data1/oa_pdf/39/dd/acb-46-272.PMC3875845.pdf
"Anat Cell Biol 2013;46: 272-284 Ji Hyun Kim, et al 282 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.272that CA9 was expressed in the rectus sheath at 7–8 weeks.",OADS,/arxiv_data1/oa_pdf/39/dd/acb-46-272.PMC3875845.pdf
Expression of CA IX in human fetus http://dx.doi.org/10.5115/acb.2013.46.4.272Anat Cell Biol 2013;46:272-284 283 www.acbjournal.orgReferences 1.,Non-OADS,/arxiv_data1/oa_pdf/39/dd/acb-46-272.PMC3875845.pdf
"Anat Cell Biol 2013;46: 272-284 Ji Hyun Kim, et al 284 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.272lottis revisited: appearance of GFAP-positive mesenchymal  cells and fibrous connections with other laryngeal and lingual  structures.",OADS,/arxiv_data1/oa_pdf/39/dd/acb-46-272.PMC3875845.pdf
"com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/25/a8/acb-46-285.PMC3875846.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.4.285 pISSN 2093-3665   eISSN 2093-3673 Histomorphological and morphometrical  changes of placental terminal villi of  normotensive and preeclamptic mothers K. Devi Sankar1, P .",Non-OADS,/arxiv_data1/oa_pdf/25/a8/acb-46-285.PMC3875846.pdf
"Anat Cell Biol 2013;46: 285-290 K. Devi Sankar, et al 286 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.285apoptosis of cytotrophoblast cells [12, 13].",OADS,/arxiv_data1/oa_pdf/25/a8/acb-46-285.PMC3875846.pdf
"Histomorphometry of placental terminal villi http://dx.doi.org/10.5115/acb.2013.46.4.285Anat Cell Biol 2013;46:285-290 287 www.acbjournal.orgHistological findings  The stem villi of the PE placentas showed numerous arte - riosclerotic blood vessels with endothelial degeneration  presenting progressive fibrosis, stem villous perivasculitis,  and subsequent lumen obliteration (Fig.",Non-OADS,/arxiv_data1/oa_pdf/25/a8/acb-46-285.PMC3875846.pdf
"Anat Cell Biol 2013;46: 285-290 K. Devi Sankar, et al 288 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.285in these TV was significantly decreased in the PE group  compared to controls ( P<0.0001), but the diameters of TV  were more or less similar between the groups and were  significant ( P<0.05).",OADS,/arxiv_data1/oa_pdf/25/a8/acb-46-285.PMC3875846.pdf
Histomorphometry of placental terminal villi http://dx.doi.org/10.5115/acb.2013.46.4.285Anat Cell Biol 2013;46:285-290 289 www.acbjournal.orgphology and cellular arrangement are important for oxygen  delivery from the mother to the fetus.,Non-OADS,/arxiv_data1/oa_pdf/25/a8/acb-46-285.PMC3875846.pdf
"Anat Cell Biol 2013;46: 285-290 K. Devi Sankar, et al 290 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.285103-11.",OADS,/arxiv_data1/oa_pdf/25/a8/acb-46-285.PMC3875846.pdf
"Case Report Corresponding author:  Gyu Yeul Ji  Department of Neurosurgery, Yonsei University College of Medicine,  50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea   Tel: +82-2-2228-2150, Fax: +82-2-393-9979, E-mail: jivago91@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/fb/de/acb-46-291.PMC3875847.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.4.291 pISSN 2093-3665   eISSN 2093-3673 Radiological anatomical consideration of  conjoined nerve root with a case review Chang Hyun Oh1, Jae Suk Park2, Won-Seok Choi1, Eunhwa Choi3, Gyu Y eul Ji4 1Department of Neurosurgery, Guro Teun Teun Hospital, Seoul, 2Department of Neurosurgery, Daegu Teun Teun Hospital, Daegu, 3Department of  Radiology, Guro Teun Teun Hospital, Seoul, 4Department of Neurosurgery, Y onsei University College of Medicine, Seoul, Korea Abstract:  Nerve root anomalies are frequently underrecognized regardless of the advances in imaging studies; they are also  underappreciated and underreported when encountered surgically.",Non-OADS,/arxiv_data1/oa_pdf/fb/de/acb-46-291.PMC3875847.pdf
"Anat Cell Biol 2013;46: 291-295 Chang Hyun Oh, et al 292 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.291and radiating pain in the right leg, with a positive straight- leg raising sign at 30o.",Non-OADS,/arxiv_data1/oa_pdf/fb/de/acb-46-291.PMC3875847.pdf
"A case with conjoined nerve root http://dx.doi.org/10.5115/acb.2013.46.4.291Anat Cell Biol 2013;46:291-295 293 www.acbjournal.orgbetween the conjoined nerve root and the asymmetric dural  sac; and “parallel sign, ” an unusual course of the entire nerve  root at the disc level, running parallel to the disc plane.Discussion A conjoined nerve root is defined as two adjacent nerve roots Fig.",Non-OADS,/arxiv_data1/oa_pdf/fb/de/acb-46-291.PMC3875847.pdf
"Anat Cell Biol 2013;46: 291-295 Chang Hyun Oh, et al 294 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.291that share a common dural envelope at some point during  their course from the thecal sac [2].",Non-OADS,/arxiv_data1/oa_pdf/fb/de/acb-46-291.PMC3875847.pdf
A case with conjoined nerve root http://dx.doi.org/10.5115/acb.2013.46.4.291Anat Cell Biol 2013;46:291-295 295 www.acbjournal.orgcomplications [1].,Non-OADS,/arxiv_data1/oa_pdf/fb/de/acb-46-291.PMC3875847.pdf
"Case Report Corresponding author:  Satheesha B. Nayak  Department of Anatomy, Melaka Manipal Medical College (Manipal  Campus), International Centre for Health Sciences, Manipal University,  Madhav Nagar, Manipal, Udupi District, Karnataka State 576 104, India Tel: +91-984-4009059, Fax: +91-820-2571905, E-mail: nayaksathish@ gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/11/cb/acb-46-296.PMC3875848.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.4.296 pISSN 2093-3665   eISSN 2093-3673 Sessile ileum, subhepatic cecum, and uncinate  appendix that might lead to a diagnostic  dilemma Satheesha B. Nayak, Bincy Muthukattu George, Snigdha Mishra, Sudarshan Surendran, Prakashchandra  Shetty, Surekha Devadasa Shetty Department of Anatomy, Melaka Manipal Medical College (Manipal Campus), Manipal University, Manipal, Karnataka, India Abstract:  The subhepatic position of the cecum and appendix is a result of embryological reasons.",Non-OADS,/arxiv_data1/oa_pdf/11/cb/acb-46-296.PMC3875848.pdf
Sessile ileum and subhepatic caecum http://dx.doi.org/10.5115/acb.2013.46.4.296Anat Cell Biol 2013;46:296-298 297 www.acbjournal.orgwas attached to its posteromedial side.,Non-OADS,/arxiv_data1/oa_pdf/11/cb/acb-46-296.PMC3875848.pdf
"Anat Cell Biol 2013;46: 296-298 Satheesha B. Nayak, et al 298 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.296of the cecum with appendices epiploicae.",OADS,/arxiv_data1/oa_pdf/11/cb/acb-46-296.PMC3875848.pdf
"A/703, Gateway Towers, Sector-4, Vaishali, Ghaziabad,  Pin-201010, Uttar Pradesh, India  Tel: +91-9899395262, Fax: +91-11-23832126, E-mail: drpreetishri  vastava  @gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/95/07/acb-46-299.PMC3875849.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.4.299 pISSN 2093-3665   eISSN 2093-3673 Right sided descending and sigmoid colon: its  embryological basis and clinical implications Preeti Shrivastava, Anita Tuli, Sohinder Kaur, Shashi Raheja Department of Anatomy, Lady Hardinge Medical College and SSK Hospital, New Delhi, India Abstract:  Anatomical variations of the colon are described by various authors, but the occurrence of right sided descending  and sigmoid colon is rare and has not been reported.",Non-OADS,/arxiv_data1/oa_pdf/95/07/acb-46-299.PMC3875849.pdf
"Anat Cell Biol 2013;46: 299-302 Preeti Shrivastava, et al 300 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.299root of the mesentery, traversing the umbilical quadrant, 3.5  cm to the right of midline at the level of L5.",Non-OADS,/arxiv_data1/oa_pdf/95/07/acb-46-299.PMC3875849.pdf
Right sided sigmoid colon http://dx.doi.org/10.5115/acb.2013.46.4.299Anat Cell Biol 2013;46:299-302 301 www.acbjournal.orgV ascular supply The inferior mesenteric artery (IMA) supplied this ano - malous colon and had an unusual course.,Non-OADS,/arxiv_data1/oa_pdf/95/07/acb-46-299.PMC3875849.pdf
"Anat Cell Biol 2013;46: 299-302 Preeti Shrivastava, et al 302 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.4.299with barium enema, by Fiorella and Donnelly [5] and Saxena  et al.",OADS,/arxiv_data1/oa_pdf/95/07/acb-46-299.PMC3875849.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ea/7c/1.PMC3875850.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.6Corresponding author E-mail pxs183@case.eduArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/ea/7c/1.PMC3875850.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.164079.113.",OADS,/arxiv_data1/oa_pdf/ea/7c/1.PMC3875850.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/0a/f5/107.PMC3875851.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/ 3.0/.3These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/0a/f5/107.PMC3875851.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.160887.113.",OADS,/arxiv_data1/oa_pdf/0a/f5/107.PMC3875851.pdf
2005) Data access The ChIP-seq reads associated with maize chromosomes from allnine oat-maize chromosome addition lines and the RNA-seq data sets have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession num-ber GSE47342.,OADS,/arxiv_data1/oa_pdf/0a/f5/107.PMC3875851.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.1Corresponding author E-mail Michel.Strubin@unige.ch Article published online before print.",Non-OADS,/arxiv_data1/oa_pdf/3d/75/117.PMC3875852.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.157792.113.",Non-OADS,/arxiv_data1/oa_pdf/3d/75/117.PMC3875852.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/22/2b/125.PMC3875853.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.5These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/22/2b/125.PMC3875853.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.163394.113.",Non-OADS,/arxiv_data1/oa_pdf/22/2b/125.PMC3875853.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.1These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/d6/ad/132.PMC3875854.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.162339.113.",Non-OADS,/arxiv_data1/oa_pdf/d6/ad/132.PMC3875854.pdf
k!20/C0k ðÞ !3 4/C18/C1920/C0k1 4/C18/C19k ; where kis the number of matched bases.Data access T h ed e e ps e q u e n c i n gd a t ah a v eb e e ns u b m i t t e dt ot h eD N A Data Bank of Japan (DDBJ Sequence Read Archive; http://trace.ddbj.nig.ac.jp/dra/index_e.html) under accession number DRA001195.,OADS,/arxiv_data1/oa_pdf/d6/ad/132.PMC3875854.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/bf/4d/14.PMC3875855.pdf
"After six months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.12Corresponding author E-mail koller@cs.stanford.eduArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/bf/4d/14.PMC3875855.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.155192.113.",OADS,/arxiv_data1/oa_pdf/bf/4d/14.PMC3875855.pdf
"Our approach unifies the full set of informative annotations analyzed for enrichment into a single framework, the latent regulatory variant model (LRVM; software available at http://dags.stanford.edu/dgn/).",Non-OADS,/arxiv_data1/oa_pdf/bf/4d/14.PMC3875855.pdf
"HTSeq was used toquantify gene expression (http://www-huber.embl.de/users/anders/ HTSeq/doc/overview.html), BEDTools (Quinlan and Hall 2010) was used to quantify exon expression, and Cufflinks (Roberts et al.",OADS,/arxiv_data1/oa_pdf/bf/4d/14.PMC3875855.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/29/9c/142.PMC3875856.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.8Corresponding authors E-mail filippo.del-bene@curie.fr E-mail jean-paul.concordet@mnhn.frArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/29/9c/142.PMC3875856.pdf
"Article, supplemental material, and publi- cation date are at http://www.ge nome.org/cgi/doi/10.1101/gr.161638.113.",Non-OADS,/arxiv_data1/oa_pdf/29/9c/142.PMC3875856.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.1These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/33/67/167.PMC3875858.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.155879.113.",OADS,/arxiv_data1/oa_pdf/33/67/167.PMC3875858.pdf
Data access Data generated in this study have been submitted to the NCBISequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra) under accession number SRP011991.,OADS,/arxiv_data1/oa_pdf/33/67/167.PMC3875858.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.3These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/ea/81/25.PMC3875859.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.159483.113.",OADS,/arxiv_data1/oa_pdf/ea/81/25.PMC3875859.pdf
"NGS data sets used in this study NGS platform hESC linesNumber of reads Length (bp) Long reads Roche 454 H1a1,545,096 235.9 (average) H9 832,438 353.7 (average) Short reads Illumina GA II H1a132,455,091 27–36 SOLiD H9 230,632,477 50 aThe NGS data were downloaded from the Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) (accession number GSE20301).",OADS,/arxiv_data1/oa_pdf/ea/81/25.PMC3875859.pdf
The ChIP-seq data of NANOG and SUZ12 were generated by the ENCODE project (The ENCODE Project Consortium 2012) and downloaded from the UCSC Genome Browser athttp://genome.ucsc.edu/.,OADS,/arxiv_data1/oa_pdf/ea/81/25.PMC3875859.pdf
2009) and downloaded from the BFAST page at http://sourceforge.net/projects/bfast/files/.,Non-OADS,/arxiv_data1/oa_pdf/ea/81/25.PMC3875859.pdf
"Data retrieval and availability The human genomic sequences, hg19 (or GRCh37), were down-loaded from the UCSC Genome Browser (http://genome.ucsc.edu/).",OADS,/arxiv_data1/oa_pdf/ea/81/25.PMC3875859.pdf
The human annotated transcripts were downloaded from the UCSC Genome Browser (RefSeq) and the Ensembl GenomeBrowser (all cDNAs; release 59) (http://www.ensembl.org/).,OADS,/arxiv_data1/oa_pdf/ea/81/25.PMC3875859.pdf
"TheH1 hESC transcriptome sequencing data, including long 454-reads and short Illumina reads, were downloaded from the Gene Expres- sion Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) database(accession number GSE20301).",OADS,/arxiv_data1/oa_pdf/ea/81/25.PMC3875859.pdf
"Data access The H9 hESC transcriptome sequencing data (including long 454- reads and short SOLiD reads) and microarray data generated in thepresent study have been submitted to the NCBI Gene ExpressionOmnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under acces- sion numbers GSE30557 and GSE32503, respectively.",OADS,/arxiv_data1/oa_pdf/ea/81/25.PMC3875859.pdf
The related in-house programs and document are publicly accessible from ourwebsite (http://idv.sinica.edu.tw/trees/TSscan/TSscan.html) orgithub (https://github.com/TreesLab/TSscan).,OADS,/arxiv_data1/oa_pdf/ea/81/25.PMC3875859.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.5Present address: Institute of the Physics of Biological Systems, Ecole polytechnique fe ´de´rale de Lausanne, 1015 Lausanne, Switzerland 6Corresponding author E-mail nouria.hernandez@unil.ch Article published online before print.",Non-OADS,/arxiv_data1/oa_pdf/74/36/37.PMC3875860.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.161570.113.",OADS,/arxiv_data1/oa_pdf/74/36/37.PMC3875860.pdf
2010) and drawn with Phylodendron (see http://iubio.bio.indiana.edu/treeapp/).,Non-OADS,/arxiv_data1/oa_pdf/74/36/37.PMC3875860.pdf
Data access The ChIP-seq data generated in this study have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/74/36/37.PMC3875860.pdf
Individual differences in KDM4C expression affect its abundance and activity; thus individuals with high KDM4C expression have more dimethylated H3K9 marks at the target gene promoters than /C2112014 Gregory and Cheung This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/9c/4d/52.PMC3875861.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/ licenses/by-nc/3.0/.6Corresponding author E-mail vgcheung@umich.eduArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/9c/4d/52.PMC3875861.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.156141.113.",OADS,/arxiv_data1/oa_pdf/9c/4d/52.PMC3875861.pdf
Data access Microarray data have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under acces- sion number GSE41040.,OADS,/arxiv_data1/oa_pdf/9c/4d/52.PMC3875861.pdf
A direct analysis revealed that the /C2112014 Koren and McCarroll This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/9f/22/64.PMC3875862.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/ licenses/by-nc/3.0/.3Corresponding author E-mail mccarroll@genetics.med.harvard.eduArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/9f/22/64.PMC3875862.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.161828.113.",OADS,/arxiv_data1/oa_pdf/9f/22/64.PMC3875862.pdf
S2) have been submitted to the NCBI Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra) under accessionnumber SRP029958.,OADS,/arxiv_data1/oa_pdf/9f/22/64.PMC3875862.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/18/56/70.PMC3875863.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/ 3.0/.5These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/18/56/70.PMC3875863.pdf
"Article, supplemental material, and publi- cation date are at http://www.gen ome.org/cgi/doi/10.1101/gr.161919.113.",Non-OADS,/arxiv_data1/oa_pdf/18/56/70.PMC3875863.pdf
Data access RNA-seq and ChIP-seq data from this study have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/18/56/70.PMC3875863.pdf
"This article, published in Genome Research , is avail- able under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.5Corresponding author E-mail cmeiklejohn2@unl.edu Article published online before print.",Non-OADS,/arxiv_data1/oa_pdf/2b/d7/84.PMC3875864.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.156414.113.",Non-OADS,/arxiv_data1/oa_pdf/2b/d7/84.PMC3875864.pdf
Data access Microarray data have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under acces- sion number GSE44329.,OADS,/arxiv_data1/oa_pdf/2b/d7/84.PMC3875864.pdf
"This article, published in Genome Research , is avail- able under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.6These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/9c/ee/96.PMC3875865.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.144469.112.",OADS,/arxiv_data1/oa_pdf/9c/ee/96.PMC3875865.pdf
Data access The data have been submitted to the NCBI Gene Expression Om-nibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) (Edgar et al.,OADS,/arxiv_data1/oa_pdf/9c/ee/96.PMC3875865.pdf
":Molecular Epidemiological … http://jad.tums.ac.ir Published Online: August 31, 2013Original Article Molecular Epidemiological Study ofCutaneous Leishmaniasis in theFocus of Bushehr City,Southwestern Iran *Mohammad RezaYaghoobi -Ershadi1,FaridehShahbazi1,Mohammad Darvishi2, AmirAhmadAkhavan1,Reza Jafari3,Mohammad Khajeian2,YavarRassi1,Hassan Soleimani4,Mohammad RezaShirzadi5,AhmadAliHanafi-Bojd1,HosseinDarabi6, Mohammad HosseinArandian3,AlirezaSanei-Dehkordi1,Mansour Heidari7 1School of Public Health, Tehran University of Medical Sciences , Tehran, Iran 2Deputyof Health Services, Bushehr University of Medical Sciences, Bushehr, Iran 3Esfahan Health Research Station, National Institute of Health Research, Esfahan, Iran 4Yazd Health Research Station, National Institute of Health Research, Yazd, Iran 5Communicable Diseases Management Center, Ministry of Health and Medical Education, Tehran, Iran 6The Persian Gulf Tropical Medicine Research, Bushehr University of Medical Sciences, Bushehr, Iran 7Department of Medical Genetics, School of Medicine, Tehran Un iversity of Medical Sciences, Tehran,Iran (Received 8June2013; accepted 4Aug2013) Abstract Background :Cutaneous leishmaniasis (CL)represents the most frequent vector borne parasitoses in Iran.",Non-OADS,/arxiv_data1/oa_pdf/7b/3a/jad-7-113.PMC3875877.pdf
":Molecular Epidemiological … http://jad.tums.ac.ir Published Online: August 31, 2013Cutaneous leishmaniasis has been epidemic duringthe years 1988 , 1997and 2008 in the city of Bushehr (Health Center of Bushehr Province, unpublished data) .It is one of the free trade -industrial zones of the country and the Bushehr nuclear power plant which is unique in terms of its technology in the Mid - dle East is located 12 km, southeast of the city along the Persia n Gulf, so lots of people travel around and some make several trips in a yearfor business.",Non-OADS,/arxiv_data1/oa_pdf/7b/3a/jad-7-113.PMC3875877.pdf
":Molecular Epidemiological … http://jad.tums.ac.ir Published Online: August 31, 2013examined by coincidence of vis iting schools in the selected parts of the city.",Non-OADS,/arxiv_data1/oa_pdf/7b/3a/jad-7-113.PMC3875877.pdf
":Molecular Epidemiological … http://jad.tums.ac.ir Published Online: August 31, 2013Additionally, for all PCR reactions one negative control without DNA and one posi - tive control with standard DNA were in - cluded to confirm the results of two rounds of nested -PCR.",Non-OADS,/arxiv_data1/oa_pdf/7b/3a/jad-7-113.PMC3875877.pdf
":Molecular Epidemiological … http://jad.tums.ac.ir Published Online: August 31, 2013direct examination but out of 7T.indica, 14.3% were infected with L.majorand 42.9% withL.turanicaby nested -PCR.",OADS,/arxiv_data1/oa_pdf/7b/3a/jad-7-113.PMC3875877.pdf
":Molecular Epidemiological … http://jad.tums.ac.ir Published Online: August 31, 2013 Fig.2.Nested-PCR amplification of DNA extracted from reference strains and Giemsa -stained smears Lane M, 100 bp DNA ladder (Fermentas) , lane 1 –4, reference strains, Leishmania ma jor, Leishmania gerbilli ,Leishmania turanica, Leishmania tropica ,respectively ,lane 5, Leishmania major isolated from Giemsa - stained smears of human ,lane 6,Leishmania tropicaisolated from Giemsa -stained smears of human ,lane 7, mixedinfection of Leishmania major andLeishmania tropica isolated from Giemsa -stained smears of human.",Non-OADS,/arxiv_data1/oa_pdf/7b/3a/jad-7-113.PMC3875877.pdf
":Molecular Epidemiological … http://jad.tums.ac.ir Published Online: August 31, 2013Discussion A study based on our detailed observation of school children and also local people showed scars of CL in all age groups with a maximum of 8.9% among 15 –19 years old indicated that the disease is prevalent with a low endemicity in the city of Bushehr.",Non-OADS,/arxiv_data1/oa_pdf/7b/3a/jad-7-113.PMC3875877.pdf
":Molecular Epidemiological … http://jad.tums.ac.ir Published Online: August 31, 2013breeding of the vector are changed (example setting up big gardens in different parts of the city and so forth and the disease be - comes epidemic in the future, deltamethrin 0.025 (g/m) spraying in the houses with ac - tive cases and also their neighboring houses and in districts with high density of Phlebotomus sergentiorP.papatasi should be applied only once during the active sea - son of sand flies and repeated once again two weeks before the beginning of sand fly activity in the next year.",Non-OADS,/arxiv_data1/oa_pdf/7b/3a/jad-7-113.PMC3875877.pdf
":Molecular Epidemiological … http://jad.tums.ac.ir Published Online: August 31, 2013Hajjaran H, Mohebali M, Alimoradi S, Abaei MR, Edrissian GH (2009) Iso - lation and charact erization of patho- genicLeishmania turanica fromNesokia indica(Rodentia; Muridae) by PCR - RFLP and ITS1 sequencing in Iran.",OADS,/arxiv_data1/oa_pdf/7b/3a/jad-7-113.PMC3875877.pdf
":Molecular Characterization of … http://jad.tums.ac.ir Published Online: August 31, 2013Original Article Molecular Characterization of Leishmania Infection from Naturally Infected Sand Flies Caught in a Focus of Cutaneous Leishmaniasis (Eastern Iran) Mohammad Akhoundi1, 2,AhmadBaghaei2,*Jérôme Depaquit1, Parviz Parvizi2 1Université de Reims Champagne -Ardenne, ANSES, EA4688-USC «Transmission vectorielle et épidémiosurveillance de maladies parasitaires (VECPAR)», Faculté de Pharmacie, Département  de la parasitologie, Reims, France 2Pasteur Institute of Iran, Department of Parasitology , Molecular Systematic Laboratory, Tehran, Iran (Received 15Feb2012; accepted 16March2013) Abstract Background :Cutaneous leishmaniasis due to Leishmania major is a serious and increasing problem affecting many rural areas of 17 out of 31 provinces in Iran.",Non-OADS,/arxiv_data1/oa_pdf/05/98/jad-7-122.PMC3875878.pdf
":Molecular Characterization of … http://jad.tums.ac.ir Published Online: August 31, 2013Seyedi-Rashti 1971, Yaghoobi -Ershadi et al.",OADS,/arxiv_data1/oa_pdf/05/98/jad-7-122.PMC3875878.pdf
":Molecular Characterization of … http://jad.tums.ac.ir Published Online: August 31, 2013the supernatant was precipitated over night at-20˚C in 96% ethanol.",Non-OADS,/arxiv_data1/oa_pdf/05/98/jad-7-122.PMC3875878.pdf
":Molecular Characterization of … http://jad.tums.ac.ir Published Online: August 31, 2013(5%) female Caucasicus group were infected byL.majorandone out of 90 (1.1%) female P.sergentitested for Leishmania DNA was also positive for L.tropicainfection using theStandard PCR method.",Non-OADS,/arxiv_data1/oa_pdf/05/98/jad-7-122.PMC3875878.pdf
":Molecular Characterization of … http://jad.tums.ac.ir Published Online: August 31, 2013Table 1.",OADS,/arxiv_data1/oa_pdf/05/98/jad-7-122.PMC3875878.pdf
":Molecular Characterization of … http://jad.tums.ac.ir Published Online: August 31, 2013 Fig.",OADS,/arxiv_data1/oa_pdf/05/98/jad-7-122.PMC3875878.pdf
":Molecular Characterization of … http://jad.tums.ac.ir Published Online: August 31, 2013ilar to several sequences deposited in Gen- Bank, including isolates from Iran and Friedlin references (Friedlin FR79 6423, Iran AY260 965, AY283793, EF413075, GQ402544, GQ4 02543, GQ466354 and GQ466350).",OADS,/arxiv_data1/oa_pdf/05/98/jad-7-122.PMC3875878.pdf
":Molecular Characterization of … http://jad.tums.ac.ir Published Online: August 31, 2013Cutaneous leishm aniasis due to L.tropica occurs in a vast distribution areas of the world.",Non-OADS,/arxiv_data1/oa_pdf/05/98/jad-7-122.PMC3875878.pdf
":Molecular Characterization of … http://jad.tums.ac.ir Published Online: August 31, 2013Assefi V (1976) Epidemiology of cu - taneous leishmaniasis in Ira n: B. Kho - rassan Part V: Report on a focus of zoonotic cutaneous leishmaniasis in Esferayen.",Non-OADS,/arxiv_data1/oa_pdf/05/98/jad-7-122.PMC3875878.pdf
":Molecular Characterization of … http://jad.tums.ac.ir Published Online: August 31, 2013Abaie MR, Rafizadeh S, Mohebai M, Mohtarami F, Zeinali MK (2011) Mo - lecular detection of Leishmania in- fection due to Leishmania major and Leishmania turanica in the vectors and reservoir host in Iran.",OADS,/arxiv_data1/oa_pdf/05/98/jad-7-122.PMC3875878.pdf
":PCR-based Detection of … http://jad.tums.ac.ir Published Online: August 31, 2013Original Article PCR-basedDetection of Babesiaspp.Infection in CollectedTicks from Cattle inWest and North -West of Iran *MousaTavassoli1, Mohammad Tabatabaei2, MoslehMohammadi1, BijanEsmaeilnejad1, HemnMohamadpour3 1Department of Pathobiolo gy, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran 2Department of Pathobiology, Faculty of Veterinary Medicine, Shiraz University, Shiraz , Iran 3Department of Immunology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran (Received 7Feb 2011; accepted 07Apr2013) Abstract Background: Babesiosis is a haemoparasitic disease of domestic and wild animals caused by species of the genus Babesia.Babesia bigemina ,B.bovis and B .divergens are known to be pathogenic in cattle.",Non-OADS,/arxiv_data1/oa_pdf/0e/be/jad-7-132.PMC3875879.pdf
":PCR-based Detection of … http://jad.tums.ac.ir Published Online: August 31, 2013ache.",Non-OADS,/arxiv_data1/oa_pdf/0e/be/jad-7-132.PMC3875879.pdf
":PCR-based Detection of … http://jad.tums.ac.ir Published Online: August 31, 2013boiled sample, which was then extracted once with phenol, pH 7.8, phenol: chlo roform(1: 1) and chloroform: isoamyl alcohol (24: 1), re - spectively.",Non-OADS,/arxiv_data1/oa_pdf/0e/be/jad-7-132.PMC3875879.pdf
":PCR-based Detection of … http://jad.tums.ac.ir Published Online: August 31, 2013Table 1.",Non-OADS,/arxiv_data1/oa_pdf/0e/be/jad-7-132.PMC3875879.pdf
":PCR-based Detection of … http://jad.tums.ac.ir Published Online: August 31, 2013been developed and used for the detection of Babesiaspp.",OADS,/arxiv_data1/oa_pdf/0e/be/jad-7-132.PMC3875879.pdf
":PCR-based Detection of … http://jad.tums.ac.ir Published Online: August 31, 2013special reference to pathogen transmis - sion.",OADS,/arxiv_data1/oa_pdf/0e/be/jad-7-132.PMC3875879.pdf
":PCR-based Detection of … http://jad.tums.ac.ir Published Online: August 31, 2013reverse line blotting.",Non-OADS,/arxiv_data1/oa_pdf/0e/be/jad-7-132.PMC3875879.pdf
": Purification of the… http://jad.tums.ac.ir Published Online: August 31, 2013Original Article Purification of the Immunogenic Fractions and Determination of Toxicity in Mesobuthus eupeus (Scorpionida: Buthidae) Venom MehdiKhoobdel1,TaghiZahraei-Salehi2,BaharNayeri-Fasaei2,*Mohammad Khosravi1, ZahraOmidian3,Mohammad Ha ssanMotedayen4,Abolfazal Akbari4 1Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran 2Department of Microbiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran 3Department of Parasitology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran 4Razi Vaccine and Serum Research Institute -Karaj Branch, Karaj, Iran (Received 25Jun2012; accepted 22Jan2013) Abstract Background: Scorpions stingsare a health problem in many parts of the wo rld.Mesobuthus eupeus (Buthidae) is the mostprevalent species in the Middle East andCentral Asia .",Non-OADS,/arxiv_data1/oa_pdf/ad/80/jad-7-139.PMC3875880.pdf
": Purification of the… http://jad.tums.ac.ir Published Online: August 31, 2013longing to the Buthidae familyand com- monly known as the lesser asianscorpion or the mottled scorpion .",Non-OADS,/arxiv_data1/oa_pdf/ad/80/jad-7-139.PMC3875880.pdf
": Purification of the… http://jad.tums.ac.ir Published Online: August 31, 2013experiment ,then, LD was calcu lated.",Non-OADS,/arxiv_data1/oa_pdf/ad/80/jad-7-139.PMC3875880.pdf
": Purification of the… http://jad.tums.ac.ir Published Online: August 31, 2013The median lethal dose (LD 50) ofM.",Non-OADS,/arxiv_data1/oa_pdf/ad/80/jad-7-139.PMC3875880.pdf
": Purification of the… http://jad.tums.ac.ir Published Online: August 31, 2013weights,whichinducebothtoxicological and immunological reactions invivo.We also developedan approach toward application andrefiningof the immunogenic frac tions of M. eupeus venom.",Non-OADS,/arxiv_data1/oa_pdf/ad/80/jad-7-139.PMC3875880.pdf
": Purification of the… http://jad.tums.ac.ir Published Online: August 31, 2013nogenic fractions and todetecting lessertox- icant fragments ,which,improvesthe quality of the antidotes and helps vac cinesdesigning.",Non-OADS,/arxiv_data1/oa_pdf/ad/80/jad-7-139.PMC3875880.pdf
"Dehghani R, Fathi B (2012) Scorpion sting in Iran: A review, Toxicon, Available at:http://dx.doi.org/10 .1016/j.toxicon.",OADS,/arxiv_data1/oa_pdf/ad/80/jad-7-139.PMC3875880.pdf
": Purification of the… http://jad.tums.ac.ir Published Online: August 31, 2013rantula spider venoms.",Non-OADS,/arxiv_data1/oa_pdf/ad/80/jad-7-139.PMC3875880.pdf
Ava ilable at: http://www.newhealth.govt.nz/neac/ .,Non-OADS,/arxiv_data1/oa_pdf/ad/80/jad-7-139.PMC3875880.pdf
": Purification of the… http://jad.tums.ac.ir Published Online: August 31, 2013Sadeghian H (2003) Transient ophtalmoplegia following enven omation by the scor - pionMesobuthus eupeus .",Non-OADS,/arxiv_data1/oa_pdf/ad/80/jad-7-139.PMC3875880.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 47–153 RBueno-Marí and R Jiménez-Peydró:Anophelism in … http://jad.tums.ac.ir Published Online: August 31, 20 13Original Article Anophelism in a Former Malaria Area of Northeastern Spain *Rubén Bueno -Marí, Ricardo Jiménez -Peydró Laboratorio de Entomología y Control de Plagas, Instituto Cavanilles de Biodiversidad y Biología Evolutiva, Universitat de València -Estudi General, Valencia, Spain (Received 6Oct2012; accepted 14 May2013) Abstract Background :A field study ondiversity and distribution of anophelines currently present in a past endemic malaria area of Spain was carried out in order to identify possibl e risk areas of local disease transmission.",Non-OADS,/arxiv_data1/oa_pdf/c8/bc/jad-7-147.PMC3875881.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 47–153 RBueno-Marí and R Jiménez-Peydró:Anophelism in … http://jad.tums.ac.ir Published Online: August 31, 20 13rian Peninsula ( EncinasGrandes 1982, Bueno Marí2011).Anopheleslabranchiae andAn.",Non-OADS,/arxiv_data1/oa_pdf/c8/bc/jad-7-147.PMC3875881.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 47–153 RBueno-Marí and R Jiménez-Peydró:Anophelism in … http://jad.tums.ac.ir Published Online: August 31, 20 13Results A total of 237 Anopheles larval speci mens were collected and identified (Table 1).",OADS,/arxiv_data1/oa_pdf/c8/bc/jad-7-147.PMC3875881.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 47–153 RBueno-Marí and R Jiménez-Peydró:Anophelism in … http://jad.tums.ac.ir Published Online: August 31, 20 13Discussion The presence of An.",Non-OADS,/arxiv_data1/oa_pdf/c8/bc/jad-7-147.PMC3875881.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 47–153 RBueno-Marí and R Jiménez-Peydró:Anophelism in … http://jad.tums.ac.ir Published Online: August 31, 20 13warmconditions the overwintering females of An.",Non-OADS,/arxiv_data1/oa_pdf/c8/bc/jad-7-147.PMC3875881.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 47–153 RBueno-Marí and R Jiménez-Peydró:Anophelism in … http://jad.tums.ac.ir Published Online: August 31, 20 13References Baldari M, Tamburro A, Sabatinelli G ,Romi R, Severini C , Cuccagna P, Fiorilli G, Allegri MP, Buriani C, Toti M (1998) Introduced malaria in Maremma, Italy, decades after eradication.",Non-OADS,/arxiv_data1/oa_pdf/c8/bc/jad-7-147.PMC3875881.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 47–153 RBueno-Marí and R Jiménez-Peydró:Anophelism in … http://jad.tums.ac.ir Published Online: August 31, 20 13northern Europe.",Non-OADS,/arxiv_data1/oa_pdf/c8/bc/jad-7-147.PMC3875881.pdf
":Evaluation of the … http://jad.tums.ac.ir Published Online: August 31, 2013Original Article Evaluation of the mtDNA -COIIRegionBased Species Specific Assay for Iden- tifyingMembers of the Anopheles culicifacies SpeciesComplex *ArulsamyMaryManonmani, A shok Kumar Mathivanan, C andassamy Sadanandane, Purushothaman Jambulingam Vector Control Research Centre, Medical Complex, Indira Nagar, Puducherry, India (Received 29Feb2012; accepted 15 May2013) Abstract Background: Anopheles culicifacies, a major malarial vector has been recognized as a complex of five sibling spe - cies,A, B, C, D and E .",Non-OADS,/arxiv_data1/oa_pdf/d0/af/jad-7-154.PMC3875882.pdf
":Evaluation of the … http://jad.tums.ac.ir Published Online: August 31, 2013This paper presents the findings of evalu- ation ofthis two step PCR assay using field specimens of An.",OADS,/arxiv_data1/oa_pdf/d0/af/jad-7-154.PMC3875882.pdf
":Evaluation of the … http://jad.tums.ac.ir Published Online: August 31, 2013contained only PCR product and 10x buffer.",Non-OADS,/arxiv_data1/oa_pdf/d0/af/jad-7-154.PMC3875882.pdf
":Evaluation of the … http://jad.tums.ac.ir Published Online: August 31, 2013 Fig.",Non-OADS,/arxiv_data1/oa_pdf/d0/af/jad-7-154.PMC3875882.pdf
":Evaluation of the … http://jad.tums.ac.ir Published Online: August 31, 2013 Fig.",Non-OADS,/arxiv_data1/oa_pdf/d0/af/jad-7-154.PMC3875882.pdf
":Evaluation of the … http://jad.tums.ac.ir Published Online: August 31, 2013Table 1.Details of collected Anopheles culicifacies samples District and State Geographical co-ordinatesVillage Habitat Type of collectionNo.",Non-OADS,/arxiv_data1/oa_pdf/d0/af/jad-7-154.PMC3875882.pdf
":Evaluation of the … http://jad.tums.ac.ir Published Online: August 31, 2013Table3.Evaluation of PCR assays for identification of individual members of Anopheles culicifacies Area rDNA-ITS2 PCR assaymtDNA-COII PCR assay PCR-RFLP A/D B/C/ETotal collected A/Dgroup B/C/Egroup -ve Numbers processed A D -ve Numbers processed B C E B/C/E -ve B/C/E E B/C Tiruvanamalai 20519178819117181253173243277 Ramanathapur am60058200004315971111131 Alwar 324284382144014 312741101201241 Malkangiri 26025100002571791916 Total 61530329913163116 02176511 441646641 515 -ve =negative Fig.",Non-OADS,/arxiv_data1/oa_pdf/d0/af/jad-7-154.PMC3875882.pdf
":Evaluation of the … http://jad.tums.ac.ir Published Online: August 31, 2013samples of An.",Non-OADS,/arxiv_data1/oa_pdf/d0/af/jad-7-154.PMC3875882.pdf
":Evaluation of the … http://jad.tums.ac.ir Published Online: August 31, 2013culicifacies complex, B/C heterozygotes were seen in forested and deforested villages of Northern Orissa, which represented inter - specific hybrids obtained due to breakdown of premating barriers between species B and C (Nanda et al.",OADS,/arxiv_data1/oa_pdf/d0/af/jad-7-154.PMC3875882.pdf
":Evaluation of the … http://jad.tums.ac.ir Published Online: August 31, 2013for sensitivity of PCR.",Non-OADS,/arxiv_data1/oa_pdf/d0/af/jad-7-154.PMC3875882.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 64–172 MAbdigoudarzi :Detection of Naturally … http://jad.tums.ac.ir Published Online: August 31, 2013Original Article Detection of NaturallyInfectedVectorTicks(Acari: Ixodidae) by DifferentSpecies of BabesiaandTheileria AgentsfromThreeDiffer- entEnzooticParts of Iran Mohammad Abdigoudarzi Reference Lab oratoryforTicks andTick-BorneDiseases, Departmentof Parasitology, Razi Vaccine and SerumResearch Ins titute, Karaj, Iran (Received 16Jan2012; accepted 1 4May 2013) Abstract Background: Diagnostic study of vector ticks for different pathogens transmitted specifically have been done by Iranian old scientists working on the basis of biological transmission of pathogens.",Non-OADS,/arxiv_data1/oa_pdf/02/12/jad-7-164.PMC3875883.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 64–172 MAbdigoudarzi :Detection of Naturally … http://jad.tums.ac.ir Published Online: August 31, 2013and regarding the presence of theileri osis due toTh.hirciin sheep in those areas, so an- othervectorshould be presented.",Non-OADS,/arxiv_data1/oa_pdf/02/12/jad-7-164.PMC3875883.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 64–172 MAbdigoudarzi :Detection of Naturally … http://jad.tums.ac.ir Published Online: August 31, 2013mount has been prepared for each samp le, staining was done by Giemsa (Giemsasolution from Merc k Company) and Feulgen staining method (using basic Fuchsin ac cording to a Laboratory Manual from Cel lularBiology Section at Shiraz University) (Fig.1 and 2).",OADS,/arxiv_data1/oa_pdf/02/12/jad-7-164.PMC3875883.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 64–172 MAbdigoudarzi :Detection of Naturally … http://jad.tums.ac.ir Published Online: August 31, 2013electrophoresis of PCRproducts related to DNA group no.",OADS,/arxiv_data1/oa_pdf/02/12/jad-7-164.PMC3875883.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 64–172 MAbdigoudarzi :Detection of Naturally … http://jad.tums.ac.ir Published Online: August 31, 2013 Fig .",OADS,/arxiv_data1/oa_pdf/02/12/jad-7-164.PMC3875883.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 64–172 MAbdigoudarzi :Detection of Naturally … http://jad.tums.ac.ir Published Online: August 31, 2013Discussion Regarding sheep and goats ,theileriosis due toTh.hirciandbabesiosis due to Ba.ovisand Ba.",Non-OADS,/arxiv_data1/oa_pdf/02/12/jad-7-164.PMC3875883.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 64–172 MAbdigoudarzi :Detection of Naturally … http://jad.tums.ac.ir Published Online: August 31, 2013Rh.sanguineus and 0.05% Hy.marginatum m. The examination of 345 tick salivary glands showed that 15% of salivary glands of Hy.",Non-OADS,/arxiv_data1/oa_pdf/02/12/jad-7-164.PMC3875883.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 64–172 MAbdigoudarzi :Detection of Naturally … http://jad.tums.ac.ir Published Online: August 31, 2013Figueroa JV, Hernandez R, Buening GM (1992) Use of polymerase chain reac - tion assay to detect Babesia bigemina in the tick Boophilus microplus .",Non-OADS,/arxiv_data1/oa_pdf/02/12/jad-7-164.PMC3875883.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 64–172 MAbdigoudarzi :Detection of Naturally … http://jad.tums.ac.ir Published Online: August 31, 2013Sparagano  OAE, Allsopp MTEP, Mank RA, Rijpkema SGT, Figueroa JV,  Jongejan F (1999) Molecular dete ction of Pathogen DNA in Ticks (Acari: Ixodidae): A review.Exp Appl Acarol.23:929–960.",Non-OADS,/arxiv_data1/oa_pdf/02/12/jad-7-164.PMC3875883.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 73–184 H Bakhshi :MtDNA CytB Structure … http://jad.tums.ac.ir Published Online: August 31, 2013Original Article MtDNA CytB Structure of Rhombomys opimus (Rodentia: Gerbellidae), the Main Reservoir of Cutaneous Leishmaniasis in the Borderline of Iran -Turkmenistan Hasan Bakhshi1,*Mohammad Ali Oshaghi1,Mohammad Reza Abai1, Yavar Rassi1, Amir Ahm ad Akhavan1, Mehdi Mohebali2, Homa Hajaran2, Fatemeh Mohtarami1, Hossein Mirzajani3, Naseh Maleki -Ravasan1 1Department of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran 2Department of Medical Parasitology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran 3Sarakhs Health Center, Sarakhs, Razavi Khorasan Province, Iran (Received 3Feb2012; accepted 18Aug2013) Abstract Background: Great gerbils, Rhombomys opimus ,are the main reservoir host of zoonootic cutaneous leishmaniasis (ZCL) in Iran and neighboring countries.",Non-OADS,/arxiv_data1/oa_pdf/12/24/jad-7-173.PMC3875884.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 73–184 H Bakhshi :MtDNA CytB Structure … http://jad.tums.ac.ir Published Online: August 31, 2013to 2009 (IMHME 2010, Oshaghi et al.",OADS,/arxiv_data1/oa_pdf/12/24/jad-7-173.PMC3875884.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 73–184 H Bakhshi :MtDNA CytB Structure … http://jad.tums.ac.ir Published Online: August 31, 2013was not uniform (Hajjaran et al.",Non-OADS,/arxiv_data1/oa_pdf/12/24/jad-7-173.PMC3875884.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 73–184 H Bakhshi :MtDNA CytB Structure … http://jad.tums.ac.ir Published Online: August 31, 2013amplifiedusing the protocol of (Maleki - Ravasan et al.",OADS,/arxiv_data1/oa_pdf/12/24/jad-7-173.PMC3875884.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 73–184 H Bakhshi :MtDNA CytB Structure … http://jad.tums.ac.ir Published Online: August 31, 2013mens of the same sex.",Non-OADS,/arxiv_data1/oa_pdf/12/24/jad-7-173.PMC3875884.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 73–184 H Bakhshi :MtDNA CytB Structure … http://jad.tums.ac.ir Published Online: August 31, 2013 Fig.",OADS,/arxiv_data1/oa_pdf/12/24/jad-7-173.PMC3875884.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 73–184 H Bakhshi :MtDNA CytB Structure … http://jad.tums.ac.ir Published Online: August 31, 2013 Fig.",OADS,/arxiv_data1/oa_pdf/12/24/jad-7-173.PMC3875884.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 73–184 H Bakhshi :MtDNA CytB Structure … http://jad.tums.ac.ir Published Online: August 31, 2013Table 2.",Non-OADS,/arxiv_data1/oa_pdf/12/24/jad-7-173.PMC3875884.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 73–184 H Bakhshi :MtDNA CytB Structure … http://jad.tums.ac.ir Published Online: August 31, 2013may lead to speciation in future if gene flow does not occur between them.",Non-OADS,/arxiv_data1/oa_pdf/12/24/jad-7-173.PMC3875884.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 73–184 H Bakhshi :MtDNA CytB Structure … http://jad.tums.ac.ir Published Online: August 31, 2013nested PCR assay from skin samples of rodent reservoirs.",OADS,/arxiv_data1/oa_pdf/12/24/jad-7-173.PMC3875884.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 73–184 H Bakhshi :MtDNA CytB Structure … http://jad.tums.ac.ir Published Online: August 31, 2013ervoir DNA for molecular testing.",OADS,/arxiv_data1/oa_pdf/12/24/jad-7-173.PMC3875884.pdf
"J Arthropod -Borne Dis, December 2013, 7(2): 1 73–184 H Bakhshi :MtDNA CytB Structure … http://jad.tums.ac.ir Published Online: August 31, 2013hosts of zoonotic cutaneous leish ma- niasis in central Iran.",Non-OADS,/arxiv_data1/oa_pdf/12/24/jad-7-173.PMC3875884.pdf
"J Arthropod-Borne Dis, December 2013, 7(2): 185 –187 S Wiwanitkit andV Wiwanitkit :Ckikungunya Virus … http://jad.tums.ac.ir Published Online: August 31, 2013ShortCommunication Ckikungunya Virus Infection and Relationship to Rainfall, the Rela - tionship Study from Southern Thailand *SomsriWiwanitkit, VirojWiwanitkit Wiwanitkit House, Bangkhae, Bangkok ,Thailand (Received 24July2012; accepted 6Apr2013) Abstract There are several important mosquito borne infectious disease in the tropical countries.",Non-OADS,/arxiv_data1/oa_pdf/7c/9b/jad-7-185.PMC3875885.pdf
"J Arthropod-Borne Dis, December 2013, 7(2): 185 –187 S Wiwanitkit andV Wiwanitkit :Ckikungunya Virus … http://jad.tums.ac.ir Published Online: August 31, 2013at: http://epid.moph.go.th: Accessed 1 May 2010) and rainfall (Royal Irrigation Depart - ment Thailand.",Non-OADS,/arxiv_data1/oa_pdf/7c/9b/jad-7-185.PMC3875885.pdf
Available at: http://www.rid.,Non-OADS,/arxiv_data1/oa_pdf/7c/9b/jad-7-185.PMC3875885.pdf
"J Arthropod-Borne Dis, December 2013, 7(2): 185 –187 S Wiwanitkit andV Wiwanitkit :Ckikungunya Virus … http://jad.tums.ac.ir Published Online: August 31, 2013ology.Many obvious factors can alter the epidemiology of mosquito -borne diseases es - peciallyinzoonotic ones.",Non-OADS,/arxiv_data1/oa_pdf/7c/9b/jad-7-185.PMC3875885.pdf
": Laboratory Evaluation of … http://jad.tums.ac.ir Published Online: August 31, 201 3Short Communication Laboratory Evaluation of a Rodenticide -insecticide, Coumavec®, againstRhombomys opimus , the Main Reservoir Host of Zoonotic Cutaneouse Leishmaniasis in Iran Arshad Veysi1, Hassan Vatandoost1, Mohammad HosseinArandian2, RezaJafari2, Mohammad Reza Yaghoobi -Ershadi1, Yavar Rassi1,*Amir Ahmad Akhavan3,1 1Department of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran 2Esfahan Health Research Station, National Inst itute of Health Research, Tehran University of Medical Sciences, Esfahan, Iran 3Institute for Environmental Research (IER), Tehran University of Medical Sciences, Tehran, Iran (Received 11Feb2013; accepted 22 Apr2013) Abstract Background: Zoonotic cu taneous leishmaniasis isa growing health problem in many rural areas of Iran.",Non-OADS,/arxiv_data1/oa_pdf/f8/58/jad-7-188.PMC3875886.pdf
": Laboratory Evaluation of … http://jad.tums.ac.ir Published Online: August 31, 201 3of ZCL in the northeast and central part of Iran(Yaghoobi -ErshadiandJavadian 1996).",Non-OADS,/arxiv_data1/oa_pdf/f8/58/jad-7-188.PMC3875886.pdf
": Laboratory Evaluation of … http://jad.tums.ac.ir Published Online: August 31, 201 3these tests, recommended for direct applica - tion as a rodenticide dust or for dilution in bait.",Non-OADS,/arxiv_data1/oa_pdf/f8/58/jad-7-188.PMC3875886.pdf
"1.Internal bleeding of a Rhombomys opimus treated by Coumavec® 190http://jad.tums.ac.ir Published Online: August 31, 2013",Non-OADS,/arxiv_data1/oa_pdf/f8/58/jad-7-188.PMC3875886.pdf
": Laboratory Evaluation of … http://jad.tums.ac.ir Published Online: August 31, 201 3Table 1.",Non-OADS,/arxiv_data1/oa_pdf/f8/58/jad-7-188.PMC3875886.pdf
": Laboratory Evaluation of … http://jad.tums.ac.ir Published Online: August 31, 201 3All concentrations have an increasing mor - tality trend, as prepared baits offered in each stage, the mo rtality increased consequently.",Non-OADS,/arxiv_data1/oa_pdf/f8/58/jad-7-188.PMC3875886.pdf
": Laboratory Evaluation of … http://jad.tums.ac.ir Published Online: August 31, 201 3Yaghoobi-Ershadi MR, Zahraei -Ramazani AR , Akhavan AA, Jalali -Zand AR, Abdoli H, Nadim A (2005) Rodent control op - erations against zoonotic cutaneous leishmaniasis in rural Iran.",Non-OADS,/arxiv_data1/oa_pdf/f8/58/jad-7-188.PMC3875886.pdf
": First Report of… http://jad.tums.ac.ir Published Online: August 31, 2013Case Report First Report of Pharyngostomy Wound Myiasis Caused by Chrysomya bezziana (Diptera: Calliphoridae) in Iran *Mussa Soleimani -Ahmadi1, 2, Hassan Vatandoost3, Ahmad Ali Hanafi -Bojd3, Fatemeh Poorahmad -Garbandi4, Mehdi Zare5, Seyed Mohammad V ahid Hosseini6 1Department of Medical Entomology and Vector Control, School of Public Health, Hormozgan University of Medical Sciences, Bandar Abbas, Iran 2Infectious Diseases Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran 3Department of Medical Entomology and Vector Control, School of Public Health and National Institute of Health Research, Tehran University of Medical Sciences, Tehran, Iran 4Bandar Abbas Health Center, Hormozgan University of Medical Sciences, Bandar Abbas , Iran 5Department of  Occupational Health Engineering, School of Public Health, Hormozgan University of Medical Sciences, Bandar Abbas, Iran 6Department of Pediatric, School of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran (Received27Aug2012; accepted 15Apr2013) Abstract Wound or traumatic Myiasis is the infestation of animal and human orifices or wounds by dipterous larvae.",Non-OADS,/arxiv_data1/oa_pdf/8c/e2/jad-7-194.PMC3875887.pdf
": First Report of… http://jad.tums.ac.ir Published Online: August 31, 2013cently, human cases of myiasis caused by C. bezziana in south and south -east of Iran have been increased as nasal myiasis (Tirgarie et al.",Non-OADS,/arxiv_data1/oa_pdf/8c/e2/jad-7-194.PMC3875887.pdf
": First Report of… http://jad.tums.ac.ir Published Online: August 31, 2013Discussion Human myiasis is a rare condition in any part of the world, but is more common in the regions with a warm and humid climate .The Old World screwworm, C.bezziana, is a majoragent of traumatic myiasis throughout the tropical regions of the Old World (Spradbery 1994).",Non-OADS,/arxiv_data1/oa_pdf/8c/e2/jad-7-194.PMC3875887.pdf
": First Report of… http://jad.tums.ac.ir Published Online: August 31, 2013authors declare that they have no conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/8c/e2/jad-7-194.PMC3875887.pdf
": First Report of… http://jad.tums.ac.ir Published Online: August 31, 2013Spradbery JP (1994) Screwworm fly: a tale of two species.",Non-OADS,/arxiv_data1/oa_pdf/8c/e2/jad-7-194.PMC3875887.pdf
2013;88(6 Suppl 1):216-9.Angelo Atalla1Abrahão Elias Hallack Neto2 Denise Bittencourt Siqueira3Gabriela Cumani Toledo3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132365 Abstract: Mycosis Fungoides is typically an indolent disease in early stages.,Non-OADS,/arxiv_data1/oa_pdf/15/bd/abd-88-06-s1-0216.PMC3875963.pdf
"2013;88(6 Suppl 1):154-7.Subcutaneous fat necrosis of the newborn: clinical  manifestations in two cases* Necrose gordurosa subcutânea do recém-nascido: manifestações  clínicas de dois casos Milena Pires de Campos Luciano Gomes1Adriana Maria Porro2 Milvia Maria Simões da Silva Enokihara3Marcos César Floriano4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132229 Abstract: Subcutaneous fat necrosis of the newborn is an unusual form of panniculitis, with few cases described in medical literature.",Non-OADS,/arxiv_data1/oa_pdf/58/c8/abd-88-06-s1-0154.PMC3875964.pdf
"s Primary systemic amyloidosis, acquired cutis laxa and  cutaneous mucinosis in a patient with multiple myeloma* Amiloidose sistêmica primária, cútis laxa adquirida e mucinose cutânea  em paciente com mieloma múltiplo Fernanda Guedes Lavorato1Maria de Fátima Guimarães Scotelaro Alves2 Juan Manuel Piñeiro Maceira3Natasha Unterstell1 Laura Araújo Serpa1Luna Azulay-Abulafia4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132531 Abstract: A 57-year-old woman presented with periorbital ecchymoses, laxity in skin folds, polyneuropathy and bilateral carpal tunnel syndrome.",Non-OADS,/arxiv_data1/oa_pdf/0c/09/abd-88-06-s1-0032.PMC3875965.pdf
2013;88(6 Suppl 1):190-2.Sheila Itamara Ferreira do Couto Meireles1Sônia Maria Fonseca de Andrade2 Cristiano Luiz Horta de Lima Júnior3Mario Cezar Pires4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132328 Abstract: Epidermodysplasia Verruciformis is a genodermatosis characterized by susceptibility to infection by specific HPV types (HPV 3/10 and beta-HPVs).,Non-OADS,/arxiv_data1/oa_pdf/95/39/abd-88-06-s1-0190.PMC3875966.pdf
2013;88(6 Suppl 1):176-8.Pyoderma gangrenosum: skin grafting and hyperbaric oxygen as adjuvants in the treatment of a deep and extensive ulcer* Pioderma gangrenoso: enxerto de pele e oxigenoterapia hiperbárica como  adjuvantes no tratamento de úlcera extensa e profunda Fernanda Mendes Araújo1Rogério Nabor Kondo2Lorivaldo Minelli3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132680 Abstract: Pyoderma gangrenosum is a rare dermatosis of unknown etiology and variable clinical presentation.,Non-OADS,/arxiv_data1/oa_pdf/2d/e5/abd-88-06-s1-0176.PMC3875967.pdf
"The dermoscopic examination showed a pink background, with some areas blackened, white stria-tions in different directions and prominent follicularorifices (Figure 2).DOI: http://dx.doi.org/10.1590/abd1806-4841.20132384 Abstract: The granuloma faciale is a rare and benign skin disease of unknown etiology, characterized by chronic leukocitoclastic vasculitis.",Non-OADS,/arxiv_data1/oa_pdf/48/a6/abd-88-06-s1-0097.PMC3875968.pdf
"suggested the simpler description ‘nodular fasciitis’ based on the analysis ofDOI: http://dx.doi.org/10.1590/abd1806-4841.20132474 Abstract: Nodular fasciitis is a benign tumor, resulting from reactive proliferation composed of fibroblastic/myofibroblastic cells.",Non-OADS,/arxiv_data1/oa_pdf/83/74/abd-88-06-s1-0089.PMC3875969.pdf
"©2013 by Anais Brasileiros de DermatologiaDOI: http://dx.doi.org/10.1590/abd1806-4841.20132413 Abstract: The authors describe a case of a female patient with Acral Pseudolymphomatous Angiokeratoma of Children, known as APACHE.",Non-OADS,/arxiv_data1/oa_pdf/59/5c/abd-88-06-s1-0039.PMC3875970.pdf
©2013 by Anais Brasileiros de DermatologiaCASEREPORT DOI: http://dx.doi.org/10.1590/abd1806-4841.20132487 Abstract: The paradoxical adverse effects of tumor necrosis factor-alpha (TNF-alpha) antagonists have been described frequent- ly as a result of the widespread use of these drugs.,Non-OADS,/arxiv_data1/oa_pdf/39/c4/abd-88-06-s1-0026.PMC3875971.pdf
"There is apredilection for the extremities and a chronic course.DOI: http://dx.doi.org/10.1590/abd1806-4841.20132510 Abstract: A case is reported of a patient presenting lymph node tuberculosis and cutaneous lesions resembling papulonecrotic tuberculid, but histologically compatible with perforating granuloma annulare and whichresponded satisfactorily to antituberculous therapy.",Non-OADS,/arxiv_data1/oa_pdf/ed/85/abd-88-06-s1-0101.PMC3875972.pdf
2013;88(6 Suppl 1):S63-6.63sCASEREPORT Congenital multiple clustered dermatofibroma and multiple eruptive dermatofibromas - unusual presentations  of a common entity* Dermatofibroma múltiplo agrupado congênito e dermatofibromas múltiplos eruptivos - apresentações singulares de uma entidade comum Teresa Pinto-Almeida1Mónica Caetano1Rosário Alves1Manuela Selores1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132647 Abstract: Dermatofibroma is one of the most common entities seen in dermatology clinical practice.,Non-OADS,/arxiv_data1/oa_pdf/c0/92/abd-88-06-s1-0063.PMC3875973.pdf
2013;88(6 Suppl 1):224-6.Felipe Maurício Soeiro Sampaio1Marcela Duarte Benez Miller2 Gustavo Vieira Gualberto2Maria Clara Gutierrez Galhardo3 Antonio Carlos Francesconi do Valle3Paulo Roberto Cotrim de Souza4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132762 Abstract: Reconstruction of surgical defects in the pubic region is a challenge to any surgeon.,Non-OADS,/arxiv_data1/oa_pdf/90/21/abd-88-06-s1-0224.PMC3875974.pdf
2013;88(6 Suppl 1):220-3.Juliana Nakano de Melo1Anita Rotter2 Maria Cecília Rivitti-Machado3Zilda Najjar Prado de Oliveira4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20131699 Abstract: Infantile hemangioma is the most common vascular tumor in early childhood.,Non-OADS,/arxiv_data1/oa_pdf/3f/dc/abd-88-06-s1-0220.PMC3875975.pdf
2013;88(6 Suppl 1):186-9.Pustular psoriasis of pregnancy (Impetigo herpetiformis) - Case report* Psoríase pustulosa da gestação (Impetigo herpetiforme) - Relato de caso  Rogerio Nabor Kondo1Fernanda Mendes Araújo2Allamanda Moura Pereira2 Vivian Cristina Holanda Lopes3Ligia Márcia Mario Martins4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132134 Abstract: Impetigo herpetiformis is a rare dermatosis of pregnancy with typical onset during the last trimester of pregnancy and rapid resolution in the postpartum period.,Non-OADS,/arxiv_data1/oa_pdf/df/6a/abd-88-06-s1-0186.PMC3875976.pdf
"2013;88(6 Suppl 1):132-5.Primary cutaneous anaplastic large-cell lymphoma - Case report* Linfoma cutâneo primário de grandes células anaplásicas - Relato de caso Luciana Silveira Rabello de Oliveira1Madeleyne Palhano Nobrega2 Maira Gomes Monteiro3Wagner Leite de Almeida4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20131731 Abstract: Primary cutaneous anaplastic large-cell lymphoma is part of the spectrum of CD30+ lymphoprolifera- tive cutaneous processes, characterized by single or multifocal nodules that ulcerate, are autoregressive andrecurrent.",Non-OADS,/arxiv_data1/oa_pdf/a6/cd/abd-88-06-s1-0132.PMC3875977.pdf
2013;88(6 Suppl 1):136-8.Primary cutaneous centrofollicular lymphoma with a  good response to radiotherapy* Linfoma centrofolicular cutâneo primário com boa resposta a radioterapia Cláudia Medeiros dos Santos Camargo1Lislaine Bomm2 Leonardo Spagnol Abraham3Rafael Daher4 Maria de Fátima Guimarães Scotelaro5Luna Azulay Abulafia6 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132427 Abstract: Primary cutaneous lymphomas have different clinical behavior and prognosis than systemic lym- phomas of similar histological subtype.,Non-OADS,/arxiv_data1/oa_pdf/22/27/abd-88-06-s1-0136.PMC3875978.pdf
2013;88(6 Suppl 1):200-2.Flavia Trevisan1Paulo Rowilson Cunha2 Clovis Antonio Lopes Pinto3Celia Antonia Xavier de Moraes Alves4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132104 Abstract: Kaposi's sarcoma is a multifactorial angioproliferative disorder.,Non-OADS,/arxiv_data1/oa_pdf/d2/53/abd-88-06-s1-0200.PMC3875979.pdf
"Available from:http://www.uptodate.comBrambilla L, Boneschi V, Taglioni M, Ferrucci S. Staging of classic Kaposi's sarcoma: 2. a useful tool for therapeutic choices.",Non-OADS,/arxiv_data1/oa_pdf/d2/53/abd-88-06-s1-0200.PMC3875979.pdf
"©2013 by Anais Brasileiros de Dermatologia s193CASEREPORT DOI: http://dx.doi.org/10.1590/abd1806-4841.20132500 Abstract: Acne fulminans is a rare and severe form of acne that may evolve from acne vulgaris, especially in male adolescents, or occur as an adverse effect of oral isotretinoin.",Non-OADS,/arxiv_data1/oa_pdf/d0/4c/abd-88-06-s1-0193.PMC3875980.pdf
2013;88(6 Suppl 1):170-2.Congenital agminated melanocytic nevus - Case report* Nevo melanocítico congênito agminado - Relato de caso Camila Roos Mariano da Rocha1Thaís Corsetti Grazziotin2Maria Carolina Widholzer Rey2 Laura Luzzatto3Renan Rangel Bonamigo4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132137 Abstract: Agminated nevus is a cluster group of melanocytic nevi confined to a localized area of the body.,Non-OADS,/arxiv_data1/oa_pdf/35/c4/abd-88-06-s1-0170.PMC3875981.pdf
©2013 by Anais Brasileiros de Dermatologia s113CASEREPORT DOI: http://dx.doi.org/10.1590/abd1806-4841.20132538 Abstract: Tufted angioma is an acquired vascular proliferation with specific histological characteristics.,Non-OADS,/arxiv_data1/oa_pdf/21/34/abd-88-06-s1-0113.PMC3875982.pdf
"s Extra ocular sebaceous adenocarcinoma in HIV-positive patient - Case report* Adenocarcinoma sebáceo extra-ocular em paciente HIV positivo - Relato de caso DOI: http://dx.doi.org/10.1590/abd1806-4841.20132476 Abstract: Sebaceous adenocarcinoma is a rare adnexal tumor that can affect the skin and is divided into ocular, a more common form and extra ocular, of a rarer occurrence.",Non-OADS,/arxiv_data1/oa_pdf/bc/b8/abd-88-06-s1-0019.PMC3875983.pdf
©2013 by Anais Brasileiros de DermatologiaCASEREPORT DOI: http://dx.doi.org/10.1590/abd1806-4841.20132332 Abstract: We present a case of PNP associated with Castleman's Disease.,Non-OADS,/arxiv_data1/oa_pdf/70/6e/abd-88-06-s1-0011.PMC3875984.pdf
"2013;88(6 Suppl 1):120-3.Implantation of autologous fat globules in localized scleroderma and idiopathic lipoatrophy - report of five patients* Implante de fragmentos de lóbulos de gordura autóloga na esclerodermia  localizada e lipoatrofia idiopática, relato de cinco pacientes Tiago Pina Zanelato1Giovana Marquesini2Paula Tavares Colpas3 Renata Ferreira Magalhães4Aparecida Machado de Moraes5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132115 Abstract: A large number of diseases may cause Atrophic skin disorders are caused by a large number of dis- eases, some of them idiopathic and others inflammatory, in which there is loss of volume of body segments.Localized scleroderma is a rare inflammatory dermatosis, manifested by atrophic skin and subcutaneous tissuealterations.",Non-OADS,/arxiv_data1/oa_pdf/ab/9e/abd-88-06-s1-0120.PMC3875985.pdf
"©2013 by Anais Brasileiros de Dermatologia s105CASEREPORT DOI: http://dx.doi.org/10.1590/abd1806-4841.20132050 Abstract: Leprosy is a chronic infectious disease caused by Mycobacterium leprae, which primarily affects the skin and peripheral nerves.",Non-OADS,/arxiv_data1/oa_pdf/36/d6/abd-88-06-s1-0105.PMC3875986.pdf
"2013;88(6 Suppl 1):128-31.Lymphocytoma cutis - Case report* Linfocitoma cutis - Relato de caso Ederson Valei Lopes de Oliveira1Giovana Bachega Badiale2Margarida M. F. S. Moraes3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132320 Abstract: We describe a clinical case involving a 62-year-old white male, diagnosed with lymphocytoma cutis (Spiegler-Fendt sarcoid) in the cephalic segment.",Non-OADS,/arxiv_data1/oa_pdf/28/e4/abd-88-06-s1-0128.PMC3875987.pdf
"CASE REPORT Male, aged 61, presenting cutaneous sclerosis involving acute onset, progressive evolution, of cen-trifugal character, for 3 months, associated with func-tional limitation of joint movements and oral opening.The dermatological exam revealed hyperpigmenta-tion and diffuse cutaneous thickening, sparing thenipples, an increase in hand volume without anyvasospastic phenomena or sclerodactyly, and tensebullous lesions in the lower limbs (Figures 1,2 and 3).He did not present comorbidity, was a smoker andDiffuse systemic sclerosis with bullous lesions without  systemic manifestations* Esclerose sistemica difusa bolhosa sem acometimentos sistemicos  Paula Renaux Wanderley Caratta Macedo1Amanda Nascimento Cavalleiro de Macedo Mota1 Alexandre Carlos Gripp2Maria de Fatima Guimarães Scotelaro Alves3 Evandro Mendes Klumb4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132160 Abstract: Here, we describe an atypical case of systemic sclerosis in its diffuse cutaneous form with acute and rapid progression of the cutaneous condition, without any systemic manifestations and the infrequent formationof bullae, showing the importance of diagnosis and early treatment in such cases.",Non-OADS,/arxiv_data1/oa_pdf/94/ae/abd-88-06-s1-0078.PMC3875988.pdf
Fernandes Abbade3 Mariângela Esther Alencar Marques4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132280 Abstract: Calciphylaxis or calcific uremic arteriolopathy is a rare cutaneous-systemic disease occurring in patients with advanced chronic kidney disease.,Non-OADS,/arxiv_data1/oa_pdf/61/b6/abd-88-06-s1-0044.PMC3875989.pdf
59sCASEREPORT Carcinomatous degeneration of pilonidal cyst with sacrum destruction and invasion of the rectum* Degeneração carcinomatosa do cisto pilonidal com destruição do  sacro e invasão da parede do reto  Luiz Fernando Nunes1Antonio Kneipp Pitta de Castro Neto2 Roberto André Torres Vasconcelos3Flávio Cajaraville4 Juliana Castilho4José Francisco Netto Rezende5 Washington Silva Noguera6 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132140 Abstract: Malignant degeneration of pilonidal cysts is rare.,Non-OADS,/arxiv_data1/oa_pdf/a3/02/abd-88-06-s1-0059.PMC3875990.pdf
©2013 by Anais Brasileiros de Dermatologia s197CASEREPORT DOI: http://dx.doi.org/10.1590/abd1806-4841.20132588 Abstract: The antagonists of tumor necrosis factor alpha (TNF- α) are increasingly being used in the treatment of inflammatory and autoimmune diseases.,Non-OADS,/arxiv_data1/oa_pdf/00/10/abd-88-06-s1-0197.PMC3875991.pdf
"©2013 by Anais Brasileiros de DermatologiaCASEREPORT23 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132187 Abstract: Biological agents are widely used for various immune-mediated diseases, with remarkable effectiveness in the treat- ment of rheumatoid arthritis (RA), psoriasis, psoriatic arthritis, ankylosing spondylitis and Crohn’s disease.",Non-OADS,/arxiv_data1/oa_pdf/93/0a/abd-88-06-s1-0023.PMC3875992.pdf
"©2013 by Anais Brasileiros de Dermatologia s139CASEREPORT DOI: http://dx.doi.org/10.1590/abd1806-4841.20131971 Abstract: Lichen planus is an uncommon disease in children, and only 2 to 3% of affected patients are under twenty years of age.",Non-OADS,/arxiv_data1/oa_pdf/73/06/abd-88-06-s1-0139.PMC3875993.pdf
©2013 by Anais Brasileiros de DermatologiaLuciana Helena Zacaron1Júlia Costa de Faria Gonçalves2 Vanessa Maria Amoreira Curty3Antonio Macedo D'Acri4 Ricardo Barbosa Lima5Carlos José Martins615CASEREPORT DOI: http://dx.doi.org/10.1590/abd1806-4841.20132150 Abstract: Erythema elevatum diutinum is a rare chronic cutaneous vasculitis which usually affects adults.,Non-OADS,/arxiv_data1/oa_pdf/3e/f8/abd-88-06-s1-0015.PMC3875994.pdf
"2013;88(6 Suppl 1):S82-4.Eumycetoma by Madurella mycetomatis with 30 years of evolution: therapeutic challenge* Eumicetoma por Madurella mycetomatis com 30 anos de evolução:  desafio terapêutico  Felipe Maurício Soeiro Sampaio1Maria Clara Gutierrez Galhardo2 Leonardo Pereira Quintella3Paulo Roberto Cotrim de Souza4 Janice Mary Chicarino de Oliveira Coelho5Antonio Carlos Francesconi do Valle2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132136 Abstract: We report a case of eumycetoma by Madurella mycetomatis on the buttocks and thighs in an adult immunocompetent patient, diagnosed after 30 years of clinical development.",Non-OADS,/arxiv_data1/oa_pdf/a1/90/abd-88-06-s1-0082.PMC3875995.pdf
"2013;88(6 Suppl 1):206-8.Liliam Dalla Corte1Mariana Vale Scribel da Silva1Carina Flores de Oliveira1 Gerson Vetoratto2Raquel Bissacotti Steglich3Josiane Borges4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132135 Abstract: Vohwinkel syndrome or keratoderma hereditaria mutilans is a rare autosomal dominant palmoplantar keratosis, which manifests in infants and becomes more evident in adulthood.",Non-OADS,/arxiv_data1/oa_pdf/78/90/abd-88-06-s1-0206.PMC3875996.pdf
©2013 by Anais Brasileiros de DermatologiaCASEREPORT29 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132241 Abstract: Psoriasis is a relatively frequent inflammatory dermatosis.,Non-OADS,/arxiv_data1/oa_pdf/59/f9/abd-88-06-s1-0029.PMC3875997.pdf
"2013;88(6 Suppl 1):212-5.Hiram Larangeira de Almeida Jr1Gláucia Thomas Heckler2Kenneth Fong3 Joey Lai-Cheong4John McGrath4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132173 Abstract: We report the case of a 28-year-old woman with Kindler syndrome, a rare form of epidermolysis bul- losa.",Non-OADS,/arxiv_data1/oa_pdf/6d/86/abd-88-06-s1-0212.PMC3875998.pdf
2013;88(6 Suppl 1):124-7.Cutaneous leiomyomatosis in a mother and daughter* Leiomiomatose cutânea em mãe e filha André Lencastre1Joana Cabete2Rui Gonçalves3 Alexandre João4Ana Fidalgo4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132449 Abstract: A 34-year-old woman with no known medical history was evaluated for multiple painful brown nod- ules and papules on the anterior aspect of the trunk.,Non-OADS,/arxiv_data1/oa_pdf/13/83/abd-88-06-s1-0124.PMC3876000.pdf
"2013;88(6 Suppl 1):146-9.Lichen planus pigmentosus inversus* Líquen plano pigmentoso invertido Hugo Rocha Barros1José Roberto Paes de Almeida2Sandra Lopes Mattos e Dinato3 Angelo Sementilli4Ney Romiti5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132599 Abstract: Twenty-five year old male patient presenting with asymptomatic brown spots, on cervical, axillary, inguinal and popliteal regions, for the last nine months.",Non-OADS,/arxiv_data1/oa_pdf/2d/aa/abd-88-06-s1-0146.PMC3876001.pdf
"sCASEREPORT52 Cowden Syndrome: report of a case and brief review  of literature* Síndrome de Cowden : Relato de caso e uma breve revisão da literatura   DOI: http://dx.doi.org/10.1590/abd1806-4841.20132578 Abstract: We present the case of a female patient with facial cutaneous lesions, a cobblestone-like pattern of the oral mucosa, and verruciform lesions on the hand since her youth.",Non-OADS,/arxiv_data1/oa_pdf/00/d7/abd-88-06-s1-0052.PMC3876002.pdf
sCASEREPORT56 Cutaneous metastasis of colon adenocarcinoma: case report and review of the literature* Metástasis cutânea de adenocarcinoma colorretal: relato de caso  e revisão da literatura Ioannis Nesseris1Charalambos Tsamakis2Stamatis Gregoriou3 Ilias Ditsos4Eleftheria Christofidou5Dimitris Rigopoulos6 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132441 Abstract: Skin metastases from colorectal carcinoma are rare and signal advanced disease.,Non-OADS,/arxiv_data1/oa_pdf/49/fd/abd-88-06-s1-0056.PMC3876003.pdf
"2013;88(6 Suppl 1):S67-70.67sCASEREPORT Linear IgA bullous dermatosis: report of an exuberant case* Dermatose por IgA Linear: relato de um caso exuberante Beatriz Cavalcanti de Souza1Nádire Cristina Freire Pontes Fregonesi1 Antônio José Tebcherani2Ana Paula Galli Sanchez3 Valéria Aoki4Juliana Christien Fernandes5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132154 Abstract: Linear immunoglobulin A dermatosis is a rare autoimmune bullous disease, but the most common autoimmune bullous dermatosis in children.",Non-OADS,/arxiv_data1/oa_pdf/59/b7/abd-88-06-s1-0067.PMC3876004.pdf
"©2013 by Anais Brasileiros de Dermatologia s173CASEREPORT DOI: http://dx.doi.org/10.1590/abd1806-4841.20132601 Abstract: Pyoderma gangrenosum is a rare, inflammatory, chronic and recurrent disease of unknown etiology, characterized by noninfectious, necrotizing and painful cutaneous ulcers.",Non-OADS,/arxiv_data1/oa_pdf/85/db/abd-88-06-s1-0173.PMC3876005.pdf
s36CASEREPORT Analysis of mutations in the PIK3CA and FGFR3 genes in  verrucous epidermal nevus* Análise de mutações nos genes PIK3CA e FGFR3 em caso de nevo  epidérmico verrucoso   Ludmilla Queirós Miranda1Tainá Scalfoni Fracaroli2João Carlos Macedo Fonseca3 Elisa Fontenelle4Raphael Pedro Machado Curvo5Luís Cristóvão Porto6 Roberto Souto7 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132055 Abstract: Verrucous epidermal nevi are congenital hamartomas composed of keratinocytes and may occur alone or in association with developmental abnormalities.,Non-OADS,/arxiv_data1/oa_pdf/6b/c5/abd-88-06-s1-0036.PMC3876006.pdf
"2013;88(6 Suppl 1):166-9.Diffuse neurofibroma - An uncommon cause of alopecia* Neurofibroma difuso - Uma causa rara de alopécia Vasco Coelho Macias1Margarida Rafael2Cândida Fernandes3Joaninha Costa Rosa4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132170 Abstract: Although infrequent, alopecia can be caused by benign cutaneous tumours.",Non-OADS,/arxiv_data1/oa_pdf/be/73/abd-88-06-s1-0166.PMC3876007.pdf
"©2013 by Anais Brasileiros de Dermatologia s109CASEREPORT DOI: http://dx.doi.org/10.1590/abd1806-4841.20131986 Abstract: Hepatitis C is an inflammatory disease of the liver caused by a single-stranded RNA virus belonging to the Hepacivirus genus in the Flaviviridae family, called the hepatitis C virus.",Non-OADS,/arxiv_data1/oa_pdf/ee/d0/abd-88-06-s1-0109.PMC3876008.pdf
©2013 by Anais Brasileiros de Dermatologia s209CASEREPORT DOI: http://dx.doi.org/10.1590/abd1806-4841.20132488 Abstract: Acrokeratosis Paraneoplastica or Bazex syndrome is a dermatologic manifestation usually associated with the diagnosis of squamous cell carcinoma of the upper aerodigestive tract.,Non-OADS,/arxiv_data1/oa_pdf/98/d8/abd-88-06-s1-0209.PMC3876009.pdf
"©2013 by Anais Brasileiros de Dermatologia s203CASEREPORT DOI: http://dx.doi.org/10.1590/abd1806-4841.20132199 Abstract: A 45-year-old woman with a history of renal carcinoma was observed for facial, cervical and truncal flesh-colored papules.",Non-OADS,/arxiv_data1/oa_pdf/5f/ba/abd-88-06-s1-0203.PMC3876010.pdf
2013;88(6 Suppl 1):162-5.Optic neuritis due to immunobiologics:  first Brazilian case report* Neurite óptica por imunobiológico: relato do primeiro caso brasileiro Luiz Gustavo Martins da Silva1Letícia Soares Sasso2 Carlos José Nelli3Fred Bernardes Filho4 Marilda Aparecida Milanez Morgado de Abreu5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132295 Abstract: The change in immunological response obtained by  immunobiologics has brought a new paradigm to the treatment of immune-mediated disorders.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/abd-88-06-s1-0162.PMC3876011.pdf
sCASEREPORT48 Inguinal ulcerated sebaceous carcinoma:  an unusual presentation* Carcinoma sebáceo inguinal ulcerado: apresentação incomum   DOI: http://dx.doi.org/10.1590/abd1806-4841.20132019 Abstract: Sebaceous carcinoma is a rare and aggressive skin tumor.,Non-OADS,/arxiv_data1/oa_pdf/e2/3a/abd-88-06-s1-0048.PMC3876012.pdf
©2013 by Anais Brasileiros de Dermatologia s183CASEREPORT DOI: http://dx.doi.org/10.1590/abd1806-4841.20132232 Abstract: Cutaneous protothecosis is a rare infection caused by achlorophyllic algae of the genus Prototheca.,Non-OADS,/arxiv_data1/oa_pdf/ed/0d/abd-88-06-s1-0183.PMC3876013.pdf
2013;88(6 Suppl 1):158-61.Blastic plasmacytoid dendritic cell neoplasm* Neoplasia blástica de células dendríticas plasmocitóides André Lencastre1Joana Cabete2Alexandre João3 Pedro Farinha4Gilda Ferreira5Sara Lestre3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132388 Abstract: Blastic plasmacytoid dendritic cell neoplasm is a rare and aggressive hematodermic neoplasia with fre- quent cutaneous involvement and leukemic dissemination.,Non-OADS,/arxiv_data1/oa_pdf/e7/9e/abd-88-06-s1-0158.PMC3876014.pdf
"©2013 by Anais Brasileiros de Dermatologia s227CASEREPORT DOI: http://dx.doi.org/10.1590/abd1806-4841.20132363 Abstract: Livedoid vasculopathy (LV) is a chronic and recurrent disease consisting of livedo reticularis and sym- metric ulcerations, primarily located on the lower extremities, which heal slowly and leave an atrophic white scar(""atrophie blanche"").",Non-OADS,/arxiv_data1/oa_pdf/a6/2f/abd-88-06-s1-0227.PMC3876016.pdf
"©2013 by Anais Brasileiros de Dermatologia s179CASEREPORT DOI: http://dx.doi.org/10.1590/abd1806-4841.20132721 Abstract: Porokeratosis is a disorder of epidermal keratinization characterized by annular plaques with an atrophic center and hyperkeratotic edges, and includes a heterogeneous group of disorders that are mostly inhe-rited in an autosomal dominant form.",Non-OADS,/arxiv_data1/oa_pdf/ae/80/abd-88-06-s1-0179.PMC3876017.pdf
"Leprous reactions are acute andDOI: http://dx.doi.org/10.1590/abd1806-4841.20132398 Abstract: Lucio's phenomenon represents a serious cutaneous necrotizing reaction, which can occur with Lucio's leprosy and also in other forms of lepromatous leprosy.",Non-OADS,/arxiv_data1/oa_pdf/9b/2c/abd-88-06-s1-0093.PMC3876018.pdf
Disponívelem: http://bvsms.saude.gov.br/bvs/publicacoes/guia_de_hanseniase.pdf.Guideline for the control of Hanseniasis.,Non-OADS,/arxiv_data1/oa_pdf/9b/2c/abd-88-06-s1-0093.PMC3876018.pdf
"Available in Portuguese athttp://bvsms.saude.gov.br/bvs/publicacoes/guia_de_hanseniase.pdf.Helmer KA, kucharski-Fleischfresser I, Esmanhoto LDK.",Non-OADS,/arxiv_data1/oa_pdf/9b/2c/abd-88-06-s1-0093.PMC3876018.pdf
Available from: http://www.nsc.gov.sg/showpage.asp?id=328.,Non-OADS,/arxiv_data1/oa_pdf/9b/2c/abd-88-06-s1-0093.PMC3876018.pdf
2013;88(6 Suppl 1):S75-7.75sCASEREPORT Systemic sclerosis with keloidal nodules* Esclerose sistêmica com nódulos queloidianos Bárbara Stadler1Aline Paula Biazus Somacal2Emilio Weingraber1 Michelle Tokarski Fontana3Thelma Larocca Skare4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132245 Abstract: Nodular sclerosis is a rare form of presentation related to both systemic and localized forms of sclero- derma.,Non-OADS,/arxiv_data1/oa_pdf/65/31/abd-88-06-s1-0075.PMC3876019.pdf
2013;88(6 Suppl 1):150-3.Pyoderma gangrenosum with renal and splenic  impairment - Case report* Manifestação esplênica e renal do pioderma gangrenoso - Relato de caso Luciana Rabelo de Carvalho1Virgínia Vinha Zanuncio1Bernardo Gontijo2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132448 Abstract: Pyoderma gangrenosum is an uncommon and recurrent neutrophilic dermatosis of unknown cause.,Non-OADS,/arxiv_data1/oa_pdf/53/23/abd-88-06-s1-0150.PMC3876020.pdf
2013;88(6 Suppl 1):S71-4.71sCASEREPORT Vulvoperineal Crohn´s disease responsive to metronidazol* Doença de Crohn vulvoperineal responsiva ao metronidazole Aristóteles Rosmaninho1Madalena Sanches2Marta Salgado3 Rosário Alves1Manuela Selores4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132243 Abstract: Crohn´s disease is a multisystem chronic granulomatous inflammatory disease that primarily affects the gastrointestinal tract.,Non-OADS,/arxiv_data1/oa_pdf/a4/0b/abd-88-06-s1-0071.PMC3876021.pdf
2013;88(6 Suppl 1):116-9.Mosaic epidermolytic ichthyosis - Case report* Ictiose epidermolítica em mosaico - Relato de caso  Marcela Sena Teixeira Mendes1Samara Silva Kouzak1 Thaissa Araújo Aquino1Gustavo Henrique Soares Takano2 Antonio de Padua Lima3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132203 Abstract: Epidermolytic ichthyosis is a rare autosomal dominant disease that manifests at birth with fragile blis- ters and erosions that evolve into hyperkeratotic lesions associated or not with erythroderma.,Non-OADS,/arxiv_data1/oa_pdf/bb/55/abd-88-06-s1-0116.PMC3876022.pdf
Available at http://www3.ntsb.gov/speeches/ hersman/daph101109.html .,Non-OADS,/arxiv_data1/oa_pdf/7f/73/wjem-14-576.PMC3876297.pdf
Available at http://www.gao.,Non-OADS,/arxiv_data1/oa_pdf/7f/73/wjem-14-576.PMC3876297.pdf
Available at: http://www.cdc.gov/injury/ wisqars/LeadingCauses.html.,OADS,/arxiv_data1/oa_pdf/7f/73/wjem-14-576.PMC3876297.pdf
Available at: http://www.cdc.gov/nchs/about/major/ahcd/ahcd.htm.,OADS,/arxiv_data1/oa_pdf/7f/73/wjem-14-576.PMC3876297.pdf
Available at: http://www.census.gov/population/ www/metroareas/metroarea.html .,OADS,/arxiv_data1/oa_pdf/7f/73/wjem-14-576.PMC3876297.pdf
Available from: http://www.cdc.gov/mmwr/preview/ mmwrhtml/00049162.htm .,OADS,/arxiv_data1/oa_pdf/7f/73/wjem-14-576.PMC3876297.pdf
Older Adult Drivers: Get the  Facts retrieved from http://www.cdc.gov/Motorvehiclesafety/Older_ Adult_Drivers/adult-drivers_factsheet.html 5.,Non-OADS,/arxiv_data1/oa_pdf/72/73/wjem-14-582.PMC3876298.pdf
Retrieved from http://www.ama-assn.org//ama/pub/physician- resources/public-health/promoting-healthy-lifestyles/geriatric-health/ older-driver-safety/why-are-older-drivers-risk.page 16.,Non-OADS,/arxiv_data1/oa_pdf/72/73/wjem-14-582.PMC3876298.pdf
Available at: http://www.acep.org/Clinical---Practice- Management/Role-of-the-Emergency-Physician-in-Injury-Prevention-and-Control-for-Adult-and-Pediatric-Patients/ 21.,Non-OADS,/arxiv_data1/oa_pdf/72/73/wjem-14-582.PMC3876298.pdf
Retrieved from: https://www.dmv.ca.gov/about/senior/ driverlicense/drivetest.htm,Non-OADS,/arxiv_data1/oa_pdf/72/73/wjem-14-582.PMC3876298.pdf
Available at: http://www.cdc.gov/nchs/data/ ahcd/nhamcs_emergency/nhamcsed2008.pdf.,OADS,/arxiv_data1/oa_pdf/0f/1a/wjem-14-598.PMC3876302.pdf
Available at: http://www.acep.org/content.,Non-OADS,/arxiv_data1/oa_pdf/0f/1a/wjem-14-598.PMC3876302.pdf
"Available at: http://www.cms.gov/ NationalHealthExpendData/  Accessed December 18, 2012.",Non-OADS,/arxiv_data1/oa_pdf/48/2b/wjem-14-609.PMC3876304.pdf
Available at:  http://www.cms.gov/transmittals/downloads/R107BP.pdf.,Non-OADS,/arxiv_data1/oa_pdf/48/2b/wjem-14-609.PMC3876304.pdf
"Available at: http://www.cdc.gov/nchs/ahcd.htm  Accessed  December 18, 2012.",OADS,/arxiv_data1/oa_pdf/48/2b/wjem-14-609.PMC3876304.pdf
Available at: http://hschange.org/index.cgi?file=cts1 .,Non-OADS,/arxiv_data1/oa_pdf/48/2b/wjem-14-609.PMC3876304.pdf
Available  at: http://www.rand.org/commentary/2013/05/22/RAND.html .,Non-OADS,/arxiv_data1/oa_pdf/59/c4/wjem-14-617.PMC3876305.pdf
Available at: http://wagner.nyu.edu/faculty/billings/nyued-background .,Non-OADS,/arxiv_data1/oa_pdf/59/c4/wjem-14-617.PMC3876305.pdf
Available  at: http://meps.ahrq.gov/mepsweb/data_files/publications/st396/ stat396.pdf .,OADS,/arxiv_data1/oa_pdf/59/c4/wjem-14-617.PMC3876305.pdf
Available at: http://www.ficklefinger.net/ blog/2011/11/08/ed-visits-vs-office-visits-why-these-cost-comparisons- are-bogus/ .,Non-OADS,/arxiv_data1/oa_pdf/59/c4/wjem-14-617.PMC3876305.pdf
Available at: http://www.rand.org/pubs/research_reports/ RR280 .,Non-OADS,/arxiv_data1/oa_pdf/59/c4/wjem-14-617.PMC3876305.pdf
Available at: http://www.hca.wa.gov/documents/legreports/Report- 3ESHB2127EmergencyDeptUtilization.pdf .,Non-OADS,/arxiv_data1/oa_pdf/59/c4/wjem-14-617.PMC3876305.pdf
4. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm326654.htm  - retrieved 22 December 2012.,Non-OADS,/arxiv_data1/oa_pdf/78/95/wjem-14-619.PMC3876306.pdf
10. http://www.forbes.com/sites/larryhusten/2012/09/27/fda-sets-new- decision-date-for-eliquis-aprixaban/  - accessed 26 December 2012 11. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm333634.htm  - accessed 2 January 2013 12.,Non-OADS,/arxiv_data1/oa_pdf/78/95/wjem-14-619.PMC3876306.pdf
14. http://clinicaltrials.gov/ct2/show/NCT00643201  - accessed 2  January 2013.,Non-OADS,/arxiv_data1/oa_pdf/78/95/wjem-14-619.PMC3876306.pdf
"For a concise explanation of the nomenclature of monoclonal  antibodies, see http://en.wikipedia.org/wiki/Nomenclature_of_ monoclonal_antibodies .",Non-OADS,/arxiv_data1/oa_pdf/78/95/wjem-14-619.PMC3876306.pdf
25. http://chemm.nlm.nih.gov/sns.htm .,Non-OADS,/arxiv_data1/oa_pdf/78/95/wjem-14-619.PMC3876306.pdf
26. http://www.fda.gov/downloads/EmergencyPreparedness/ MedicalCountermeasures/UCM283166.pdf .,Non-OADS,/arxiv_data1/oa_pdf/78/95/wjem-14-619.PMC3876306.pdf
31. http://www.cdc.gov/phpr/stockpile/stockpile.htm  - accessed 26 December 2012 32.,Non-OADS,/arxiv_data1/oa_pdf/78/95/wjem-14-619.PMC3876306.pdf
"Global Strategy for Diagnosis, Management, and Prevention of  COPD, Global Initiative for Chronic Obstructive Lung Disease  (GOLD) 2011. http://www.goldcopd.org/guidelines-global-strategy- for-diagnosis-management.html .",Non-OADS,/arxiv_data1/oa_pdf/78/95/wjem-14-619.PMC3876306.pdf
"November 2, 2010. http://www.cdc.gov/ parasites/lice/head/treatment.html .",Non-OADS,/arxiv_data1/oa_pdf/78/95/wjem-14-619.PMC3876306.pdf
(2011) http://www.fda.gov/downloads/ BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/ LicensedProductsBLAs/FractionatedPlasmaProducts/UCM266725.,Non-OADS,/arxiv_data1/oa_pdf/78/95/wjem-14-619.PMC3876306.pdf
"For an elegant, icky, and somewhat horrifying tale of one man’s  venture into the stool transplant thickets, see http://www.epmonthly.",Non-OADS,/arxiv_data1/oa_pdf/78/95/wjem-14-619.PMC3876306.pdf
75. https://www.goodrx.com/rectiv  - accessed 28 December 2012.,Non-OADS,/arxiv_data1/oa_pdf/78/95/wjem-14-619.PMC3876306.pdf
79. http://www.goodrx.com/epipen#/epipen/kit/all/all/1.0/all/browse- price__Epipen  - accessed 2 January 2013.,Non-OADS,/arxiv_data1/oa_pdf/78/95/wjem-14-619.PMC3876306.pdf
Available as a free download  from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1825316/   (accessed 2 January 2013) 83. http://www.irhythmtech.com/zio-solution/zio-patch/  - accessed 2  January 2013 84.,OADS,/arxiv_data1/oa_pdf/78/95/wjem-14-619.PMC3876306.pdf
Available at: http://www.who.int/ cancer/palliative/definition/en/.,Non-OADS,/arxiv_data1/oa_pdf/bc/8c/wjem-14-633.PMC3876308.pdf
Available at: http://www.nursingworld.org/dnrposition.,Non-OADS,/arxiv_data1/oa_pdf/bc/8c/wjem-14-633.PMC3876308.pdf
Available at: http://www.acep.org/ Content.aspx?id=36598.,Non-OADS,/arxiv_data1/oa_pdf/bc/8c/wjem-14-633.PMC3876308.pdf
Available at: http://www.cdc.gov/std/treatment/2010/pid.,Non-OADS,/arxiv_data1/oa_pdf/08/a6/wjem-14-641.PMC3876312.pdf
2012 Available at: http://www.cdc.gov/nchs/data/ databriefs/db82.pdf.,OADS,/arxiv_data1/oa_pdf/5a/9e/wjem-14-650.PMC3876316.pdf
Available at: http://www.acgme.org/acWebsite/RRC_110/110_ guidelines.asp#res .,Non-OADS,/arxiv_data1/oa_pdf/8a/00/wjem-14-654.PMC3876318.pdf
"JAK-STAT 2013; 2:e25112;  http://dx.doi.org/10.4161/jkst.25112The term dendritic cell (DC) refers to a population of  hematopoietic cells with critical roles in immunity, including immune activation in response to pathogen-elicited danger  signals and immune tolerance.",OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Exp Med  2003; 198:305-13; PMID:12874263; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Exp Med 2003; 198:293- 303; PMID:12874262; http://dx.doi.org/10.1084/ jem.20030107 4.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Nat Immunol  2008; 9:676-83; PMID:18469816; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Nat Immunol 2007; 8:1207-16; PMID:17922016;  http://dx.doi.org/10.1038/ni1518 7.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Nat Immunol  2007; 8:1217-26; PMID:17922015; http://dx.doi.org/10.1038/ni15228.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Blood  2013; 121:11-9; PMID:23053574; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Immunol Rev 2010; 234:45-54;  PMID:20193011; http://dx.doi.org/10.1111/j.0105- 2896.2009.00879.x 11.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Nat Rev Immunol 2012; 12:101-13; PMID:22273772; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Leukoc Biol 2012; 92:445-59;  PMID:22550127; http://dx.doi.org/10.1189/ jlb.0212052 14.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Annu Rev Immunol 2013; 31:563- 604; PMID:23516985; http://dx.doi.org/10.1146/ annurev-immunol-020711-074950 15.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Immunol Rev  2010; 234:90-104; PMID:20193014; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Nat Immunol 2012; 13:888-99;  PMID:22797772; http://dx.doi.org/10.1038/ni.237017.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Annu Rev Immunol 2005; 23:275-306;  PMID:15771572; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Annu Rev Immunol 2011; 29:163-83;  PMID:21219184; http://dx.doi.org/10.1146/annurev- immunol-031210-101345 19.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Exp Med 2000; 192:219-26; PMID:10899908; http://dx.doi.org/10.1084/ jem.192.2.219 21.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Immunity 2008; 29:464- 75; PMID:18789731; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Immunity 2008; 28:509-20;  PMID:18342552; http://dx.doi.org/10.1016/j.immu- ni.2008.02.013 23.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Blood 2012; 120:4363-73;  PMID:23033267; http://dx.doi.org/10.1182/blood- 2012-07-441311 24.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Cell 2008; 135:37-48; PMID:18854153;  http://dx.doi.org/10.1016/j.cell.2008.09.016,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Immunity 1999; 10:39- 49; PMID:10023769; http://dx.doi.org/10.1016/ S1074-7613(00)80005-9 54.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Immunol 2010; 184:1765-75; PMID:20083662; http://dx.doi.org/10.4049/jimmu- nol.0902133 56.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Eur J Immunol 2011; 41:413- 24; PMID:21225954; http://dx.doi.org/10.1002/ eji.201040979 57.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Exp Med 2011; 208:235-49; PMID:21300911;  http://dx.doi.org/10.1084/jem.20100799 59.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Immunol 2012; 188:5227-37; PMID:22508931; http://dx.doi.org/10.4049/jimmunol.1103382 60.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Cell 2010; 140:883-99;  PMID:20303878; http://dx.doi.org/10.1016/j.cell.2010.01.025 61.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Eur J Cancer  2005; 41:2502-12; PMID:16199153; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Eur J Immunol 1997;  27:40-4; PMID:9021996; http://dx.doi.org/10.1002/eji.183027010739.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Immunol 2012; 188:5319-26; PMID:22539792;  http://dx.doi.org/10.4049/jimmunol.1101044 40.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Immunity 2005; 22:247-57;  PMID:15723812; http://dx.doi.org/10.1016/j.immu- ni.2005.01.005 41.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Exp Med  2011; 208:2367-74; PMID:22084408; http://dx.doi.org/10.1084/jem.20110654 42.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Nature 2009; 458:904-8; PMID:19212321; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Nature 2010; 465:793-7; PMID:20535209;  http://dx.doi.org/10.1038/nature09135 44.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Blood 2011; 118:3879-89;  PMID:21828128; http://dx.doi.org/10.1182/blood- 2011-04-349761 45.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Exp Med 1996; 184:1953- 62; PMID:8920882; http://dx.doi.org/10.1084/ jem.184.5.1953 47.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Immunity  2010; 33:597-606; PMID:20933441; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Immunol 2010; 184:2638-45; PMID:20124100;  http://dx.doi.org/10.4049/jimmunol.0902960 51.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Immunity 2003; 19:903-12; PMID:14670306;  http://dx.doi.org/10.1016/S1074-7613(03)00332-7 52.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Exp Med 2002; 195:953- 8; PMID:11927638; http://dx.doi.org/10.1084/ jem.20020045 26.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Curr Opin Immunol 2008; 20:61-7; PMID:18082389;  http://dx.doi.org/10.1016/j.coi.2007.10.009 27.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Immunol Rev 2010; 234:55-75;  PMID:20193012; http://dx.doi.org/10.1111/j.0105- 2896.2009.00885.x 29.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Exp Med  2009; 206:3115-30; PMID:20008528; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Exp Med  2010; 207:823-36; PMID:20351058; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Blood 2009; 114:835-43;  PMID:19465690; http://dx.doi.org/10.1182/blood- 2009-02-206318 33.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Immunity 2012; 36:1031-46; PMID:22749353;  http://dx.doi.org/10.1016/j.immuni.2012.03.027 34.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Immunol  2009; 183:2286-93; PMID:19620292; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Exp Med 2011; 208:1989- 2003; PMID:21930769; http://dx.doi.org/10.1084/ jem.20101158 38.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
PLoS Pathog 2012; 8:e1002763; PMID:22719255; http://dx.doi.org/10.1371/journal.ppat.1002763,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Immunity 2010; 33:905-16; PMID:21145760;  http://dx.doi.org/10.1016/j.immuni.2010.11.023 81.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Immunity  2012; 36:515-28; PMID:22520845; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Blood  2011; 118:2656-8; PMID:21765025; http://dx.doi.org/10.1182/blood-2011-06-36031373.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Immunol  Rev 2010; 238:76-92; PMID:20969586; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Exp Med 2002; 196:1415-25; PMID:12461077;  http://dx.doi.org/10.1084/jem.20021263 75.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Blood 2012; 119:2003-12;  PMID:22238324; http://dx.doi.org/10.1182/blood-2011-06-364976 77.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
J Exp Med  2012; 209:1135-52; PMID:22615127; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Immunity 2009; 31:513-25;  PMID:19733489; http://dx.doi.org/10.1016/j.immu- ni.2009.08.010 69.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
Nat Immunol 2013; 14:364- 71; PMID:23435120; http://dx.doi.org/10.1038/ ni.2541 72.,Non-OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
T rends Immunol 2006; 27:140- 5; PMID:16406699; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e4/bc/jkst-2-e25112.PMC3876424.pdf
JAK-STAT 2013; 2:e25097; http://dx.doi.org/10.4161/jkst.25097STAT3 is the quintessential pleiotropic transcription factor with  many biological roles throughout development as well as in multiple adult tissues.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cell 1987; 51:987-1000; PMID:3690668;  http://dx.doi.org/10.1016/0092-8674(87)90585-X 2.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cell 2006; 126:663- 76; PMID:16904174; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Science 2009; 324:1720-3; PMID:19443739; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cell 2008;  133:1266-76; PMID:18585359; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cell 2013; 152:327- 39; PMID:23332764; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cell 2012; 151:929-31; PMID:23178114; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Genes Dev 1998; 12:2048-60; PMID:9649508; http://dx.doi.org/10.1101/ gad.12.13.2048 11.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Endocrinology 2008; 149:1581-90;  PMID:18096662; http://dx.doi.org/10.1210/en.2007- 1148 12.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Mol Cell Biol 2004; 24:258- 69; PMID:14673160; http://dx.doi.org/10.1128/ MCB.24.1.258-269.2004 13.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Nat Immunol 2003; 4:551-6; PMID:12754507;  http://dx.doi.org/10.1038/ni938 43.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
N Engl J Med 2007; 357:1608- 19; PMID:17881745; http://dx.doi.org/10.1056/ NEJMoa073687 44.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Blood 2012; 119:3997-4008;  PMID:22403255; http://dx.doi.org/10.1182/blood-2011-11-392985 45.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Immunity  2011; 35:806-18; PMID:22118528; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Nature 2007; 448:1058-62; PMID:17676033;  http://dx.doi.org/10.1038/nature06096 47.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cytokine Growth Factor Rev 2010; 21:11-9;  PMID:20018552; http://dx.doi.org/10.1016/j.cytog- fr.2009.11.005 48.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cancer Cell  2009; 15:283-93; PMID:19345327; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cancer Cell 2011; 19:429- 31; PMID:21481782; http://dx.doi.org/10.1016/j.ccr.2011.03.018 52.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cell Stem Cell 2013; 12:304- 15; PMID:23472872; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Nucleic Acids Res  2013; 41:2155-70; PMID:23295670; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Immunity 2010; 32:605-15;  PMID:20493732; http://dx.doi.org/10.1016/j.immu- ni.2010.05.003 28.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Nat Immunol  2011; 12:247-54; PMID:21278738; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Nat Immunol 2012; 13:916-24;  PMID:22990889; http://dx.doi.org/10.1038/ni.2391 33.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Immunity 1999; 10:39- 49; PMID:10023769; http://dx.doi.org/10.1016/ S1074-7613(00)80005-9 34.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Immunity  2008; 29:628-36; PMID:18848474; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
J Biol Chem 2013; 288:2986- 93; PMID:23166328; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
J Biol Chem 2000; 275:12848-56; PMID:10777583; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Biochem Biophys  Res Commun 2004; 319:1159-70; PMID:15194489;  http://dx.doi.org/10.1016/j.bbrc.2004.05.095 15.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cell Metab 2006; 4:49- 60; PMID:16814732; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Mol Cell Biol  2004; 24:407-19; PMID:14673173; http://dx.doi.org/10.1128/MCB.24.1.407-419.2004 17.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
J Biol Chem 1996; 271:5929-40; PMID:8621467;  http://dx.doi.org/10.1074/jbc.271.10.5929 18.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
J Biol Chem 2000;  275:15099-105; PMID:10747872; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
EMBO J 1999; 18:4657- 68; PMID:10469645; http://dx.doi.org/10.1093/ emboj/18.17.4657 20.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Proc Natl Acad Sci U S A 2003; 100:12929- 34; PMID:14566054; http://dx.doi.org/10.1073/ pnas.2134694100 21.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
J Hepatol 2005; 43:799- 807; PMID:16083985; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Immunity 2002; 17:63-72; PMID:12150892; http://dx.doi.org/10.1016/S1074- 7613(02)00336-9 24.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Immunity 2003; 19:903-12; PMID:14670306;  http://dx.doi.org/10.1016/S1074-7613(03)00332-7 25.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Immunity 2013; 38:514-27;  PMID:23453633; http://dx.doi.org/10.1016/j.immu- ni.2013.02.011 26.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Blood 2006;  107:1085-91; PMID:16223771; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
J Biol Chem 2004;  279:1768-76; PMID:14593105; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Genes Dev 2007; 21:1396- 408; PMID:17510282; http://dx.doi.org/10.1101/ gad.1553707 85.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Biochem Soc T rans 2012; 40:475- 91; PMID:22616857; http://dx.doi.org/10.1042/ BST20120056 87.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
J Biol Chem  2008; 283:30725-34; PMID:18782771; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Proc Natl Acad Sci U S A 2012; 109:12058- 63; PMID:22783022; http://dx.doi.org/10.1073/ pnas.1206458109 90.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
JAK-STAT 2012; 1:257-60; http://dx.doi.org/10.4161/ jkst.22436 91.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Immunity  2010; 32:317-28; PMID:20206554; http://dx.doi.org/10.1016/j.immuni.2010.02.008 92.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Nucleic Acids Res 2012; 40:e77; PMID:22328731;  http://dx.doi.org/10.1093/nar/gks149 93.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cell 2013; 152:157- 71; PMID:23332752; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Immunity 2011; 35:299-311; PMID:21867929;  http://dx.doi.org/10.1016/j.immuni.2011.08.007 96.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Nat Biotechnol 2011; 29:644-52;  PMID:21572440; http://dx.doi.org/10.1038/nbt.1883 97.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Nature 2012; 488:116-20; PMID:22763441;  http://dx.doi.org/10.1038/nature1124370.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Proc Natl Acad Sci U S A  2009; 106:5117-22; PMID:19282476; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Blood 2003; 102:4123-9;  PMID:12907458; http://dx.doi.org/10.1182/blood- 2003-04-1228 72.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Oncogene 2006; 25:7297-304; PMID:16732314; http://dx.doi.org/10.1038/ sj.onc.1209711 73.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Mol Cell Biol 2003; 23:3753- 62; PMID:12748279; http://dx.doi.org/10.1128/ MCB.23.11.3753-3762.2003 74.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cell  2008; 133:1106-17; PMID:18555785; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Nat Immunol 2010; 11:635-43; PMID:20543837; http://dx.doi.org/10.1038/ni.1891 77.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Nucleic Acids Res 2008; 36(Database issue):D88-92;  PMID:18073188; http://dx.doi.org/10.1093/nar/ gkm964 78.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Science 2005; 307:269-73;  PMID:15653507; http://dx.doi.org/10.1126/sci- ence.1105166 79.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Gastroenterology 2005; 129:1616-32;  PMID:16285960; http://dx.doi.org/10.1053/j.gas-tro.2005.07.055 81.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Nucleic Acids Res  2008; 36:4510-20; PMID:18611949; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cancer Discov 2012; 2:694-705;  PMID:22719020; http://dx.doi.org/10.1158/2159- 8290.CD-12-0191 57.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Science 2009; 323:793-7;  PMID:19131594; http://dx.doi.org/10.1126/sci- ence.1164551 58.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
J Biol Chem 2011; 286:29610- 20; PMID:21715323; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Nat Immunol 2004;  5:401-9; PMID:15021879; http://dx.doi.org/10.1038/ ni1052 61.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
PLoS Genet  2013; 9:e1003288; PMID:23437007; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Immunity 2012; 36:586-99;  PMID:22520852; http://dx.doi.org/10.1016/j.immu-ni.2012.02.017 65.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
J Biol Chem 1996; 271:18350- 4; PMID:8702476; http://dx.doi.org/10.1074/ jbc.271.31.18350 67.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
JAK-STAT  2013; 2:e23060; http://dx.doi.org/10.4161/jkst.23060 68.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Mol Endocrinol 2006; 20:675-85; PMID:16293640;  http://dx.doi.org/10.1210/me.2005-0392 69.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Blood 2005; 105:635-7; PMID:15358627; http://dx.doi.org/10.1182/blood- 2004-07-2681,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Nat Genet  2013; 45:325-9; PMID:23396136; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cell  2013; 152:248-61; PMID:23332759; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cell  2012; 151:1417-30; PMID:23260135; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Nature 2012; 490:543-6;  PMID:22992523; http://dx.doi.org/10.1038/ nature11530 102.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Nat Immunol 2012; 13:1187-95; PMID:23104097;  http://dx.doi.org/10.1038/ni.2449 103.,Non-OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cell  2012; 151:981-93; PMID:23178119; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Genes Dev  2011; 25:2453-64; PMID:22085726; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Genomics  2012; 100:303-13; PMID:22884873; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
Cell 2013; 152:570-83;  PMID:23352431; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/19/jkst-2-e25097.PMC3876425.pdf
"JAK-STAT 2013; 3:e26458; http://dx.doi.org/10.4161/jkst.26458JAK-STAT signaling and myocardial glucose  metabolism Miguel A Frias1 and Christophe Montessuit2,* 1Division of e ndocrinology, Diabetology and Nutrition; University of Geneva School of Medicine; Geneva, Switzerland;   2Division of Cardiology; Department of Medical Specialties; University of Geneva School of Medicine; Geneva, Switzerland Keywords:  cardiac myocytes, glucose metabolism, insulin, insulin resistance, Janus kinase, JAK, myocardium,  signal transducer and activator of transcription, STAT, suppressor of cytokine signaling, SOCS Abbreviations: Acetyl-CoA, acetyl-coenzyme A; ADP, adenosine diphosphate; AMP, adenosine monophosphate; ATP, adenosine  triphosphate; AMPK, AMP-activated protein kinase; Ang II, angiotensin II; AGTR1, angiotensin receptor type 1; CT-1,  cardiotrophin-1; F1,6BP, fructose-1,6-bisphosphate F2,6BP, fructose-2,6-bisphosphate; F6P, fructose-6-phosphate; GLUT1 or  4, facilitative glucose transporters; gp130, glycoprotein 130; Ins, insulin; IR α/β: insulin receptor, subunit α /β; IRS, insulin  receptor substrate; LIF, leukemia inhibitory factor; LIFR, LIF receptor; mTORC2, mammalian target of rapamycin complex 2;  PDC, pyruvate dehydrogenase complex; PDH-E1, pyruvate dehydrogenase enzyme; PDK1-4, pyruvate dehydrogenase kinase  1 to 4; PDPK1, Phosphoinositide-dependent protein kinase 1; PDPC1-2, pyruvate dehydrogenase phosphatase 1 or 2; PFK-1,  6-phosphofructo-1-kinase; PFK-2, 6-phosphofructo-2-kinase; PI3K α, phosphoinositide 3-kinase α ; PIP3, phosphatidylinositol- 3,4,5-trisphosphate; SGLT1, sodium-glucose cotransporter 1; SOCS3, suppressor of cytokine signaling 3; WISK, wortmannin- sensitive and insulin-stimulated protein kinase JAK-STAT signaling occurs in virtually every tissue of the  body, and so does glucose metabolism.",Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Circ Res 1994; 75:1103-12; PMID:7955147 ;  http://dx.doi.org/10.1161/01.RES.75.6.1103 5.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Cell Mol Life Sci 2007; 64:3069-83;  PMID:17882378 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
J Physiol  2006; 571:253-73;  PMID:16410283 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Endocrinology 1992; 130:837-46;  PMID:1370797 ;  http://dx.doi.org/10.1210/en.130.2.837 8.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Proc Natl Acad Sci U  S A 1991; 88:7815-9; PMID:1881917 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Cardiovasc Res 2009; 84:111-8;  PMID:19509029 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Biochim Biophys Acta 1994; 1196:191-200;  PMID:7841183 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Circulation  1994; 89:793-8;  PMID:8313568 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Cardiovasc Res  2008; 79:238-48;  PMID:18390897 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Nat Rev Mol Cell Biol 2012; 13:251-62;   PMID:22436748 ; http://dx.doi.org/10.1038/ nrm3311 14.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Diabetes 2007; 56:414- 23; PMID:17259386 ; http://dx.doi.org/10.2337/ db06-0900 15.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Biochim  Biophys Acta 2013; 1833:848-56; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Biochem  J 2004; 381:561-79; PMID :15170386 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
J Biol Chem 2001; 276:45088-97; PMID:11577086 ;  http://dx.doi.org/10.1074/jbc.M105451200 19.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Science 1997; 277:1630-5;  PMID:9287210 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Nat Rev Mol Cell Biol 2002; 3:651-62;  PMID:12209125 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
J Biol Chem 2007;  282:20059-63;  PMID:17502367 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Growth Factors  2012; 30:88-106;  PMID:22339650 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Circ Res 1999; 84:1127-36; PMID:10347087 ; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Proc Natl Acad Sci U S A 2001; 98:9050-5; PMID:11481471 ; http://dx.doi.org/10.1073/ pnas.161283798 25.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Proc Natl Acad Sci U S A 1997; 94:3801- 4; PMID:9108058 ; http://dx.doi.org/10.1073/ pnas.94.8.3801 26.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Circ Res  2004; 95:187-95;  PMID:15192020 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Cardiovasc Res 2004; 63:611-6; PMID :15306216 ;  http://dx.doi.org/10.1016/j.cardiores.2004.06.019 29.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Circ Res 2008; 102:131-5;  PMID:17967780 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
J Mol  Cell Cardiol 2002; 34:509-18; PMID:12056855 ;  http://dx.doi.org/10.1006/jmcc.2002.153331.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Basic Res Cardiol 2008; 103:444- 53; PMID:18500485 ; http://dx.doi.org/10.1007/ s00395-008-0728-x 32.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
J Pineal Res  2011; 50:374-80;  PMID:21342247 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Cardiovasc Drugs Ther 2012; 26:227-37;   PMID:22392184 ; http://dx.doi.org/10.1007/ s10557-012-6376-2 34.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Atherosclerosis 2013; 228:110- 6; PMID:23497785 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Pharmacol Ther 2008; 120:172- 85; PMID:18786563 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Trends Mol Med 2007; 13:82-9; PMID:17194625 ;  http://dx.doi.org/10.1016/j.molmed.2006.12.002 39.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Cell  1999; 97:189-98;  PMID:10219240 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
J Cell Mol Med 2012; 16:386-93;  PMID:21447043 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Proc Natl Acad Sci U S A 2001; 98:1543- 8; PMID:11171987 ; http://dx.doi.org/10.1073/ pnas.98.4.1543 43.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
J Biol Chem  1996; 271:22100-4;  PMID:8703019 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Endocrinology 1998; 139:884- 93; PMID:9492017 ; http://dx.doi.org/10.1210/ en.139.3.884 45.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Proc Natl Acad Sci U S A 1997; 94:2295- 300; PMID:9122188 ; http://dx.doi.org/10.1073/ pnas.94.6.2295 46.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Endocrinology 2000; 141:1977-88;  PMID:10830280 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Mol Endocrinol 2002; 16:2764-79; PMID:12456798 ;  http://dx.doi.org/10.1210/me.2002-0017 48.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Oncogene 1997; 15:2529- 39; PMID:9399641 ; http://dx.doi.org/10.1038/ sj.onc.1201429 49.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Diabetologia 1997; 40:1358-62;  PMID:9389430 ;  http://dx.doi.org/10.1007/s001250050832 50.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Endocrinology 1999; 140:55-62;  PMID:9886807 ;  http://dx.doi.org/10.1210/en.140.1.55 51.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Am J Physiol Heart Circ Physiol 2011; 300:H522-6; PMID:21131482 ;  http://dx.doi.org/10.1152/ajpheart.00231.2010 52.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Cardiovasc Res  2000; 47:797-805;  PMID:10974228 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
J Mol Cell Cardiol 2001; 33:307-16; PMID:11162135 ;  http://dx.doi.org/10.1006/jmcc.2000.1303 54.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
J Mol Cell Cardiol 2013; 56:106-15; PMID:23277190 ;  http://dx.doi.org/10.1016/j.yjmcc.2012.12.015 55.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Horm Metab Res  2002; 34:111-5;  PMID:11972298 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Biochem Biophys Res Commun 2011; 408:208- 13; PMID:21406183 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
J Mol Cell Cardiol 1998; 30:751-61; PMID:9602424 ; http://dx.doi.org/10.1006/ jmcc.1998.0639 59.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
J Mol Cell Cardiol  1997; 29:2513-24;  PMID:9299374 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Endocrinology 2005; 146:579- 88; PMID:15514089 ; http://dx.doi.org/10.1210/ en.2004-0466 61.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
J  Biol Chem 2001; 276:22892-900; PMID:11303022 ;  http://dx.doi.org/10.1074/jbc.M011647200 63.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Circulation  1996; 94:2626-32;  PMID:8921810 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Diabetologia 2006; 49:724-31;  PMID:16489447 ;  http://dx.doi.org/10.1007/s00125-006-0150-6 65.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Endocrinology 2003; 144:4586- 96; PMID:12960061 ; http://dx.doi.org/10.1210/ en.2003-0046 68.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Circ Res  2001; 88:727-32;  PMID:11304496 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
J Biol Chem 2003; 278:13740-6;   PMID:12560330 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Proc Natl Acad Sci U S A 1999; 96:6964- 9; PMID:10359822 ; http://dx.doi.org/10.1073/ pnas.96.12.6964 74.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Mol Cell Endocrinol 1999; 158:111-6; PMID:10630411 ;  http://dx.doi.org/10.1016/S0303-7207(99)00175-6 75.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
J Endocrinol  2004; 181:129-38;  PMID:15072573 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Endocrinology 2003; 144:5604- 14; PMID:12960006 ; http://dx.doi.org/10.1210/ en.2003-0788 78.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Proc Natl Acad Sci U S A 1996; 93:12490-5;  PMID:8901609 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Am J Physiol Endocrinol Metab 2011;  301:E836-43;  PMID:21771966 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Diabetes 2007; 56:1623- 9; PMID:17360981 ; http://dx.doi.org/10.2337/ db06-1286 81.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
Circ Heart Fail 2012; 5:493-503;  PMID:22705769 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/f6/jkst-2-e26458.PMC3876426.pdf
"JAK-STAT 2013; 2:e26102; http://dx.doi.org/10.4161/jkst.26102STAT5 acetylation Mechanisms and consequences   for immunological control and leukemogenesis Christian Kosan1, Torsten Ginter1, Thorsten Heinzel1, and Oliver H Krämer1,2,* 1Center for Molecular Biomedicine (CMB); i nstitute of Biochemistry and Biophysics; University of Jena; Jena, Germany;   2institute of Toxicology; Medical Center of the University Mainz; Mainz, Germany Keywords:  acetylation, cancer, leukemia, STAT, STAT5, HDAC, HDACi, HAT, SIAH, UBCH8 The cytokine-inducible transcription factors signal trans - ducer and activator of transcription 5A and 5B (STAT5A and  STAT5B) are important for the proper development of multicel - lular eukaryotes.",OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Cytokine Growth Factor Rev 2012; 23:293- 305; PMID:22795479 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Biochem  Pharmacol 2006; 72:1538-46; PMID:16750817 ;  http://dx.doi.org/10.1016/j.bcp.2006.04.013 4.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
JAK-STAT 2012; 1:203-7; http://dx.doi.org/10.4161/ jkst.21232 5.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Blood  2009; 113:4856-65;  PMID:19258595 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
JAK-STAT 2011; 1:13-22; http://dx.doi.org/10.4161/jkst.19316 9.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Genes Dev  1995; 9:984-94;  PMID:7774815 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Mol Cell Biol 2000; 20:389-401; PMID:10594041 ;  http://dx.doi.org/10.1128/MCB.20.1.389-401.2000 12.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Immunity 2012; 36:586-99; PMID:22520852 ;  http://dx.doi.org/10.1016/j.immuni.2012.02.017 14.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Cancer Cell 2005; 7:87- 99; PMID:15652752 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Semin Cell Dev Biol 2008; 19:311- 8; PMID:18765289 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Endocrinology 2010; 151:43-55; PMID:19966185 ; http://dx.doi.org/10.1210/ en.2009-0651 18.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Cell 2011; 144:646-74;  PMID:21376230 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Clin Rev Allergy Immunol 2010; 39:78- 84; PMID:19662539 ; http://dx.doi.org/10.1007/ s12016-009-8173-7 20.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Cancer Lett 2009; 280:134-44;  PMID:19345000 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Cancer Lett 2009;  280:160-7;  PMID :19342155 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Trends Pharmacol Sci 2009; 30:647- 55; PMID:19892411 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Bioorg Med Chem Lett  2010; 20:3142-5;  PMID:20392638 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Proc Natl Acad Sci U S A 2010; 107:19314-9; PMID:20962278 ; http://dx.doi.org/10.1073/ pnas.1010253107 30.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Genes Dev 2009; 23:223-35; PMID:19171783 ; http://dx.doi.org/10.1101/ gad.479209 31.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Cell 2007; 131:93-105;  PMID:17923090 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
J Biol Chem 2005; 280:40782- 7; PMID:16192273 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
J Biol Chem 2003; 278:34133-40; PMID:12832402 ;  http://dx.doi.org/10.1074/jbc.M304531200 36.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
J Biol Chem 1999; 274:25499-509; PMID:10464281 ; http://dx.doi.org/10.1074/ jbc.274.36.25499 37.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Biochem J 2004; 377:289-97; PMID:12974672 ;  http://dx.doi.org/10.1042/BJ20030708 38.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
J Biol Chem 1996; 271:4134- 7; PMID:8626752 ; http://dx.doi.org/10.1074/ jbc.271.8.4134 39.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Cell 2002; 108:475-87; PMID:11909519 ; http://dx.doi.org/10.1016/ S0092-8674(02)00654-2 40.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Mol  Cell Endocrinol 2010; 315:40-8; PMID:19879327 ;  http://dx.doi.org/10.1016/j.mce.2009.10.007 41.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
EMBO J 2001; 20:6836-44;  PMID:11726519 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
J Biol Chem 2004; 279:40362- 7; PMID :15194680 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Blood  2009; 114:1820-30;  PMID:19571317 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
EMBO J 2003; 22:893-904; PMID:12574125 ; http://dx.doi.org/10.1093/ emboj/cdg094 48.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Proc Natl Acad Sci U S A 2008; 105:14981-6; PMID:18815361 ; http://dx.doi.org/10.1073/ pnas.080398810549.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
EMBO J 2001; 20:6969-78; PMID:11742974 ; http://dx.doi.org/10.1093/ emboj/20.24.6969 51.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
J Virol 2012; 86:4566-77;  PMID:22318143 ; http://dx.doi.org/10.1128/ JVI.05545-11 52.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Nat Immunol 2010; 11:171-9;  PMID:19946273 ; http://dx.doi.org/10.1038/ni.1827 54.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Cell 1999; 98:181- 91; PMID:10428030 ; http://dx.doi.org/10.1016/ S0092-8674(00)81013-2 55.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Blood 2001; 98:3261-73;  PMID:11719363 ; http://dx.doi.org/10.1182/blood.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
EMBO J 1999; 18:4754-65;  PMID:10469654 ; http://dx.doi.org/10.1093/ emboj/18.17.4754 58.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
J Biol Chem 1999; 274:35553- 61; PMID:10585430 ; http://dx.doi.org/10.1074/ jbc.274.50.35553 60.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Blood 2010; 115:3269- 77; PMID:20190194 ; http://dx.doi.org/10.1182/ blood-2009-10-246876 61.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Mol Cell 2009; 36:754-67;  PMID:20005840 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
"Exp Hematol 2013; 41:261, e4; PMID:23111066 ;  http://dx.doi.org/10.1016/j.exphem.2012.10.012 64.",OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Mol Carcinog 2012; 51:174- 84; PMID :21520296 ; http://dx.doi.org/10.1002/ mc.20777 65.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Nat Rev Mol Cell Biol  2007; 8:947-56;  PMID:18000527 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Cell 2007; 131:584- 95; PMID:17981124 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Immunity 2010; 33:917-28; PMID:21167753 ;  http://dx.doi.org/10.1016/j.immuni.2010.11.028 69.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Blood 2011;  117:3370-81;  PMID:21258009 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Immunity 1997; 7:155- 62; PMID:9252128 ; http://dx.doi.org/10.1016/ S1074-7613(00)80518-X 71.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Blood 2010; 116:1548-58; PMID:20508164 ; http://dx.doi.org/10.1182/ blood-2009-12-258913 73.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Genes Cancer  2012; 3:503-11;  PMID:23264850 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Cell Signal 2009; 21:1717-26; PMID:19540337 ;  http://dx.doi.org/10.1016/j.cellsig.2009.06.002 76.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Cell Cycle 2011; 10:250- 60; PMID:21220945 ; http://dx.doi.org/10.4161/ cc.10.2.14537 77.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Leukemia  2012; 26:2172-5;  PMID:22504141 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Leukemia 2013; 27:792-802; PMID:23038274 ;  http://dx.doi.org/10.1038/leu.2012.284 79.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Curr Oncol Rep 2010; 12:358-65; PMID:20809224 ;  http://dx.doi.org/10.1007/s11912-010-0126-z 80.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Blood 2009; 113:3568-76;  PMID:19204327 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Mol Cell 2009; 36:326-39; PMID:19854140 ;  http://dx.doi.org/10.1016/j.molcel.2009.09.019 82.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Oncogene 2013; 32:3587-97;  PMID:22926520 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Blood 2012; 119:4499-511; PMID:22438257 ; http://dx.doi.org/10.1182/ blood-2011-02-336446 84.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Blood 2012; 119:4253-63;  PMID:22411871 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
PLoS One  2012; 7:e34050;  PMID:22807997 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Clin Cancer Res 2011; 17:3219-32;  PMID:21474579 ; http://dx.doi.org/10.1158/1078- 0432.CCR-11-0234 87.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Cancer Lett 2013; 332:237- 48; PMID:22261329 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
EMBO Mol Med  2010; 2:98-110;  PMID:20201032 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Blood 2011; 117:3409-20;  PMID:21220747 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Leukemia 2010; 24:1397-405;  PMID :20535152 ; http://dx.doi.org/10.1038/ leu.2010.131 91.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Clin Cancer Res  2012; 18:64-76;  PMID:22215907 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Biochim Biophys Acta 2012; 1823:648- 55; PMID:21856339 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Biochem Pharmacol 2012; 84:756-65;  PMID:22728920 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
ACS Chem  Biol 2012; 7:331-9; PMID:22047054 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Mol Pharmacol  2005; 67:1166-76;  PMID :15625278 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Leuk Lymphoma 2007; 48:2189-95;  PMID:17926180 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Leuk Res 2008; 32:1382-92; PMID:18394702 ;  http://dx.doi.org/10.1016/j.leukres.2008.02.018 100.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Oncogene 2007; 26:5468-76; PMID:17694087 ;  http://dx.doi.org/10.1038/sj.onc.1210614101.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
EMBO J 2003; 22:3411-20;  PMID:12840003 ; http://dx.doi.org/10.1093/emboj/ cdg315 103.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
J Mol Cell Biol 2012; 4:284-93; PMID:22493095 ; http://dx.doi.org/10.1093/ jmcb/mjs013 104.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Leuk Res 2011; 35:921- 31; PMID:21382639 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Mol Cancer Ther 2012; 11:2373-83;  PMID:22942377 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Leukemia 2010; 24:1412-21; PMID:20508617 ; http://dx.doi.org/10.1038/ leu.2010.114 107.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
FASEB J 2008; 22:1369-79;  PMID:18073335 ; http://dx.doi.org/10.1096/ fj.06-8050com 108.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Mol Oncol  2013; 7:693-703;  PMID:23548639 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Haematologica 2012;  97:1064-72;  PMID:22271894 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
PLoS One 2012; 7:e34912;  PMID:22523564 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Haematologica 2007; 92:145- 7; PMID:17296561 ; http://dx.doi.org/10.3324/ haematol.11187,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Arch Pathol  Lab Med 2013; 137:259-69;  PMID:23368869 ;  http://dx.doi.org/10.5858/arpa.2011-0597-RA 115.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Blood 2008; 112:946-56;  PMID:18684881 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Breast Cancer Res 2011; 13:220; PMID:22018398 ;  http://dx.doi.org/10.1186/bcr2921 117.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Chem Biol  2011; 18:314-23;  PMID:21439476 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Haematologica 2009; 94:1085-93;  PMID:19644140 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
J Med Chem 2009; 52:2265-79; PMID:19301902 ;  http://dx.doi.org/10.1021/jm800988r 122.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Anticancer Drugs 2010; 21:759-65; PMID:20613486 ; http://dx.doi.org/10.1097/ CAD.0b013e32833ccf25 123.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Genes Immun 2010; 11:599-608;  PMID:20535135 ; http://dx.doi.org/10.1038/ gene.2010.35 124.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Eur J Pharmacol 2012; 675:57-62; PMID:22173128 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Expert Opin Investig Drugs 2013;  22:103-15;  PMID:23127174 ; http://dx.doi.org/10.15 17/13543784.2013.740010 126.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Cancer Res 2009; 69:6941-50; PMID:19706776 ;  http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
J Biol Chem 2011; 286:5956-66; PMID:21135090 ;  http://dx.doi.org/10.1074/jbc.M110.182642128.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Blood 2008; 112:2463- 73; PMID:18579792 ; http://dx.doi.org/10.1182/ blood-2007-09-115477 129.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Invest New Drugs 2010; 28(Suppl 1):S50-7; PMID:21127942 ; http://dx.doi.org/10.1007/ s10637-010-9590-4 130.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Blood  2010; 115:4217-25;  PMID:20233974 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Mol Cell Biol 2008; 28:1688- 701; PMID:18180281 ; http://dx.doi.org/10.1128/ MCB.01154-06 132.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
Blood 2008; 112:2896-905;  PMID:18660379 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
J Pharmacol Exp Ther  2007; 322:1084-92;  PMID:17569822 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/jkst-2-e26102.PMC3876427.pdf
"JAK-STAT 2013; 2:e26141; http://dx.doi.org/10.4161/jkst.26141Redox regulation of Janus kinase The elephant in the room Roy J Duhé Department of Pharmacology and Toxicology and Department of Radiation Oncology; University of Mississippi Medical Center; Jackson, MS USA Keywords:  oxidative stress, redox regulation, cysteine modification, thiol chemistry, Janus kinases, cytokine biology The redox regulation of Janus kinases (JAKs) is a complex  subject.",Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Biochemistry 1964; 3:480- 2; PMID:14192894 ; http://dx.doi.org/10.1021/ bi00892a002 2.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Biochim Biophys  Acta 1977 ; 459:20-6; PMID:137745 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Curr Opin Chem Biol 2011 ;  15:129-36; PMID:21087893 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Biochemistry   2007 ; 46:14810 -8; PMID:18052197 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Biochemistry  2010 ;  49:7748 -55; PMID:20712299 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Blood   2006 ; 108:2770 -9; PMID:16804112 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Haematologica  2011 ; 96:845-53; PMID:21393331 ;  http://dx.doi.org/10.3324/haematol.2010.036350 12.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Proc Natl Acad Sci U S A 2009 ; 106:9414 -8;  PMID:19470474 ; http://dx.doi.org/10.1073/ pnas.0811761106 13.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Nature  2003 ;  423:773-7; PMID:12802339 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
J Cell Physiol 2007 ; 212:424- 31; PMID:17385713 ; http://dx.doi.org/10.1002/ jcp.21033 16.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
J Hepatol 2006 ; 45:271- 9; PMID :16595158 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Nucleic  Acids Res 2010 ; 38(Web Server issue ):W695-9 ;  PMID:20439314 ; http://dx.doi.org/10.1093/nar/ gkq313 18.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
FEBS J 2013 ; 280:1944 -65;  PMID:23461806 ; http://dx.doi.org/10.1111/ febs.12224 20.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Mol Cell Biol   2005 ; 25:6391 -403; PMID:16024778 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
J Biol Chem 1995 ; 270:25028 - 36; PMID:7559633 ; http://dx.doi.org/10.1074/ jbc.270.42.25028 23.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
J Neuroendocrinol   2008 ; 20:752-63; PMID:18601698 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Microbes Infect 2012 ; 14:238- 46; PMID:22094132 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Biochemistry   2004 ; 43:4272 -83; PMID :15065871 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Nature  1995 ; 375:247-50; PMID:7746328 ;  http://dx.doi.org/10.1038/375247a0 28.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
PLoS One  2010 ; 5:e15068 ;  PMID :21151926 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Growth Factors 2011 ;  29:245-52; PMID:21892841 ; http://dx.doi.org/10.3 109/08977194.2011.614949 31.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Oncogene  2011 ;  30:3502 -12; PMID:21423214 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Mol Cell Biochem  2002 ; 236:23-35; PMID:12190118 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Nature  2009 ; 461:819- 22; PMID:19783980 ; http://dx.doi.org/10.1038/ nature08448 35.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Cancer Discov   2012 ; 2:512-23; PMID:22684457 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Nature  2012 ; 489:155- 9; PMID:22820254 ; http://dx.doi.org/10.1038/ nature11303 37.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Nat Struct Mol Biol  2012 ; 19:754- 9; PMID:22820988 ; http://dx.doi.org/10.1038/ nsmb.2348 39.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Nat Chem Biol 2011 ; 8:57- 64; PMID :22158416 ; http://dx.doi.org/10.1038/ nchembio.736 40.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Antioxid Redox Signal  2011 ; 15:135-46; PMID:20812876 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Free Radic Biol Med  2007 ; 43:100-10; PMID:17561098 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
J Neurochem 2005 ; 92:1521-30; PMID :15748169 ;  http://dx.doi.org/10.1111/j.1471-4159.2004.02990.x 46.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Free Radic Biol Med 2006 ; 41:493- 502; PMID:16843830 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Toxicol Sci  2006 ;  94:129-38; PMID:16896058 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
PLoS One   2013 ; 8:e58764 ; PMID:23505558 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Int J Biochem Cell Biol  2012 ; 44:2106 -15; PMID:22939972 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Vascul Pharmacol   2005 ; 43:320-6; PMID:16257269 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Circ Res 2000 ;  87:1195 -201; PMID:11110778 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Cardiovasc  Res 2011 ; 91:171-9; PMID:21354995 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Diabetes  2005 ; 54:394-401; PMID :15677497 ;  http://dx.doi.org/10.2337/diabetes.54.2.394 59.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Cell Signal   2007 ; 19:600-9; PMID:17027227 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
PLoS One   2013 ; 8:e57941 ; PMID:23483946 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
J Biol Chem 2004 ;  279:34547 -52; PMID :15159394 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Vascul Pharmacol  2005 ; 43:327- 35; PMID:16269269 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Gastroenterology  2007 ; 133:1637 - 48; PMID:17983808 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
J Biol Chem 1999 ; 274:17580 - 6; PMID:10364193 ; http://dx.doi.org/10.1074/ jbc.274.25.17580 65.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Eur  J Immunol  2012 ; 42:2152 -64; PMID:22674013 ;  http://dx.doi.org/10.1002/eji.20114228966.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
J Biol Chem 1999 ; 274:33131 - 42; PMID:10551884 ; http://dx.doi.org/10.1074/ jbc.274.46.33131 67.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
PLoS One  2009 ; 4:e7707 ;  PMID:19888448 ; http://dx.doi.org/10.1371/ journal.pone.0007707 68.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Glia 2007 ; 55:1313 -24; PMID:17607690 ;  http://dx.doi.org/10.1002/glia.20542 71.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Free Radic Biol Med 2012 ; 52:539-55;  PMID:22080087 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Curr Med Chem 2012 ;  19:2504 -20; PMID:22489713 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Circulation  2003 ; 108:2034 -40;  PMID:14581381 ; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Free Radic Biol Med  2011 ; 51:978-92; PMID:21627987 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Am  J Physiol Heart Circ Physiol 2009 ; 297:H1545 - 56; PMID:19717737 ; http://dx.doi.org/10.1152/ ajpheart.00032.2009 79.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Circ Res 2010 ; 107:1058 - 70; PMID:21030723 ; http://dx.doi.org/10.1161/ CIRCRESAHA.110.223545 80.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Exp  Diabetes Res  2012 ; 2012 :703538 ; PMID:22110477 ;  http://dx.doi.org/10.1155/2012/703538 83.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
J Exp Med  2010 ; 207:2831 -42; PMID:21149549 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Am J Physiol Endocrinol Metab 2004 ;  287:E405 -13; PMID :15138153 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Endocrinology  2002 ; 143:1378 - 85; PMID:11897695 ; http://dx.doi.org/10.1210/ en.143.4.1378 86.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
J Surg Res  2012 ; 178:339-45; PMID:22883438 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Am J Physiol Renal Physiol  2006 ; 290:F762 -8; PMID:16527921 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
J Pathol  2007 ; 211:144- 56; PMID:17200946 ; http://dx.doi.org/10.1002/ path.2104 92.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Immunity   2012 ; 36:515-28; PMID:22520845 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Immunity  2012 ; 36:542-50;  PMID:22520847 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
J Leukoc Biol 2011 ; 89:873-91; PMID:21233414 ;  http://dx.doi.org/10.1189/jlb.1010550,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Nature  1995 ;  375:497-500; PMID:7539892 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Proc Natl Acad Sci U S A 1993 ; 90:7632 - 6; PMID:8395050 ; http://dx.doi.org/10.1073/ pnas.90.16.7632 101.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Proc Natl Acad Sci U S A  2005 ; 102:3756 -9; PMID:15738407 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Cytotherapy  2000 ; 2:25-37; PMID:12042052 ;  http://dx.doi.org/10.1080/146532400539026 105.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Proc Natl Acad Sci U S A 2008 ; 105:5111- 6; PMID:18364393 ; http://dx.doi.org/10.1073/ pnas.0712363105 106.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Oncogene  2000 ; 19:2474 -88;  PMID:10851046 ; http://dx.doi.org/10.1038/ sj.onc.1203527 107.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Curr Oncol Rep 2009 ; 11:117-24; PMID:19216843 ;  http://dx.doi.org/10.1007/s11912-009-0018-2 109.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Curr Med Chem  2010 ; 17:4551-8; PMID:21062251 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Clin  Cancer Res 2012 ; 18:3212 -7; PMID:22544377 ;  http://dx.doi.org/10.1158/1078-0432.CCR-12-0653 111.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Haematologica   2013 ; 98:404-8; PMID:22875628 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
PLoS One   2012 ; 7:e43437 ; PMID:22916261 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Free Radic Biol Med 2010 ; 49:1603 - 16; PMID:20840865 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Antioxid Redox Signal 2009 ; 11:1123 -37;  PMID:19018667 ; http://dx.doi.org/10.1089/ ars.2008.2302 115.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Br J Radiol  2009 ; 82:89-104; PMID:19168690 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Cancer Res 2004 ; 64:3599 -606; PMID :15150118 ;  http://dx.doi.org/10.1158/0008-5472.CAN-03-2999 118.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
PLoS One   2011 ; 6:e19861 ; PMID:21625473 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Proc Natl Acad Sci U S A 2004 ;  101:1714 -9; PMID:14755057 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
BMC  Med 2009 ; 7:68; PMID:19891767 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
J Clin Invest 2011 ; 121:2723 - 35; PMID:21633165 ; http://dx.doi.org/10.1172/ JCI44745 122.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Epigenetics   2011 ; 6:428-39; PMID:21266853 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Cell Stem Cell  2010 ; 7:150- 61; PMID:20682444 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
Blood  2006 ; 107:176-83; PMID:16174768 ;  http://dx.doi.org/10.1182/blood-2005-06-2413 126.,Non-OADS,/arxiv_data1/oa_pdf/f2/bc/jkst-2-e26141.PMC3876428.pdf
"JAK-STAT 2013; 2:e25530; http://dx.doi.org/10.4161/jkst.25530The intestinal mucosal immune system is challenged with  bacteria, viruses, and parasites, in addition to food and environmental antigens, that require dynamic immune  responsiveness for homeostasis.",Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Cell Mol Life Sci 2011; 68:3635-41; PMID:21947475; http://dx.doi.org/10.1007/s00018-011-0822-3 3.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
J Cell Biol  1989; 108:1687-95; PMID:2715173; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
J Clin Invest 1995; 95:603- 10; PMID:7860744; http://dx.doi.org/10.1172/ JCI117704 7.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Adv Exp Med Biol  1995; 371A:251-5; PMID:8525919; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
"J T rauma 1995; 39:44-51, discussion 51-2; PMID:7636909;  http://dx.doi.org/10.1097/00005373-199507000- 00006 9.",Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Arch Surg 1997; 132:1303- 9; PMID:9403534; http://dx.doi.org/10.1001/arch- surg.1997.01430360049009 10.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Science 2002; 296:1653- 5; PMID:12040185; http://dx.doi.org/10.1126/sci- ence.1071545,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Nat Rev Immunol 2002; 2:933-44;  PMID:12461566; http://dx.doi.org/10.1038/nri954 47.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Curr Opin Immunol 2006; 18:349-56; PMID:16616472;  http://dx.doi.org/10.1016/j.coi.2006.03.017 48.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Nature 2006; 441:231-4; PMID:16648837;  http://dx.doi.org/10.1038/nature04754 49.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Immunity 2006; 24:677- 88; PMID:16782025; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Semin Immunol  2007; 19:400-8; PMID:18166487; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
J Exp Med 1995; 181:1519- 26; PMID:7699333; http://dx.doi.org/10.1084/ jem.181.4.1519 52.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
J Exp Med 1994; 180:1955-60; PMID:7964471; http://dx.doi.org/10.1084/ jem.180.5.1955 53.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Immunity 1995; 2:223-38;  PMID:7697543; http://dx.doi.org/10.1016/1074- 7613(95)90047-0 55.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Proc Natl Acad Sci U S A 1995; 92:377- 81; PMID:7831294; http://dx.doi.org/10.1073/ pnas.92.2.377 56.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Science  1995; 270:794-7; PMID:7481767; http://dx.doi.org/10.1126/science.270.5237.794 57.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Genes Dev 2008; 22:711-21; PMID:18347089; http://dx.doi.org/10.1101/ gad.1643908 58.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Immunity  1999; 10:249-59; PMID:10072077; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Annu Rev Immunol 1989;  7:145-73; PMID:2523712; http://dx.doi.org/10.1146/ annurev.iy.07.040189.001045 32.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Immunol Today  2000; 21:479-83; PMID:11071525; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Annu Rev Immunol 2000;  18:451-94; PMID:10837066; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Immunity 1996; 4:471-81;  PMID:8630732; http://dx.doi.org/10.1016/S1074- 7613(00)80413-6 37.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Science  1991; 254:707-10; PMID:1948049; http://dx.doi.org/10.1126/science.1948049 39.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Nature 1993; 362:245-8; PMID:8384701; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Cytokine Growth Factor  Rev 2003; 14:361-8; PMID:12948519; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Nature 1996; 382:171-4;  PMID:8700208; http://dx.doi.org/10.1038/382171a0 44.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Nature 1996; 380:627-30; PMID:8602263;  http://dx.doi.org/10.1038/380627a0 45.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Immunity 1996; 4:313- 9; PMID:8624821; http://dx.doi.org/10.1016/S1074-7613(00)80439-212.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Gene 2002; 285:1-24;  PMID:12039028; http://dx.doi.org/10.1016/S0378- 1119(02)00398-0 13.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
J Cell Sci 2004; 117:1281- 3; PMID:15020666; http://dx.doi.org/10.1242/ jcs.00963 15.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Nat Rev Immunol 2006; 6:602-12; PMID:16868551;  http://dx.doi.org/10.1038/nri1885 16.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
J Biol Chem  2007; 282:20059-63; PMID:17502367; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Nat Rev Mol Cell Biol  2002; 3:651-62; PMID:12209125; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Am J Surg  2002; 183:390-8; PMID:11975926; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
JPEN J Parenter  Enteral Nutr 2007; 31:246-58; PMID:17463152;  http://dx.doi.org/10.1177/0148607107031003246 22.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Clin Nutr 1999; 18:337-44;  PMID:10634917; http://dx.doi.org/10.1016/S0261- 5614(99)80012-0 23.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Nature 1993; 366:695-8; PMID:7505053; http://dx.doi.org/10.1038/366695a0 24.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Cell 1993; 74:185-95; PMID:7687523;  http://dx.doi.org/10.1016/0092-8674(93)90305-A 25.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
T rends Immunol  2004; 25:570-7; PMID:15489184; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Crit Care Med  2003; 31:598-607; PMID:12576972; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Cell Mol Life Sci 2002; 59:156-70;  PMID:11846026; http://dx.doi.org/10.1007/s00018- 002-8412-z 83.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
J Immunol 2009; 182:4737-43; PMID:19342650;  http://dx.doi.org/10.4049/jimmunol.0801941 84.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Ann Surg 2013;  In press; PMID:23426341; http://dx.doi.org/10.1097/ SLA.0b013e318284f510.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Pediatr  Int 2010; 52:584-9; PMID:20030749; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
EMBO Mol Med 2012; 4:109- 24; PMID:22228679; http://dx.doi.org/10.1002/ emmm.201100192 87.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Inflamm Bowel Dis 2013; 19:512-25;  PMID:23429443; http://dx.doi.org/10.1097/ MIB.0b013e31828028ad 88.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Proc Natl Acad Sci U S A 1989; 86:10085-9; PMID:2513574; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
"Infect Dis Clin North Am 1999; 13:465-81, x;  PMID:10340178; http://dx.doi.org/10.1016/S0891- 5520(05)70086-6 72.",OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Biochimie 2010; 92:425-44;  PMID:20159032; http://dx.doi.org/10.1016/j.bio- chi.2010.02.009 73.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Nature 2007; 449:819- 26; PMID:17943118; http://dx.doi.org/10.1038/ nature06246 74.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Semin Immunol 2007; 19:1-2; PMID:22228983;  http://dx.doi.org/10.1016/j.smim.2007.02.001 75.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Cell 2004; 118:229-41;  PMID:15260992; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Fish Shellfish Immunol 2011; 31:10- 21; PMID:21272652; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Cell Div 2010; 5:14; PMID:20478049; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
J  Immunol 2010; 185:6921-9; PMID:20974983; http://dx.doi.org/10.4049/jimmunol.1000450 80.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Differentiation  2005; 73:36-44; PMID:15733066; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
J Crohns Colitis  2012; 6:425-34; PMID:22398066; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Inflamm Res 2001; 50:435-41;  PMID:11603847; http://dx.doi.org/10.1007/ PL00000267 62.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Eur J Immunol 1998; 28:1161- 71; PMID:9565355; http://dx.doi.org/10.1002/ (SICI)1521-4141(199804)28:04<1161::AID- IMMU1161>3.0.CO;2-S 63.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Immunol Rev 2005; 206:83-99; PMID:16048543; http://dx.doi.org/10.1111/j.0105- 2896.2005.00278.x 65.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
T rends Immunol  2004; 25:150-7; PMID:15036043; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Immunol Rev 2005; 206:83-99;  PMID:16048543; http://dx.doi.org/10.1111/j.0105- 2896.2005.00278.x 68.,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Ann Surg 2013; In press;  PMID:23160152; http://dx.doi.org/10.1097/ SLA.0b013e318277ea9e.,OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
Nutr Clin Pract 1992;  7:100-8; PMID:1289681; http://dx.doi.org/10.1177/0115426592007003100,Non-OADS,/arxiv_data1/oa_pdf/82/8a/jkst-2-e25530.PMC3876429.pdf
"JAK-STAT 2013; 2:e25301; http://dx.doi.org/10.4161/jkst.25301Lung inflammation has many etiologies, including diseases  of Th2-type immunity, such as asthma and anti-parasitic responses.",OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
"J Allergy Clin Immunol  2003; 111:227-42, quiz 243; PMID:12589338; http://dx.doi.org/10.1067/mai.2003.139 3.",Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Oncogene 2000; 19:2577-84;  PMID:10851056; http://dx.doi.org/10.1038/ sj.onc.1203485 4.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunol Res 2011; 50:87-96;  PMID:21442426; http://dx.doi.org/10.1007/s12026- 011-8205-2 5.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
"J Allergy Clin Immunol 2012; 130:829-42, quiz  843-4; PMID:22951057; http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Curr Opin Immunol  2007; 19:676-80; PMID:17720466; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Exp Med 2001; 193:1087- 96; PMID:11342593; http://dx.doi.org/10.1084/ jem.193.9.1087 8.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Exp Med 1998; 187:939- 48; PMID:9500796; http://dx.doi.org/10.1084/ jem.187.6.939 9.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Exp Med 1998; 187:1537- 42; PMID:9565645; http://dx.doi.org/10.1084/ jem.187.9.1537 10.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunol Rev 2004; 201:139-55;  PMID:15361238; http://dx.doi.org/10.1111/j.0105-2896.2004.00192.x 11.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Annu Rev Immunol 1999; 17:701-38; PMID:10358772; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Biochim Biophys Acta 2002; 1592:237-50; PMID:12421669; http://dx.doi.org/10.1016/S0167- 4889(02)00318-X 13.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Eur Respir Rev  2010; 19:46-54; PMID:20956165; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Am J Physiol Lung Cell Mol Physiol 2013; 304:L112- 24; PMID:23125252; http://dx.doi.org/10.1152/ ajplung.00101.2012 16.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Nat Med 2006; 12:99-106;  PMID:16327802; http://dx.doi.org/10.1038/nm1332 17.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunity 1996; 4:113-21; PMID:8624802; http://dx.doi.org/10.1016/S1074-7613(00)80676-7 18.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Proc Natl Acad Sci U S A 1995; 92:7971-5; PMID:7544011; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunity 1996; 4:123-32;  PMID:8624803; http://dx.doi.org/10.1016/S1074- 7613(00)80677-9 20.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Cytokine Growth Factor  Rev 2006; 17:173-88; PMID:16540365; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Am J Respir Cell Mol Biol  2001; 25:474-85; PMID:11694453; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Immunity 1996; 4:313- 9; PMID:8624821; http://dx.doi.org/10.1016/S1074-7613(00)80439-2 23.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Nature 1996; 380:627-30; PMID:8602263; http://dx.doi.org/10.1038/380627a024.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Nature 1996; 380:630-3; PMID:8602264;  http://dx.doi.org/10.1038/380630a0 25.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Nat Rev Immunol 2011; 11:750-61;  PMID:22025054; http://dx.doi.org/10.1038/nri3088 26.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Pharmacol Res 2010; 61:466- 72; PMID:20006706; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Am J Respir Cell Mol Biol 2009; 40:159-67; PMID:18688040; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Am J Respir  Crit Care Med 2002; 165:1161-71; PMID:11956062;  http://dx.doi.org/10.1164/ajrccm.165.8.2107158 32.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Eur J Immunol 2012; 42:2827-33; PMID:23041833;  http://dx.doi.org/10.1002/eji.201242433 33.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Protein Cell 2013; 4:27-39;  PMID:22996173; http://dx.doi.org/10.1007/s13238- 012-2063-0 64.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Cell 2011; 147:436- 46; PMID:22000020; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Clin Invest 2012; 122:2741- 8; PMID:22850884; http://dx.doi.org/10.1172/ JCI60325 66.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Am J Pathol  2006; 169:2117-26; PMID:17148674; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Am J Respir Cell Mol Biol  2006; 35:337-46; PMID:16645178; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Clin Invest 1998; 101:2129-39; PMID:9593769; http://dx.doi.org/10.1172/ JCI741 69.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Biochem Biophys  Res Commun 2001; 288:747-51; PMID:11688970;  http://dx.doi.org/10.1006/bbrc.2001.5853 71.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Am J Pathol 2004; 164:1315-26;  PMID:15039219; http://dx.doi.org/10.1016/S0002- 9440(10)63218-X 72.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
J Immunol 2010; 185:5539-48; PMID:20889544; http://dx.doi.org/10.4049/jimmunol.0904021 73.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
Clin Exp Allergy  2003; 33:1711-6; PMID:14656359; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d5/36/jkst-2-e25301.PMC3876430.pdf
